{ "meta": { "tracker_site_url": "https://psilocybin-research.com", "publication_tracker_url": "https://psilocybin-research.com/", "generated_at_utc": "2026-07-11 21:32:09", "record_count": 1135, "schema_variant": "rights-safe-core-v1", "text_redistribution": "Source-derived abstracts, descriptions, keywords, and unrestricted payload text are not redistributed." }, "papers": [ { "id": 3502, "title": "PSilocybin Microdose for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site Phase 3 Double-blind, Placebo-controlled, Parallel-arm Clinical Trial", "authors": "Bruyère Health Research Institute.", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-09", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07063862", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Receptor Pharmacology,Default Mode Network,Aging,Microdosing,Clinical Trial,Randomized Controlled Trial,Observational Study,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-11 01:24:11", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07063862", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07063862", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07063862", "source_url": "https://clinicaltrials.gov/study/NCT07063862", "doi": "", "pmid": "", "publication_date": "2026-07-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3467, "title": "PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL): A Multi-site, Open-label, Single Arm Phase I/II Proof-of-concept, Dose-finding, and Feasibility Clinical Trial", "authors": "Ottawa Hospital Research Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-09", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04754061", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Aging,Microdosing,Wellbeing,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-11 01:24:10", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04754061", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04754061", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04754061", "source_url": "https://clinicaltrials.gov/study/NCT04754061", "doi": "", "pmid": "", "publication_date": "2026-07-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5680, "title": "Psychedelics stores, their regulation and public health: knowledge, perceptions, attitudes and opinions of Canadians.", "authors": "Gagnon F, Philibert A, Carignan B, Labonté E, Dufresne Y.", "journal": null, "publication_date": "2026-07-08", "publication_year": 2026, "doi": "10.1016/j.drugpo.2026.105427", "pubmed_id": "42424668", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.drugpo.2026.105427", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-10 01:20:03", "last_checked": "2026-07-11 01:20:09", "bibtex": null, "source_record_id": "PMID:42424668", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.drugpo.2026.105427", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42424668", "source_url": "https://doi.org/10.1016/j.drugpo.2026.105427", "doi": "10.1016/j.drugpo.2026.105427", "pmid": "42424668", "publication_date": "2026-07-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3610, "title": "Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression: A Randomized Phase II Clinical Trial Comparing One Versus Two Psychedelic Doses of Psilocybin (PSI-1V2)", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-08", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06341426", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-11 01:24:11", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06341426", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06341426", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06341426", "source_url": "https://clinicaltrials.gov/study/NCT06341426", "doi": "", "pmid": "", "publication_date": "2026-07-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5676, "title": "Psilocybin therapy for adult females with anorexia nervosa: pilot study.", "authors": "Douglass HM, Spriggs MJ, Godfrey K, Danby JL, de Magalhaes FJC, Macdonald L, Alderton KL, Archer S, Ahmad K, Martell J, Frias JT, Sawicka G, Read T, Blemings A, Lafrance A, Nicholls D, Erritzoe D, Park RJ, Nutt DJ, Carhart-Harris RL.", "journal": "The British Journal of Psychiatry", "publication_date": "2026-07-07", "publication_year": 2026, "doi": "10.1192/bjp.2026.10687", "pubmed_id": "42414058", "openalex_id": "https://openalex.org/W7167587921", "source_url": "https://doi.org/10.1192/bjp.2026.10687", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Headache / Migraine,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-08 01:20:22", "last_checked": "2026-07-11 01:20:14", "bibtex": null, "source_record_id": "PMID:42414058", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1192/bjp.2026.10687", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42414058", "source_url": "https://doi.org/10.1192/bjp.2026.10687", "doi": "10.1192/bjp.2026.10687", "pmid": "42414058", "publication_date": "2026-07-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3652, "title": "Phase I Study of the Safety and Adjunctive Effects of Psilocybin in Adults With Opioid Use Disorder Maintained on a Buprenorphine/Naloxone Formulation", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04161066", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Clinical Trial,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-11 01:24:10", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04161066", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04161066", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04161066", "source_url": "https://clinicaltrials.gov/study/NCT04161066", "doi": "", "pmid": "", "publication_date": "2026-07-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3495, "title": "A Multicenter Phase 1 Safety and Tolerability Trial of Psilocybin in Healthy Older Adults", "authors": "University of Colorado, Denver", "journal": "ClinicalTrials.gov", "publication_date": "2026-07-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07516405", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Aging,Wellbeing,Clinical Trial,Observational Study,Healthy Volunteers,Older Adults,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-11 01:24:11", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07516405", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07516405", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07516405", "source_url": "https://clinicaltrials.gov/study/NCT07516405", "doi": "", "pmid": "", "publication_date": "2026-07-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5672, "title": "Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development", "authors": "Enriquez-Geppert Stefanie, Bevers Lisa, Rosander Arvid, Fodran Peter, Polito Vince", "journal": "Biomolecules", "publication_date": "2026-07-02", "publication_year": 2026, "doi": "10.3390/biom16070983", "pubmed_id": null, "openalex_id": "https://openalex.org/W7167239267", "source_url": "https://doi.org/10.3390/biom16070983", "substance_tags": "psilocybin", "topic_tags": "Review Article,Animal Study,Safety", "study_type": "Review Article", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-05 01:20:15", "last_checked": "2026-07-10 01:20:13", "bibtex": null, "source_record_id": "DOI:10.3390/biom16070983", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.3390/biom16070983", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.3390/biom16070983", "source_url": "https://doi.org/10.3390/biom16070983", "doi": "10.3390/biom16070983", "pmid": "", "publication_date": "2026-07-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3982, "title": "Policy Considerations for Psychedelics in Research and Medicine - What’s Next on the Schedule?", "authors": "Matthew A. Boehm, Oriana Mayorga", "journal": "Journal of Science Policy & Governance", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.38126/jspg280103", "pubmed_id": null, "openalex_id": "https://openalex.org/W7167073096", "source_url": "https://doi.org/10.38126/jspg280103", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 01:20:30", "last_checked": "2026-07-09 01:20:16", "bibtex": null, "source_record_id": "DOI:10.38126/jspg280103", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.38126/jspg280103", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.38126/jspg280103", "source_url": "https://doi.org/10.38126/jspg280103", "doi": "10.38126/jspg280103", "pmid": "", "publication_date": "2026-07-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3976, "title": "Psilocybin as a Transdiagnostic Treatment for Eating Disorders and Comorbid Psychopathology: Implications for Clinical Nosology and Research Directions.", "authors": "Koning E, Richard J, Keshen A.", "journal": "International Journal of Eating Disorders", "publication_date": "2026-07-01", "publication_year": 2026, "doi": "10.1002/eat.70164", "pubmed_id": "42393007", "openalex_id": "https://openalex.org/W7167014213", "source_url": "https://doi.org/10.1002/eat.70164", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-04 01:20:05", "last_checked": "2026-07-09 01:20:16", "bibtex": null, "source_record_id": "PMID:42393007", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/eat.70164", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42393007", "source_url": "https://doi.org/10.1002/eat.70164", "doi": "10.1002/eat.70164", "pmid": "42393007", "publication_date": "2026-07-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3662, "title": "Efficacy in Relapse Prevention: Psilocybin in Alcohol Use Disorder With Depressive Symptoms", "authors": "Centre Hospitalier Universitaire de Nīmes", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07638553", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-07 01:23:04", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07638553", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07638553", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07638553", "source_url": "https://clinicaltrials.gov/study/NCT07638553", "doi": "", "pmid": "", "publication_date": "2026-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3547, "title": "A Phase 2, Open-Label Study Investigating the Safety and Efficacy of Psilocybin-Assisted Therapy for Sexual Assault-Related Posttraumatic Stress Disorder (PTSD)", "authors": "Sunstone Medical", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06902974", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-07 01:23:04", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06902974", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06902974", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06902974", "source_url": "https://clinicaltrials.gov/study/NCT06902974", "doi": "", "pmid": "", "publication_date": "2026-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 107, "title": "Implementing psilocybin-assisted therapy in palliative care settings: A survey of stakeholders.", "authors": "Plourde L, Chang SL, Nguyen O, Garel N, Farzin H, Stephan JF, Fallu JS, Dorval M, P3A Research Group", "journal": "Palliative medicine", "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1177/02692163261446141", "pubmed_id": "42154482", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42154482/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-08 01:20:05", "bibtex": null, "source_record_id": "PMID:42154482", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42154482/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42154482", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42154482/", "doi": "10.1177/02692163261446141", "pmid": "42154482", "publication_date": "2026-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 9, "title": "Psychedelics as a potential treatment for borderline personality disorder: A narrative review.", "authors": "Artna E, Sandhu G, Chisamore N, Lipsitz O, Kaczmarek ES, Johnson DE, Rosenblat JD, Sediqzadah S", "journal": "Psychiatry research", "publication_date": "2026-06-30", "publication_year": 2026, "doi": "10.1016/j.psychres.2026.117152", "pubmed_id": "41955843", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41955843/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Personality Change,Review Article,Safety,Toxicity", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-08 01:20:05", "bibtex": null, "source_record_id": "PMID:41955843", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41955843/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41955843", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41955843/", "doi": "10.1016/j.psychres.2026.117152", "pmid": "41955843", "publication_date": "2026-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 303, "title": "Study Protocol for \"Exploring the safety and therapeutic potential of psilocybin in the treatment of anorexia nervosa in adolescents and young adults\".", "authors": "Sjöström D, Schau Rybäck O, Claesdotter Knutsson E, Kajonius P, Jensen Sondén O, Carlbring P, Björkstrand J, Movahed Rad P.", "journal": "PLoS ONE", "publication_date": "2026-06-29", "publication_year": 2026, "doi": "10.1371/journal.pone.0352246", "pubmed_id": "42378255", "openalex_id": "https://openalex.org/W7166779507", "source_url": "https://doi.org/10.1371/journal.pone.0352246", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Brain Imaging,Aging,Wellbeing,Personality Change,Clinical Trial,Randomized Controlled Trial,Review Article,Adolescents,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:03", "last_checked": "2026-07-07 01:20:41", "bibtex": null, "source_record_id": "PMID:42378255", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0352246", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42378255", "source_url": "https://doi.org/10.1371/journal.pone.0352246", "doi": "10.1371/journal.pone.0352246", "pmid": "42378255", "publication_date": "2026-06-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3979, "title": "Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development", "authors": "Stefanie Enriquez Geppert, Lisa Bevers, Arvid Rosander, Peter Fodran, Vince Polito", "journal": "University of Groningen research database (University of Groningen / Centre for Information Technology)", "publication_date": "2026-06-28", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7167168218", "source_url": "https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 01:20:27", "last_checked": "2026-07-06 01:20:37", "bibtex": null, "source_record_id": "https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b", "source_url": "https://research.rug.nl/en/publications/370a82bd-d8db-4a02-b644-bf0c9131680b", "doi": "", "pmid": "", "publication_date": "2026-06-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3561, "title": "The Efficacy of Psilocybin Therapy for Depression in Parkinson's Disease", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-28", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07610369", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-05 01:22:40", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07610369", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07610369", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07610369", "source_url": "https://clinicaltrials.gov/study/NCT07610369", "doi": "", "pmid": "", "publication_date": "2026-06-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 25, "title": "Classical psychedelic microdosing, mood, and cognitive function: An umbrella review with narrative synthesis.", "authors": "Özaydın Y, Canlan Özaydın B.", "journal": "Journal of Psychopharmacology", "publication_date": "2026-06-27", "publication_year": 2026, "doi": "10.1177/02698811261456196", "pubmed_id": "42365488", "openalex_id": "https://openalex.org/W7166465028", "source_url": "https://doi.org/10.1177/02698811261456196", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Receptor Pharmacology,Microdosing,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-05 01:20:22", "bibtex": null, "source_record_id": "PMID:42365488", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811261456196", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42365488", "source_url": "https://doi.org/10.1177/02698811261456196", "doi": "10.1177/02698811261456196", "pmid": "42365488", "publication_date": "2026-06-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3621, "title": "Psilocybin-Assisted Massed Cognitive Processing Therapy for Chronic Posttraumatic Stress Disorder: An Open-label Trial", "authors": "Unity Health Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-25", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06386003", "substance_tags": "psilocybin", "topic_tags": "PTSD,Healthcare Workers,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-02 23:06:03", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06386003", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06386003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06386003", "source_url": "https://clinicaltrials.gov/study/NCT06386003", "doi": "", "pmid": "", "publication_date": "2026-06-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3522, "title": "Psilocybin-Assisted Therapy for Physician Well-Being and Burnout: Feasibility, Safety, Clinical Effectiveness and Biomarkers of Response [PAT-B (Psilocybin-Assisted Therapy for Physician Well-Being and Burnout)]", "authors": "University of California, San Diego", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-25", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06814522", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Biomarkers,Wellbeing,Emotional Processing,Healthcare Workers,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-02 23:06:03", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06814522", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06814522", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06814522", "source_url": "https://clinicaltrials.gov/study/NCT06814522", "doi": "", "pmid": "", "publication_date": "2026-06-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3595, "title": "Acute Effects of MDMA Co-administration on the Response to Psilocybin in Healthy Subjects", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-24", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06884514", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Consciousness,Wellbeing,Personality Change,Emotional Processing,Safety", "study_type": "Qualitative Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 23:13:10", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06884514", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06884514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06884514", "source_url": "https://clinicaltrials.gov/study/NCT06884514", "doi": "", "pmid": "", "publication_date": "2026-06-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 30, "title": "The intersection between psychedelics and schizophrenia spectrum disorders: Reevaluating risk and therapeutic potential.", "authors": "Brar PS, Price RB, Ross S, Tofighi B, Sarpal DK", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-06-24", "publication_year": 2026, "doi": "10.1177/02698811261456191", "pubmed_id": "42345450", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42345450/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-02 23:03:18", "bibtex": null, "source_record_id": "PMID:42345450", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42345450/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42345450", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42345450/", "doi": "10.1177/02698811261456191", "pmid": "42345450", "publication_date": "2026-06-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3684, "title": "TRIP - TReatment to Improve Depression and/or Anxiety Using Psilocybin-Assisted Psychotherapy in Patients With Advanced Cancer on Maintenance Therapy", "authors": "M.D. Anderson Cancer Center", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06200155", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Wellbeing,Mystical Experience,Healthcare Workers,Safety,Inflammation,Immune Function", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06200155", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06200155", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06200155", "source_url": "https://clinicaltrials.gov/study/NCT06200155", "doi": "", "pmid": "", "publication_date": "2026-06-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3674, "title": "TRIPS - Treatment to Improve Depression and/or Anxiety Using Psilocybin-assisted Psychotherapy in Cancer Survivors", "authors": "M.D. Anderson Cancer Center", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-23", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06801041", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Wellbeing,Mystical Experience,Healthcare Workers,Safety,Inflammation,Immune Function", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06801041", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06801041", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06801041", "source_url": "https://clinicaltrials.gov/study/NCT06801041", "doi": "", "pmid": "", "publication_date": "2026-06-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3987, "title": "Psychedelics and autism spectrum disorder: Mechanistic insights, translational evidence and ethical challenges", "authors": "Júlio César Claudino dos Santos, Sofia Januário Bolan, Guilherme Lodetti da Silva, Germano Lapa Viana, Eduardo Pacheco Rico, Cinara Ludvig Gonçalves", "journal": "Journal of Psychiatric Research", "publication_date": "2026-06-22", "publication_year": 2026, "doi": "10.1016/j.jpsychires.2026.06.035", "pubmed_id": "42385294", "openalex_id": "https://openalex.org/W7165638399", "source_url": "https://doi.org/10.1016/j.jpsychires.2026.06.035", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Animal Study,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:34", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42385294", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.jpsychires.2026.06.035", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42385294", "source_url": "https://doi.org/10.1016/j.jpsychires.2026.06.035", "doi": "10.1016/j.jpsychires.2026.06.035", "pmid": "42385294", "publication_date": "2026-06-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3705, "title": "Effects of Psilocybin Microdosing on Cognition, Mood and Quality of Life: A Pilot Study", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07449351", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Aging,Longevity,Microdosing,Wellbeing,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07449351", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07449351", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07449351", "source_url": "https://clinicaltrials.gov/study/NCT07449351", "doi": "", "pmid": "", "publication_date": "2026-06-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3650, "title": "Psilocybin-assisted Existential, Attachment and Relational (PEARL) Therapy for Caregivers of Patients With Advanced Cancer: A Phase II Open-Label Trial", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07048743", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Spirituality,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07048743", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07048743", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07048743", "source_url": "https://clinicaltrials.gov/study/NCT07048743", "doi": "", "pmid": "", "publication_date": "2026-06-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 33, "title": "Cardiovascular effects associated with acute recreational drug toxicity presentations to the emergency department: a European drug emergencies network (Euro-DEN plus) study.", "authors": "van den Busken WJ, Dines AM, Eyer F, Heyerdahl F, Hovda KE, Liechti ME, Miró Ò, Vallersnes OM, Wood DM, Yates C, Dargan PI, (on behalf of the Euro-DEN Plus Research Group), Gresnigt FMJ, Euro-DEN Plus Research Group", "journal": "Clinical toxicology (Philadelphia, Pa.)", "publication_date": "2026-06-22", "publication_year": 2026, "doi": "10.1080/15563650.2026.2669671", "pubmed_id": "42334445", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42334445/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Mechanism of Action,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:20:34", "bibtex": null, "source_record_id": "PMID:42334445", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42334445/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42334445", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42334445/", "doi": "10.1080/15563650.2026.2669671", "pmid": "42334445", "publication_date": "2026-06-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5685, "title": "Synthesis and Biological Evaluation of 4-Bromo-N,N-dimethyltryptamine (4-Br-DMT): A Synthetic Building Block for Future Analog Development.", "authors": "Bray E, Glatfelter GC, Maitland AD, Gonzalez NR, Walther D, Yacoub J, Baumann MH, von Salm JL.", "journal": null, "publication_date": "2026-06-21", "publication_year": 2026, "doi": "10.1021/acsomega.6c02996", "pubmed_id": "42428867", "openalex_id": null, "source_url": "https://doi.org/10.1021/acsomega.6c02996", "substance_tags": "psilocin", "topic_tags": "Animal Study,Safety", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-11 01:20:04", "last_checked": "2026-07-11 19:28:10", "bibtex": null, "source_record_id": "PMID:42428867", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsomega.6c02996", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42428867", "source_url": "https://doi.org/10.1021/acsomega.6c02996", "doi": "10.1021/acsomega.6c02996", "pmid": "42428867", "publication_date": "2026-06-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3574, "title": "Low-Dose Psilocybin Therapy for Palliative Care Patients With Chronic Cancer Pain Requiring Opioids", "authors": "Roswell Park Cancer Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06827054", "substance_tags": "psilocybin", "topic_tags": "Addiction,End-of-Life Distress,Chronic Pain,Brain Imaging,Mechanism of Action,Aging,Spirituality,Clinical Trial,Cancer Patients,Safety,Toxicity,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06827054", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06827054", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06827054", "source_url": "https://clinicaltrials.gov/study/NCT06827054", "doi": "", "pmid": "", "publication_date": "2026-06-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3471, "title": "Psilocybin for PTSD With or Without Psychotherapy: A Pilot Study of Safety and Efficacy", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06407635", "substance_tags": "psilocybin", "topic_tags": "PTSD,Receptor Pharmacology,Consciousness,Wellbeing,Mystical Experience,Randomized Controlled Trial,Healthcare Workers,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06407635", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06407635", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06407635", "source_url": "https://clinicaltrials.gov/study/NCT06407635", "doi": "", "pmid": "", "publication_date": "2026-06-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3460, "title": "Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) Therapy for Patients With Advanced Cancer: A Phase II Open-Label Trial", "authors": "University Health Network, Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06416085", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06416085", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06416085", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06416085", "source_url": "https://clinicaltrials.gov/study/NCT06416085", "doi": "", "pmid": "", "publication_date": "2026-06-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3988, "title": "Psychedelics and related compounds in cluster headache and migraine: a systematic review and meta-analysis v1", "authors": "Camille Racca, Cécilie Cordier", "journal": null, "publication_date": "2026-06-20", "publication_year": 2026, "doi": "10.17504/protocols.io.j8nlk7ey6g5r/v1", "pubmed_id": null, "openalex_id": "https://openalex.org/W7165566978", "source_url": "https://doi.org/10.17504/protocols.io.j8nlk7ey6g5r/v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Headache / Migraine,Meta-Analysis,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:34", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.17504/protocols.io.j8nlk7ey6g5r/v1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17504/protocols.io.j8nlk7ey6g5r/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17504/protocols.io.j8nlk7ey6g5r/v1", "source_url": "https://doi.org/10.17504/protocols.io.j8nlk7ey6g5r/v1", "doi": "10.17504/protocols.io.j8nlk7ey6g5r/v1", "pmid": "", "publication_date": "2026-06-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3990, "title": "Beyond Psychedelic Microdosing: Therapeutic Potential, Neuropharmacology, and Safety Considerations in Low-Dose Psychoactive Use", "authors": "Eric P. Rubenstein", "journal": "Journal of Advances in Developmental Research", "publication_date": "2026-06-17", "publication_year": 2026, "doi": "10.71097/ijaidr.v17.i1.1997", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166450540", "source_url": "https://doi.org/10.71097/ijaidr.v17.i1.1997", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Microdosing,Emotional Processing,Creativity,Spirituality,Psychological Flexibility,Review Article,Safety,Toxicity,Drug Interactions", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 06:34:35", "bibtex": null, "source_record_id": "DOI:10.71097/ijaidr.v17.i1.1997", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.71097/ijaidr.v17.i1.1997", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.71097/ijaidr.v17.i1.1997", "source_url": "https://doi.org/10.71097/ijaidr.v17.i1.1997", "doi": "10.71097/ijaidr.v17.i1.1997", "pmid": "", "publication_date": "2026-06-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1923, "title": "Psilocybin-assisted therapy in treatment-resistant depression: rapid remission, uncertain durability, and the next phase of clinical evidence", "authors": "Astrit Sabani, Adnan Khatak", "journal": "Annals of Medicine and Surgery", "publication_date": "2026-06-17", "publication_year": 2026, "doi": "10.1097/ms9.0000000000005244", "pubmed_id": null, "openalex_id": "https://openalex.org/W7165127045", "source_url": "https://doi.org/10.1097/ms9.0000000000005244", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1097/ms9.0000000000005244", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/ms9.0000000000005244", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/ms9.0000000000005244", "source_url": "https://doi.org/10.1097/ms9.0000000000005244", "doi": "10.1097/ms9.0000000000005244", "pmid": "", "publication_date": "2026-06-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 39, "title": "DESI-MSI-Based Multi-Organ Distribution Mapping of Psilocin in Zebrafish", "authors": "Mengxuan Dong, Yi Zhang, Manzhu Cao, Tong Shi, Liqin Li, Xingxing Zong, Chen Wang", "journal": "Molecules", "publication_date": "2026-06-17", "publication_year": 2026, "doi": "10.3390/molecules31122143", "pubmed_id": "42357539", "openalex_id": "https://openalex.org/W7165199227", "source_url": "https://doi.org/10.3390/molecules31122143", "substance_tags": "psilocybin,psilocin", "topic_tags": "Brain Imaging,Aging,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42357539", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/molecules31122143", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42357539", "source_url": "https://doi.org/10.3390/molecules31122143", "doi": "10.3390/molecules31122143", "pmid": "42357539", "publication_date": "2026-06-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3993, "title": "“I even saw four deer grazing”: online-offline entanglements in the psilocybin pluriverse", "authors": "Michał Wanke, Paweł Matuszewski, Piotr Siuda", "journal": null, "publication_date": "2026-06-16", "publication_year": 2026, "doi": "10.31235/osf.io/tk4bv_v1", "pubmed_id": null, "openalex_id": "https://openalex.org/W7165030356", "source_url": "https://doi.org/10.31235/osf.io/tk4bv_v1", "substance_tags": "psilocybin", "topic_tags": "Aging,Safety,Toxicity", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.31235/osf.io/tk4bv_v1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31235/osf.io/tk4bv_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31235/osf.io/tk4bv_v1", "source_url": "https://doi.org/10.31235/osf.io/tk4bv_v1", "doi": "10.31235/osf.io/tk4bv_v1", "pmid": "", "publication_date": "2026-06-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1924, "title": "Community engagement as a foundation for implementation research for group psilocybin assisted therapy in New Mexico", "authors": "Lawrence Leeman, Maya Armstrong, Dara Menashi, Hanifa Nayo-Washington, Elliot Marseille, Janus Herrera, Crystal Romero, Janet Page-Reeves", "journal": "Frontiers in Public Health", "publication_date": "2026-06-16", "publication_year": 2026, "doi": "10.3389/fpubh.2026.1845943", "pubmed_id": null, "openalex_id": "https://openalex.org/W7165032301", "source_url": "https://doi.org/10.3389/fpubh.2026.1845943", "substance_tags": "psilocybin", "topic_tags": "PTSD,Chronic Pain,Aging,Clinical Trial,Veterans,Healthcare Workers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.3389/fpubh.2026.1845943", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpubh.2026.1845943", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3389/fpubh.2026.1845943", "source_url": "https://doi.org/10.3389/fpubh.2026.1845943", "doi": "10.3389/fpubh.2026.1845943", "pmid": "", "publication_date": "2026-06-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3996, "title": "Dextromethorphan Beyond the Cough: Exploring Its Psychedelic Potential: A Systematic Review", "authors": "Edward P. Hackett, Aditi Chaudhri -, Linda Hasman, Rajbala Thakur, Michael Scott, Robert H. Dworkin", "journal": "CNS Drugs", "publication_date": "2026-06-14", "publication_year": 2026, "doi": "10.1007/s40263-026-01305-9", "pubmed_id": "42295696", "openalex_id": "https://openalex.org/W7164826955", "source_url": "https://doi.org/10.1007/s40263-026-01305-9", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mystical Experience,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Case Report,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 06:34:35", "bibtex": null, "source_record_id": "PMID:42295696", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s40263-026-01305-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42295696", "source_url": "https://doi.org/10.1007/s40263-026-01305-9", "doi": "10.1007/s40263-026-01305-9", "pmid": "42295696", "publication_date": "2026-06-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3440, "title": "Psilocybin-Assisted Psychotherapy for the Treatment of Severe Alcohol Use Disorder: A Double-Blind, Dose-Comparison Concurrent Control Randomized Trial", "authors": "Brigham and Women's Hospital", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-14", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07296094", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07296094", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07296094", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07296094", "source_url": "https://clinicaltrials.gov/study/NCT07296094", "doi": "", "pmid": "", "publication_date": "2026-06-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1927, "title": "Psilocybin and Mental Health Outcomes: Scoping Review with ☸SAIMSARA", "authors": "SAIMSARA", "journal": "SAIMSARA Journal", "publication_date": "2026-06-14", "publication_year": 2026, "doi": "10.62487/saimsara7a54f680", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164845889", "source_url": "https://doi.org/10.62487/saimsara7a54f680", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Clinical Trial,Review Article,Observational Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.62487/saimsara7a54f680", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.62487/saimsara7a54f680", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.62487/saimsara7a54f680", "source_url": "https://doi.org/10.62487/saimsara7a54f680", "doi": "10.62487/saimsara7a54f680", "pmid": "", "publication_date": "2026-06-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1926, "title": "Efficacy of Psilocybin-Assisted Therapy in Major Depressive Disorder: A Systematic Review and Meta-Analysis", "authors": "Angel Labra-Lorenzana, Dania Nimbe Lima Sanchez, Christian Alejandro Delaflor-Wagner, Diana Martínez-Hernández, Christian Ramos-Jiménez, Christian Gabriel Toledo-Lozano", "journal": "Psychiatry International", "publication_date": "2026-06-14", "publication_year": 2026, "doi": "10.3390/psychiatryint7030137", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164820747", "source_url": "https://doi.org/10.3390/psychiatryint7030137", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.3390/psychiatryint7030137", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychiatryint7030137", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychiatryint7030137", "source_url": "https://doi.org/10.3390/psychiatryint7030137", "doi": "10.3390/psychiatryint7030137", "pmid": "", "publication_date": "2026-06-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 51, "title": "Balancing safety and access in Oregon’s psilocybin services", "authors": "Katherine Cheung, Caleigh Propes, David B. Yaden", "journal": "International Journal of Drug Policy", "publication_date": "2026-06-12", "publication_year": 2026, "doi": "10.1016/j.drugpo.2026.105384", "pubmed_id": "42288041", "openalex_id": "https://openalex.org/W7164654902", "source_url": "https://doi.org/10.1016/j.drugpo.2026.105384", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42288041", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42288041", "source_url": "https://doi.org/10.1016/j.drugpo.2026.105384", "doi": "10.1016/j.drugpo.2026.105384", "pmid": "42288041", "publication_date": "2026-06-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 49, "title": "Barriers and Facilitators for Psychedelic Research and Regulation in Brazil: Insights From Diverse Stakeholders.", "authors": "Guimarães AL, Beserra FR, Cruz L, Bienemmann B, Freind JMK, Guinle V, Rodrigues RS, Regalado JA, Mograbi DC", "journal": "Clinical therapeutics", "publication_date": "2026-06-12", "publication_year": 2026, "doi": "10.1016/j.clinthera.2026.05.012", "pubmed_id": "42288429", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/42288429/", "substance_tags": "psilocybin", "topic_tags": "Mystical Experience,Healthcare Workers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:20:34", "bibtex": null, "source_record_id": "PMID:42288429", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42288429/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:42288429", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42288429/", "doi": "10.1016/j.clinthera.2026.05.012", "pmid": "42288429", "publication_date": "2026-06-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3999, "title": "Integrating psychedelic-assisted psychotherapy into addiction care in the Czech Republic: Clinical evidence, safety, and regulatory developments", "authors": "Zuzana Postránecká, Matyáš Lucký, Viktor Mravčík, Tomáš Páleníček", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-06-11", "publication_year": 2026, "doi": "10.1556/2054.2026.00514", "pubmed_id": null, "openalex_id": "https://openalex.org/W7165879237", "source_url": "https://doi.org/10.1556/2054.2026.00514", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00514", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2026.00514", "source_url": "https://doi.org/10.1556/2054.2026.00514", "doi": "10.1556/2054.2026.00514", "pmid": "", "publication_date": "2026-06-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3238, "title": "Altered States, Enhanced Potential: Psychedelics and Physical Performance", "authors": "", "journal": "PsyArXiv", "publication_date": "2026-06-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/txgq2_v2", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Consciousness,Microdosing,Emotional Processing,Safety", "study_type": "Qualitative Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/txgq2_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/txgq2_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/txgq2_v2", "source_url": "https://osf.io/preprints/psyarxiv/txgq2_v2", "doi": "", "pmid": "", "publication_date": "2026-06-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3565, "title": "Psilocybin as a Treatment for Chronic Pain in Smokers", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-08", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07118332", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Headache / Migraine,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07118332", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07118332", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07118332", "source_url": "https://clinicaltrials.gov/study/NCT07118332", "doi": "", "pmid": "", "publication_date": "2026-06-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1929, "title": "Psilocybin-assisted Physiotherapy for Refractory Motor Functional Neurological Disorder: A Randomized Dose-comparison Pilot Study (P7-17.001)", "authors": "Alexander Bryson, Chiranth Bhagavan, O. Carter, Glenn Nielsen, David Berlowitz, Sara Issak, Zachary Attard, Dina Eleftheriadis, Gina Oliver, Deanne Mayne, Greg Roebuck, James Rucker, Matthew Butler, Richard Kanaan", "journal": "Neurology", "publication_date": "2026-06-08", "publication_year": 2026, "doi": "10.1212/wnl.0000000000212934", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164192013", "source_url": "https://doi.org/10.1212/wnl.0000000000212934", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:49:23", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1212/wnl.0000000000212934", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1212/wnl.0000000000212934", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1212/wnl.0000000000212934", "source_url": "https://doi.org/10.1212/wnl.0000000000212934", "doi": "10.1212/wnl.0000000000212934", "pmid": "", "publication_date": "2026-06-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3452, "title": "A Double Blind, Randomized Trial Investigating the Safety, Feasibility, and Mechanisms of Psychedelics in Healthy Older Adults With Low Well-being as Moderated by Biomarkers for Preclinical Alzheimer's Disease", "authors": "Jennifer Mitchell", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-07", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07386730", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Mechanism of Action,Biomarkers,Aging,Wellbeing,Animal Study,Healthy Volunteers,Older Adults,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07386730", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07386730", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07386730", "source_url": "https://clinicaltrials.gov/study/NCT07386730", "doi": "", "pmid": "", "publication_date": "2026-06-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3472, "title": "A Multi-site Randomized Controlled Trial of Psilocybin for Treatment-Resistant Depression (TRD) in Veterans", "authors": "VA Office of Research and Development", "journal": "ClinicalTrials.gov", "publication_date": "2026-06-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07226232", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Randomized Controlled Trial,Treatment-Resistant Depression,Veterans,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07226232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07226232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07226232", "source_url": "https://clinicaltrials.gov/study/NCT07226232", "doi": "", "pmid": "", "publication_date": "2026-06-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 60, "title": "Prenatal stress, excitatory-inhibitory imbalance, and ADHD risk: a hypothesis-driven perspective on psilocybin-induced neuroplasticity", "authors": "Samaneh Ahmadian-Moghadam, Shiva Roshan-Milani, Ehsan Saboory", "journal": "Translational Psychiatry", "publication_date": "2026-06-04", "publication_year": 2026, "doi": "10.1038/s41398-026-04151-x", "pubmed_id": "42248832", "openalex_id": "https://openalex.org/W7163694045", "source_url": "https://doi.org/10.1038/s41398-026-04151-x", "substance_tags": "psilocybin", "topic_tags": "Addiction,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing,Clinical Trial,Animal Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42248832", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41398-026-04151-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42248832", "source_url": "https://doi.org/10.1038/s41398-026-04151-x", "doi": "10.1038/s41398-026-04151-x", "pmid": "42248832", "publication_date": "2026-06-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1, "title": "A cross-national comparison of nonmedical and medical use of psychedelic drugs in the international cannabis policy study", "authors": "Myfanwy Graham, Yimin Ge, Rosalie Liccardo Pacula, Seema Choksy Pessar, Chris Wilkins, Wayne Hall, David Hammond", "journal": "International Journal of Drug Policy", "publication_date": "2026-06-04", "publication_year": 2026, "doi": "10.1016/j.drugpo.2026.105348", "pubmed_id": "42247761", "openalex_id": "https://openalex.org/W7163656829", "source_url": "https://doi.org/10.1016/j.drugpo.2026.105348", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Clinical Trial,Observational Study,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42247761", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.drugpo.2026.105348", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42247761", "source_url": "https://doi.org/10.1016/j.drugpo.2026.105348", "doi": "10.1016/j.drugpo.2026.105348", "pmid": "42247761", "publication_date": "2026-06-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 66, "title": "Classic Psychedelics for Chronic Pain: A Critical Review of the Literature and Practical Advice for Clinicians", "authors": "Kevin F. Boehnke, Niloufar Pouyan, Jacob S. Aday", "journal": "Drugs", "publication_date": "2026-06-03", "publication_year": 2026, "doi": "10.1007/s40265-026-02339-5", "pubmed_id": "42243569", "openalex_id": "https://openalex.org/W7163536837", "source_url": "https://doi.org/10.1007/s40265-026-02339-5", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Observational Study,Animal Study,Healthcare Workers,Safety,Toxicity,Drug Interactions,Contraindications,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42243569", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s40265-026-02339-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42243569", "source_url": "https://doi.org/10.1007/s40265-026-02339-5", "doi": "10.1007/s40265-026-02339-5", "pmid": "42243569", "publication_date": "2026-06-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3367, "title": "Prolonged Grief Symptom Outcomes During At-Home Ketamine-Assisted Therapy: A Real-World Retrospective Analysis of 503 Adults", "authors": "Carter D, Reardon I, Swain J, Vando L.", "journal": "Research Square", "publication_date": "2026-06-01", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9839240/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9839240/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Emotional Processing,Randomized Controlled Trial,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9839240/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9839240/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9839240/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9839240/v1", "doi": "10.21203/rs.3.rs-9839240/v1", "pmid": "", "publication_date": "2026-06-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3615, "title": "A Phase 3, Randomized, Double-Blind, Multicenter Study to Evaluate the Efficacy, Safety, and Tolerability of Psilocybin in Adults With Major Depressive Disorder (MDD)", "authors": "Usona Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-31", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06308653", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06308653", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06308653", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06308653", "source_url": "https://clinicaltrials.gov/study/NCT06308653", "doi": "", "pmid": "", "publication_date": "2026-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3095, "title": "Patient perceptions towards psychedelics for musculoskeletal pain: A cross-sectional survey", "authors": "Li EJ, Mosharraf B, Ali H, Noyes M, Doshi P, Wallace C, Petranker R, Adili A, Khan M, Busse JW, MacKillop J, Madden K.", "journal": "medRxiv", "publication_date": "2026-05-31", "publication_year": 2026, "doi": "10.64898/2026.05.29.26354422", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.05.29.26354422", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Microdosing,Observational Study,Safety", "study_type": "Observational Study", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.64898/2026.05.29.26354422", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.05.29.26354422", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.64898/2026.05.29.26354422", "source_url": "https://doi.org/10.64898/2026.05.29.26354422", "doi": "10.64898/2026.05.29.26354422", "pmid": "", "publication_date": "2026-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 53, "title": "Psilocybin restores behavior and 5-HT2A signaling while reducing microglial density after chronic traumatic brain injury in rats", "authors": "Josh Allen, Bianca Jupp, Tamara L. Baker, Mohammad B. Haskali, Robert Brkljača, Zoe Plummer, Mujun Sun, Justin Brand, Brian R. Christie, Chantel T. Debert, Stuart J. McDonald, Terence J. O’Brien, Pablo M. Casillas-Espinosa, Sandy R. Shultz", "journal": "Cell Reports Medicine", "publication_date": "2026-05-31", "publication_year": 2026, "doi": "10.1016/j.xcrm.2026.102867", "pubmed_id": "42285092", "openalex_id": "https://openalex.org/W7164582898", "source_url": "https://doi.org/10.1016/j.xcrm.2026.102867", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Safety,Toxicity,Inflammation", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42285092", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.xcrm.2026.102867", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42285092", "source_url": "https://doi.org/10.1016/j.xcrm.2026.102867", "doi": "10.1016/j.xcrm.2026.102867", "pmid": "42285092", "publication_date": "2026-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 26, "title": "U.S. Psychedelic Use and Microdosing in 2025: Insights from a Probability-Based and Nationally Representative Survey.", "authors": "Michelle Priest, Beau Kilmer, Ben Senator, Claude Messan Setodji", "journal": "PubMed", "publication_date": "2026-05-31", "publication_year": 2026, "doi": null, "pubmed_id": "42368324", "openalex_id": "https://openalex.org/W7166596602", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42368324", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42368324", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/42368324", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42368324", "source_url": "https://pubmed.ncbi.nlm.nih.gov/42368324", "doi": "", "pmid": "42368324", "publication_date": "2026-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3576, "title": "A Phase 2a Study of Group Retreat Psilocybin Therapy for Cancer-Related Anxiety and Depression", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-28", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07336238", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07336238", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07336238", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07336238", "source_url": "https://clinicaltrials.gov/study/NCT07336238", "doi": "", "pmid": "", "publication_date": "2026-05-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 90, "title": "Psychedelic-induced hypomania and mania: a systematic review and meta-analysis.", "authors": "Eskinazi M, Nasserdine R, Cusin RM, Baniotoupoulos P, Saccaro LF, De Pieri M, Corino T, Seragnoli F, Briefer JF, Aboulafia Brakha T, Richard-Lepouriel H, Penzenstadler L, Böge K, Kirchner M, Zullino D, Højlund M, Sapienza J, Bosia M, Catalan A, Vieta E, Solmi M, Sabé M.", "journal": null, "publication_date": "2026-05-28", "publication_year": 2026, "doi": "10.1038/s41380-026-03657-6", "pubmed_id": "42215638", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41380-026-03657-6", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Meta-Analysis,Systematic Review,Review Article,Observational Study,Safety", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:42215638", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41380-026-03657-6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42215638", "source_url": "https://doi.org/10.1038/s41380-026-03657-6", "doi": "10.1038/s41380-026-03657-6", "pmid": "42215638", "publication_date": "2026-05-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 97, "title": "Psilocybin-induced neurocardiogenic syncope: a case report", "authors": "Mazen A. Atiq, Eli Weisman, Rodrigo B. Guerra, Luis Luna Martinez, David B. Yaden, Frederick S. Barrett, Sandeep Nayak, Ceyda Sayalı", "journal": "Psychopharmacology", "publication_date": "2026-05-27", "publication_year": 2026, "doi": "10.1007/s00213-026-07079-8", "pubmed_id": "42207275", "openalex_id": "https://openalex.org/W7162662445", "source_url": "https://doi.org/10.1007/s00213-026-07079-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Brain Imaging,Consciousness,Aging,Emotional Processing,Clinical Trial,Case Report,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42207275", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s00213-026-07079-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42207275", "source_url": "https://doi.org/10.1007/s00213-026-07079-8", "doi": "10.1007/s00213-026-07079-8", "pmid": "42207275", "publication_date": "2026-05-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3660, "title": "The Safety and Acceptability of Psilocybin With Support and With Massed Prolonged Exposure Therapy for PTSD", "authors": "Emory University", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-25", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07332143", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07332143", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07332143", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07332143", "source_url": "https://clinicaltrials.gov/study/NCT07332143", "doi": "", "pmid": "", "publication_date": "2026-05-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2, "title": "Mystery shopper assessments of cannabis retailer practices and regulatory compliance in five U.S. states, 2025.", "authors": "Berg CJ, LoParco CR, Rossheim ME, McCready DM, Langan L, Platt E, Romm KF, Johnson M, Speer MB, Burris S, Cavazos-Rehg PA.", "journal": null, "publication_date": "2026-05-25", "publication_year": 2026, "doi": "10.1016/j.drugalcdep.2026.113218", "pubmed_id": "42224931", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.drugalcdep.2026.113218", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:42224931", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.drugalcdep.2026.113218", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42224931", "source_url": "https://doi.org/10.1016/j.drugalcdep.2026.113218", "doi": "10.1016/j.drugalcdep.2026.113218", "pmid": "42224931", "publication_date": "2026-05-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 52, "title": "Overcoming Pharmacokinetic and Peripheral Safety Challenges in Psychedelic Therapies: The Promise of Advanced Drug Delivery Systems.", "authors": "Zhang T, Lin C, Wang X.", "journal": null, "publication_date": "2026-05-24", "publication_year": 2026, "doi": "10.1021/acsptsci.6c00146", "pubmed_id": "42312173", "openalex_id": null, "source_url": "https://doi.org/10.1021/acsptsci.6c00146", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:42312173", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsptsci.6c00146", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42312173", "source_url": "https://doi.org/10.1021/acsptsci.6c00146", "doi": "10.1021/acsptsci.6c00146", "pmid": "42312173", "publication_date": "2026-05-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4012, "title": "Psilocybin for Treatment-Resistant Depression: A Comprehensive Review of Mechanisms and Therapeutic Potential", "authors": "Dallas T Mason", "journal": "Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)", "publication_date": "2026-05-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7162235135", "source_url": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "source_url": "https://digitalshowcase.lynchburg.edu/dmscjournal/vol8/iss1/6", "doi": "", "pmid": "", "publication_date": "2026-05-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4011, "title": "The Use of Psilocybin for Managing Refractory Behavioral Health Conditions: A New and Promising Approach", "authors": "Rachel N Clark", "journal": "Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)", "publication_date": "2026-05-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7162225828", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3694&context=dmscjournal", "doi": "", "pmid": "", "publication_date": "2026-05-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4010, "title": "Psilocybin-Assisted Therapy in the Management of Anxiety and Depression Among Cancer Patients", "authors": "Caleb Lemus", "journal": "Digital Showcase Research, Scholarship, & Creative Works (University of Lynchburg)", "publication_date": "2026-05-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7162222410", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Neuroplasticity,Aging,Wellbeing,Emotional Processing,Randomized Controlled Trial,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "source_url": "https://digitalshowcase.lynchburg.edu/cgi/viewcontent.cgi?article=3713&context=dmscjournal", "doi": "", "pmid": "", "publication_date": "2026-05-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3614, "title": "Group Psilocybin-Assisted Therapy for Post-Traumatic Stress Disorder", "authors": "University of New Mexico", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07506395", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07506395", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07506395", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07506395", "source_url": "https://clinicaltrials.gov/study/NCT07506395", "doi": "", "pmid": "", "publication_date": "2026-05-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3529, "title": "Evaluating the Feasibility, Clinical Effects, and Safety of Psilocybin-assisted Psychotherapy for Treatment-resistant Obsessive-compulsive Disorder: An Open-label Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-17", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06299319", "substance_tags": "psilocybin", "topic_tags": "Addiction,OCD,Brain Imaging,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Case Report,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06299319", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06299319", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06299319", "source_url": "https://clinicaltrials.gov/study/NCT06299319", "doi": "", "pmid": "", "publication_date": "2026-05-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 109, "title": "Corrigendum to: “Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscape”", "authors": "", "journal": "Australian & New Zealand Journal of Psychiatry", "publication_date": "2026-05-17", "publication_year": 2026, "doi": "10.1177/00048674261450797", "pubmed_id": "42145135", "openalex_id": "https://openalex.org/W7161606725", "source_url": "https://doi.org/10.1177/00048674261450797", "substance_tags": "psilocybin", "topic_tags": "Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42145135", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42145135", "source_url": "https://doi.org/10.1177/00048674261450797", "doi": "10.1177/00048674261450797", "pmid": "42145135", "publication_date": "2026-05-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3606, "title": "Exploring the Safety, Acceptability, and Efficacy of Psilocybin Among Non-Small Cell Lung Cancer Patients With Major Depressive Disorder: A Proof-of-Concept Trial (DREAM LUNG STUDY)", "authors": "Alan Davis", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07216404", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07216404", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07216404", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07216404", "source_url": "https://clinicaltrials.gov/study/NCT07216404", "doi": "", "pmid": "", "publication_date": "2026-05-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3035, "title": "Low doses of psilocybin as adjunct pharmacological treatment to virtual reality exposure therapy for social anxiety disorder: A study protocol for a double-blind randomized controlled trial.", "authors": "", "journal": "PsyArXiv", "publication_date": "2026-05-13", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Brain Imaging,Biomarkers,Aging,Microdosing,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "source_url": "https://osf.io/preprints/psyarxiv/3b9fx_v1", "doi": "", "pmid": "", "publication_date": "2026-05-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 110, "title": "Psilocybin-Assisted Therapy for Adolescent Anorexia Nervosa: Clinical Considerations and Emerging Models of Care", "authors": "Jamarie Geller, Rachel Pacilio, Amanda E. Downey, Anya Ragnhildstveit, Marissa Raymond-Flesch, Stephanie Knatz-Peck, Natalie Gukasyan", "journal": "Current Psychiatry Reports", "publication_date": "2026-05-13", "publication_year": 2026, "doi": "10.1007/s11920-026-01679-z", "pubmed_id": "42128951", "openalex_id": "https://openalex.org/W7161007383", "source_url": "https://doi.org/10.1007/s11920-026-01679-z", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Review Article,Adolescents,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42128951", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s11920-026-01679-z", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42128951", "source_url": "https://doi.org/10.1007/s11920-026-01679-z", "doi": "10.1007/s11920-026-01679-z", "pmid": "42128951", "publication_date": "2026-05-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1944, "title": "Ethical Complexities and Best Practices in Informed Consent Processes for Psilocybin Services: A Qualitative Study", "authors": "Christina Chwyl, Alissa Bazinet, Adrianne R. Wilson-Poe, Kim Hoffman, Kellie Pertl, R. Cameron Wolf, P. Todd Korthuis, Jason B. Luoma", "journal": "Neuroethics", "publication_date": "2026-05-12", "publication_year": 2026, "doi": "10.1007/s12152-026-09645-5", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160917606", "source_url": "https://doi.org/10.1007/s12152-026-09645-5", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1007/s12152-026-09645-5", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s12152-026-09645-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s12152-026-09645-5", "source_url": "https://doi.org/10.1007/s12152-026-09645-5", "doi": "10.1007/s12152-026-09645-5", "pmid": "", "publication_date": "2026-05-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 112, "title": "Inaugural year of regulated psilocybin services in Oregon: safety, motivations, and utilization", "authors": "Feliciano Yu, Joe Tafur, Francisco Moreno, Stephen Dahmer", "journal": "Frontiers in Psychiatry", "publication_date": "2026-05-12", "publication_year": 2026, "doi": "10.3389/fpsyt.2026.1777387", "pubmed_id": "42233004", "openalex_id": "https://openalex.org/W7161045271", "source_url": "https://doi.org/10.3389/fpsyt.2026.1777387", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Wellbeing,Observational Study,Safety,Adverse Events,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42233004", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2026.1777387", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42233004", "source_url": "https://doi.org/10.3389/fpsyt.2026.1777387", "doi": "10.3389/fpsyt.2026.1777387", "pmid": "42233004", "publication_date": "2026-05-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3710, "title": "A Randomized Double-masked Dose-controlled Trial to Assess the Tolerability, Safety, Subjective Experience, and Efficacy of Repeated Administration of Three Different Doses of Psilocybin Whole Mushroom for the Treatment of Obsessive-compulsive Disorder.", "authors": "Francisco A Moreno", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07347405", "substance_tags": "psilocybin", "topic_tags": "OCD,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07347405", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07347405", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07347405", "source_url": "https://clinicaltrials.gov/study/NCT07347405", "doi": "", "pmid": "", "publication_date": "2026-05-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3527, "title": "Safety and Feasibility of Psilocybin in Methamphetamine Use Disorder in a Community-Based Sample", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05322954", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05322954", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05322954", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05322954", "source_url": "https://clinicaltrials.gov/study/NCT05322954", "doi": "", "pmid": "", "publication_date": "2026-05-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3490, "title": "A Phase 2b/3, Multicentre, Randomised, Double-blind, Controlled Trial, With an Open Label Extension, to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07570654", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07570654", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07570654", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07570654", "source_url": "https://clinicaltrials.gov/study/NCT07570654", "doi": "", "pmid": "", "publication_date": "2026-05-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1945, "title": "Rapid-acting interventions in treatment-resistant depression - a comparative review of esketamine and psilocybin", "authors": "Bartłomiej Kosiarski, Anna Skrzypek, Patrycja Markowicz, Mikołaj Zbrożek, Krzysztof Biłyk, Maciej Hutkowski, Zuzanna Chwostek, Hanna Maruchniak, Wiktoria Marzec, Paulina Biedroń", "journal": "Journal of Pre-Clinical and Clinical Research", "publication_date": "2026-05-11", "publication_year": 2026, "doi": "10.26444/jpccr/221219", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160910785", "source_url": "https://doi.org/10.26444/jpccr/221219", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Animal Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.26444/jpccr/221219", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.26444/jpccr/221219", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26444/jpccr/221219", "source_url": "https://doi.org/10.26444/jpccr/221219", "doi": "10.26444/jpccr/221219", "pmid": "", "publication_date": "2026-05-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 113, "title": "Efficacy and Safety of a Single Dose of Psilocybin for Chronic Suicidal Ideation", "authors": "Andrew van der Vaart, Jeffrey LaPratt, Kimberly Swartz, Audrey Shoultz, Margo Lauterbach, Trisha Suppes, Harold A. Sackeïm, Scott T. Aaronson", "journal": "The Journal of Clinical Psychiatry", "publication_date": "2026-05-11", "publication_year": 2026, "doi": "10.4088/jcp.26m16338", "pubmed_id": "42138588", "openalex_id": "https://openalex.org/W7160906477", "source_url": "https://doi.org/10.4088/jcp.26m16338", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42138588", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4088/jcp.26m16338", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42138588", "source_url": "https://doi.org/10.4088/jcp.26m16338", "doi": "10.4088/jcp.26m16338", "pmid": "42138588", "publication_date": "2026-05-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3022, "title": "Safety and Efficacy of Psilocybin in the Management of Treatment-Resistant Depression: A Systematic Review", "authors": "Walters CK, Chetty S, Rants’o TA, Gossayn S, Lerotholi LJ.", "journal": "Research Square", "publication_date": "2026-05-10", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9283280/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9283280/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9283280/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9283280/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9283280/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9283280/v1", "doi": "10.21203/rs.3.rs-9283280/v1", "pmid": "", "publication_date": "2026-05-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4019, "title": "From Trials to Clinics: Considerations for Implementing Psychedelic-Assisted Therapy Into Clinical Practice", "authors": "Jessie Kim, Liam Lochhead, Cory R. Weissman", "journal": "Pharmacology Research & Perspectives", "publication_date": "2026-05-09", "publication_year": 2026, "doi": "10.1002/prp2.70262", "pubmed_id": "42108552", "openalex_id": "https://openalex.org/W7160830727", "source_url": "https://doi.org/10.1002/prp2.70262", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Mystical Experience,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42108552", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/prp2.70262", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42108552", "source_url": "https://doi.org/10.1002/prp2.70262", "doi": "10.1002/prp2.70262", "pmid": "42108552", "publication_date": "2026-05-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3570, "title": "The Safety and Efficacy of Psilocybin Therapy Compared to Low-dose Control in Reducing Depressive Symptoms in Patients With COPD, ALS, MS, or APD.", "authors": "University Medical Center Groningen", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-07", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06782724", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Brain Imaging,Biomarkers,Spirituality,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06782724", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06782724", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06782724", "source_url": "https://clinicaltrials.gov/study/NCT06782724", "doi": "", "pmid": "", "publication_date": "2026-05-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 116, "title": "Exploring new avenues: Psychedelic-assisted therapy for young people", "authors": "Ioanna Artemis Vamvakopoulou, D. P. Nicholls, David J. Nutt, M. Di Simplicio", "journal": "British Journal of Clinical Pharmacology", "publication_date": "2026-05-07", "publication_year": 2026, "doi": "10.1002/bcp.70579", "pubmed_id": "42101062", "openalex_id": "https://openalex.org/W7160597817", "source_url": "https://doi.org/10.1002/bcp.70579", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Wellbeing,Review Article,Observational Study,Adolescents,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42101062", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/bcp.70579", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42101062", "source_url": "https://doi.org/10.1002/bcp.70579", "doi": "10.1002/bcp.70579", "pmid": "42101062", "publication_date": "2026-05-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3496, "title": "Does Psilocybin Require Psychedelic Effects to Treat Depression? A4-Week, Double-Blind, Proof-of-Concept Randomized Controlled Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05710237", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05710237", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05710237", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05710237", "source_url": "https://clinicaltrials.gov/study/NCT05710237", "doi": "", "pmid": "", "publication_date": "2026-05-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1947, "title": "Psilocybin-Assisted Therapy in Depressive Disorders: Efficacy, Safety, and Persistence of Clinical Effects - A Narrative Review", "authors": "Kinga Zachar, Maksymilian Sito, Filip Jurkowski, Łukasz Wójcik, Natalia Gawron, Hubert Tomasz Bojanowski, Aleksandra Dobracka, Zuzanna Marczak, Monika Jarowicz, Jędrzej Czmyr", "journal": "Journal of Education Health and Sport", "publication_date": "2026-05-06", "publication_year": 2026, "doi": "10.12775/jehs.2026.91.70672", "pubmed_id": null, "openalex_id": "https://openalex.org/W7160694792", "source_url": "https://doi.org/10.12775/jehs.2026.91.70672", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2026.91.70672", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/jehs.2026.91.70672", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2026.91.70672", "source_url": "https://doi.org/10.12775/jehs.2026.91.70672", "doi": "10.12775/jehs.2026.91.70672", "pmid": "", "publication_date": "2026-05-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 127, "title": "Psilocybin in the Treatment of Cocaine Use Disorder", "authors": "Peter S. Hendricks, Sara Lappan, Richard C. Shelton, Adrienne C. Lahti, Karen L. Cropsey, Matthew W. Johnson, Melissa Bradley, Otto Simonsson, Lori L. Davis, Daniel H. Grossman, Cynthia E. Ortiz", "journal": "JAMA Network Open", "publication_date": "2026-05-06", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2026.11029", "pubmed_id": "42096204", "openalex_id": "https://openalex.org/W7160534089", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.11029", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42096204", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2026.11029", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42096204", "source_url": "https://doi.org/10.1001/jamanetworkopen.2026.11029", "doi": "10.1001/jamanetworkopen.2026.11029", "pmid": "42096204", "publication_date": "2026-05-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 117, "title": "The magic of mushrooms: psilocybin influences behavior in the mangrove rivulus fish, Kryptolebias marmoratus", "authors": "Dayna Forsyth, Nicoletta Faraone, Simon G. Lamarre, Suzanne Currie", "journal": "Frontiers in Behavioral Neuroscience", "publication_date": "2026-05-06", "publication_year": 2026, "doi": "10.3389/fnbeh.2026.1767175", "pubmed_id": "42182826", "openalex_id": "https://openalex.org/W7160487085", "source_url": "https://doi.org/10.3389/fnbeh.2026.1767175", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Safety,Drug Interactions", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42182826", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fnbeh.2026.1767175", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42182826", "source_url": "https://doi.org/10.3389/fnbeh.2026.1767175", "doi": "10.3389/fnbeh.2026.1767175", "pmid": "42182826", "publication_date": "2026-05-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4020, "title": "Announcement of special issue: ‘Behavioural pharmacology of ketamine and psychedelic drugs’", "authors": "Bart A. Ellenbroek, Gernot Riedel", "journal": "Behavioural Pharmacology", "publication_date": "2026-05-05", "publication_year": 2026, "doi": "10.1097/fbp.0000000000000878", "pubmed_id": "42100839", "openalex_id": "https://openalex.org/W7160630756", "source_url": "https://doi.org/10.1097/fbp.0000000000000878", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42100839", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/fbp.0000000000000878", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42100839", "source_url": "https://doi.org/10.1097/fbp.0000000000000878", "doi": "10.1097/fbp.0000000000000878", "pmid": "42100839", "publication_date": "2026-05-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3620, "title": "A Phase 2, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of up to Two Doses of Psilocybin for the Treatment of Major Depressive Disorder in Adults With Cancer", "authors": "Sunstone Medical", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05947383", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05947383", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05947383", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05947383", "source_url": "https://clinicaltrials.gov/study/NCT05947383", "doi": "", "pmid": "", "publication_date": "2026-05-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3536, "title": "A Phase 2 Randomized Study Examining the Safety, Feasibility, and Effectiveness of Masking Psilocybin Therapy With General Anesthesia in Major Depressive Disorder", "authors": "Stanford University", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07479550", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07479550", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07479550", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07479550", "source_url": "https://clinicaltrials.gov/study/NCT07479550", "doi": "", "pmid": "", "publication_date": "2026-05-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3559, "title": "A Phase 2 Sequential Dose-Finding Study of Preparation for Group Retreat Psilocybin Therapy for Healthcare Clinicians With Loss of Meaning in Their Work and Symptoms of Depression", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-03", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07565909", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07565909", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07565909", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07565909", "source_url": "https://clinicaltrials.gov/study/NCT07565909", "doi": "", "pmid": "", "publication_date": "2026-05-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3531, "title": "Safety, Tolerability, Outcomes of Psilocybin for Depression (STOP Depression) in Veterans With Spinal Cord Injury", "authors": "James J. Peters Veterans Affairs Medical Center", "journal": "ClinicalTrials.gov", "publication_date": "2026-05-03", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07251491", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Wellbeing,Veterans,Safety,Adverse Events", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07251491", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07251491", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07251491", "source_url": "https://clinicaltrials.gov/study/NCT07251491", "doi": "", "pmid": "", "publication_date": "2026-05-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3600, "title": "Psilocybin-Assisted Therapy for Treatment-Resistant Depression in Bipolar II Disorder: A Randomized Controlled Trial", "authors": "Lakshmi N Yatham", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-30", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06943573", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06943573", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06943573", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06943573", "source_url": "https://clinicaltrials.gov/study/NCT06943573", "doi": "", "pmid": "", "publication_date": "2026-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1958, "title": "Prevalence and Correlates of Past-Year Psilocybin Use in the U.S., 2024, USA", "authors": "R Andrew Yockey, Amber Amis, Elise Devier, Aminul Apu, Rachel Hoopsick", "journal": "AJPM Focus", "publication_date": "2026-04-30", "publication_year": 2026, "doi": "10.1016/j.focus.2026.100518", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162075570", "source_url": "https://doi.org/10.1016/j.focus.2026.100518", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Adolescents,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1016/j.focus.2026.100518", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.focus.2026.100518", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.focus.2026.100518", "source_url": "https://doi.org/10.1016/j.focus.2026.100518", "doi": "10.1016/j.focus.2026.100518", "pmid": "", "publication_date": "2026-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 130, "title": "Trip killers: Addressing a critical knowledge gap in psychedelic research.", "authors": "O'Mahony B, Harrington C, Harkin A, Lally N", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2026-04-30", "publication_year": 2026, "doi": "10.1177/02698811261431056", "pubmed_id": "41869862", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41869862/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:20:34", "bibtex": null, "source_record_id": "PMID:41869862", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41869862/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41869862", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41869862/", "doi": "10.1177/02698811261431056", "pmid": "41869862", "publication_date": "2026-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 122, "title": "New Approach Methodologies and Open Access Tools Help Characterize Risks for DART, DNT, or Endocrine Effects From Exposure to Hallucinogens With Potential Pesticide Contaminants", "authors": "Marilyn H. Silva", "journal": "Birth Defects Research", "publication_date": "2026-04-30", "publication_year": 2026, "doi": "10.1002/bdr2.70048", "pubmed_id": "42163018", "openalex_id": "https://openalex.org/W7161947696", "source_url": "https://doi.org/10.1002/bdr2.70048", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Mechanism of Action,Receptor Pharmacology,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42163018", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/bdr2.70048", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42163018", "source_url": "https://doi.org/10.1002/bdr2.70048", "doi": "10.1002/bdr2.70048", "pmid": "42163018", "publication_date": "2026-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5709, "title": "Acute Cardiovascular Effects of Psilocybin: A Pooled Analysis of 14 Studies with Safety Recommendations", "authors": "Nayak SM, Sepeda ND, Dick MN, Tiwari P, Zahid Z, Sayalı C, Weiss BM, Yaden DB, Garcia-Romeu A, Barnett BS, Barrett FS.", "journal": "medRxiv", "publication_date": "2026-04-28", "publication_year": 2026, "doi": "10.64898/2026.04.28.26351625", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.04.28.26351625", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-07-11 19:28:11", "bibtex": null, "source_record_id": "DOI:10.64898/2026.04.28.26351625", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.04.28.26351625", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.64898/2026.04.28.26351625", "source_url": "https://doi.org/10.64898/2026.04.28.26351625", "doi": "10.64898/2026.04.28.26351625", "pmid": "", "publication_date": "2026-04-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3041, "title": "The Ecstasy of Gold in Neurodiversity: Focus on the Use of Psychedelics in Autism Spectrum Disorder", "authors": "Marini S, De Berardis D.", "journal": "Preprints.org", "publication_date": "2026-04-28", "publication_year": 2026, "doi": "10.20944/preprints202604.1998.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202604.1998.v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Neuroplasticity,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202604.1998.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202604.1998.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202604.1998.v1", "source_url": "https://doi.org/10.20944/preprints202604.1998.v1", "doi": "10.20944/preprints202604.1998.v1", "pmid": "", "publication_date": "2026-04-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1952, "title": "6. Open-Label Extension of Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Continued Safety and Short-Term Efficacy Signal for Drinking, Craving, and Self-Efficacy", "authors": "Broc Pagni, Stephen Ross, Yuna Kim, Michael Bogenschutz", "journal": "Biological Psychiatry", "publication_date": "2026-04-24", "publication_year": 2026, "doi": "10.1016/j.biopsych.2026.03.240", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155643158", "source_url": "https://doi.org/10.1016/j.biopsych.2026.03.240", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2026.03.240", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2026.03.240", "source_url": "https://doi.org/10.1016/j.biopsych.2026.03.240", "doi": "10.1016/j.biopsych.2026.03.240", "pmid": "", "publication_date": "2026-04-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 159, "title": "Methamphetamine-Fentanyl Polysubstance Administration Produces Social Deficits and Corticolimbic Stress-Reward Circuit Adaptations", "authors": "Salinsky LM, Fox JL, Diaz KC, Timmons BC, Ferguson SM.", "journal": "Research Square", "publication_date": "2026-04-22", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9306429/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9306429/v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9306429/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9306429/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9306429/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9306429/v1", "doi": "10.21203/rs.3.rs-9306429/v1", "pmid": "", "publication_date": "2026-04-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 35, "title": "Serotonergic psychedelics for Autism spectrum disorder: Neurobiological mechanisms and translational prospects.", "authors": "Low ZXB.", "journal": null, "publication_date": "2026-04-22", "publication_year": 2026, "doi": "10.1016/j.pnpbp.2026.111717", "pubmed_id": "42034276", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2026.111717", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Safety,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:42034276", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2026.111717", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42034276", "source_url": "https://doi.org/10.1016/j.pnpbp.2026.111717", "doi": "10.1016/j.pnpbp.2026.111717", "pmid": "42034276", "publication_date": "2026-04-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3658, "title": "Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder", "authors": "Portland VA Research Foundation, Inc", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04982796", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04982796", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04982796", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04982796", "source_url": "https://clinicaltrials.gov/study/NCT04982796", "doi": "", "pmid": "", "publication_date": "2026-04-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3596, "title": "A Randomized, Double-Blind Study of Single-Dose Psilocybin for Major Depressive Disorder (MDD)", "authors": "Usona Institute", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03866174", "substance_tags": "psilocybin", "topic_tags": "Depression,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03866174", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03866174", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03866174", "source_url": "https://clinicaltrials.gov/study/NCT03866174", "doi": "", "pmid": "", "publication_date": "2026-04-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3567, "title": "Toward Patient-Tailored Care for Treatment-Resistant Depression: A Pilot Patient-Preference Clinical Trial of Music and Mindfulness in Psilocybin-Assisted Psychotherapy", "authors": "Kyle Greenway", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07373535", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07373535", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07373535", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07373535", "source_url": "https://clinicaltrials.gov/study/NCT07373535", "doi": "", "pmid": "", "publication_date": "2026-04-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1968, "title": "Psilocybin as an alternative to conventional treatments: A systematic review", "authors": "Deivid Antonio Cahuasqui-Mendoza", "journal": "Gaceta Médica de Caracas", "publication_date": "2026-04-21", "publication_year": 2026, "doi": "10.47307/gmc.2026.134.s2.32", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155199454", "source_url": "https://doi.org/10.47307/gmc.2026.134.s2.32", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.47307/gmc.2026.134.s2.32", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.47307/gmc.2026.134.s2.32", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.47307/gmc.2026.134.s2.32", "source_url": "https://doi.org/10.47307/gmc.2026.134.s2.32", "doi": "10.47307/gmc.2026.134.s2.32", "pmid": "", "publication_date": "2026-04-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2978, "title": "The efficacy and safety of psilocybin-assisted therapy for major depressive disorder: a meta-analytic review of clinical outcomes", "authors": "Mohsen Khosravi, Domenico De Berardis, Massimo Tusconi", "journal": "Mental Wellness", "publication_date": "2026-04-20", "publication_year": 2026, "doi": "10.4081/mw.2026.40", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155066504", "source_url": "https://doi.org/10.4081/mw.2026.40", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.4081/mw.2026.40", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4081/mw.2026.40", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4081/mw.2026.40", "source_url": "https://doi.org/10.4081/mw.2026.40", "doi": "10.4081/mw.2026.40", "pmid": "", "publication_date": "2026-04-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2977, "title": "Efficacy and Safety of Psilocybin-Assisted Therapy for Depression: A Meta-Analysis of Randomised Controlled Trials", "authors": "Siti Nashria Rusdhy, Andrian Fajar Kusumadewi, Carla Raymondalexas Marchira, Mustika Suci Mahardikaningrum, Teresa Lalita Wiryarini, Devira Ayu Wulandari", "journal": "Open Access Indonesian Journal of Medical Reviews", "publication_date": "2026-04-20", "publication_year": 2026, "doi": "10.37275/oaijmr.v6i2.883", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155091271", "source_url": "https://doi.org/10.37275/oaijmr.v6i2.883", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:55:42", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.37275/oaijmr.v6i2.883", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.37275/oaijmr.v6i2.883", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.37275/oaijmr.v6i2.883", "source_url": "https://doi.org/10.37275/oaijmr.v6i2.883", "doi": "10.37275/oaijmr.v6i2.883", "pmid": "", "publication_date": "2026-04-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4036, "title": "Oregon’s Psilocybin Services: A summary and public health commentary", "authors": "Cassidy R. LoParco, Carlton Bone, Annalynn M. Galvin, Matthew E. Rossheim, Carla Berg", "journal": "New Prairie Press (Kansas State University)", "publication_date": "2026-04-16", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7154872659", "source_url": "https://newprairiepress.org/hbr/vol9/iss1/20", "substance_tags": "psilocybin", "topic_tags": "Addiction,Emotional Processing,Spirituality,Adolescents,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:35", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "https://newprairiepress.org/hbr/vol9/iss1/20", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://newprairiepress.org/hbr/vol9/iss1/20", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://newprairiepress.org/hbr/vol9/iss1/20", "source_url": "https://newprairiepress.org/hbr/vol9/iss1/20", "doi": "", "pmid": "", "publication_date": "2026-04-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3117, "title": "Psilocybin’s Kinematic Effect on Manual Dexterity", "authors": "Klintefors P, Bhagavan C, Kanaan R, Bryson A, Berlowitz D, Attard Z, Carter O.", "journal": "Research Square", "publication_date": "2026-04-14", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9291780/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9291780/v1", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9291780/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9291780/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9291780/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9291780/v1", "doi": "10.21203/rs.3.rs-9291780/v1", "pmid": "", "publication_date": "2026-04-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3019, "title": "Psilocybin in Older Adults: Therapeutic Opportunities in Inflammation-Driven Disorders of Aging-From Depression to Neurodegeneration", "authors": "Jóźwiak-Bębenista M, Stasiak A, Sienkiewicz M, Kwiatkowski P, Kowalczyk E.", "journal": "Preprints.org", "publication_date": "2026-04-14", "publication_year": 2026, "doi": "10.20944/preprints202604.1125.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202604.1125.v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Inflammaging,Review Article,Older Adults,Treatment-Resistant Depression,Safety,Drug Interactions,Inflammation,Immune Function", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202604.1125.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202604.1125.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202604.1125.v1", "source_url": "https://doi.org/10.20944/preprints202604.1125.v1", "doi": "10.20944/preprints202604.1125.v1", "pmid": "", "publication_date": "2026-04-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 172, "title": "A phase 1 study of a second experience with Group Retreat Psilocybin Therapy for partial responders after a first experience", "authors": "Anthony L. Back, Bonnie A. McGregor, Leslie L. Thorn, Kalin Harvey, Dianna Blom, George Callan, John Guy, Sameet Kumar, Rob Hershberg, Melissa Layer, Jackie Levin, Susanna Myers, Juliana Perez, Kathy Salmonson, Peter Thompson, Joseph Whinney", "journal": "Frontiers in Public Health", "publication_date": "2026-04-13", "publication_year": 2026, "doi": "10.3389/fpubh.2026.1810904", "pubmed_id": "42058096", "openalex_id": "https://openalex.org/W7154396122", "source_url": "https://doi.org/10.3389/fpubh.2026.1810904", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mystical Experience,Clinical Trial,Cancer Patients,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:42058096", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpubh.2026.1810904", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42058096", "source_url": "https://doi.org/10.3389/fpubh.2026.1810904", "doi": "10.3389/fpubh.2026.1810904", "pmid": "42058096", "publication_date": "2026-04-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1970, "title": "Psilocybin for Treatment of Prolonged Grief Disorder: An Open-Label Feasibility Study Protocol", "authors": "J. Morgan Penberthy, Fatma Wise, Nicholas P. Cherup, Evaline Mitchell, Madeline Burns, Oluwafunmilayo Akinlade, David Chung, Harshit Parmar, Jonathan Singer", "journal": "Psychoactives", "publication_date": "2026-04-12", "publication_year": 2026, "doi": "10.3390/psychoactives5020012", "pubmed_id": null, "openalex_id": "https://openalex.org/W7153973756", "source_url": "https://doi.org/10.3390/psychoactives5020012", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Brain Imaging,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives5020012", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives5020012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives5020012", "source_url": "https://doi.org/10.3390/psychoactives5020012", "doi": "10.3390/psychoactives5020012", "pmid": "", "publication_date": "2026-04-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 177, "title": "Severe Illness Associated with Eating Mushroom-Containing Chocolate Products - United States, January-October 2024.", "authors": "Rumph JT, Winquist A, Troeschel AN, Pulver S, Schnall AH, Ebersole J, Yeh M, Burt B, Federman SL, Klontz K, Dasenbrock C, Leahy HL, Brady S, Stuteville H, Patel K, Daniel J, Chang A", "journal": "MMWR. Morbidity and mortality weekly report", "publication_date": "2026-04-08", "publication_year": 2026, "doi": "10.15585/mmwr.mm7513a2", "pubmed_id": "41955162", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41955162/", "substance_tags": "psilocin", "topic_tags": "Microdosing,Safety,Toxicity", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 06:54:12", "bibtex": null, "source_record_id": "PMID:41955162", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41955162/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41955162", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41955162/", "doi": "10.15585/mmwr.mm7513a2", "pmid": "41955162", "publication_date": "2026-04-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3656, "title": "Safety Profile of 25 mg Psilocybin in Individuals With Cocaine Use Disorder", "authors": "University of California, Los Angeles", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-06", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06102434", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Aging,Healthcare Workers,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06102434", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06102434", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06102434", "source_url": "https://clinicaltrials.gov/study/NCT06102434", "doi": "", "pmid": "", "publication_date": "2026-04-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3542, "title": "Activating Neuroplasticity to ENHANCE the Perception Box Expanding Effects of Psilocybin", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-02", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05866471", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05866471", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05866471", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05866471", "source_url": "https://clinicaltrials.gov/study/NCT05866471", "doi": "", "pmid": "", "publication_date": "2026-04-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3651, "title": "Effects of Psilocybin in Obsessive Compulsive Disorder", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-04-01", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05546658", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Mechanism of Action,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05546658", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05546658", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05546658", "source_url": "https://clinicaltrials.gov/study/NCT05546658", "doi": "", "pmid": "", "publication_date": "2026-04-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1972, "title": "Therapeutic Potential of Psilocybin in Psychiatric Disorders: Mechanisms, Efficacy, and Clinical Implications", "authors": "Shakila Meshkat, Manish K. Jha, Venkat Bhat", "journal": "FOCUS The Journal of Lifelong Learning in Psychiatry", "publication_date": "2026-03-31", "publication_year": 2026, "doi": "10.1176/appi.focus.20250043", "pubmed_id": null, "openalex_id": "https://openalex.org/W7154344405", "source_url": "https://doi.org/10.1176/appi.focus.20250043", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,End-of-Life Distress,Headache / Migraine,Neuroplasticity,Mechanism of Action,Aging,Emotional Processing,Clinical Trial,Review Article,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1176/appi.focus.20250043", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.focus.20250043", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.focus.20250043", "source_url": "https://doi.org/10.1176/appi.focus.20250043", "doi": "10.1176/appi.focus.20250043", "pmid": "", "publication_date": "2026-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 190, "title": "Clinical Characteristics of Emergency Visits Related to Recreational Psychedelic Use", "authors": "Kush V. Bhatt, Joseph Friedman, Lindsay Benster, Rekha Narasimhan, Ke Yang, Jyoti Mishra, Cory R. Weissman, Dhakshin Ramanathan", "journal": "Community Mental Health Journal", "publication_date": "2026-03-31", "publication_year": 2026, "doi": "10.1007/s10597-026-01620-x", "pubmed_id": "41920509", "openalex_id": "https://openalex.org/W7147451430", "source_url": "https://doi.org/10.1007/s10597-026-01620-x", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Review Article,Observational Study,Safety,Adverse Events,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41920509", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s10597-026-01620-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41920509", "source_url": "https://doi.org/10.1007/s10597-026-01620-x", "doi": "10.1007/s10597-026-01620-x", "pmid": "41920509", "publication_date": "2026-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 207, "title": "In-silico toxicity study of tryptamine, psilocin, psilocybin, N,N-dimethyltryptamine, 5’-methoxy-N,N-dimethyltryptamine and O-acetylpsilocin", "authors": "Kamil Jurowski, Damian Kobylarz, Maciej Noga", "journal": "Archives of Toxicology", "publication_date": "2026-03-30", "publication_year": 2026, "doi": "10.1007/s00204-026-04365-4", "pubmed_id": "41915186", "openalex_id": "https://openalex.org/W7144218147", "source_url": "https://doi.org/10.1007/s00204-026-04365-4", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41915186", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41915186", "source_url": "https://doi.org/10.1007/s00204-026-04365-4", "doi": "10.1007/s00204-026-04365-4", "pmid": "41915186", "publication_date": "2026-03-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4054, "title": "Therapeutic Potential of Classical Psychedelics and NonHallucinogenic Psychoplastogens in Psychiatric Disorders", "authors": "Kenji Hashimoto, Feyza Arıcıoğlu, Mesut Çetin", "journal": "Psychiatry and Clinical Psychopharmacology", "publication_date": "2026-03-29", "publication_year": 2026, "doi": "10.65801/pcp.3512", "pubmed_id": null, "openalex_id": "https://openalex.org/W7143411647", "source_url": "https://doi.org/10.65801/pcp.3512", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.65801/pcp.3512", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.65801/pcp.3512", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.65801/pcp.3512", "source_url": "https://doi.org/10.65801/pcp.3512", "doi": "10.65801/pcp.3512", "pmid": "", "publication_date": "2026-03-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3478, "title": "Psilocybin Assisted Psychotherapy for Treatment Resistant Depression and Co-occurring Substance Use Disorder", "authors": "Indiana University", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-29", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07499583", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Default Mode Network,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07499583", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07499583", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07499583", "source_url": "https://clinicaltrials.gov/study/NCT07499583", "doi": "", "pmid": "", "publication_date": "2026-03-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3696, "title": "Psilocybe Cubensis Mushrooms With or Without Fluoxetine for Refractory Depression", "authors": "Federal University of Latin American Integration", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-26", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06898606", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06898606", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06898606", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06898606", "source_url": "https://clinicaltrials.gov/study/NCT06898606", "doi": "", "pmid": "", "publication_date": "2026-03-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4057, "title": "Classic psychedelic medicines for adolescent refractory mental health disease", "authors": "Aly Shah Aziz", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-03-25", "publication_year": 2026, "doi": "10.1556/2054.2026.00452", "pubmed_id": null, "openalex_id": "https://openalex.org/W7140928407", "source_url": "https://doi.org/10.1556/2054.2026.00452", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Adolescents,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2026.00452", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2026.00452", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2026.00452", "source_url": "https://doi.org/10.1556/2054.2026.00452", "doi": "10.1556/2054.2026.00452", "pmid": "", "publication_date": "2026-03-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3037, "title": "Safety and Efficacy of Psilocybin-Assisted Therapy for Alcohol Use Disorder: Open-Label Extension of a Phase II Randomized Controlled Trial", "authors": "", "journal": "PsyArXiv", "publication_date": "2026-03-25", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/7xfek_v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/7xfek_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/7xfek_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/7xfek_v1", "source_url": "https://osf.io/preprints/psyarxiv/7xfek_v1", "doi": "", "pmid": "", "publication_date": "2026-03-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 186, "title": "Psychedelic-assisted pharmacotherapy: clinical applications and regulatory considerations", "authors": "Donatella Marazziti, Matteo Gambini, Riccardo Gurrieri, Gerardo Russomanno, Giorgia Sità, Elena Pescini, FRANCESCA RITA DIGIUSEPPE, Federico Mucci", "journal": "Expert Opinion on Pharmacotherapy", "publication_date": "2026-03-23", "publication_year": 2026, "doi": "10.1080/14656566.2026.2654682", "pubmed_id": "41944071", "openalex_id": "https://openalex.org/W7151630586", "source_url": "https://doi.org/10.1080/14656566.2026.2654682", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41944071", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/14656566.2026.2654682", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41944071", "source_url": "https://doi.org/10.1080/14656566.2026.2654682", "doi": "10.1080/14656566.2026.2654682", "pmid": "41944071", "publication_date": "2026-03-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 129, "title": "Pharmacotherapy in Disorders of Consciousness: A Mechanism-Based Review.", "authors": "Gillet A, Geron C, Vitello MM, Lejeune N.", "journal": null, "publication_date": "2026-03-23", "publication_year": 2026, "doi": "10.1007/s40263-026-01274-z", "pubmed_id": "41876835", "openalex_id": null, "source_url": "https://doi.org/10.1007/s40263-026-01274-z", "substance_tags": "psilocin", "topic_tags": "Addiction,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Consciousness,Biomarkers,Aging,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:41876835", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40263-026-01274-z", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41876835", "source_url": "https://doi.org/10.1007/s40263-026-01274-z", "doi": "10.1007/s40263-026-01274-z", "pmid": "41876835", "publication_date": "2026-03-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4060, "title": "Psychedelic-Assisted Psychotherapy: Attitudes of Law Enforcement and Military Personnel", "authors": "Alexandra Hopkins, Cassandra A. Bailey, Emily Rybak, Mia M. Ricardo", "journal": "Journal of Police and Criminal Psychology", "publication_date": "2026-03-22", "publication_year": 2026, "doi": "10.1007/s11896-026-09807-4", "pubmed_id": null, "openalex_id": "https://openalex.org/W7140131017", "source_url": "https://doi.org/10.1007/s11896-026-09807-4", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 06:34:36", "bibtex": null, "source_record_id": "DOI:10.1007/s11896-026-09807-4", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s11896-026-09807-4", "source_url": "https://doi.org/10.1007/s11896-026-09807-4", "doi": "10.1007/s11896-026-09807-4", "pmid": "", "publication_date": "2026-03-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 218, "title": "Editorial: Psychedelic-assisted psychotherapies: from clinical trials to credibility", "authors": "Malkanthi Evans, Andrew Charrette", "journal": "Frontiers in Neuroscience", "publication_date": "2026-03-22", "publication_year": 2026, "doi": "10.3389/fnins.2026.1816932", "pubmed_id": "41947857", "openalex_id": "https://openalex.org/W7140128776", "source_url": "https://doi.org/10.3389/fnins.2026.1816932", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Chronic Pain,Headache / Migraine,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Aging,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41947857", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fnins.2026.1816932", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41947857", "source_url": "https://doi.org/10.3389/fnins.2026.1816932", "doi": "10.3389/fnins.2026.1816932", "pmid": "41947857", "publication_date": "2026-03-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4061, "title": "“You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practice", "authors": "Jordan J. Negrine, Stephen Bright, Monica J. Barratt, Matthew Pennell, Anthony Barnett, James Bennett-Levy, Timothy Piatkowski", "journal": "Drugs Education Prevention and Policy", "publication_date": "2026-03-21", "publication_year": 2026, "doi": "10.1080/09687637.2026.2645025", "pubmed_id": null, "openalex_id": "https://openalex.org/W7140027232", "source_url": "https://doi.org/10.1080/09687637.2026.2645025", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Safety", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1080/09687637.2026.2645025", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/09687637.2026.2645025", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/09687637.2026.2645025", "source_url": "https://doi.org/10.1080/09687637.2026.2645025", "doi": "10.1080/09687637.2026.2645025", "pmid": "", "publication_date": "2026-03-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3657, "title": "Precision Phenotyping of Behavioral Risk and Response to Electromagnetic and Psychedelic Therapies", "authors": "University of New Mexico", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-19", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07484906", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing,Observational Study,Veterans,Safety,Transcriptomics", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07484906", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07484906", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07484906", "source_url": "https://clinicaltrials.gov/study/NCT07484906", "doi": "", "pmid": "", "publication_date": "2026-03-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3582, "title": "Psilocybin for Treatment-Resistant Depression in Autism: a Pilot Trial With Pre-Post Brain and Cognitive Measurement to Understand Mechanism", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-19", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06731621", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06731621", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06731621", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06731621", "source_url": "https://clinicaltrials.gov/study/NCT06731621", "doi": "", "pmid": "", "publication_date": "2026-03-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 131, "title": "Psychological support in psychedelic-assisted therapy clinical trials: A systematic review", "authors": "Bonnie Brusky, Katia M’Baïlara, François Alla, M. Barrault", "journal": "Journal of Psychopharmacology", "publication_date": "2026-03-19", "publication_year": 2026, "doi": "10.1177/02698811261424204", "pubmed_id": "41859988", "openalex_id": "https://openalex.org/W7139121355", "source_url": "https://doi.org/10.1177/02698811261424204", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Healthcare Workers,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41859988", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811261424204", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41859988", "source_url": "https://doi.org/10.1177/02698811261424204", "doi": "10.1177/02698811261424204", "pmid": "41859988", "publication_date": "2026-03-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1975, "title": "Raman Activity Investigation and Utilization of Psilocybin", "authors": "Mingyu Sun, Xiaoyu Zhao, Fandi Kong, Jinsong Wang, Yunchang Lu, Liang Tong", "journal": "Journal of Raman Spectroscopy", "publication_date": "2026-03-18", "publication_year": 2026, "doi": "10.1002/jrs.70133", "pubmed_id": null, "openalex_id": "https://openalex.org/W7139132619", "source_url": "https://doi.org/10.1002/jrs.70133", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.1002/jrs.70133", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/jrs.70133", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/jrs.70133", "source_url": "https://doi.org/10.1002/jrs.70133", "doi": "10.1002/jrs.70133", "pmid": "", "publication_date": "2026-03-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1974, "title": "PSILOCYBIN AS AN ADJUNCTIVE TREATMENT FOR DEPRESSION AND PSYCHOLOGICAL DISTRESS IN ONCOLOGY: CURRENT EVIDENCE AND CLINICAL IMPLICATIONS", "authors": "Anna Komarczewska, Michał Kociński, Patryk Iglewski, Michał Pietrasz, Jakub Idziński, Anna Lubomska", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-03-18", "publication_year": 2026, "doi": "10.31435/ijitss.1(49).2026.5034", "pubmed_id": null, "openalex_id": "https://openalex.org/W7164003040", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.5034", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Neuroplasticity,Receptor Pharmacology,Wellbeing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.1(49).2026.5034", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.1(49).2026.5034", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.1(49).2026.5034", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.5034", "doi": "10.31435/ijitss.1(49).2026.5034", "pmid": "", "publication_date": "2026-03-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3641, "title": "Safety and Efficacy of Psilocybin-assisted Psychotherapy for Demoralization Syndrome in Patients Diagnosed With Advanced Stage Cancer: a Pilot Study", "authors": "Gustavo Vazquez", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-17", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06818994", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Aging,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06818994", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06818994", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06818994", "source_url": "https://clinicaltrials.gov/study/NCT06818994", "doi": "", "pmid": "", "publication_date": "2026-03-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 133, "title": "Efficacy and Safety of Psilocybin in Treatment-Resistant Major Depression", "authors": "Lea J. Mertens, Michael Koslowski, Felix Betzler, Manuela Brand, Ricarda Evens, Laura Kärtner, Andrea Jungaberle, Henrik Jungaberle, Tomislav Majić, Christian N. Schmitz, Andreas Ströhle, Dennis Scharf, Moritz Spangemacher, Max Wolff, Zahra Assadi, Scharif Bahri, Lilith Becher, Luca V. Färber, Niklas Kirchen, Eugenia Kulakova, Linda C. Kunz, Andy Meijer, Barbara Rohrmoser, Stefan Wellek, Moritz Berger, Gerhard Gründer", "journal": "JAMA Psychiatry", "publication_date": "2026-03-17", "publication_year": 2026, "doi": "10.1001/jamapsychiatry.2026.0132", "pubmed_id": "41848690", "openalex_id": "https://openalex.org/W7138853109", "source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0132", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41848690", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0132", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41848690", "source_url": "https://doi.org/10.1001/jamapsychiatry.2026.0132", "doi": "10.1001/jamapsychiatry.2026.0132", "pmid": "41848690", "publication_date": "2026-03-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1976, "title": "Explainable AI framework for psilocybin depression treatment optimization", "authors": "Akey Sungheetha, R. Rajesh Sharma, Oluwasegun Julius Aroba, Sheila Mahapatra, P. D. Mahendhiran", "journal": "Frontiers in Computer Science", "publication_date": "2026-03-15", "publication_year": 2026, "doi": "10.3389/fcomp.2025.1652190", "pubmed_id": null, "openalex_id": "https://openalex.org/W7136253679", "source_url": "https://doi.org/10.3389/fcomp.2025.1652190", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Brain Imaging,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.3389/fcomp.2025.1652190", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fcomp.2025.1652190", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3389/fcomp.2025.1652190", "source_url": "https://doi.org/10.3389/fcomp.2025.1652190", "doi": "10.3389/fcomp.2025.1652190", "pmid": "", "publication_date": "2026-03-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 231, "title": "The renaissance of research on psychedelics in child and adolescent psychopharmacology", "authors": "Marc-Antoine Crocq, Philippe Auby", "journal": "Child and Adolescent Psychiatry and Mental Health", "publication_date": "2026-03-12", "publication_year": 2026, "doi": "10.1186/s13034-026-01069-6", "pubmed_id": "41826990", "openalex_id": "https://openalex.org/W7135184973", "source_url": "https://doi.org/10.1186/s13034-026-01069-6", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,OCD,Eating Disorders,Neuroplasticity,Pharmacology,Receptor Pharmacology,Clinical Trial,Review Article,Adolescents,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41826990", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s13034-026-01069-6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41826990", "source_url": "https://doi.org/10.1186/s13034-026-01069-6", "doi": "10.1186/s13034-026-01069-6", "pmid": "41826990", "publication_date": "2026-03-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 134, "title": "A randomized clinical trial of repeated doses of psilocybin for the treatment of obsessive-compulsive disorder", "authors": "Francisco A. Moreno, Katja Ehrmann Allen, Christopher B. Wiegand, Rajan Dunne, James I. Prickett, Brian Bayze, John J. B. Allen", "journal": "Journal of Psychopharmacology", "publication_date": "2026-03-12", "publication_year": 2026, "doi": "10.1177/02698811261424214", "pubmed_id": "41825921", "openalex_id": "https://openalex.org/W7135170485", "source_url": "https://doi.org/10.1177/02698811261424214", "substance_tags": "psilocybin", "topic_tags": "Anxiety,OCD,Chronic Pain,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41825921", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811261424214", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41825921", "source_url": "https://doi.org/10.1177/02698811261424214", "doi": "10.1177/02698811261424214", "pmid": "41825921", "publication_date": "2026-03-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 82, "title": "Psychedelics for treatment of negative symptoms and depressive symptoms in schizophrenia spectrum disorder: A narrative review", "authors": "Michel Sabé, Paul Grof, Nathan Sackett, Sara Tai, Pamela Kryskow, Anya K. Bershad, Douglas Turkington, Matteo Buonarroti, Marco De Pieri, Pantelis Baniotopoulos, Mickael Eskinazi, Kerem Böge, Stefan Leucht, Federico Seragnoli, Leonice Furtado, Tatiana Aboulafia Brakha, Logos Curtis, Matthias Kirschner, Stefan Kaiser, Louise Penzenstadler, Daniele Zullino, Mikkel Højlund, Jade Gallo, Marco Solmi, Jacopo Sapienza, Marta Bosia, Joseph La Torre", "journal": "Schizophrenia Research", "publication_date": "2026-03-12", "publication_year": 2026, "doi": "10.1016/j.schres.2026.03.003", "pubmed_id": "41830808", "openalex_id": "https://openalex.org/W7135185290", "source_url": "https://doi.org/10.1016/j.schres.2026.03.003", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Default Mode Network,Review Article,Case Report,Animal Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41830808", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.schres.2026.03.003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41830808", "source_url": "https://doi.org/10.1016/j.schres.2026.03.003", "doi": "10.1016/j.schres.2026.03.003", "pmid": "41830808", "publication_date": "2026-03-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3517, "title": "Psilocybin-facilitated Treatment for Chronic Pain", "authors": "University of Alabama at Birmingham", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05068791", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Personality Change,Emotional Processing,Mystical Experience,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05068791", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05068791", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05068791", "source_url": "https://clinicaltrials.gov/study/NCT05068791", "doi": "", "pmid": "", "publication_date": "2026-03-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3473, "title": "Safety, Feasibility, and Tolerability of Psilocybin Treatment for Individuals With Functional Impairment Related to Mood, Anxiety, Trauma and/or Addiction Symptoms: An Open-label Proof-of-concept Study", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-10", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06442423", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Receptor Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06442423", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06442423", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06442423", "source_url": "https://clinicaltrials.gov/study/NCT06442423", "doi": "", "pmid": "", "publication_date": "2026-03-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 233, "title": "Strategic Neurodelivery of Psychedelic Compounds: Bridging MolecularPharmacology with Therapeutic Innovation in CNS Disorders", "authors": "Shikha Baghel Chauhan, Naziya Akhtar, chirag Jain, Indu Singh", "journal": "CNS & Neurological Disorders - Drug Targets", "publication_date": "2026-03-10", "publication_year": 2026, "doi": "10.2174/0118715273434237251212095005", "pubmed_id": "41833044", "openalex_id": "https://openalex.org/W7135100807", "source_url": "https://doi.org/10.2174/0118715273434237251212095005", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41833044", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2174/0118715273434237251212095005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41833044", "source_url": "https://doi.org/10.2174/0118715273434237251212095005", "doi": "10.2174/0118715273434237251212095005", "pmid": "41833044", "publication_date": "2026-03-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3228, "title": "Age moderates the relationship between psychedelics use and mental health in naturalistic settings", "authors": "Gregorio GD, Basset S, Manmohan H, Nixon WC, Pogaku A, Zhou J, Sanderson DJ, Lengieza ML, Bocchio M.", "journal": "Research Square", "publication_date": "2026-03-09", "publication_year": 2026, "doi": "10.21203/rs.3.rs-9022170/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-9022170/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Longevity,Mystical Experience,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-9022170/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-9022170/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-9022170/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-9022170/v1", "doi": "10.21203/rs.3.rs-9022170/v1", "pmid": "", "publication_date": "2026-03-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3028, "title": "Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response", "authors": "Floris G, Jefferson SJ, Rondeau J, Yu AL, Menniti FS, Kwan AC, De Aquino JP, Krystal JH, Pittenger C, Kaye AP.", "journal": "bioRxiv", "publication_date": "2026-03-09", "publication_year": 2026, "doi": "10.64898/2026.03.06.710108", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2026.03.06.710108", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Safety,Proteomics", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.64898/2026.03.06.710108", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.64898/2026.03.06.710108", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.64898/2026.03.06.710108", "source_url": "https://doi.org/10.64898/2026.03.06.710108", "doi": "10.64898/2026.03.06.710108", "pmid": "", "publication_date": "2026-03-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3654, "title": "An Open-Label, Phase 1 Study of the Safety Pharmacokinetic Profile, and Preliminary Efficacy, of Organic Whole Psilocybin-Containing Mushrooms in Patients Suffering From PTSD", "authors": "Suzanne \"Sue\" Sisley MD", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-08", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07275970", "substance_tags": "psilocybin", "topic_tags": "PTSD,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07275970", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07275970", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07275970", "source_url": "https://clinicaltrials.gov/study/NCT07275970", "doi": "", "pmid": "", "publication_date": "2026-03-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1978, "title": "Behavioural investigations of psilocybin in non-human animals 1962-2021: A scoping review", "authors": "Shore Ronald, Dobson Kat, Thomson Nina, Barnim Nigel, Bergman Hailey, Rideout Katie, McKeown Sandra, Olmstead Mary C., Goldie Craig, Dumont Eric", "journal": "Journal of Psychedelic Studies", "publication_date": "2026-03-08", "publication_year": 2026, "doi": "10.1556/2054.2025.00364", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1556/2054.2025.00364", "substance_tags": "psilocybin,psilocin", "topic_tags": "Mechanism of Action,Review Article,Safety,Adverse Events,Toxicity", "study_type": "Review Article", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-01 11:21:33", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2025.00364", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.1556/2054.2025.00364", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.1556/2054.2025.00364", "source_url": "https://doi.org/10.1556/2054.2025.00364", "doi": "10.1556/2054.2025.00364", "pmid": "", "publication_date": "2026-03-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3296, "title": "Substance-induced manic psychosis in which delusions were corroborated by a chatbot - case report", "authors": "Shah S, Morrin H.", "journal": "Research Square", "publication_date": "2026-03-07", "publication_year": 2026, "doi": "10.21203/rs.3.rs-8919841/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8919841/v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Spirituality,Case Report,Healthcare Workers,Safety,Drug Interactions", "study_type": "Case Report", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8919841/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8919841/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8919841/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8919841/v1", "doi": "10.21203/rs.3.rs-8919841/v1", "pmid": "", "publication_date": "2026-03-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 237, "title": "The combination of exercise and psychedelics for the treatment of major depressive disorder.", "authors": "Fabiano N, Stubbs B, Lawrence DW, Rosenblat JD, Teixeira PJ, Wong S, Zhou C, Carhart-Harris R", "journal": "Discover mental health", "publication_date": "2026-03-06", "publication_year": 2026, "doi": "10.1007/s44192-026-00408-5", "pubmed_id": "41793582", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41793582/", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Neurogenesis,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Resilience,Emotional Processing,Psychological Flexibility,Safety,Inflammation", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:20:34", "bibtex": null, "source_record_id": "PMID:41793582", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41793582/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41793582", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41793582/", "doi": "10.1007/s44192-026-00408-5", "pmid": "41793582", "publication_date": "2026-03-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3626, "title": "The Therapeutic Potential of Psilocybin in Anorexia Nervosa in Young Adults", "authors": "Region Skane", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-05", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07169747", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Eating Disorders,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Biomarkers,Aging,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Adolescents,Healthcare Workers,Safety,Adverse Events,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07169747", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07169747", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07169747", "source_url": "https://clinicaltrials.gov/study/NCT07169747", "doi": "", "pmid": "", "publication_date": "2026-03-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3497, "title": "Examining the Safety and Clinical Efficacy of Psilocybin Therapy for Veterans With PTSD: An Open-Label Proof-of-Concept Trial", "authors": "Ohio State University", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-03", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05554094", "substance_tags": "psilocybin", "topic_tags": "PTSD,Veterans,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05554094", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05554094", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05554094", "source_url": "https://clinicaltrials.gov/study/NCT05554094", "doi": "", "pmid": "", "publication_date": "2026-03-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 240, "title": "Efficacy and risks of psychedelics in the treatment of posttraumatic stress disorder: A systematic review", "authors": "Jennifer E. Thomas, Anna Dellarole, Joshua Caballero", "journal": "American Journal of Health-System Pharmacy", "publication_date": "2026-03-03", "publication_year": 2026, "doi": "10.1093/ajhp/zxag062", "pubmed_id": "41784123", "openalex_id": "https://openalex.org/W7133953253", "source_url": "https://doi.org/10.1093/ajhp/zxag062", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Veterans,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41784123", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ajhp/zxag062", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41784123", "source_url": "https://doi.org/10.1093/ajhp/zxag062", "doi": "10.1093/ajhp/zxag062", "pmid": "41784123", "publication_date": "2026-03-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3616, "title": "A Phase 2b Double-blind, Randomized, Low-dose Comparator-controlled Clinical Trial to Assess the Efficacy and Safety of NPX-5 in Psilocybin-assisted Psychotherapy for the Treatment of Adjustment Disorder Associated With Cancer.", "authors": "Psyence Australia Pty Ltd", "journal": "ClinicalTrials.gov", "publication_date": "2026-03-02", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07072728", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07072728", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07072728", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07072728", "source_url": "https://clinicaltrials.gov/study/NCT07072728", "doi": "", "pmid": "", "publication_date": "2026-03-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 258, "title": "Meaning and Psychedelics in Palliative Care: A Narrative Review.", "authors": "Alexander WB, Hansen ED, Anderson BT, Zarrabi AJ, Rogers AH, Loewen G, Ficarro ZR, Alexander MH, Schaefer D, Case AA", "journal": "Journal of pain and symptom management", "publication_date": "2026-02-28", "publication_year": 2026, "doi": "10.1016/j.jpainsymman.2025.10.015", "pubmed_id": "41173063", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41173063/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:41173063", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41173063/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41173063", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41173063/", "doi": "10.1016/j.jpainsymman.2025.10.015", "pmid": "41173063", "publication_date": "2026-02-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 206, "title": "Psychedelic exposure in pregnancy: a scoping review to inform perinatal drug safety and clinical counseling", "authors": "Ovie Martin Albert, Alexander Arthur", "journal": "Therapeutic Advances in Drug Safety", "publication_date": "2026-02-28", "publication_year": 2026, "doi": "10.1177/20420986261436104", "pubmed_id": "41930230", "openalex_id": "https://openalex.org/W7143884623", "source_url": "https://doi.org/10.1177/20420986261436104", "substance_tags": "psilocybin", "topic_tags": "Meta-Analysis,Review Article,Case Report,Observational Study,Healthcare Workers,Safety,Toxicity", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41930230", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20420986261436104", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41930230", "source_url": "https://doi.org/10.1177/20420986261436104", "doi": "10.1177/20420986261436104", "pmid": "41930230", "publication_date": "2026-02-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4076, "title": "Psilocybin-assisted therapy for major depressive disorder: implications for clinical effectiveness, health economics, and regulatory decision-making", "authors": "C Faria, Diana Dias da Silva, João José Sousa", "journal": "Instituto Politécnico do Porto", "publication_date": "2026-02-26", "publication_year": 2026, "doi": "10.26537/prpaeh.v4i3.7173", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166641777", "source_url": "https://doi.org/10.26537/prpaeh.v4i3.7173", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.26537/prpaeh.v4i3.7173", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.26537/prpaeh.v4i3.7173", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26537/prpaeh.v4i3.7173", "source_url": "https://doi.org/10.26537/prpaeh.v4i3.7173", "doi": "10.26537/prpaeh.v4i3.7173", "pmid": "", "publication_date": "2026-02-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 247, "title": "Pharmacological regulation of adult brain neuroplasticity: Synergistic roles of neuropeptide signaling, psychedelics, and synaptic modulators.", "authors": "Shokr MM, Fawzy MN, Abdelaziz AM.", "journal": null, "publication_date": "2026-02-25", "publication_year": 2026, "doi": "10.1016/j.mcn.2026.104076", "pubmed_id": "41763341", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.mcn.2026.104076", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Resilience,Emotional Processing,Review Article,Animal Study,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:41763341", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.mcn.2026.104076", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41763341", "source_url": "https://doi.org/10.1016/j.mcn.2026.104076", "doi": "10.1016/j.mcn.2026.104076", "pmid": "41763341", "publication_date": "2026-02-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 83, "title": "Psilocybin for psychiatric disorders: History, clinical trials, neuroimaging, and regulations", "authors": "Kengo Yonezawa, M. Hirata, Hiroaki Takano, Keisuke Kusudo, Sota Tomiyama, Lisa Harada, Kota Suzuki, DJ Nutt, H. Uchida, Hideaki Tani", "journal": "Psychiatry and Clinical Neurosciences", "publication_date": "2026-02-25", "publication_year": 2026, "doi": "10.1111/pcn.70042", "pubmed_id": "41749057", "openalex_id": "https://openalex.org/W7131868995", "source_url": "https://doi.org/10.1111/pcn.70042", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,End-of-Life Distress,Chronic Pain,Brain Imaging,Aging,Spirituality,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "PMID:41749057", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/pcn.70042", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41749057", "source_url": "https://doi.org/10.1111/pcn.70042", "doi": "10.1111/pcn.70042", "pmid": "41749057", "publication_date": "2026-02-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4078, "title": "Psilocin as a Broad Inhibitor of CYP450 Enzymes: Integrated In Vitro and In Silico Evidence", "authors": "Diana Silva, Andreia Machado Brito-da-Costa, Mariana Carvalho, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho, Sérgio F. Sousa", "journal": "Instituto Politécnico do Porto", "publication_date": "2026-02-24", "publication_year": 2026, "doi": "10.26537/prpaeh.v4i3.7159", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166650553", "source_url": "https://doi.org/10.26537/prpaeh.v4i3.7159", "substance_tags": "psilocybin,psilocin", "topic_tags": "Neuroplasticity,Pharmacology,In Vitro Study,Safety,Toxicity,Drug Interactions", "study_type": "In Vitro Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:31", "bibtex": null, "source_record_id": "DOI:10.26537/prpaeh.v4i3.7159", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.26537/prpaeh.v4i3.7159", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26537/prpaeh.v4i3.7159", "source_url": "https://doi.org/10.26537/prpaeh.v4i3.7159", "doi": "10.26537/prpaeh.v4i3.7159", "pmid": "", "publication_date": "2026-02-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 244, "title": "Efficacy and Safety of Psychoactive Tryptamines in Addiction: A Systematic Review.", "authors": "van der Meer PB, Schukking N, Dik M, van Reemst A, Fuentes JJ, Kaptein AA, Schoones JW, Verboeket S, de Waal MM, Goudriaan AE, Kramers C, Schellekens A, Bossong MG, Somers M, Batalla A.", "journal": null, "publication_date": "2026-02-23", "publication_year": 2026, "doi": "10.1177/28314425251364182", "pubmed_id": "42130778", "openalex_id": null, "source_url": "https://doi.org/10.1177/28314425251364182", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:42130778", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/28314425251364182", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42130778", "source_url": "https://doi.org/10.1177/28314425251364182", "doi": "10.1177/28314425251364182", "pmid": "42130778", "publication_date": "2026-02-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3602, "title": "Safety for Home Administration of Microdose Psilocybin Use", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06450210", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06450210", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06450210", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06450210", "source_url": "https://clinicaltrials.gov/study/NCT06450210", "doi": "", "pmid": "", "publication_date": "2026-02-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3032, "title": "Safety and Efficacy of Microdosing Psilocybin over 8 Weeks for Major Depressive Disorder: A Randomized Clinical Trial", "authors": "Petranker R, Farb N, Syed O, Li E, Shore D, Anderson T, Blackman A.", "journal": "Research Square", "publication_date": "2026-02-22", "publication_year": 2026, "doi": "10.21203/rs.3.rs-8319478/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8319478/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8319478/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8319478/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8319478/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8319478/v1", "doi": "10.21203/rs.3.rs-8319478/v1", "pmid": "", "publication_date": "2026-02-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3182, "title": "Ethical Complexities and Best Practices in Informed Consent for Psychedelic Services: A Qualitative Study on Expert Perspectives", "authors": "", "journal": "PsyArXiv", "publication_date": "2026-02-18", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/mdz73_v2", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/mdz73_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/mdz73_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/mdz73_v2", "source_url": "https://osf.io/preprints/psyarxiv/mdz73_v2", "doi": "", "pmid": "", "publication_date": "2026-02-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3520, "title": "Pilot Study of Psilocybin-Assisted Therapy for Demoralization in Patients Receiving Hospice Care - PATH Study", "authors": "Yvan Beaussant, MD, MSci", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-16", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04950608", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Cancer Patients,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04950608", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04950608", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04950608", "source_url": "https://clinicaltrials.gov/study/NCT04950608", "doi": "", "pmid": "", "publication_date": "2026-02-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 269, "title": "Microdosing psilocybin for major depressive disorder: study protocol for a phase II double-blind placebo-controlled randomised partial crossover trial", "authors": "Zeina Beidas, Anya Ragnhildstveit, Adam Blackman, Thomas Anderson, Emily C. Fewster, Omer A. Syed, Valentyne Sobolenko, Ismail Kaan Kanca, Magdalena Jaglinska, Tatiana Son, Norman Farb, Rotem Petranker", "journal": "BJPsych Open", "publication_date": "2026-02-15", "publication_year": 2026, "doi": "10.1192/bjo.2025.10968", "pubmed_id": "41693474", "openalex_id": "https://openalex.org/W7129015437", "source_url": "https://doi.org/10.1192/bjo.2025.10968", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Microdosing,Wellbeing,Creativity,Clinical Trial,Randomized Controlled Trial,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41693474", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2025.10968", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41693474", "source_url": "https://doi.org/10.1192/bjo.2025.10968", "doi": "10.1192/bjo.2025.10968", "pmid": "41693474", "publication_date": "2026-02-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3541, "title": "A Phase 1 Translational Study to Assess Brain Activity Using Functional Magnetic Resonance Imaging (fMRI) and to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Volunteers", "authors": "MycoMedica Life Sciences PBC", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07050368", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Pharmacology,Aging,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07050368", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07050368", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07050368", "source_url": "https://clinicaltrials.gov/study/NCT07050368", "doi": "", "pmid": "", "publication_date": "2026-02-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3425, "title": "Psychedelic Healing: Adjunct Therapy Harnessing Opened Malleability", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-12", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07053917", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07053917", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07053917", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07053917", "source_url": "https://clinicaltrials.gov/study/NCT07053917", "doi": "", "pmid": "", "publication_date": "2026-02-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3704, "title": "Single Dose Psilocybin for a Post-surgical Trauma Inpatient Population for Pain, Mood, and Opioid Use Disorder", "authors": "Trent Emerick", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07406828", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Review Article,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07406828", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07406828", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07406828", "source_url": "https://clinicaltrials.gov/study/NCT07406828", "doi": "", "pmid": "", "publication_date": "2026-02-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3624, "title": "Psilocybin-assisted Therapy for Comorbid Major Depressive Disorder and Alcohol Use Disorder: A Pilot Randomized Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07405606", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07405606", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07405606", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07405606", "source_url": "https://clinicaltrials.gov/study/NCT07405606", "doi": "", "pmid": "", "publication_date": "2026-02-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 86, "title": "Therapeutic effects of psilocybin in major depressive disorder: a systematic review and meta-analysis exploring dose effects", "authors": "Ziping He, Yijie Wang, Jie Chen, Junzhe Cheng, Yuxin Feng, Shuliang Niu, J. Yan", "journal": "European Archives of Psychiatry and Clinical Neuroscience", "publication_date": "2026-02-11", "publication_year": 2026, "doi": "10.1007/s00406-025-02165-y", "pubmed_id": "41677823", "openalex_id": "https://openalex.org/W7128718542", "source_url": "https://doi.org/10.1007/s00406-025-02165-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41677823", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41677823", "source_url": "https://doi.org/10.1007/s00406-025-02165-y", "doi": "10.1007/s00406-025-02165-y", "pmid": "41677823", "publication_date": "2026-02-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 222, "title": "Psychedelics in functional disorders: A scoping review", "authors": "Chiranth Bhagavan, Olivia P. Carter, Alexander Bryson, Orwa Dandash, Richard Kanaan", "journal": "Progress in Neuro-Psychopharmacology and Biological Psychiatry", "publication_date": "2026-02-09", "publication_year": 2026, "doi": "10.1016/j.pnpbp.2026.111642", "pubmed_id": "41679377", "openalex_id": "https://openalex.org/W7128528342", "source_url": "https://doi.org/10.1016/j.pnpbp.2026.111642", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Review Article,Observational Study,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41679377", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2026.111642", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41679377", "source_url": "https://doi.org/10.1016/j.pnpbp.2026.111642", "doi": "10.1016/j.pnpbp.2026.111642", "pmid": "41679377", "publication_date": "2026-02-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3690, "title": "Safety and Psychological Effects of Psilocybin and D-Serine Formulation in Healthy Volunteers", "authors": "Hadassah Medical Organization", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07079930", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Consciousness,Biomarkers,Clinical Trial,Observational Study,Animal Study,Healthy Volunteers,Safety,Toxicity,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07079930", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07079930", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07079930", "source_url": "https://clinicaltrials.gov/study/NCT07079930", "doi": "", "pmid": "", "publication_date": "2026-02-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3550, "title": "A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Oral Psilocybin (TRP-8802) Administration in Concert With Psychotherapy Among Adult Patients With Irritable Bowel Syndrome: A Randomized Delayed Treatment Control Design", "authors": "TRYP Therapeutics", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06206265", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Brain Imaging,Aging,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06206265", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06206265", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06206265", "source_url": "https://clinicaltrials.gov/study/NCT06206265", "doi": "", "pmid": "", "publication_date": "2026-02-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3486, "title": "Psilocybin AsSisted pSychotherapy for the treatmENt of Gambling disordER: a Pilot Study", "authors": "Nantes University Hospital", "journal": "ClinicalTrials.gov", "publication_date": "2026-02-04", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07391332", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07391332", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07391332", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07391332", "source_url": "https://clinicaltrials.gov/study/NCT07391332", "doi": "", "pmid": "", "publication_date": "2026-02-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 250, "title": "Cardiac Consequences Associated with Psychedelic Use: A Systematic Review of Lysergic Acid Diethylamide, 3,4-Methylenedioxymethamphetamine, and 5-Hydroxytryptamine 2B-Mediated Valvular Heart Disease", "authors": "Tianyi Xu, Sabrina Wong, Gia Han Le, Christine E. Dri, Kayla M. Teopiz, Andy Lu, Serene M. L. Lee, Taeho Greg Rhee, Liyang Yin, Stavroula I. Bargiota, Roger Ho, Roger S. McIntyre", "journal": "Pharmacopsychiatry", "publication_date": "2026-02-04", "publication_year": 2026, "doi": "10.1055/a-2794-6487", "pubmed_id": "41643722", "openalex_id": "https://openalex.org/W7128030169", "source_url": "https://doi.org/10.1055/a-2794-6487", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Animal Study,In Vitro Study,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41643722", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/a-2794-6487", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41643722", "source_url": "https://doi.org/10.1055/a-2794-6487", "doi": "10.1055/a-2794-6487", "pmid": "41643722", "publication_date": "2026-02-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 138, "title": "Challenges with clinical trial participants in studies with classical psychedelics: A position statement from the National Network of Depression Centers’ task group on psychedelics and related compounds", "authors": "Benjamin R. Lewis, M. Carrington Reid, Andrew M. Novick, Kevin Byrne, Mark J. Niciu, Gregory A. Fonzo, Thomas D. Meyer, David Feifel, Rif S. El-Mallakh, Jair Soares, Trisha Suppes, Frederick S. Barrett", "journal": "Journal of Psychopharmacology", "publication_date": "2026-02-04", "publication_year": 2026, "doi": "10.1177/02698811251413490", "pubmed_id": "41645048", "openalex_id": "https://openalex.org/W7128008256", "source_url": "https://doi.org/10.1177/02698811251413490", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Healthcare Workers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41645048", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811251413490", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41645048", "source_url": "https://doi.org/10.1177/02698811251413490", "doi": "10.1177/02698811251413490", "pmid": "41645048", "publication_date": "2026-02-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3272, "title": "Can LLMs Get High? A Dual-Metric Framework for Evaluating Psychedelic Simulation and Safety in Large Language Models", "authors": "Ben-Zion Z, Simon G, Lazebnik T.", "journal": "Research Square", "publication_date": "2026-02-01", "publication_year": 2026, "doi": "10.21203/rs.3.rs-8682370/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8682370/v1", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Mystical Experience,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8682370/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8682370/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8682370/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8682370/v1", "doi": "10.21203/rs.3.rs-8682370/v1", "pmid": "", "publication_date": "2026-02-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 295, "title": "Difficulties following naturalistic psychedelic use and associations with adverse childhood experiences.", "authors": "Olofsson M, Osika W, Goldberg SB, Hendricks PS, Petrovic P, White T, Stenfors CUD, Chaturvedi S, Simonsson O", "journal": "The International journal on drug policy", "publication_date": "2026-01-31", "publication_year": 2026, "doi": "10.1016/j.drugpo.2025.105105", "pubmed_id": "41389560", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41389560/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Safety", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:41389560", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41389560/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41389560", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41389560/", "doi": "10.1016/j.drugpo.2025.105105", "pmid": "41389560", "publication_date": "2026-01-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 288, "title": "Participant Experiences of Therapeutic Touch in Psilocybin-Assisted Therapy", "authors": "Rachel Ham, John Gardner, Adrian Carter, Paul Liknaitzky", "journal": "Brain and Behavior", "publication_date": "2026-01-31", "publication_year": 2026, "doi": "10.1002/brb3.71262", "pubmed_id": "41699875", "openalex_id": "https://openalex.org/W7129297531", "source_url": "https://doi.org/10.1002/brb3.71262", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Emotional Processing,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41699875", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/brb3.71262", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41699875", "source_url": "https://doi.org/10.1002/brb3.71262", "doi": "10.1002/brb3.71262", "pmid": "41699875", "publication_date": "2026-01-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4097, "title": "Protecting patient autonomy in psychedelic-assisted psychotherapy: a nursing ethics perspective", "authors": "Aditi Kanwar, Nitin Jeengar, Pramod Kumar Ashaiya", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-01-29", "publication_year": 2026, "doi": "10.5281/zenodo.18425838", "pubmed_id": null, "openalex_id": "https://openalex.org/W7126227261", "source_url": "https://doi.org/10.5281/zenodo.18425838", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Consciousness,Emotional Processing,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18425838", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18425838", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18425838", "source_url": "https://doi.org/10.5281/zenodo.18425838", "doi": "10.5281/zenodo.18425838", "pmid": "", "publication_date": "2026-01-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1989, "title": "PSILOCYBIN IN PSYCHIATRIC PRACTICE AND PSYCHEDELIC-ASSISTED THERAPY FOR TREATMENT-RESISTANT DEPRESSION", "authors": "Łukasz Deska, Cezary Kosmecki, Dawid Głaz, Natalia Kamińska, Wojciech Sołtys, Magdalena Stolarczyk, Maksymilian Głaz, Mateusz Stronczyński, Aleksandra Jagura-Sukiennik, Julia Wawerska", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-01-27", "publication_year": 2026, "doi": "10.31435/ijitss.1(49).2026.4711", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125929049", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4711", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4711", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4711", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4711", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4711", "doi": "10.31435/ijitss.1(49).2026.4711", "pmid": "", "publication_date": "2026-01-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4101, "title": "Psychedelics in psychiatric treatment: a literature review", "authors": "Adam Wolski, Ewa Szplit, Mikołaj Franciszek Patalong, Roman Cemaga, Mateusz Kubicki, Przemysław Kołodziej, Natalia Bruska, Bartłomiej Błaszkowski, Andrii Bilyk, Katarzyna Więckowska", "journal": "Quality in Sport", "publication_date": "2026-01-25", "publication_year": 2026, "doi": "10.12775/qs.2026.50.68013", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125801196", "source_url": "https://doi.org/10.12775/qs.2026.50.68013", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.12775/qs.2026.50.68013", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/qs.2026.50.68013", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/qs.2026.50.68013", "source_url": "https://doi.org/10.12775/qs.2026.50.68013", "doi": "10.12775/qs.2026.50.68013", "pmid": "", "publication_date": "2026-01-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4100, "title": "The therapeutic efficacy of psilocybin in major depressive disorder: A review of recent clinical and mechanistic evidence", "authors": "Fernando Mora López, Johynny Solís Solís, Ekaterina Daniela Hernández Baker, Olger Herrera Barboza, David Diaz Polo, Daniela Consumi Cordero", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-01-25", "publication_year": 2026, "doi": "10.5281/zenodo.18375715", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125699554", "source_url": "https://doi.org/10.5281/zenodo.18375715", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Aging,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18375715", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18375715", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18375715", "source_url": "https://doi.org/10.5281/zenodo.18375715", "doi": "10.5281/zenodo.18375715", "pmid": "", "publication_date": "2026-01-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 249, "title": "Self-medication with psychedelics: a scoping review and narrative synthesis of review-level evidence", "authors": "S Shiju, Rohan P. Tirumala, Elliot Marseille", "journal": "Exploratory Research in Clinical and Social Pharmacy", "publication_date": "2026-01-25", "publication_year": 2026, "doi": "10.1016/j.rcsop.2026.100709", "pubmed_id": "41674667", "openalex_id": "https://openalex.org/W7125712119", "source_url": "https://doi.org/10.1016/j.rcsop.2026.100709", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Microdosing,Review Article,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41674667", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.rcsop.2026.100709", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41674667", "source_url": "https://doi.org/10.1016/j.rcsop.2026.100709", "doi": "10.1016/j.rcsop.2026.100709", "pmid": "41674667", "publication_date": "2026-01-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1991, "title": "The Evaluation of the Efficacy and Safety of the Use of Psilocybin in the Treatment of Adults with Treatment-Resistant Depression", "authors": "Rishika Scott, James Smith", "journal": "Emerging Minds Journal for Student Research", "publication_date": "2026-01-24", "publication_year": 2026, "doi": "10.59973/emjsr.317", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125652025", "source_url": "https://doi.org/10.59973/emjsr.317", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.59973/emjsr.317", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.59973/emjsr.317", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.59973/emjsr.317", "source_url": "https://doi.org/10.59973/emjsr.317", "doi": "10.59973/emjsr.317", "pmid": "", "publication_date": "2026-01-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3673, "title": "A Phase 2 Trial of Psilocybin as an Adjunctive Treatment for OUD Patients Who Continue to Use Illicit Opioids Despite Adherence to Methadone Treatment", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2026-01-22", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06796062", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06796062", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06796062", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06796062", "source_url": "https://clinicaltrials.gov/study/NCT06796062", "doi": "", "pmid": "", "publication_date": "2026-01-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1992, "title": "THE PSYCHEDELIC RENAISSANCE: A SYSTEMATIC REVIEW OF PSILOCYBIN AND LSD IN THE TREATMENT OF PSYCHIATRIC DISORDERS", "authors": "Jakub Klepacz, Radosław Swędrak, Marzena Swojnóg, Zuzanna Dobrakowska", "journal": "International Journal of Innovative Technologies in Social Science", "publication_date": "2026-01-22", "publication_year": 2026, "doi": "10.31435/ijitss.1(49).2026.4582", "pubmed_id": null, "openalex_id": "https://openalex.org/W7127606273", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4582", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4582", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4582", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.31435/ijitss.1(49).2026.4582", "source_url": "https://doi.org/10.31435/ijitss.1(49).2026.4582", "doi": "10.31435/ijitss.1(49).2026.4582", "pmid": "", "publication_date": "2026-01-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 196, "title": "Consistency of protocol and safety data reporting in clinical trial registrations and corresponding publications of interventions involving MDMA and psilocybin", "authors": "Marija Franka Žuljević, Antonija Mijatović, Renata Orhanović, Glenn Goasdoué, Diana Gujinović", "journal": "Journal of Clinical Epidemiology", "publication_date": "2026-01-22", "publication_year": 2026, "doi": "10.1016/j.jclinepi.2026.112170", "pubmed_id": "41581835", "openalex_id": "https://openalex.org/W7125471543", "source_url": "https://doi.org/10.1016/j.jclinepi.2026.112170", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41581835", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41581835", "source_url": "https://doi.org/10.1016/j.jclinepi.2026.112170", "doi": "10.1016/j.jclinepi.2026.112170", "pmid": "41581835", "publication_date": "2026-01-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4106, "title": "Does psilocybin help with mental health conditions?", "authors": "Tripdatabase", "journal": "Zenodo (CERN European Organization for Nuclear Research)", "publication_date": "2026-01-21", "publication_year": 2026, "doi": "10.5281/zenodo.18339283", "pubmed_id": null, "openalex_id": "https://openalex.org/W7125428177", "source_url": "https://doi.org/10.5281/zenodo.18339283", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.5281/zenodo.18339283", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5281/zenodo.18339283", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5281/zenodo.18339283", "source_url": "https://doi.org/10.5281/zenodo.18339283", "doi": "10.5281/zenodo.18339283", "pmid": "", "publication_date": "2026-01-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3703, "title": "The STARLIGHT Protocol: State-Funded Trial Assessing Recovery and Long-Term Impact of Guided Psilocybin for Healing Trauma", "authors": "Baylor College of Medicine", "journal": "ClinicalTrials.gov", "publication_date": "2026-01-21", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06888128", "substance_tags": "psilocybin", "topic_tags": "PTSD,Veterans,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06888128", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06888128", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06888128", "source_url": "https://clinicaltrials.gov/study/NCT06888128", "doi": "", "pmid": "", "publication_date": "2026-01-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4108, "title": "Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy: A Systematic Review and Meta-Analysis.", "authors": "Florineth, Gianluca Andri, Klima, Isabell, Boeker, Anna Laura, Catzeflis, Polina, Wopfner, Alexander, Denier, Niklaus, Bracht, Tobias, Adorjan, Kristina, Pfammatter, Mario, Müller, Felix, Soravia, Leila Maria", "journal": "Open Access CRIS of the University of Bern", "publication_date": "2026-01-20", "publication_year": 2026, "doi": "10.48620/94398", "pubmed_id": null, "openalex_id": "https://openalex.org/W7128014083", "source_url": "https://doi.org/10.48620/94398", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Case Report,Safety,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:36", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.48620/94398", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.48620/94398", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.48620/94398", "source_url": "https://doi.org/10.48620/94398", "doi": "10.48620/94398", "pmid": "", "publication_date": "2026-01-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 334, "title": "Psychological Therapy Quantity and Depressive Symptom Reduction in Psychedelic-Assisted Therapy", "authors": "Gianluca Andri Florineth, Isabell Klima, Anna Laura Boeker, Polina Catzeflis, Alexander Wopfner, Niklaus Denier, Tobias Bracht, Kristina Adorjan, Mario Pfammatter, Felix Müller, Leila Maria Soravia", "journal": "JAMA Network Open", "publication_date": "2026-01-20", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2025.54843", "pubmed_id": "41563753", "openalex_id": "https://openalex.org/W7125277592", "source_url": "https://doi.org/10.1001/jamanetworkopen.2025.54843", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Microdosing,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Case Report,Safety,Toxicity,Drug Interactions", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41563753", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2025.54843", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41563753", "source_url": "https://doi.org/10.1001/jamanetworkopen.2025.54843", "doi": "10.1001/jamanetworkopen.2025.54843", "pmid": "41563753", "publication_date": "2026-01-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 141, "title": "Insights into psilocybin use among people with bipolar disorder: A thematic analysis of Reddit posts", "authors": "Laura Mills, Susan L. Rossell, Sean Carruthers", "journal": "Journal of Affective Disorders", "publication_date": "2026-01-19", "publication_year": 2026, "doi": "10.1016/j.jad.2026.121220", "pubmed_id": "41571194", "openalex_id": "https://openalex.org/W7124978464", "source_url": "https://doi.org/10.1016/j.jad.2026.121220", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41571194", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.jad.2026.121220", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41571194", "source_url": "https://doi.org/10.1016/j.jad.2026.121220", "doi": "10.1016/j.jad.2026.121220", "pmid": "41571194", "publication_date": "2026-01-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1993, "title": "Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Symptoms of Anxiety and Depression: Safety and Efficacy Outcomes of a Phase 1/2 Study", "authors": "Anthony L. Back, Bonnie A. McGregor, Leslie Lazar Thorn, Kelsey K. Baker, T. Gooley, Mendel Kaelen, Kalin Harvey, John M. Guy, Susanna Myers, Juliana Pérez, Peter Thompson, Lindsay Billingsley, Cheryl Sesnon", "journal": "Psychedelic Medicine", "publication_date": "2026-01-17", "publication_year": 2026, "doi": "10.1177/28314425251413856", "pubmed_id": null, "openalex_id": "https://openalex.org/W7124682544", "source_url": "https://doi.org/10.1177/28314425251413856", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Observational Study,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251413856", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251413856", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251413856", "source_url": "https://doi.org/10.1177/28314425251413856", "doi": "10.1177/28314425251413856", "pmid": "", "publication_date": "2026-01-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3029, "title": "Psilocybin for Treatment-Resistant OCD: A Randomized Controlled Trial", "authors": "", "journal": "PsyArXiv", "publication_date": "2026-01-14", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/atfum_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/atfum_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/atfum_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/atfum_v1", "source_url": "https://osf.io/preprints/psyarxiv/atfum_v1", "doi": "", "pmid": "", "publication_date": "2026-01-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 184, "title": "The Psychological Support Model in Psilocybin Research: Psychotherapy in Disguise?", "authors": "Celia Faye Jacobsen, Dea Siggaard Stenbæk, Stig Poulsen, Sophia Armand", "journal": "Psychiatric Research and Clinical Practice", "publication_date": "2026-01-13", "publication_year": 2026, "doi": "10.1176/appi.prcp.20250113", "pubmed_id": "42022021", "openalex_id": "https://openalex.org/W7123730053", "source_url": "https://doi.org/10.1176/appi.prcp.20250113", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Emotional Processing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:42022021", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.prcp.20250113", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:42022021", "source_url": "https://doi.org/10.1176/appi.prcp.20250113", "doi": "10.1176/appi.prcp.20250113", "pmid": "42022021", "publication_date": "2026-01-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3532, "title": "A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2026-01-11", "publication_year": 2026, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05711940", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05711940", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05711940", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05711940", "source_url": "https://clinicaltrials.gov/study/NCT05711940", "doi": "", "pmid": "", "publication_date": "2026-01-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 335, "title": "Reported Safety Practices of Publicly Advertised Psychedelic Retreats", "authors": "AL McGuire, Logan Neitzke-Spruill, Jill O. Robinson, Caroline Beit, Nikita Singh, David S. Mathai, Lynnette A. Averill", "journal": "JAMA Network Open", "publication_date": "2026-01-06", "publication_year": 2026, "doi": "10.1001/jamanetworkopen.2025.52505", "pubmed_id": "41499117", "openalex_id": "https://openalex.org/W7118708255", "source_url": "https://doi.org/10.1001/jamanetworkopen.2025.52505", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety,Toxicity", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41499117", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2025.52505", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41499117", "source_url": "https://doi.org/10.1001/jamanetworkopen.2025.52505", "doi": "10.1001/jamanetworkopen.2025.52505", "pmid": "41499117", "publication_date": "2026-01-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 333, "title": "An open-label pilot study of psilocybin-assisted therapy for binge eating disorder", "authors": "Jesse Dallery, Jennifer L. Miller, Jeff Boissoneault, Lauren Harvey, Lindsey Ives, Alexandra Knerr, Shelby Blaes, Morgan N. Ransom, Melissa S. Munson, James P. Gilligan, Michael H. Silverman, Peter R. Guzzo, Beverlee Loeser", "journal": "Journal of Eating Disorders", "publication_date": "2026-01-02", "publication_year": 2026, "doi": "10.1186/s40337-025-01508-3", "pubmed_id": "41485073", "openalex_id": "https://openalex.org/W7118124310", "source_url": "https://doi.org/10.1186/s40337-025-01508-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Brain Imaging,Biomarkers,Aging,Emotional Processing,Psychological Flexibility,Safety,Adverse Events", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41485073", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s40337-025-01508-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41485073", "source_url": "https://doi.org/10.1186/s40337-025-01508-3", "doi": "10.1186/s40337-025-01508-3", "pmid": "41485073", "publication_date": "2026-01-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 337, "title": "Daily Administration of Psilocin Mucate (L-130) Produces a Favorable Safety Profile and Anxiolytic Effects in Rodents Exposed to Chronic Unpredictable Mild Stress", "authors": "Frederick D. Sancilio, Maghsoud Dariani, Purvi Chavda, Harsha Mysore Rajagopal, Lyl Tomlinson", "journal": "Journal of Psychoactive Drugs", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1080/02791072.2025.2607726", "pubmed_id": "41482437", "openalex_id": "https://openalex.org/W7118088356", "source_url": "https://doi.org/10.1080/02791072.2025.2607726", "substance_tags": "psilocybin,psilocin", "topic_tags": "Anxiety,Pharmacology,Receptor Pharmacology,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41482437", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2025.2607726", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41482437", "source_url": "https://doi.org/10.1080/02791072.2025.2607726", "doi": "10.1080/02791072.2025.2607726", "pmid": "41482437", "publication_date": "2026-01-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 336, "title": "The effects of psilocybin on psychological distress in cancer patients: a systematic review and meta-analysis", "authors": "Reza Moshfeghinia, Sara Mostafavi, Kimia Jazi, Amir Reza Ghasemi, Yasamin Khosravaninezhad, Santhosshi Narayanan, Jamshid Ahmadi, Mehdi Pasalar", "journal": "BMC Psychology", "publication_date": "2026-01-01", "publication_year": 2026, "doi": "10.1186/s40359-025-03935-y", "pubmed_id": "41484687", "openalex_id": "https://openalex.org/W7118088637", "source_url": "https://doi.org/10.1186/s40359-025-03935-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Wellbeing,Emotional Processing,Spirituality,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41484687", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s40359-025-03935-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41484687", "source_url": "https://doi.org/10.1186/s40359-025-03935-y", "doi": "10.1186/s40359-025-03935-y", "pmid": "41484687", "publication_date": "2026-01-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4179, "title": "Psychedelics and Mental Health: Psilocybin and Depression. A Sistematic Review", "authors": "Marta Gómez Álvarez, Javier Calleja-Conde, Víctor Echeverry-Alzate", "journal": "Open Science Framework", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.17605/osf.io/yu3n9", "pubmed_id": null, "openalex_id": "https://openalex.org/W7162447643", "source_url": "https://doi.org/10.17605/osf.io/yu3n9", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/yu3n9", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17605/osf.io/yu3n9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/yu3n9", "source_url": "https://doi.org/10.17605/osf.io/yu3n9", "doi": "10.17605/osf.io/yu3n9", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4163, "title": "Psilocybin-Therapie vorteilhaft für Stimmungsstörungen von Parkinsonkranken", "authors": "", "journal": "Fortschritte der Neurologie · Psychiatrie", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1055/a-2700-8978", "pubmed_id": null, "openalex_id": "https://openalex.org/W7124268562", "source_url": "https://doi.org/10.1055/a-2700-8978", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1055/a-2700-8978", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/a-2700-8978", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1055/a-2700-8978", "source_url": "https://doi.org/10.1055/a-2700-8978", "doi": "10.1055/a-2700-8978", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4161, "title": "‘Shroom’ for concern: a case of psychedelic mushroom-induced acute kidney injury", "authors": "Maurice Lam, C. Khor, S. Hultin, J. J. Cheung, N. A. Shah", "journal": "Internal Medicine Journal", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1111/imj.70313", "pubmed_id": "41518153", "openalex_id": "https://openalex.org/W7119893738", "source_url": "https://doi.org/10.1111/imj.70313", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41518153", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/imj.70313", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41518153", "source_url": "https://doi.org/10.1111/imj.70313", "doi": "10.1111/imj.70313", "pmid": "41518153", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4158, "title": "Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE): Results of a randomized active placebo-controlled trial", "authors": "L.J. Mertens, M. Koslowski, F. Betzler, M. Brand, R. Evens, L. Krätner, A. Jungaberle, H. Jungaberle, T. Majić, C.N. Schmitz, A. Ströhle, D. Scharf, M. Spangemacher, M. Wolff, Z. Assadi, B. Scharif, L. Becher, L.V. Färber, N. Kirchen, E. Kulakova, L. Kunz, A. Meijer, B. Rohrmoser, S. Wellek, M. Berger, G. Gründer", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.105779", "pubmed_id": null, "openalex_id": "https://openalex.org/W7118005769", "source_url": "https://doi.org/10.1016/j.nsa.2025.105779", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2025.105779", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2025.105779", "source_url": "https://doi.org/10.1016/j.nsa.2025.105779", "doi": "10.1016/j.nsa.2025.105779", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4155, "title": "An open-label study of single-dose COMP360 psilocybin for post-traumatic stress disorder: safety, tolerability, and secondary efficacy outcomes", "authors": "N. Mcgowan, J. Rucker, R. Yehuda, M. Agrawal, H. Simmons, S. Das, G. Goodwin", "journal": "Neuroscience Applied", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.106821", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117964120", "source_url": "https://doi.org/10.1016/j.nsa.2025.106821", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2025.106821", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2025.106821", "source_url": "https://doi.org/10.1016/j.nsa.2025.106821", "doi": "10.1016/j.nsa.2025.106821", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4152, "title": "Psilocybin Treatment for Refractory Depression: A Clinical Review", "authors": "Jensen, Hailey A", "journal": "Digital Commons - Gardner-Webb University (Gardner-Webb University)", "publication_date": "2025-12-31", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110564344", "source_url": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "source_url": "https://digitalcommons.gardner-webb.edu/pa-department-journal-of-medical-science/63", "doi": "", "pmid": "", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 374, "title": "Pharmacological Properties of Psychedelics with a Special Focus on Potential Harms.", "authors": "Holze F, Liechti ME, Müller F.", "journal": null, "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1007/7854_2024_510", "pubmed_id": "39080236", "openalex_id": null, "source_url": "https://doi.org/10.1007/7854_2024_510", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Pharmacology,Receptor Pharmacology,Emotional Processing,Safety,Adverse Events,Drug Interactions", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39080236", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/7854_2024_510", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39080236", "source_url": "https://doi.org/10.1007/7854_2024_510", "doi": "10.1007/7854_2024_510", "pmid": "39080236", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 372, "title": "Anxiety and Affective Symptoms Related to the Use of Classic Psychedelics: A Systematic Review.", "authors": "Viljoen G, Betzler F", "journal": "Current topics in behavioral neurosciences", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1007/7854_2024_534", "pubmed_id": "39436632", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39436632/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:39436632", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39436632/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39436632", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39436632/", "doi": "10.1007/7854_2024_534", "pmid": "39436632", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 367, "title": "Informed Consent in Psychedelic-Assisted Therapy.", "authors": "Bradberry MM, Appelbaum PS, Gukasyan N.", "journal": null, "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1007/7854_2024_559", "pubmed_id": "39739178", "openalex_id": null, "source_url": "https://doi.org/10.1007/7854_2024_559", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:39739178", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/7854_2024_559", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39739178", "source_url": "https://doi.org/10.1007/7854_2024_559", "doi": "10.1007/7854_2024_559", "pmid": "39739178", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 363, "title": "Building standards of psychedelic care: Qualitative examination of expert perspectives on safety, inclusion, and accountability.", "authors": "Chwyl C, Wilson-Poe AR, Hoffman KA, Bazinet A, Pertl K, Luoma JB, des Jarlais D, Bielavitz S, Korthuis PT", "journal": "The International journal on drug policy", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1016/j.drugpo.2025.104938", "pubmed_id": "40803962", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40803962/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:40803962", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40803962/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40803962", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40803962/", "doi": "10.1016/j.drugpo.2025.104938", "pmid": "40803962", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 360, "title": "Psychedelic Drug Checking: Analytical and Strategic Challenges in Harm Reduction for Classic Psychedelics.", "authors": "Hirschfeld T, Blei F, Stegemann L, van der Gouwe D, Smit-Rigter L.", "journal": null, "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1007/7854_2025_606", "pubmed_id": "41087826", "openalex_id": null, "source_url": "https://doi.org/10.1007/7854_2025_606", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:41087826", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/7854_2025_606", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41087826", "source_url": "https://doi.org/10.1007/7854_2025_606", "doi": "10.1007/7854_2025_606", "pmid": "41087826", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 347, "title": "Pharmacological Management of Anxiety in End-of-Life Care: A Systematic Review of Benzodiazepines, Opioids, and Psilocybin", "authors": "Brunno Freitas da Costa, Paula Hartmann, Daniel Pagnin", "journal": "Human Psychopharmacology Clinical and Experimental", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1002/hup.70032", "pubmed_id": "41502021", "openalex_id": "https://openalex.org/W7118595574", "source_url": "https://doi.org/10.1002/hup.70032", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41502021", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/hup.70032", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41502021", "source_url": "https://doi.org/10.1002/hup.70032", "doi": "10.1002/hup.70032", "pmid": "41502021", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 346, "title": "Indigenous Knowledge Systems & Psychedelic Science: Towards Ethical and Reciprocal Collaboration", "authors": "Magar, Marlena Robbins, Óscar Martín López Fernández (Lobo Blanco), Ismail Lourido Ali, Brian Anderson, Charlie Grob, Jack E. Henningfield, Pamela Kryskow, Heather Kuiper, Anja Loizaga-Velder, Brian Rush, Miriam Volat, Sandor Iron Rope", "journal": "Journal of Psychopharmacology", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1177/02698811251387104", "pubmed_id": "41618525", "openalex_id": "https://openalex.org/W7126158169", "source_url": "https://doi.org/10.1177/02698811251387104", "substance_tags": "psilocybin", "topic_tags": "Spirituality,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41618525", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811251387104", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41618525", "source_url": "https://doi.org/10.1177/02698811251387104", "doi": "10.1177/02698811251387104", "pmid": "41618525", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 342, "title": "Classifying Psychedelic-Related Complications.", "authors": "Majić T, Gouzoulis-Mayfrank E, Evens R.", "journal": null, "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1007/7854_2026_614", "pubmed_id": "41749025", "openalex_id": null, "source_url": "https://doi.org/10.1007/7854_2026_614", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety,Toxicity", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:41749025", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/7854_2026_614", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41749025", "source_url": "https://doi.org/10.1007/7854_2026_614", "doi": "10.1007/7854_2026_614", "pmid": "41749025", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 341, "title": "Contextualizing Violence Risk Associated With Hallucinogens", "authors": "Tyler Durns, Greg Iannuzzi", "journal": "FOCUS The Journal of Lifelong Learning in Psychiatry", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1176/appi.focus.20250027", "pubmed_id": "41953889", "openalex_id": "https://openalex.org/W7124312498", "source_url": "https://doi.org/10.1176/appi.focus.20250027", "substance_tags": "psilocybin", "topic_tags": "Addiction,Review Article,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41953889", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.focus.20250027", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41953889", "source_url": "https://doi.org/10.1176/appi.focus.20250027", "doi": "10.1176/appi.focus.20250027", "pmid": "41953889", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 340, "title": "New Antidepressant Development in the Treatment of Depression.", "authors": "Spiti A, Caldirola D, Perna G.", "journal": null, "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1007/978-981-95-6872-7_23", "pubmed_id": "42036580", "openalex_id": null, "source_url": "https://doi.org/10.1007/978-981-95-6872-7_23", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:42036580", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/978-981-95-6872-7_23", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:42036580", "source_url": "https://doi.org/10.1007/978-981-95-6872-7_23", "doi": "10.1007/978-981-95-6872-7_23", "pmid": "42036580", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 323, "title": "[Clinical application and mechanistic studies of psychedelics for treatment of depression: progress and future challenges].", "authors": "Xia K, Gao T.", "journal": null, "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.12122/j.issn.1673-4254.2026.01.01", "pubmed_id": "41540686", "openalex_id": null, "source_url": "https://doi.org/10.12122/j.issn.1673-4254.2026.01.01", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Biomarkers,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:41540686", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.12122/j.issn.1673-4254.2026.01.01", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41540686", "source_url": "https://doi.org/10.12122/j.issn.1673-4254.2026.01.01", "doi": "10.12122/j.issn.1673-4254.2026.01.01", "pmid": "41540686", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 235, "title": "Psychedelic therapy and postpartum depression: priorities and prospects.", "authors": "Thuery G, Crossen F, Mc Loone D, Hinds C, Duffy R, Jairaj C, Harkin A, Kelly JR", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2025-12-31", "publication_year": 2025, "doi": "10.1177/20451253251408280", "pubmed_id": "41816502", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41816502/", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Aging,Review Article,Safety,Immune Function", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:20:34", "bibtex": null, "source_record_id": "PMID:41816502", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41816502/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41816502", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41816502/", "doi": "10.1177/20451253251408280", "pmid": "41816502", "publication_date": "2025-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3479, "title": "A Randomized Double-blinded Controlled Trial for the Treatment of Persisting Symptoms After Concussion With Psilocybin-assisted Therapy: A Safety and Feasibility Trial", "authors": "University of Calgary", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-29", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06615908", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Headache / Migraine,Emotional Processing,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06615908", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06615908", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06615908", "source_url": "https://clinicaltrials.gov/study/NCT06615908", "doi": "", "pmid": "", "publication_date": "2025-12-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3464, "title": "Microdosing Psychedelics to Improve Mood", "authors": "Rotem Petranker", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-29", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05259943", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05259943", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05259943", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05259943", "source_url": "https://clinicaltrials.gov/study/NCT05259943", "doi": "", "pmid": "", "publication_date": "2025-12-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3017, "title": "Psilocybin as a Serotonergic Therapy in Epilepsy: Narrative Review of Therapeutic Potentials and Seizure Risks", "authors": "Miguel Benjamín Cervera-Sánchez, Daniel San-Juan, Roberto Díaz-Peregrino, Evelin Zulema Camacho-Castillo, Sthefany Anahi Bringas-Ortiz, Christian Padilla-Cabezutd", "journal": null, "publication_date": "2025-12-28", "publication_year": 2025, "doi": "10.22541/au.176701186.65064859/v1", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117461912", "source_url": "https://doi.org/10.22541/au.176701186.65064859/v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Chronic Pain,Receptor Pharmacology,Clinical Trial,Review Article,Observational Study,Animal Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 11:03:45", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.22541/au.176701186.65064859/v1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.22541/au.176701186.65064859/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.22541/au.176701186.65064859/v1", "source_url": "https://doi.org/10.22541/au.176701186.65064859/v1", "doi": "10.22541/au.176701186.65064859/v1", "pmid": "", "publication_date": "2025-12-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 377, "title": "Efficacy and Safety of Psychedelics in Mental Disorder Cases: An Umbrella Review of Meta-Analyses of Randomized Controlled Trials", "authors": "Monika Dominiak, Adam Gędek, Szymon Modrzejewski, Agnieszka Permoda-Osip, Anna Zofia Antosik", "journal": "Journal of Clinical Medicine", "publication_date": "2025-12-28", "publication_year": 2025, "doi": "10.3390/jcm15010253", "pubmed_id": "41517502", "openalex_id": "https://openalex.org/W7117705718", "source_url": "https://doi.org/10.3390/jcm15010253", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Review Article,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41517502", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/jcm15010253", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41517502", "source_url": "https://doi.org/10.3390/jcm15010253", "doi": "10.3390/jcm15010253", "pmid": "41517502", "publication_date": "2025-12-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 255, "title": "Adverse events associated with classic psychedelics and MDMA: a real-world population-based study using the WHO pharmacovigilance database (VigiBase)", "authors": "Omer A. Syed, Sean M. Nestor, Muhammad Ishrat Husain, Mark Sinyor, Fahad Alam, Peter Giacobbe", "journal": "Psychiatry Research", "publication_date": "2025-12-28", "publication_year": 2025, "doi": "10.1016/j.psychres.2025.116929", "pubmed_id": "41485400", "openalex_id": "https://openalex.org/W7117472051", "source_url": "https://doi.org/10.1016/j.psychres.2025.116929", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety,Adverse Events,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41485400", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2025.116929", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41485400", "source_url": "https://doi.org/10.1016/j.psychres.2025.116929", "doi": "10.1016/j.psychres.2025.116929", "pmid": "41485400", "publication_date": "2025-12-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 200, "title": "Comparing single- and repeat-dose psilocybin with active placebo for migraine prevention in an exploratory randomized controlled clinical trial", "authors": "Emmanuelle A. D. Schindler, Christopher Gottschalk, Brian Pittman, Deepak D'Souza", "journal": "Headache The Journal of Head and Face Pain", "publication_date": "2025-12-28", "publication_year": 2025, "doi": "10.1111/head.70024", "pubmed_id": "41459830", "openalex_id": "https://openalex.org/W7117472148", "source_url": "https://doi.org/10.1111/head.70024", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41459830", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/head.70024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41459830", "source_url": "https://doi.org/10.1111/head.70024", "doi": "10.1111/head.70024", "pmid": "41459830", "publication_date": "2025-12-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4189, "title": "A Systematic Review of the efficacy, safety, and Tolerability of Psychedelics in the Treatment of post-traumatic Stress Disorder", "authors": "Manasicha Wongpaiboon, Jackson L. Shelton, Eric Delgado Rendon, Maddison Vail", "journal": "Current Treatment Options in Psychiatry", "publication_date": "2025-12-25", "publication_year": 2025, "doi": "10.1007/s40501-025-00373-w", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117327267", "source_url": "https://doi.org/10.1007/s40501-025-00373-w", "substance_tags": "psilocybin", "topic_tags": "PTSD,Pharmacology,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Meta-Analysis", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 06:34:37", "bibtex": null, "source_record_id": "DOI:10.1007/s40501-025-00373-w", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s40501-025-00373-w", "source_url": "https://doi.org/10.1007/s40501-025-00373-w", "doi": "10.1007/s40501-025-00373-w", "pmid": "", "publication_date": "2025-12-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 378, "title": "Knowledge, perceptions, and use of psychedelics for mental health among autistic adults: An online survey", "authors": "Sahba Afsharnia, Vivian Liang, Yona Lunsky, A Orsini, Ami Tint, Hsiang-yuan Lin", "journal": "PLOS mental health.", "publication_date": "2025-12-25", "publication_year": 2025, "doi": "10.1371/journal.pmen.0000514", "pubmed_id": "41662127", "openalex_id": "https://openalex.org/W7117295770", "source_url": "https://doi.org/10.1371/journal.pmen.0000514", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Clinical Trial,Observational Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41662127", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pmen.0000514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41662127", "source_url": "https://doi.org/10.1371/journal.pmen.0000514", "doi": "10.1371/journal.pmen.0000514", "pmid": "41662127", "publication_date": "2025-12-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3701, "title": "The Safety and Efficacy of Psilocybin in Patients With Treatment-resistant Depression and Chronic Suicidal Ideation", "authors": "Sheppard Pratt Health System", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-23", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05220410", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05220410", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05220410", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05220410", "source_url": "https://clinicaltrials.gov/study/NCT05220410", "doi": "", "pmid": "", "publication_date": "2025-12-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3506, "title": "An Open Label Study of Single-Dose Psilocybin for Major Depressive Disorder With Co-occurring Borderline Personality Disorder", "authors": "University of Chicago", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-22", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05399498", "substance_tags": "psilocybin", "topic_tags": "Depression,Personality Change,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05399498", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05399498", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05399498", "source_url": "https://clinicaltrials.gov/study/NCT05399498", "doi": "", "pmid": "", "publication_date": "2025-12-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3055, "title": "A Randomised, Triple-Blind, Dose-Finding Study of the Impact of Psilocybin on Motor Function in Healthy Participants", "authors": "Bhagavan C, Carter O, Nielsen G, Berlowitz D, Issak S, Braat S, Zaloumis S, Attard Z, Oliver G, Mayne D, Rucker J, Butler M, Dandash O, Bryson A, Kanaan RA.", "journal": "medRxiv", "publication_date": "2025-12-22", "publication_year": 2025, "doi": "10.64898/2025.12.22.25342874", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.64898/2025.12.22.25342874", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Consciousness,Clinical Trial,Review Article,Healthy Volunteers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.64898/2025.12.22.25342874", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.64898/2025.12.22.25342874", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.64898/2025.12.22.25342874", "source_url": "https://doi.org/10.64898/2025.12.22.25342874", "doi": "10.64898/2025.12.22.25342874", "pmid": "", "publication_date": "2025-12-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1990, "title": "Group Retreat Psilocybin Therapy for People with Metastatic Cancer with Anxiety and Depression: A Rite of Passage Facilitation Model for a Phase 1/2 Study", "authors": "Anthony L. Back, Bonnie A. McGregor, Lindsay Billingsley, Dianna Blom, George Callan, Susanna Myers, John Guy, Sameet Kumar, Melissa Layer, Jackie Levin, Juliana Pérez, Peter Thompson, Kathy Salmonson, Joseph Whinney, Leslie Lazar Thorn", "journal": "Psychedelic Medicine", "publication_date": "2025-12-22", "publication_year": 2025, "doi": "10.1177/28314425251404460", "pubmed_id": null, "openalex_id": "https://openalex.org/W7116873484", "source_url": "https://doi.org/10.1177/28314425251404460", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Cancer Patients,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251404460", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251404460", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251404460", "source_url": "https://doi.org/10.1177/28314425251404460", "doi": "10.1177/28314425251404460", "pmid": "", "publication_date": "2025-12-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 380, "title": "Psychedelics as a Therapeutic Opportunity or Threat: A Narrative Review", "authors": "Paweł Liszka, Agata Ogórek, Klaudia M Olejnik-Chlewicka, Konrad Puchalski, Marta Zasiadła, Klaudia M Patrzykąt, Jakub Perediatkiewicz, Wojciech Urbański, Paweł M Łuczak, Jakub Brodowski", "journal": "Cureus", "publication_date": "2025-12-22", "publication_year": 2025, "doi": "10.7759/cureus.99942", "pubmed_id": "41583322", "openalex_id": "https://openalex.org/W7116864166", "source_url": "https://doi.org/10.7759/cureus.99942", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Toxicity,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41583322", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.7759/cureus.99942", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41583322", "source_url": "https://doi.org/10.7759/cureus.99942", "doi": "10.7759/cureus.99942", "pmid": "41583322", "publication_date": "2025-12-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3585, "title": "Effects of Psilocybin on Speech Fluency, Struggle, and Brain Activity in People Who Stutter", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-21", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07296328", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07296328", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07296328", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07296328", "source_url": "https://clinicaltrials.gov/study/NCT07296328", "doi": "", "pmid": "", "publication_date": "2025-12-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4197, "title": "Assessing The Readiness of Psychiatrists in Louisiana to Incorporate Psilocybin into Clinical Practice-Lessons Learned from a State Underrepresented in Clinical Psychedelic Research", "authors": "Amanda Husein, Madalynn Traylor, M. Frances Vest, Bo Jarrett Wood, Madison Brogan, Alfred Thomas, Shawn E. McNeil, M Alfrad Nobel Bhuiyan, Peter S. Hendricks, John R. Kelly, Andrew Gribben, Sultan Alqahtani, Kelsea Keys, Amber N. Edinoff, J C Patterson, Kevin S. Murnane", "journal": "Psychedelic Medicine", "publication_date": "2025-12-18", "publication_year": 2025, "doi": "10.1177/28314425251381806", "pubmed_id": null, "openalex_id": "https://openalex.org/W7117566828", "source_url": "https://doi.org/10.1177/28314425251381806", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251381806", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251381806", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251381806", "source_url": "https://doi.org/10.1177/28314425251381806", "doi": "10.1177/28314425251381806", "pmid": "", "publication_date": "2025-12-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3093, "title": "Psilocybin Treatment as an Adjunct to Cognitive Behavioral Therapy for Eating Disorders: Therapeutic Rationale & Considerations for Protocol Development", "authors": "Koning E, Gamberg S, Keshen A.", "journal": "Preprints.org", "publication_date": "2025-12-18", "publication_year": 2025, "doi": "10.20944/preprints202512.1705.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202512.1705.v1", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Neuroplasticity,Emotional Processing,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202512.1705.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202512.1705.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202512.1705.v1", "source_url": "https://doi.org/10.20944/preprints202512.1705.v1", "doi": "10.20944/preprints202512.1705.v1", "pmid": "", "publication_date": "2025-12-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3521, "title": "A Phase III, Multicentre, Randomised, Double-blind, Placebo-controlled Study to Investigate the Efficacy, Safety, and Tolerability of COMP360 in Participants With Treatment-resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-17", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05624268", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05624268", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05624268", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05624268", "source_url": "https://clinicaltrials.gov/study/NCT05624268", "doi": "", "pmid": "", "publication_date": "2025-12-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 392, "title": "Psilocybin reporting in media (PRiMe) for the treatment of depression", "authors": "Gurjot Brar, T. R. JUN. BURKE, Andrew Gribben, Colm Harrington, Guillaume Thuery, John R. Kelly", "journal": "Irish Journal of Psychological Medicine", "publication_date": "2025-12-17", "publication_year": 2025, "doi": "10.1017/ipm.2025.10142", "pubmed_id": "41410115", "openalex_id": "https://openalex.org/W4417453981", "source_url": "https://doi.org/10.1017/ipm.2025.10142", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41410115", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/ipm.2025.10142", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41410115", "source_url": "https://doi.org/10.1017/ipm.2025.10142", "doi": "10.1017/ipm.2025.10142", "pmid": "41410115", "publication_date": "2025-12-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 353, "title": "Psilocybin-assisted therapy for individuals with palliative care needs: A systematic review of safety and efficacy.", "authors": "Matos ARS, Silva AC, Rego L, Fernandes R, Gonçalves S.", "journal": null, "publication_date": "2025-12-17", "publication_year": 2025, "doi": "10.1177/02692163251383335", "pubmed_id": "41410211", "openalex_id": null, "source_url": "https://doi.org/10.1177/02692163251383335", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:41410211", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02692163251383335", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41410211", "source_url": "https://doi.org/10.1177/02692163251383335", "doi": "10.1177/02692163251383335", "pmid": "41410211", "publication_date": "2025-12-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 156, "title": "Exploring Psilocybin-Assisted Schema Therapy: A Conceptual Framework for Potential Therapeutic Synergies in Personality Disorders", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-12-17", "publication_year": 2025, "doi": "10.47626/2237-6089-2025-1273", "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/v7pxn_v1", "substance_tags": "psilocybin", "topic_tags": "Personality Change,Emotional Processing,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "DOI:10.47626/2237-6089-2025-1273", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/v7pxn_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.47626/2237-6089-2025-1273", "source_url": "https://osf.io/preprints/psyarxiv/v7pxn_v1", "doi": "10.47626/2237-6089-2025-1273", "pmid": "", "publication_date": "2025-12-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4198, "title": "Subjective Effects of Psychedelics Are the Plausible Mechanism of Psychedelic Moral Enhancement Rather than a Risk. Comment on Tang, B.L. Psychedelics for Moral Bioenhancement in Healthy Individuals-A Violation of the Non-Maleficence Principle? Psychoactives 2025, 4, 5", "authors": "Juuso Kähönen", "journal": "Psychoactives", "publication_date": "2025-12-16", "publication_year": 2025, "doi": "10.3390/psychoactives4040043", "pubmed_id": null, "openalex_id": "https://openalex.org/W4417423291", "source_url": "https://doi.org/10.3390/psychoactives4040043", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4040043", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4040043", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4040043", "source_url": "https://doi.org/10.3390/psychoactives4040043", "doi": "10.3390/psychoactives4040043", "pmid": "", "publication_date": "2025-12-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 294, "title": "Psilocybin in the real world: Regulatory, ethical, and operational challenges in Australia’s clinical landscape", "authors": "Megan Dutton, Paul Schwenn, Jules Mitchell, Per Hoffmann, Neil W. Bailey, Paul B. Fitzgerald, Jim Lagopoulos, Adem Can", "journal": "Australian & New Zealand Journal of Psychiatry", "publication_date": "2025-12-16", "publication_year": 2025, "doi": "10.1177/00048674251398677", "pubmed_id": "41405025", "openalex_id": "https://openalex.org/W4417431364", "source_url": "https://doi.org/10.1177/00048674251398677", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Clinical Trial,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41405025", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00048674251398677", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41405025", "source_url": "https://doi.org/10.1177/00048674251398677", "doi": "10.1177/00048674251398677", "pmid": "41405025", "publication_date": "2025-12-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4200, "title": "Psychedelic-Assisted Therapy (Pat): A New Frontier in Mental Health Treatment", "authors": "M. H. M. Wickramasekara, G. D. M. C. Gonapaladeniya", "journal": "˜The œjournal of desk research review and analysis.", "publication_date": "2025-12-15", "publication_year": 2025, "doi": "10.4038/jdrra.v3i2.87", "pubmed_id": null, "openalex_id": "https://openalex.org/W7115587785", "source_url": "https://doi.org/10.4038/jdrra.v3i2.87", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Older Adults,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:37", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.4038/jdrra.v3i2.87", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4038/jdrra.v3i2.87", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4038/jdrra.v3i2.87", "source_url": "https://doi.org/10.4038/jdrra.v3i2.87", "doi": "10.4038/jdrra.v3i2.87", "pmid": "", "publication_date": "2025-12-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3437, "title": "Feasibility Phase 2 Study of Psilocybin-Assisted Therapy for Opioid-Refractory Pain in Patients With Advanced Cancer", "authors": "Yvan Beaussant, MD, MSci", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-15", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06001749", "substance_tags": "psilocybin", "topic_tags": "Addiction,End-of-Life Distress,Chronic Pain,Receptor Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06001749", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06001749", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06001749", "source_url": "https://clinicaltrials.gov/study/NCT06001749", "doi": "", "pmid": "", "publication_date": "2025-12-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 394, "title": "Psilocybin-assisted psychotherapy for treatment-resistant obsessive-compulsive disorder: protocol for an open-label pilot study", "authors": "Nicole Ledwos, Jenna Baer, Muhammad Ishrat Husain, Daniel M. Blumberger, Rachel Patterson, Elizabeth Hollingdrake, Ezmond S.L. Cheung, Colin Hawco, Christoph Zrenner, Brigitte Zrenner, Jamie D. Feusner, Susan L. Rossell, David Castle, Gwyneth Zai", "journal": "BJPsych Open", "publication_date": "2025-12-14", "publication_year": 2025, "doi": "10.1192/bjo.2025.10895", "pubmed_id": "41392767", "openalex_id": "https://openalex.org/W4417362478", "source_url": "https://doi.org/10.1192/bjo.2025.10895", "substance_tags": "psilocybin", "topic_tags": "OCD,Chronic Pain,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Biomarkers,Aging,Clinical Trial,Randomized Controlled Trial,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41392767", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2025.10895", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41392767", "source_url": "https://doi.org/10.1192/bjo.2025.10895", "doi": "10.1192/bjo.2025.10895", "pmid": "41392767", "publication_date": "2025-12-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3048, "title": "Real-World Psilocybin Therapy for Treatment-Resistant Depression: a Retrospective Observational Study", "authors": "Jungwirth J, Westenhöfer S, Aicher H, Provaznikova B, Kronenberg G, Seifritz E, Prinz S, Olbrich S.", "journal": "Research Square", "publication_date": "2025-12-09", "publication_year": 2025, "doi": "10.21203/rs.3.rs-8079137/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-8079137/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-8079137/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-8079137/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-8079137/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-8079137/v1", "doi": "10.21203/rs.3.rs-8079137/v1", "pmid": "", "publication_date": "2025-12-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 354, "title": "Psilocybin in late-life mental health: Addressing depression, loneliness, and existential anxiety", "authors": "Gerasimos Konstantinou, Joshua D. Rosenblat, Sarah Hales, Muhammad Ishrat Husain, Daniel M. Blumberger", "journal": "General Hospital Psychiatry", "publication_date": "2025-12-08", "publication_year": 2025, "doi": "10.1016/j.genhosppsych.2025.12.005", "pubmed_id": "41401486", "openalex_id": "https://openalex.org/W4417166023", "source_url": "https://doi.org/10.1016/j.genhosppsych.2025.12.005", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Default Mode Network,Aging,Clinical Trial,Review Article,Safety,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41401486", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.genhosppsych.2025.12.005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41401486", "source_url": "https://doi.org/10.1016/j.genhosppsych.2025.12.005", "doi": "10.1016/j.genhosppsych.2025.12.005", "pmid": "41401486", "publication_date": "2025-12-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3625, "title": "Investigating the Effects of a Psychedelic-augmented Mental Imagery-based Intervention for Young People With Self-harm Behaviour: an Experimental Medicine Study", "authors": "Imperial College London", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06798636", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06798636", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06798636", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06798636", "source_url": "https://clinicaltrials.gov/study/NCT06798636", "doi": "", "pmid": "", "publication_date": "2025-12-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4210, "title": "Psychedelics as neuroplasticity enhancers: Mechanisms, therapeutic applications, and translational challenges", "authors": "Taslim Uddin, Suma Akter, Kanak Yadab Ghosh", "journal": "Advanced Neurology", "publication_date": "2025-12-03", "publication_year": 2025, "doi": "10.36922/an025410095", "pubmed_id": null, "openalex_id": "https://openalex.org/W4417099564", "source_url": "https://doi.org/10.36922/an025410095", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.36922/an025410095", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.36922/an025410095", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.36922/an025410095", "source_url": "https://doi.org/10.36922/an025410095", "doi": "10.36922/an025410095", "pmid": "", "publication_date": "2025-12-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3692, "title": "Standardized Natural Psilocybin-assisted Psychotherapy for Tapering of Opioid Medication in Patients With Chronic Pain: an Open-label Feasibility Study", "authors": "University of British Columbia", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-03", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05585229", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Mechanism of Action,Safety,Adverse Events,Contraindications", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05585229", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05585229", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05585229", "source_url": "https://clinicaltrials.gov/study/NCT05585229", "doi": "", "pmid": "", "publication_date": "2025-12-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3513, "title": "A Phase 2b, Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of Psilocybin-assisted Psychotherapy on Psychiatric and Existential Distress in Advanced Cancer", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2025-12-03", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05398484", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05398484", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05398484", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05398484", "source_url": "https://clinicaltrials.gov/study/NCT05398484", "doi": "", "pmid": "", "publication_date": "2025-12-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4212, "title": "Magic Mushrooms as Medicine: What the United States Can Learn from Jamaica’s Unregulated Psilocybin Industry as FDA Approval Nears", "authors": "Spohn, Kyle", "journal": "eYLS (Yale Law School)", "publication_date": "2025-12-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7112471464", "source_url": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "source_url": "https://repository.law.miami.edu/umialr/vol57/iss1/7", "doi": "", "pmid": "", "publication_date": "2025-12-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4230, "title": "Efficacy of psilocybin on death anxiety in terminal patients: a narrative review", "authors": "Morris Lintong Barimbing, Dian Pritasari Jeger, Made Edwin Sridana", "journal": "Progress in Palliative Care", "publication_date": "2025-11-30", "publication_year": 2025, "doi": "10.1080/09699260.2026.2657096", "pubmed_id": null, "openalex_id": "https://openalex.org/W7152631097", "source_url": "https://doi.org/10.1080/09699260.2026.2657096", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "DOI:10.1080/09699260.2026.2657096", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/09699260.2026.2657096", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/09699260.2026.2657096", "source_url": "https://doi.org/10.1080/09699260.2026.2657096", "doi": "10.1080/09699260.2026.2657096", "pmid": "", "publication_date": "2025-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3252, "title": "Safety, feasibility, and tolerability of psilocybin in older adults with amnestic MCI: Preliminary data from a SV2a PET imaging study", "authors": "Bukovsky D, Amaev A, Song J, Torres-Carmona E, Kyte S, Ueno F, Deluca V, Bowie C, Flint A, Husain I, Graff-Guerrero A, Gerretsen P.", "journal": null, "publication_date": "2025-11-30", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC12740486", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Aging,Older Adults,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC12740486", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC12740486", "source_url": "https://europepmc.org/article/PMC/PMC12740486", "doi": "", "pmid": "", "publication_date": "2025-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3154, "title": "Real-World Effectiveness and Safety of Psychedelic-Assisted Psychotherapy: Outcomes from a Large-Scale Compassionate Use Cohort in Switzerland", "authors": "Aboulafia-Brakha T, Buchard A, Mabilais C, Alaux S, Amberger C, Furtado L, Seragnoli F, Briefer J, Thorens G, Sabé M, Szczesniak L, Iuga R, Zullino D, Penzenstadler L.", "journal": "medRxiv", "publication_date": "2025-11-30", "publication_year": 2025, "doi": "10.1101/2025.12.01.25341335", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.12.01.25341335", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Emotional Processing,Observational Study,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2025.12.01.25341335", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.12.01.25341335", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2025.12.01.25341335", "source_url": "https://doi.org/10.1101/2025.12.01.25341335", "doi": "10.1101/2025.12.01.25341335", "pmid": "", "publication_date": "2025-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 401, "title": "Investigational psilocybin treatment for post-traumatic stress disorder: a qualitative study of participant experience, trauma engagement, and differences from standard treatment", "authors": "Nadav Liam Modlin, Victoria Williamson, Guy M. Goodwin, Ekaterina Malievskaia, Merve Atli, Zsofia Elek, Alice Gaillard, Don Koelpin, Anthony J. Cleare, Manish Agrawal, Rachel Yehuda, Namik Kirlić, James Rucker", "journal": "EClinicalMedicine", "publication_date": "2025-11-30", "publication_year": 2025, "doi": "10.1016/j.eclinm.2025.103692", "pubmed_id": "41497513", "openalex_id": "https://openalex.org/W4417031290", "source_url": "https://doi.org/10.1016/j.eclinm.2025.103692", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41497513", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.eclinm.2025.103692", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41497513", "source_url": "https://doi.org/10.1016/j.eclinm.2025.103692", "doi": "10.1016/j.eclinm.2025.103692", "pmid": "41497513", "publication_date": "2025-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 384, "title": "Griffiths et al.’s Study of Psilocybin with Religious Professionals: A Theological Response from a Christian Perspective", "authors": "Joseph G. Lorenz, Scott A. Hawkins, Bryan C. McCarthy", "journal": "Psychedelic Medicine", "publication_date": "2025-11-30", "publication_year": 2025, "doi": "10.1177/28314425251406251", "pubmed_id": "41869005", "openalex_id": "https://openalex.org/W4417034603", "source_url": "https://doi.org/10.1177/28314425251406251", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Spirituality,Mystical Experience,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41869005", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251406251", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41869005", "source_url": "https://doi.org/10.1177/28314425251406251", "doi": "10.1177/28314425251406251", "pmid": "41869005", "publication_date": "2025-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3681, "title": "Assessing the Safety, Tolerability, and Efficacy of Psilocybin Therapy Followed by Accelerated Intermittent Theta Burst (aiTBS) Repetitive Transcranial Magnetic Stimulation (rTMS) for Treatment-Resistant Major Depressive Disorder", "authors": "University of Texas at Austin", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-25", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06132178", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Biomarkers,Aging,Clinical Trial,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06132178", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06132178", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06132178", "source_url": "https://clinicaltrials.gov/study/NCT06132178", "doi": "", "pmid": "", "publication_date": "2025-11-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3700, "title": "Pragmatic Trial of Psilocybin Therapy in Palliative Care (PT2PC): A Multicenter Triple-blind Phase 2 Randomized Controlled Trial of Psilocybin Therapy for Demoralized Adults Near the End of Life", "authors": "Charles S. Grob, M.D.", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-24", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05403086", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05403086", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05403086", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05403086", "source_url": "https://clinicaltrials.gov/study/NCT05403086", "doi": "", "pmid": "", "publication_date": "2025-11-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 423, "title": "Best practices for first psychedelic experiences: harm reduction advice from the psychedelic community", "authors": "Daniel J. Kruger, Gina Mersereau, Ashley F. Sullivan, Julie Barron, Moss Herberholz, Niloufar Pouyan, Jacob S. Aday, Kevin F. Boehnke", "journal": "Harm Reduction Journal", "publication_date": "2025-11-24", "publication_year": 2025, "doi": "10.1186/s12954-025-01337-2", "pubmed_id": "41291774", "openalex_id": "https://openalex.org/W4416671509", "source_url": "https://doi.org/10.1186/s12954-025-01337-2", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Observational Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41291774", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s12954-025-01337-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41291774", "source_url": "https://doi.org/10.1186/s12954-025-01337-2", "doi": "10.1186/s12954-025-01337-2", "pmid": "41291774", "publication_date": "2025-11-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 348, "title": "Advancing treatment paradigms: the role of psilocybin in managing major depressive disorder", "authors": "Sana Rasheed, Rida Arif, Ahmed Asad Raza, Abedin Samadi", "journal": "Annals of Medicine and Surgery", "publication_date": "2025-11-23", "publication_year": 2025, "doi": "10.1097/ms9.0000000000004349", "pubmed_id": "41497122", "openalex_id": "https://openalex.org/W4416592848", "source_url": "https://doi.org/10.1097/ms9.0000000000004349", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Aging,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41497122", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/ms9.0000000000004349", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41497122", "source_url": "https://doi.org/10.1097/ms9.0000000000004349", "doi": "10.1097/ms9.0000000000004349", "pmid": "41497122", "publication_date": "2025-11-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 425, "title": "Psilocybin and Chronic Pain: A New Perspective for Future Pain Therapists?", "authors": "Silvia Natoli, Arturo Cuomo, Maurizio Marchesini, Livio Luongo, Giuliano Lo Bianco, Vittorio Guardamagna, Shigeki Yamaguchi", "journal": "Medical Sciences", "publication_date": "2025-11-19", "publication_year": 2025, "doi": "10.3390/medsci13040277", "pubmed_id": "41283278", "openalex_id": "https://openalex.org/W4416407616", "source_url": "https://doi.org/10.3390/medsci13040277", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Resilience,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Toxicity,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:32", "bibtex": null, "source_record_id": "PMID:41283278", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/medsci13040277", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41283278", "source_url": "https://doi.org/10.3390/medsci13040277", "doi": "10.3390/medsci13040277", "pmid": "41283278", "publication_date": "2025-11-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3548, "title": "A Double-blind, Phase II Feasibility Study to Assess the Safety and Efficacy of Psilocybin Microdosing Combined With Psychotherapy in Treatment-resistant Depression", "authors": "Beersheva Mental Health Center", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-18", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07183748", "substance_tags": "psilocybin", "topic_tags": "Depression,Biomarkers,Microdosing,Clinical Trial,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07183748", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07183748", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07183748", "source_url": "https://clinicaltrials.gov/study/NCT07183748", "doi": "", "pmid": "", "publication_date": "2025-11-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3454, "title": "Open Label, Phase 2 Study for Evaluating the Feasibility, Safety and Efficacy of Psychotherapy Assisted Psilocybin for Treatment of Severe Obsessive Compulsive Disorder (OCD) in Drug and/or Psychotherapy Resistant Patients.", "authors": "Beersheva Mental Health Center", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-18", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04882839", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Emotional Processing,Spirituality,Clinical Trial,Case Report,Animal Study,Cancer Patients,Safety,Adverse Events,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04882839", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04882839", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04882839", "source_url": "https://clinicaltrials.gov/study/NCT04882839", "doi": "", "pmid": "", "publication_date": "2025-11-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3061, "title": "Psilocybin Experiential Therapist Training: Insights from a World-First Study", "authors": "Ioakimidis-MacDougall G, Gardner J, Liknaitzky P.", "journal": "medRxiv", "publication_date": "2025-11-16", "publication_year": 2025, "doi": "10.1101/2025.11.15.25340324", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.11.15.25340324", "substance_tags": "psilocybin", "topic_tags": "Emotional Processing,Healthcare Workers,Safety", "study_type": "Other", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2025.11.15.25340324", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.11.15.25340324", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2025.11.15.25340324", "source_url": "https://doi.org/10.1101/2025.11.15.25340324", "doi": "10.1101/2025.11.15.25340324", "pmid": "", "publication_date": "2025-11-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3058, "title": "Microdosing Psilocybin for Major Depressive Disorder: Study Protocol for a Phase II Double-Blind Placebo-Controlled Randomized Partial Crossover Trial", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-11-15", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Microdosing,Wellbeing,Creativity,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "source_url": "https://osf.io/preprints/psyarxiv/hmnsw_v1", "doi": "", "pmid": "", "publication_date": "2025-11-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 441, "title": "Psychedelic Augmentation of 12-Step Engagement: A Novel, Accessible Approach to Enhance Community-Based Recovery from Substance Use Disorders", "authors": "Nicky J. Mehtani, Maha N. Mian, Gabrielle Agin-Liebes, Allison R. Coker, Christopher Huebner, B. Anderson, Jennifer Mitchell", "journal": "Journal of Psychoactive Drugs", "publication_date": "2025-11-09", "publication_year": 2025, "doi": "10.1080/02791072.2025.2583960", "pubmed_id": "41214462", "openalex_id": "https://openalex.org/W4416137526", "source_url": "https://doi.org/10.1080/02791072.2025.2583960", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Wellbeing,Spirituality,Safety,Toxicity", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41214462", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2025.2583960", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41214462", "source_url": "https://doi.org/10.1080/02791072.2025.2583960", "doi": "10.1080/02791072.2025.2583960", "pmid": "41214462", "publication_date": "2025-11-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 443, "title": "The Relationship Between Psychedelic Use and Alcohol Use Disorder in a Nationally Representative Sample.", "authors": "Zech JM, Richard J, Jones GM", "journal": "Journal of psychoactive drugs", "publication_date": "2025-11-08", "publication_year": 2025, "doi": "10.1080/02791072.2025.2583967", "pubmed_id": "41208129", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41208129/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:41208129", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41208129/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41208129", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41208129/", "doi": "10.1080/02791072.2025.2583967", "pmid": "41208129", "publication_date": "2025-11-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 408, "title": "Efficacy, all-cause discontinuation, and safety of serotonergic psychedelics and MDMA to treat mental disorders: A living systematic review with meta-analysis.", "authors": "Højlund M, Kafali HY, Kırmızı B, Fusar-Poli P, Correll CU, Cortese S, Sabé M, Fiedorowicz J, Saraf G, Zein J, Berk M, Husain MI, Rosenblat JD, Rubaiyat R, Corace K, Wong S, Hatcher S, Kaluzienski M, Yatham LN, Cipriani A, Gosling CJ, Carhart-Harris R, Tanuseputro P, Myran DT, Fabiano N, Moher D, Mayo LM, Nicholls SG, White T, Prisco M, Radua J, Vieta E, Ladha KS, Katz J, Veroniki AA, Solmi M.", "journal": null, "publication_date": "2025-11-06", "publication_year": 2025, "doi": "10.1016/j.euroneuro.2025.09.011", "pubmed_id": "41205366", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.euroneuro.2025.09.011", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:41205366", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.euroneuro.2025.09.011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41205366", "source_url": "https://doi.org/10.1016/j.euroneuro.2025.09.011", "doi": "10.1016/j.euroneuro.2025.09.011", "pmid": "41205366", "publication_date": "2025-11-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3489, "title": "A Phase 1/2 Study of a Group Model of Psilocybin-Assisted Therapy for Cancer-Related Anxiety in Patients With Metastatic Cancer", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2025-11-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05847686", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05847686", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05847686", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05847686", "source_url": "https://clinicaltrials.gov/study/NCT05847686", "doi": "", "pmid": "", "publication_date": "2025-11-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 446, "title": "Psilocybin and chronic neuropathic pain: a systematic review.", "authors": "Jevotovsky DS, Chopra H, Pak DJ, Durbhakula S, Shustorovich A, Juneja T, Broachwala MY, AlFarra T, Silver C, Kreitzer G, Oreoluwa P, Weissman BB, AlFarra A, Mayrsohn BG, Orhurhu V, Emerick T, Furnish T, Castellanos JP.", "journal": null, "publication_date": "2025-11-04", "publication_year": 2025, "doi": "10.1136/rapm-2024-105532", "pubmed_id": "39106989", "openalex_id": null, "source_url": "https://doi.org/10.1136/rapm-2024-105532", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Aging,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39106989", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1136/rapm-2024-105532", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39106989", "source_url": "https://doi.org/10.1136/rapm-2024-105532", "doi": "10.1136/rapm-2024-105532", "pmid": "39106989", "publication_date": "2025-11-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 357, "title": "Psilocybin Outside the Clinic", "authors": "Kent E. Hutchison, Jake F. Hooper, Hollis C. Karoly", "journal": "JAMA Psychiatry", "publication_date": "2025-11-04", "publication_year": 2025, "doi": "10.1001/jamapsychiatry.2025.3038", "pubmed_id": "41191341", "openalex_id": "https://openalex.org/W4415929140", "source_url": "https://doi.org/10.1001/jamapsychiatry.2025.3038", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41191341", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2025.3038", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41191341", "source_url": "https://doi.org/10.1001/jamapsychiatry.2025.3038", "doi": "10.1001/jamapsychiatry.2025.3038", "pmid": "41191341", "publication_date": "2025-11-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 448, "title": "Psilocybin-assisted physiotherapy for refractory motor functional neurological disorder: protocol for a randomised dose-comparison pilot study", "authors": "Chiranth Bhagavan, Alexander Bryson, Olivia Carter, Glenn Nielsen, David J. Berlowitz, Sara Issak, Sabine Braat, Sophie Zaloumis, Zachary Attard, Dina Eleftheriadis, Georgina Oliver, Deanne Mayne, Greg Roebuck, James Rucker, Matthew Butler, Richard Kanaan", "journal": "Acta Neuropsychiatrica", "publication_date": "2025-11-03", "publication_year": 2025, "doi": "10.1017/neu.2025.10042", "pubmed_id": "41186141", "openalex_id": "https://openalex.org/W4415851344", "source_url": "https://doi.org/10.1017/neu.2025.10042", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Brain Imaging,Aging,Personality Change,Clinical Trial,Randomized Controlled Trial,Observational Study,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41186141", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/neu.2025.10042", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41186141", "source_url": "https://doi.org/10.1017/neu.2025.10042", "doi": "10.1017/neu.2025.10042", "pmid": "41186141", "publication_date": "2025-11-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 261, "title": "Psilocybin-assisted therapy for demoralisation in hospice patients: feasibility, safety and preliminary efficacy", "authors": "Yvan Beaussant, Zachary Sager, Caitlin W. Brennan, Isabel Kristan, Michael Ljuslin, Emanuele Mazzola, David R. Macdonald, M. Murphy, Kabir Nigam, Alden Doerner Rinaldi, Justin J. Sanders, Kristen G. Schaefer, Roxanne Sholevar, Lisa Summer, Alifia Waliji-Banglawala, Sandra Yudilevich-Espinoza, James A. Tulsky", "journal": "BMJ Supportive & Palliative Care", "publication_date": "2025-11-02", "publication_year": 2025, "doi": "10.1136/spcare-2025-005773", "pubmed_id": "41184102", "openalex_id": "https://openalex.org/W4415820910", "source_url": "https://doi.org/10.1136/spcare-2025-005773", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Emotional Processing,Safety,Adverse Events,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41184102", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/spcare-2025-005773", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41184102", "source_url": "https://doi.org/10.1136/spcare-2025-005773", "doi": "10.1136/spcare-2025-005773", "pmid": "41184102", "publication_date": "2025-11-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 84, "title": "Lifetime Psychedelic Use and Opioid Use Disorder Severity: Substance-Use Pattern Specific and Mental Health-Dependent Associations in a National Survey", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-11-01", "publication_year": 2025, "doi": "10.1016/j.addbeh.2026.108652", "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/jd2rk_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-06-30 22:38:07", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "DOI:10.1016/j.addbeh.2026.108652", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/jd2rk_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.1016/j.addbeh.2026.108652", "source_url": "https://osf.io/preprints/psyarxiv/jd2rk_v1", "doi": "10.1016/j.addbeh.2026.108652", "pmid": "", "publication_date": "2025-11-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1987, "title": "Ketamine and psilocybin for athletes: A therapeutic breakthrough or a slippery slope?", "authors": "Thomas Zandonai, Sofia Venturini, Ornella Corazza", "journal": "Performance Enhancement & Health", "publication_date": "2025-10-31", "publication_year": 2025, "doi": "10.1016/j.peh.2025.100386", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415757045", "source_url": "https://doi.org/10.1016/j.peh.2025.100386", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Receptor Pharmacology,Resilience,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.peh.2025.100386", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.peh.2025.100386", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.peh.2025.100386", "source_url": "https://doi.org/10.1016/j.peh.2025.100386", "doi": "10.1016/j.peh.2025.100386", "pmid": "", "publication_date": "2025-10-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 458, "title": "The therapeutic use of psychedelic drugs: Legal, policy, and neuroscientific perspectives.", "authors": "Rahmani S, Crupi R, Riley AL, Davidson T", "journal": "Pharmacology, biochemistry, and behavior", "publication_date": "2025-10-31", "publication_year": 2025, "doi": "10.1016/j.pbb.2025.174087", "pubmed_id": "40849009", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40849009/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:40849009", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40849009/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40849009", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40849009/", "doi": "10.1016/j.pbb.2025.174087", "pmid": "40849009", "publication_date": "2025-10-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 449, "title": "Reporting of side-effects in clinical trials of psilocybin-assisted psychotherapy for psychiatric conditions: systematic review", "authors": "Jonathon Marinis, Sarah Clarke, Alexandre A. Guerin, Adam J. Guastella, Gillinder Bedi", "journal": "BJPsych Open", "publication_date": "2025-10-31", "publication_year": 2025, "doi": "10.1192/bjo.2025.10847", "pubmed_id": "41178084", "openalex_id": "https://openalex.org/W4415782096", "source_url": "https://doi.org/10.1192/bjo.2025.10847", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41178084", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2025.10847", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41178084", "source_url": "https://doi.org/10.1192/bjo.2025.10847", "doi": "10.1192/bjo.2025.10847", "pmid": "41178084", "publication_date": "2025-10-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4256, "title": "Use of psilocybin for chronic pain: a scoping review with current evidence and prospection of literature and technology for future applications", "authors": "André Leão Dantas, Lara Moreira Jalles Milani, Saulo Gabriel Moreira Falci, João Américo da Silveira, Cristina Pereira Isolan, Lia Dietrich", "journal": "Caderno Pedagógico", "publication_date": "2025-10-30", "publication_year": 2025, "doi": "10.54033/cadpedv22n12-345", "pubmed_id": null, "openalex_id": "https://openalex.org/W4415830103", "source_url": "https://doi.org/10.54033/cadpedv22n12-345", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Neuroplasticity,Pharmacology,Receptor Pharmacology,Microdosing,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.54033/cadpedv22n12-345", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.54033/cadpedv22n12-345", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.54033/cadpedv22n12-345", "source_url": "https://doi.org/10.54033/cadpedv22n12-345", "doi": "10.54033/cadpedv22n12-345", "pmid": "", "publication_date": "2025-10-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 306, "title": "Psilocybin use in bipolar disorder: A comprehensive review.", "authors": "Do A, Cloutier L, Hébert-Tremblay L, Thauvin C.", "journal": null, "publication_date": "2025-10-30", "publication_year": 2025, "doi": "10.1016/j.jad.2025.120485", "pubmed_id": "41177271", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2025.120485", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:41177271", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2025.120485", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41177271", "source_url": "https://doi.org/10.1016/j.jad.2025.120485", "doi": "10.1016/j.jad.2025.120485", "pmid": "41177271", "publication_date": "2025-10-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3597, "title": "A Wellcome Leap for the Opioid Crisis: Can the 5HT2A Agonist Psilocybin Improve Brain, Behavioral, and Clinical Outcomes in Opioid Use Disorder (OUD)?", "authors": "Anna Rose Childress, Ph.D.", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-28", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06786325", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Receptor Pharmacology,Consciousness,Biomarkers,Emotional Processing,Spirituality,Mystical Experience,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06786325", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06786325", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06786325", "source_url": "https://clinicaltrials.gov/study/NCT06786325", "doi": "", "pmid": "", "publication_date": "2025-10-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 467, "title": "Psilocybin-assisted Existential, Attachment and RelationaL (PEARL) therapy for patients with advanced cancer: protocol for a multi-method feasibility trial", "authors": "Candice Richardson, Cindy Chan, Emily Macgregor, Crystal Hare, Breffni Hannon, SarahRose Black, Evan E. Schneider, Daniel Z. Buchman, Stella Wang, Valeria E. Rac, Lusine Abrahamyan, Ella Huszti, Rinat Nissim, Madeline Li, Camilla Zimmermann, Emma Hapke, Daniel M. Rosenbaum, Sarah Hales", "journal": "Pilot and Feasibility Studies", "publication_date": "2025-10-27", "publication_year": 2025, "doi": "10.1186/s40814-025-01706-5", "pubmed_id": "41152967", "openalex_id": "https://openalex.org/W4415616586", "source_url": "https://doi.org/10.1186/s40814-025-01706-5", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41152967", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s40814-025-01706-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41152967", "source_url": "https://doi.org/10.1186/s40814-025-01706-5", "doi": "10.1186/s40814-025-01706-5", "pmid": "41152967", "publication_date": "2025-10-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 391, "title": "Adverse event reporting and management in psilocybin therapy clinical trials: A systematic review to guide clinical and research protocol development.", "authors": "Bukovsky D, Amaev A, Song J, Kyte S, Carmona-Torres E, Ueno F, Deluca V, Strafella AP, Husain MI, Graff-Guerrero A, Gerretsen P.", "journal": null, "publication_date": "2025-10-22", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111541", "pubmed_id": "41138900", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111541", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:41138900", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2025.111541", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41138900", "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111541", "doi": "10.1016/j.pnpbp.2025.111541", "pmid": "41138900", "publication_date": "2025-10-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 359, "title": "Mind the gap! Addressing unresolved aspects of abuse potential evaluation and scheduling of classic and novel psychedelic drugs", "authors": "David J. Heal, Jane Gosden, Sharon L. Smith", "journal": "Journal of Psychopharmacology", "publication_date": "2025-10-15", "publication_year": 2025, "doi": "10.1177/02698811251382147", "pubmed_id": "41099474", "openalex_id": "https://openalex.org/W4415246143", "source_url": "https://doi.org/10.1177/02698811251382147", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety,Toxicity,Abuse Liability", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41099474", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811251382147", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41099474", "source_url": "https://doi.org/10.1177/02698811251382147", "doi": "10.1177/02698811251382147", "pmid": "41099474", "publication_date": "2025-10-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 358, "title": "A novel psychedelic 5-HT2A receptor agonist GM-2505: The pharmacokinetic, safety, and pharmacodynamic profile from a randomized trial healthy volunteer", "authors": "Gerard J. Marek, Soma Makai-Bölöni, Daniel Umbricht, Edward P. Christian, Jason Winters, Dino Dvořák, Shane Raines, Zoë A. Hughes, Eric W. Austin, Adam K. Klein, William Leong, Fas J. Krol, Anne J. van der Graaf, Maria J. Juachon, Marije E. Otto, Laura Borghans, Gabriël E. Jacobs, Andrew C. Kruegel, Jonathan Sporn", "journal": "Journal of Psychopharmacology", "publication_date": "2025-10-15", "publication_year": 2025, "doi": "10.1177/02698811251378512", "pubmed_id": "41099491", "openalex_id": "https://openalex.org/W4415246252", "source_url": "https://doi.org/10.1177/02698811251378512", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Pharmacology,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41099491", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811251378512", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41099491", "source_url": "https://doi.org/10.1177/02698811251378512", "doi": "10.1177/02698811251378512", "pmid": "41099491", "publication_date": "2025-10-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3640, "title": "A Phase 1 Study of a Second Psilocybin Group Retreat for Partial Responders With Anxiety Associated With Metastatic Cancer", "authors": "University of Washington", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-13", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06644170", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Receptor Pharmacology,Wellbeing,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06644170", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06644170", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06644170", "source_url": "https://clinicaltrials.gov/study/NCT06644170", "doi": "", "pmid": "", "publication_date": "2025-10-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3590, "title": "Psilocybin and Affective Function in Chronic Lower Back Pain Depression", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-13", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06355414", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Observational Study,Safety", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06355414", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06355414", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06355414", "source_url": "https://clinicaltrials.gov/study/NCT06355414", "doi": "", "pmid": "", "publication_date": "2025-10-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 428, "title": "Zalsupindole is a Nondissociative, Nonhallucinogenic Neuroplastogen with Therapeutic Effects Comparable to Ketamine and Psychedelics", "authors": "Rajiv Agrawal, Daniel J. Gillie, Alison E. Mungenast, Milan Chytil, Sharon Engel, Michael C. Wu, Kurt Rasmussen, Eliseo Salinas, David E. Olson", "journal": "ACS Chemical Neuroscience", "publication_date": "2025-10-12", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00667", "pubmed_id": "41078264", "openalex_id": "https://openalex.org/W4415115279", "source_url": "https://doi.org/10.1021/acschemneuro.5c00667", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Neurogenesis,Pharmacology,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41078264", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.5c00667", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41078264", "source_url": "https://doi.org/10.1021/acschemneuro.5c00667", "doi": "10.1021/acschemneuro.5c00667", "pmid": "41078264", "publication_date": "2025-10-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4272, "title": "Psychedelics in Practice: Science, Safety, and the Future of Healing", "authors": "Renee Ireland", "journal": "˜The œproceedings of sliit international conference on advancements in science and humanities", "publication_date": "2025-10-09", "publication_year": 2025, "doi": "10.54389/epsd8792", "pubmed_id": null, "openalex_id": "https://openalex.org/W7119484008", "source_url": "https://doi.org/10.54389/epsd8792", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Treatment-Resistant Depression,Safety,Toxicity,Contraindications", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.54389/epsd8792", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.54389/epsd8792", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.54389/epsd8792", "source_url": "https://doi.org/10.54389/epsd8792", "doi": "10.54389/epsd8792", "pmid": "", "publication_date": "2025-10-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3455, "title": "Psilocybin for Chronic Pelvic Pain (CPP) in Women: A Pilot Feasibility Study", "authors": "Oregon Health and Science University", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-09", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06988319", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Safety,Adverse Events", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06988319", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06988319", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06988319", "source_url": "https://clinicaltrials.gov/study/NCT06988319", "doi": "", "pmid": "", "publication_date": "2025-10-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 438, "title": "Stabilizing Psilocybin Pharmacology and Tuning Safety with Atypical Antipsychotic Cotherapy.", "authors": "Renner AC, Kargbo RB.", "journal": null, "publication_date": "2025-10-09", "publication_year": 2025, "doi": "10.1021/acsmedchemlett.5c00595", "pubmed_id": "41256989", "openalex_id": null, "source_url": "https://doi.org/10.1021/acsmedchemlett.5c00595", "substance_tags": "psilocybin,psilocin", "topic_tags": "Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Biomarkers,Animal Study,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:41256989", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsmedchemlett.5c00595", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41256989", "source_url": "https://doi.org/10.1021/acsmedchemlett.5c00595", "doi": "10.1021/acsmedchemlett.5c00595", "pmid": "41256989", "publication_date": "2025-10-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3668, "title": "A Pilot Study in North Louisiana to Assess the Tolerability of Psilocybin as Well as Its Capacity to Promote Abstinence From Methamphetamine", "authors": "Kevin Murnane", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-06", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06899594", "substance_tags": "psilocybin", "topic_tags": "Addiction,Emotional Processing,Review Article,Safety", "study_type": "Review Article", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06899594", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06899594", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06899594", "source_url": "https://clinicaltrials.gov/study/NCT06899594", "doi": "", "pmid": "", "publication_date": "2025-10-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3575, "title": "Efficacy of Psilocybin and Trazodone Combination in Treatment-resistant Depression: a Randomized Controlled Proof-of-concept Study (PSILOTRAZ)", "authors": "Centre Hospitalier St Anne", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-06", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07210112", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07210112", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07210112", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07210112", "source_url": "https://clinicaltrials.gov/study/NCT07210112", "doi": "", "pmid": "", "publication_date": "2025-10-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4275, "title": "Neurobiological and Therapeutic Potential of Psilocybin in Psychiatric Disorders", "authors": "M Loganathan, A Saravanakumar, P. Parthiban, G Anandharaj, S Gobika, D Dharshana, Mohamed Safir Ali", "journal": "Journal of Pharma Insights and Research.", "publication_date": "2025-10-04", "publication_year": 2025, "doi": "10.69613/thv1dn30", "pubmed_id": null, "openalex_id": "https://openalex.org/W4416779935", "source_url": "https://doi.org/10.69613/thv1dn30", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,End-of-Life Distress,Chronic Pain,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.69613/thv1dn30", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.69613/thv1dn30", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.69613/thv1dn30", "source_url": "https://doi.org/10.69613/thv1dn30", "doi": "10.69613/thv1dn30", "pmid": "", "publication_date": "2025-10-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 480, "title": "Harm reduction practises for users of psychedelic drugs: a scoping review.", "authors": "Dutton C, North E, Chun Tie Y, Oliva J, Skeffington P", "journal": "Harm reduction journal", "publication_date": "2025-10-02", "publication_year": 2025, "doi": "10.1186/s12954-025-01264-2", "pubmed_id": "41044617", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41044617/", "substance_tags": "psilocybin", "topic_tags": "Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:41044617", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41044617/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41044617", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41044617/", "doi": "10.1186/s12954-025-01264-2", "pmid": "41044617", "publication_date": "2025-10-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3677, "title": "Retrospective Observational Study of Intensity Effects in Psychedelic-assisted Treatment", "authors": "University Hospital, Geneva", "journal": "ClinicalTrials.gov", "publication_date": "2025-10-01", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07164287", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07164287", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07164287", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07164287", "source_url": "https://clinicaltrials.gov/study/NCT07164287", "doi": "", "pmid": "", "publication_date": "2025-10-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4278, "title": "B-302 Psychedelics and Dissociative Anesthetics: Concentrations in Suspected Impaired Driving Investigations, 2024", "authors": "Stephanie Marco", "journal": "Clinical Chemistry", "publication_date": "2025-09-30", "publication_year": 2025, "doi": "10.1093/clinchem/hvaf086.689", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414740466", "source_url": "https://doi.org/10.1093/clinchem/hvaf086.689", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Emotional Processing,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1093/clinchem/hvaf086.689", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/clinchem/hvaf086.689", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/clinchem/hvaf086.689", "source_url": "https://doi.org/10.1093/clinchem/hvaf086.689", "doi": "10.1093/clinchem/hvaf086.689", "pmid": "", "publication_date": "2025-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3552, "title": "Psilocybin and MDMA for Post-traumatic Stress Disorder (PTSD)", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-30", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06989957", "substance_tags": "psilocybin", "topic_tags": "PTSD,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06989957", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06989957", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06989957", "source_url": "https://clinicaltrials.gov/study/NCT06989957", "doi": "", "pmid": "", "publication_date": "2025-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 491, "title": "Clinical psychedelic research in adolescents: a scoping review and overview of ethical considerations.", "authors": "Rajwani K, Jacobs E, Bruce L, Hokanson J, Almonte MT, Feroz F, Waldman E, Cheung K, Levy N, Savulescu J, Singh I, Yaden DB, Earp BD.", "journal": null, "publication_date": "2025-09-30", "publication_year": 2025, "doi": "10.1016/s2352-4642(25)00208-1", "pubmed_id": "40908054", "openalex_id": null, "source_url": "https://doi.org/10.1016/s2352-4642(25)00208-1", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Review Article,Adolescents,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40908054", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/s2352-4642(25)00208-1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40908054", "source_url": "https://doi.org/10.1016/s2352-4642(25)00208-1", "doi": "10.1016/s2352-4642(25)00208-1", "pmid": "40908054", "publication_date": "2025-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 485, "title": "[Role of psychedelics in psychiatry: a true therapeutic revolution or a trend?]", "authors": "Michel Sabé, Federico Seragnoli, Louise Penzenstadler, Gabriel Thorens", "journal": "PubMed", "publication_date": "2025-09-30", "publication_year": 2025, "doi": null, "pubmed_id": "41575100", "openalex_id": "https://openalex.org/W7125566383", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41575100", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41575100", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41575100", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41575100", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41575100", "doi": "", "pmid": "41575100", "publication_date": "2025-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 505, "title": "Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring", "authors": "Cassandra J. Hatzipantelis, Min Liu, A. H. G. Love, Sadie J. Leventhal, Hero Maera, Srinidhi Viswanathan, Emily Avetisyan, Liana Belinsky, McKenna M. Rangel, Nina J. Jain, Max Kelly, C. Copeland, Yara A. Khatib, Oliver Fiehn, David E. Olson, Danielle S. Stolzenberg", "journal": "Nature Communications", "publication_date": "2025-09-29", "publication_year": 2025, "doi": "10.1038/s41467-025-64371-5", "pubmed_id": "41027992", "openalex_id": "https://openalex.org/W4414669838", "source_url": "https://doi.org/10.1038/s41467-025-64371-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41027992", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41467-025-64371-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41027992", "source_url": "https://doi.org/10.1038/s41467-025-64371-5", "doi": "10.1038/s41467-025-64371-5", "pmid": "41027992", "publication_date": "2025-09-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 508, "title": "Ethical issues with psychedelic-assisted treatments in psychiatry: A systematic scoping review.", "authors": "Caporuscio C, Poppe C, Gieselmann A, Repantis D.", "journal": null, "publication_date": "2025-09-28", "publication_year": 2025, "doi": "10.1017/s0033291725101761", "pubmed_id": "41017267", "openalex_id": null, "source_url": "https://doi.org/10.1017/s0033291725101761", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:41017267", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/s0033291725101761", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41017267", "source_url": "https://doi.org/10.1017/s0033291725101761", "doi": "10.1017/s0033291725101761", "pmid": "41017267", "publication_date": "2025-09-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3507, "title": "An Exploratory Study of Feasibility, Efficacy, and Mechanisms of Mindfulness-Assisted Psychedelic Therapy", "authors": "University of Southern California", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-25", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06233344", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Mechanism of Action,Biomarkers,Spirituality,Clinical Trial,Observational Study,Safety,Adverse Events,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06233344", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06233344", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06233344", "source_url": "https://clinicaltrials.gov/study/NCT06233344", "doi": "", "pmid": "", "publication_date": "2025-09-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3262, "title": "“So many relationships in the room”: Participant perspectives on the affordances and challenges of co-therapy in psychedelic assisted therapy", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-09-25", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/4cn5r_v1", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/4cn5r_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/4cn5r_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/4cn5r_v1", "source_url": "https://osf.io/preprints/psyarxiv/4cn5r_v1", "doi": "", "pmid": "", "publication_date": "2025-09-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4289, "title": "Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative review", "authors": "Stefania Chiappini, Clara Cavallotto, Andrea Miuli, Giacomo d’Andrea, Alessio Mosca, Carlotta Marrangone, Rita Allegretti, Serena Panichella, Antonio d'Attilio, Giovanna Mammarella, Luca Persico, Alessia Santeusanio, Gianfranco Tamagnini, Mauro Pettorruso, Giovanni Martinotti", "journal": "Clinical Neuropsychopharmacology and Addiction", "publication_date": "2025-09-24", "publication_year": 2025, "doi": "10.53941/cna.2025.100006", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414523550", "source_url": "https://doi.org/10.53941/cna.2025.100006", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Biomarkers,Aging,Review Article,Animal Study,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.53941/cna.2025.100006", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.53941/cna.2025.100006", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.53941/cna.2025.100006", "source_url": "https://doi.org/10.53941/cna.2025.100006", "doi": "10.53941/cna.2025.100006", "pmid": "", "publication_date": "2025-09-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3588, "title": "Observational Pilot Study to Explore the Social and Health Impacts of a New Model of Care in Oregon: Psilocybin Services on Alcoholism", "authors": "Healing Advocacy Fund", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-23", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07189988", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Wellbeing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07189988", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07189988", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07189988", "source_url": "https://clinicaltrials.gov/study/NCT07189988", "doi": "", "pmid": "", "publication_date": "2025-09-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4290, "title": "With great power comes great responsibility: Promise and caution in the new psychedelic renaissance", "authors": "Matthew Halma, R. Levy, Joseph Varón", "journal": "Brain Disorders", "publication_date": "2025-09-22", "publication_year": 2025, "doi": "10.1016/j.dscb.2025.100286", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414440106", "source_url": "https://doi.org/10.1016/j.dscb.2025.100286", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Consciousness,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:38", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.dscb.2025.100286", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.dscb.2025.100286", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.dscb.2025.100286", "source_url": "https://doi.org/10.1016/j.dscb.2025.100286", "doi": "10.1016/j.dscb.2025.100286", "pmid": "", "publication_date": "2025-09-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 453, "title": "Considerations and cautions for the integration of psilocybin into routine clinical care: a consensus statement from the US National Network of Depression Centers' Task Group on Psychedelics and Related Compounds.", "authors": "Hosein MM, Reid MJ, Walser S, Charney S, Fonzo GA, Lewis BR, Yaden DB, Suppes T, Cordner ZA, Barrett FS.", "journal": null, "publication_date": "2025-09-22", "publication_year": 2025, "doi": "10.1016/j.eclinm.2025.103517", "pubmed_id": "41048658", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.eclinm.2025.103517", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:41048658", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.eclinm.2025.103517", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41048658", "source_url": "https://doi.org/10.1016/j.eclinm.2025.103517", "doi": "10.1016/j.eclinm.2025.103517", "pmid": "41048658", "publication_date": "2025-09-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 509, "title": "Psilocybin-assisted psychotherapy for methamphetamine use disorder: A pilot open-label safety and feasibility study", "authors": "Elizabeth Knock, Krista J. Siefried, Gillinder Bedi, Steven M. Albert, Richard O. Day, Nadine Ezard, Margaret Ross, Paul Liknaitzky, Jonathan Brett", "journal": "Addiction", "publication_date": "2025-09-19", "publication_year": 2025, "doi": "10.1111/add.70187", "pubmed_id": "40974259", "openalex_id": "https://openalex.org/W4414374510", "source_url": "https://doi.org/10.1111/add.70187", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40974259", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.70187", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40974259", "source_url": "https://doi.org/10.1111/add.70187", "doi": "10.1111/add.70187", "pmid": "40974259", "publication_date": "2025-09-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 513, "title": "Reappraisal of the hype and hope offered by psilocybin treatment of depression.", "authors": "Beaglehole B, Manuel J.", "journal": null, "publication_date": "2025-09-18", "publication_year": 2025, "doi": "10.26635/6965.7138", "pubmed_id": "40966702", "openalex_id": null, "source_url": "https://doi.org/10.26635/6965.7138", "substance_tags": "psilocybin", "topic_tags": "Depression,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40966702", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.26635/6965.7138", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40966702", "source_url": "https://doi.org/10.26635/6965.7138", "doi": "10.26635/6965.7138", "pmid": "40966702", "publication_date": "2025-09-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 512, "title": "Psilocybin-assisted group psychotherapy and mindfulness-based stress reduction for frontline healthcare provider COVID-19-related depression and burnout: A randomized controlled trial", "authors": "Benjamin R. Lewis, John Hendrick, Kevin Byrne, Madeleine Odette, Chaorong Wu, Eric L. Garland", "journal": "PLoS Medicine", "publication_date": "2025-09-18", "publication_year": 2025, "doi": "10.1371/journal.pmed.1004519", "pubmed_id": "40972137", "openalex_id": "https://openalex.org/W4414366251", "source_url": "https://doi.org/10.1371/journal.pmed.1004519", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40972137", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pmed.1004519", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40972137", "source_url": "https://doi.org/10.1371/journal.pmed.1004519", "doi": "10.1371/journal.pmed.1004519", "pmid": "40972137", "publication_date": "2025-09-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 511, "title": "Evolution and Comparative Analysis of Clinical Trials on Psilocybin in the Treatment of Psychopathologies: Trends in the EU and the US", "authors": "Anastasia Calin, Ana Flavia Burlec, Cornelia Mircea, Irina Macovei, Monica Hăncianu, Andreia Corciovă", "journal": "Journal of Clinical Medicine", "publication_date": "2025-09-18", "publication_year": 2025, "doi": "10.3390/jcm14186613", "pubmed_id": "41010814", "openalex_id": "https://openalex.org/W4414341779", "source_url": "https://doi.org/10.3390/jcm14186613", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41010814", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/jcm14186613", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41010814", "source_url": "https://doi.org/10.3390/jcm14186613", "doi": "10.3390/jcm14186613", "pmid": "41010814", "publication_date": "2025-09-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4294, "title": "Trauma under psychedelics: how psychoactive substances impact trauma processing", "authors": "Ophir Netzer, Noa Magal, Yonatan Stern, Tzuk Polinsky, Raz Gross, Roee Admon, Roy Salomon", "journal": "World Psychiatry", "publication_date": "2025-09-14", "publication_year": 2025, "doi": "10.1002/wps.21363", "pubmed_id": "40948086", "openalex_id": "https://openalex.org/W4414167960", "source_url": "https://doi.org/10.1002/wps.21363", "substance_tags": "psilocybin", "topic_tags": "PTSD,Addiction,End-of-Life Distress,Receptor Pharmacology,Observational Study,Safety,Drug Interactions", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40948086", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/wps.21363", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40948086", "source_url": "https://doi.org/10.1002/wps.21363", "doi": "10.1002/wps.21363", "pmid": "40948086", "publication_date": "2025-09-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3435, "title": "The Impact of Psilocybin on Pain in Fibromyalgia Patients: a Multicentre Trial.", "authors": "Maastricht University", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-14", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06368492", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Headache / Migraine,Review Article,Case Report,Observational Study,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06368492", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06368492", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06368492", "source_url": "https://clinicaltrials.gov/study/NCT06368492", "doi": "", "pmid": "", "publication_date": "2025-09-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 504, "title": "Multianalytical Investigation of Psilocybe cubensis Mushrooms: Physicochemical Characterization and Biological Evaluation of Psilocybin and Psilocin Compounds", "authors": "Taynah Pereira Galdino, Antônio Braz de Medeiros Bisneto, Marcelo da Silva Pedro, Lucas Cordeiro de Oliveira, Mateus Araújo da Luz, Antônio Gilson Barbosa de Lima, Suédina Maria de Lima Silva, Marcus Vinícius Lia Fook", "journal": "ACS Omega", "publication_date": "2025-09-14", "publication_year": 2025, "doi": "10.1021/acsomega.5c05606", "pubmed_id": "41048717", "openalex_id": "https://openalex.org/W4414250218", "source_url": "https://doi.org/10.1021/acsomega.5c05606", "substance_tags": "psilocybin,psilocin", "topic_tags": "Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41048717", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acsomega.5c05606", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41048717", "source_url": "https://doi.org/10.1021/acsomega.5c05606", "doi": "10.1021/acsomega.5c05606", "pmid": "41048717", "publication_date": "2025-09-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 487, "title": "Dynamic myocardial injury and variable hallucination latency in Psilocybe keralensis poisoning: a molecularly confirmed case series from China", "authors": "Zhifan He, Rui Tang, Min Feng, Xiaohui Li, Changhong Zhang, Jing Li", "journal": "Clinical Toxicology", "publication_date": "2025-09-14", "publication_year": 2025, "doi": "10.1080/15563650.2025.2552438", "pubmed_id": "40948398", "openalex_id": "https://openalex.org/W4414167818", "source_url": "https://doi.org/10.1080/15563650.2025.2552438", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Case Report,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40948398", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/15563650.2025.2552438", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40948398", "source_url": "https://doi.org/10.1080/15563650.2025.2552438", "doi": "10.1080/15563650.2025.2552438", "pmid": "40948398", "publication_date": "2025-09-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 456, "title": "Emerging mechanisms of psilocybin-induced neuroplasticity.", "authors": "Sonda S, Pendin D, Comai S, De Martin S, Manfredi P, Mattarei A.", "journal": null, "publication_date": "2025-09-14", "publication_year": 2025, "doi": "10.1016/j.tips.2025.08.012", "pubmed_id": "40957728", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.tips.2025.08.012", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40957728", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.tips.2025.08.012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40957728", "source_url": "https://doi.org/10.1016/j.tips.2025.08.012", "doi": "10.1016/j.tips.2025.08.012", "pmid": "40957728", "publication_date": "2025-09-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 326, "title": "Temporal dynamics in neuroimaging as correlates of therapeutic response to psilocybin in major depressive disorder: A systematic review and critical appraisal.", "authors": "Sabbah SG, Li S, Wong S, Le GH, Badulescu S, Hawco C, Rosenblat JD, McIntyre RS.", "journal": null, "publication_date": "2025-09-14", "publication_year": 2025, "doi": "10.1016/j.jad.2025.120335", "pubmed_id": "40962065", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2025.120335", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:40962065", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2025.120335", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40962065", "source_url": "https://doi.org/10.1016/j.jad.2025.120335", "doi": "10.1016/j.jad.2025.120335", "pmid": "40962065", "publication_date": "2025-09-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5626, "title": "Serotonin 5-HT2C Receptor SignalingAnalysis Reveals Psychedelic Biased Agonism", "authors": "Emma M. Bonniwell (14267047), Rana Alabdali (22241286), Joseph J. Hennessey (22241289), John L. McKee (22179170), Natalie G. Cavalco (20388684), Josie C. Lammers (22241292), Ethan J. Moore (22241295), Luca Franchini (10578054), Cesare Orlandi (204175), John D. McCorvy (1416910)", "journal": "Figshare", "publication_date": "2025-09-12", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00647.s001", "pubmed_id": null, "openalex_id": "https://openalex.org/W7111383702", "source_url": "https://figshare.com/articles/journal_contribution/Serotonin_5_HT_sub_2C_sub_Receptor_Signaling_Analysis_Reveals_Psychedelic_Biased_Agonism/30120024", "substance_tags": "psilocin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:10", "last_checked": "2026-07-04 06:52:10", "bibtex": null, "source_record_id": "DOI:10.1021/acschemneuro.5c00647.s001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://figshare.com/articles/journal_contribution/Serotonin_5_HT_sub_2C_sub_Receptor_Signaling_Analysis_Reveals_Psychedelic_Biased_Agonism/30120024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/acschemneuro.5c00647.s001", "source_url": "https://figshare.com/articles/journal_contribution/Serotonin_5_HT_sub_2C_sub_Receptor_Signaling_Analysis_Reveals_Psychedelic_Biased_Agonism/30120024", "doi": "10.1021/acschemneuro.5c00647.s001", "pmid": "", "publication_date": "2025-09-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 488, "title": "Serotonin 5-HT2C Receptor Signaling Analysis Reveals Psychedelic Biased Agonism.", "authors": "Bonniwell EM, Alabdali R, Hennessey JJ, McKee JL, Cavalco NG, Lammers JC, Moore EJ, Franchini L, Orlandi C, McCorvy JD.", "journal": null, "publication_date": "2025-09-12", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00647", "pubmed_id": "40944639", "openalex_id": "https://openalex.org/W4414162276", "source_url": "https://doi.org/10.1021/acschemneuro.5c00647", "substance_tags": "psilocin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40944639", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.5c00647", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40944639", "source_url": "https://doi.org/10.1021/acschemneuro.5c00647", "doi": "10.1021/acschemneuro.5c00647", "pmid": "40944639", "publication_date": "2025-09-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 517, "title": "Supporting Meaningful Choices: A Decision Aid for Individuals Facing Existential Distress and Considering Psilocybin-Assisted Therapy", "authors": "Ariane Bélanger, Sue-Ling Chang, Jean-François Stephan, Florence Moureaux, Diane Tapp, Robert Foxman, Pierre Gagnon, Johanne Hébert, Houman Farzin, Michel Dorval", "journal": "Healthcare", "publication_date": "2025-09-11", "publication_year": 2025, "doi": "10.3390/healthcare13182290", "pubmed_id": "41008422", "openalex_id": "https://openalex.org/W4414258408", "source_url": "https://doi.org/10.3390/healthcare13182290", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41008422", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/healthcare13182290", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41008422", "source_url": "https://doi.org/10.3390/healthcare13182290", "doi": "10.3390/healthcare13182290", "pmid": "41008422", "publication_date": "2025-09-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 489, "title": "Concomitant use of antidepressants and classic psychedelics: A scoping review.", "authors": "Tap SC, Thomas K, Páleníček T, Stenbæk DS, Oliveira-Maia AJ, van Dalfsen JH, Schoevers RA.", "journal": null, "publication_date": "2025-09-11", "publication_year": 2025, "doi": "10.1177/02698811251368360", "pubmed_id": "40937732", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811251368360", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40937732", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811251368360", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40937732", "source_url": "https://doi.org/10.1177/02698811251368360", "doi": "10.1177/02698811251368360", "pmid": "40937732", "publication_date": "2025-09-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4296, "title": "The Legal Perspective on Psilocybin for Medical Use in Czechia: A Key Milestone and the Case for Broader Consideration Beyond the Clinical Setting", "authors": "Tereza Dleštíková", "journal": "Psychoactives", "publication_date": "2025-09-10", "publication_year": 2025, "doi": "10.3390/psychoactives4030034", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414123257", "source_url": "https://doi.org/10.3390/psychoactives4030034", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Safety", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4030034", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4030034", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4030034", "source_url": "https://doi.org/10.3390/psychoactives4030034", "doi": "10.3390/psychoactives4030034", "pmid": "", "publication_date": "2025-09-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3699, "title": "Measurement of Serum Cytokine Levels in Samples Collected as Part of a Clinical Trial of Psilocybin for Treatment-resistant Depression.", "authors": "King's College London", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-09", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT07164755", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Biomarkers,Clinical Trial,Animal Study,In Vitro Study,Treatment-Resistant Depression,Safety,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT07164755", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT07164755", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT07164755", "source_url": "https://clinicaltrials.gov/study/NCT07164755", "doi": "", "pmid": "", "publication_date": "2025-09-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3562, "title": "Processing Intergenerational Trauma With Psilocybin-Assisted Therapy", "authors": "Rachel Yehuda", "journal": "ClinicalTrials.gov", "publication_date": "2025-09-07", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06899165", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Biomarkers,Wellbeing,Resilience,Healthcare Workers,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06899165", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06899165", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06899165", "source_url": "https://clinicaltrials.gov/study/NCT06899165", "doi": "", "pmid": "", "publication_date": "2025-09-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 521, "title": "Effect of psilocybin therapy on suicidal ideation, attempts, and deaths in people with psychiatric diagnoses: a systematic review and meta-analysis.", "authors": "Wong S, Meckling G, Fabiano N, Lee S, Jones BDM, Shorr R, Dargel A, Davis AK, Fiedorowicz JG, Solmi M, Rosenblat JD, Mulsant BH, Blumberger DM, Husain MI.", "journal": null, "publication_date": "2025-09-06", "publication_year": 2025, "doi": "10.1177/20451253251372449", "pubmed_id": "40933784", "openalex_id": null, "source_url": "https://doi.org/10.1177/20451253251372449", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40933784", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/20451253251372449", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40933784", "source_url": "https://doi.org/10.1177/20451253251372449", "doi": "10.1177/20451253251372449", "pmid": "40933784", "publication_date": "2025-09-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4297, "title": "Five-year outcomes of psilocybin-assisted therapy for Major Depressive Disorder", "authors": "Alan K. Davis, Meghan DellaCrosse, Nathan D. Sepeda, Adam W. Levin, Mary P Cosimano, Hillary Shaub, Washington Taylor, Peter M. Gooch, Shoval Gilead, Skylar J. Gaughan, Stacey B. Armstrong, Frederick S. Barrett", "journal": "Journal of Psychedelic Studies", "publication_date": "2025-09-03", "publication_year": 2025, "doi": "10.1556/2054.2025.00461", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413975912", "source_url": "https://doi.org/10.1556/2054.2025.00461", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Emotional Processing,Randomized Controlled Trial,Healthcare Workers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2025.00461", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2025.00461", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2025.00461", "source_url": "https://doi.org/10.1556/2054.2025.00461", "doi": "10.1556/2054.2025.00461", "pmid": "", "publication_date": "2025-09-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3775, "title": "Blunted psychedelic drug effects in older adults", "authors": "Aday JS, Carhart-Harris R, Boehnke KF.", "journal": "PsyArXiv", "publication_date": "2025-09-03", "publication_year": 2025, "doi": "10.31234/osf.io/yz4cd_v2", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/yz4cd_v2", "substance_tags": "psilocybin", "topic_tags": "Aging,Longevity,Older Adults,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:20", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/yz4cd_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/yz4cd_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/yz4cd_v2", "source_url": "https://doi.org/10.31234/osf.io/yz4cd_v2", "doi": "10.31234/osf.io/yz4cd_v2", "pmid": "", "publication_date": "2025-09-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3239, "title": "Blunted psychedelic drug effects in older adults", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-09-03", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/yz4cd_v2", "substance_tags": "psilocybin", "topic_tags": "Aging,Longevity,Older Adults,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/yz4cd_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/yz4cd_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/yz4cd_v2", "source_url": "https://osf.io/preprints/psyarxiv/yz4cd_v2", "doi": "", "pmid": "", "publication_date": "2025-09-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 524, "title": "Therapeutic Use of Psilocybin in Depression: a Systematic Review of Clinical Evidence.", "authors": "Andrade FRT, Buchborn T, Thalheimer G, Meinhardt MW, Joca S, de Almeida RMM.", "journal": null, "publication_date": "2025-09-02", "publication_year": 2025, "doi": "10.1017/neu.2025.10039", "pubmed_id": "40899152", "openalex_id": null, "source_url": "https://doi.org/10.1017/neu.2025.10039", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40899152", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/neu.2025.10039", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40899152", "source_url": "https://doi.org/10.1017/neu.2025.10039", "doi": "10.1017/neu.2025.10039", "pmid": "40899152", "publication_date": "2025-09-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 522, "title": "Psychedelics and mental health: reimagining care through science, insight, and compassion", "authors": "Georgios Mikellides, Marios Kyriazis", "journal": "Frontiers in Pharmacology", "publication_date": "2025-09-02", "publication_year": 2025, "doi": "10.3389/fphar.2025.1649929", "pubmed_id": "40969944", "openalex_id": "https://openalex.org/W4413961399", "source_url": "https://doi.org/10.3389/fphar.2025.1649929", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,End-of-Life Distress,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Wellbeing,Emotional Processing,Spirituality,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40969944", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fphar.2025.1649929", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40969944", "source_url": "https://doi.org/10.3389/fphar.2025.1649929", "doi": "10.3389/fphar.2025.1649929", "pmid": "40969944", "publication_date": "2025-09-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4300, "title": "Gregor Hasler: Three Guiding Questions - How do psychedelics shape the brain? How can they heal psychiatric disorders such as depression and PTSD? How can we ensure their safe and responsible use?", "authors": "Gregor Hasler", "journal": "Psychedelics.", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.61373/pp025k.0032", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413911705", "source_url": "https://doi.org/10.61373/pp025k.0032", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Neuroplasticity,Pharmacology,Mechanism of Action,Biomarkers,Safety,Genomics", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.61373/pp025k.0032", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61373/pp025k.0032", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61373/pp025k.0032", "source_url": "https://doi.org/10.61373/pp025k.0032", "doi": "10.61373/pp025k.0032", "pmid": "", "publication_date": "2025-09-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4298, "title": "Neuroplasticity and Neuro-Generation: The Promise of Psychedelics in Dementia Care", "authors": "Kerem Kemal Soylemez, Emma Marie de Boo, Aysil Susuzlu, Joanne Lusher", "journal": "Psychoactives", "publication_date": "2025-09-01", "publication_year": 2025, "doi": "10.3390/psychoactives4030031", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413908189", "source_url": "https://doi.org/10.3390/psychoactives4030031", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Wellbeing,Resilience,Emotional Processing,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4030031", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4030031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4030031", "source_url": "https://doi.org/10.3390/psychoactives4030031", "doi": "10.3390/psychoactives4030031", "pmid": "", "publication_date": "2025-09-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4305, "title": "Psilocybin-Assisted Psychotherapy for Chronic Somatoform Pain Disorder: A Case Report", "authors": "M Mercier, Cédric Mabilais, Vasileios Chytas, Leonice Furtado, Federico Seragnoli, Albert Buchard, Tatiana Aboulafia Brakha, Gabriel Thorens, Daniele Zullino, Louise Penzenstadler", "journal": "Psychoactives", "publication_date": "2025-08-31", "publication_year": 2025, "doi": "10.3390/psychoactives4030030", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413893315", "source_url": "https://doi.org/10.3390/psychoactives4030030", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mechanism of Action,Case Report,Safety", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4030030", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4030030", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4030030", "source_url": "https://doi.org/10.3390/psychoactives4030030", "doi": "10.3390/psychoactives4030030", "pmid": "", "publication_date": "2025-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4303, "title": "A lexicon for psychedelic research and treatment", "authors": "David Nutt, David Erritzøe, Anne Katrin Schlag, David Luke, Deborah C. Mash, Hiroyuki Uchida, Jacob S. Aday, James Rucker, Liliana Galindo, Mark Sweeney, Matthew X. Lowe, Oliver Davis, Plinio Ferreira, Rayyan Zafar, Robin Carhart-Harris, Tadeusz Hawrot, Joanna C. Neill", "journal": "Drug Science Policy and Law", "publication_date": "2025-08-31", "publication_year": 2025, "doi": "10.1177/20503245251380511", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414407628", "source_url": "https://doi.org/10.1177/20503245251380511", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Microdosing,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1177/20503245251380511", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20503245251380511", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/20503245251380511", "source_url": "https://doi.org/10.1177/20503245251380511", "doi": "10.1177/20503245251380511", "pmid": "", "publication_date": "2025-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 483, "title": "Psilocybin with psychotherapeutic support for treatment-resistant depression: a pilot clinical trial", "authors": "Sally Meikle, Olivia Carter, Paul Liknaitzky, Lauren Johansen, Ravi Iyer, Nigel Strauss, M.L. Williams, David Castle, Susan L. Rossell", "journal": "Therapeutic Advances in Psychopharmacology", "publication_date": "2025-08-31", "publication_year": 2025, "doi": "10.1177/20451253251377187", "pubmed_id": "41050149", "openalex_id": "https://openalex.org/W4414745551", "source_url": "https://doi.org/10.1177/20451253251377187", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Spirituality,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41050149", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20451253251377187", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41050149", "source_url": "https://doi.org/10.1177/20451253251377187", "doi": "10.1177/20451253251377187", "pmid": "41050149", "publication_date": "2025-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 490, "title": "US Poison Center Encounters for Psilocybin-Related Exposures: 2013-2022", "authors": "Juan Carlos C. Montoy, Ralph C. Wang, Allison R. Coker, Craig G. Smollin, B. Anderson", "journal": "Journal of the American College of Emergency Physicians Open", "publication_date": "2025-08-29", "publication_year": 2025, "doi": "10.1016/j.acepjo.2025.100231", "pubmed_id": "40927687", "openalex_id": "https://openalex.org/W4413851486", "source_url": "https://doi.org/10.1016/j.acepjo.2025.100231", "substance_tags": "psilocybin", "topic_tags": "Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40927687", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.acepjo.2025.100231", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40927687", "source_url": "https://doi.org/10.1016/j.acepjo.2025.100231", "doi": "10.1016/j.acepjo.2025.100231", "pmid": "40927687", "publication_date": "2025-08-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 557, "title": "Psilocybin-assisted therapy for treatment-resistant depression in the US: a model-based cost-effectiveness analysis", "authors": "Anton L.V. Avanceña, Linh N. Vuong, James G. Kahn, Elliot Marseille", "journal": "Translational Psychiatry", "publication_date": "2025-08-28", "publication_year": 2025, "doi": "10.1038/s41398-025-03556-4", "pubmed_id": "40883271", "openalex_id": "https://openalex.org/W4413817374", "source_url": "https://doi.org/10.1038/s41398-025-03556-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40883271", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41398-025-03556-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40883271", "source_url": "https://doi.org/10.1038/s41398-025-03556-4", "doi": "10.1038/s41398-025-03556-4", "pmid": "40883271", "publication_date": "2025-08-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 361, "title": "Investigating the safety and tolerability of single-dose psilocybin for post-traumatic stress disorder: A nonrandomized open-label clinical trial", "authors": "Niall M. McGowan, James Rucker, Rachel Yehuda, Manish Agrawal, Nadav Liam Modlin, Hollie Simmons, Agata Tofil-Kaluza, Shriya Das, Guy M. Goodwin", "journal": "Journal of Psychopharmacology", "publication_date": "2025-08-28", "publication_year": 2025, "doi": "10.1177/02698811251362390", "pubmed_id": "40883964", "openalex_id": "https://openalex.org/W4413839750", "source_url": "https://doi.org/10.1177/02698811251362390", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Headache / Migraine,Pharmacology,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40883964", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811251362390", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40883964", "source_url": "https://doi.org/10.1177/02698811251362390", "doi": "10.1177/02698811251362390", "pmid": "40883964", "publication_date": "2025-08-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3485, "title": "A Phase 2 Single-site, Double-blind, Placebo-controlled, Randomized Clinical Trial With an Open-label Extension Phase to Examine the Safety, Subjective Experiences, Acute Effects, and Suitability of Psilocybin Combined With Psychological Support (Psi-PS) for Military Veterans and First Responders With Co-occurring Alcohol Use Disorder (AUD) and Posttraumatic Stress Disorder (PTSD)", "authors": "Nathan Brashares Sackett", "journal": "ClinicalTrials.gov", "publication_date": "2025-08-27", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06853912", "substance_tags": "psilocybin", "topic_tags": "PTSD,Addiction,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06853912", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06853912", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06853912", "source_url": "https://clinicaltrials.gov/study/NCT06853912", "doi": "", "pmid": "", "publication_date": "2025-08-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4312, "title": "Psychedelic minimalism: the case against music in psychedelic therapy settings", "authors": "Samir A Nader", "journal": "Frontiers in Psychiatry", "publication_date": "2025-08-25", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1652568", "pubmed_id": "40933801", "openalex_id": "https://openalex.org/W4413614435", "source_url": "https://doi.org/10.3389/fpsyt.2025.1652568", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Consciousness,Personality Change,Emotional Processing,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40933801", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2025.1652568", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40933801", "source_url": "https://doi.org/10.3389/fpsyt.2025.1652568", "doi": "10.3389/fpsyt.2025.1652568", "pmid": "40933801", "publication_date": "2025-08-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4314, "title": "“To Have the Encounter with Our Own Finiteness in that Existential Way”: Descriptions of Existential Experience in Patients with Cancer and Major Depression Participating in Psilocybin-Assisted Group Therapy", "authors": "Elise C. Tarbi, Skye A. Miner, Kabir Nigam, Zachary Sager, Justin J. Sanders, Michael Ljuslin, Benjamin Guérin, Kimberly Roddy, James A. Tulsky, Manish Agrawal, Yvan Beaussant", "journal": "Psychedelic Medicine", "publication_date": "2025-08-24", "publication_year": 2025, "doi": "10.1177/28314425251370303", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414955208", "source_url": "https://doi.org/10.1177/28314425251370303", "substance_tags": "psilocybin", "topic_tags": "Depression,Spirituality,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1177/28314425251370303", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/28314425251370303", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/28314425251370303", "source_url": "https://doi.org/10.1177/28314425251370303", "doi": "10.1177/28314425251370303", "pmid": "", "publication_date": "2025-08-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 561, "title": "Psychedelics and the Serotonin Hypothesis of Eating Disorders.", "authors": "Bilenker D, Avena NM.", "journal": null, "publication_date": "2025-08-20", "publication_year": 2025, "doi": "10.3390/brainsci15080893", "pubmed_id": "40867224", "openalex_id": null, "source_url": "https://doi.org/10.3390/brainsci15080893", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Neuroplasticity,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40867224", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/brainsci15080893", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40867224", "source_url": "https://doi.org/10.3390/brainsci15080893", "doi": "10.3390/brainsci15080893", "pmid": "40867224", "publication_date": "2025-08-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3557, "title": "Effect of Psilocybin on the Positive Valence System in Treatment-resistant Depression: a Pilot Clinical Neuroimaging Study", "authors": "Centre Hospitalier Universitaire de Nīmes", "journal": "ClinicalTrials.gov", "publication_date": "2025-08-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06650800", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06650800", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06650800", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06650800", "source_url": "https://clinicaltrials.gov/study/NCT06650800", "doi": "", "pmid": "", "publication_date": "2025-08-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 459, "title": "Psilocybin-assisted psychotherapy, combined antipsychotic and antidepressant treatment for bipolar depression, duration of birth control pill use and risk of depression, handgrip strength and cognitive function, mood disorders in epilepsy, and mental health issues among physicians.", "authors": "Koenig HG.", "journal": null, "publication_date": "2025-08-19", "publication_year": 2025, "doi": "10.1177/00912174251369880", "pubmed_id": "40833259", "openalex_id": null, "source_url": "https://doi.org/10.1177/00912174251369880", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40833259", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40833259", "source_url": "https://doi.org/10.1177/00912174251369880", "doi": "10.1177/00912174251369880", "pmid": "40833259", "publication_date": "2025-08-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3466, "title": "A Phase II, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of COMP360 in Participants With Recurrent Major Depressive Disorder", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2025-08-18", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05733546", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05733546", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05733546", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05733546", "source_url": "https://clinicaltrials.gov/study/NCT05733546", "doi": "", "pmid": "", "publication_date": "2025-08-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3307, "title": "Attitudes Toward Psychedelic-Assisted Therapies for Cancer-Related Psychosocial Symptoms: A Multi- Stakeholder Analysis", "authors": "Schuman HD, Deleemans JM, Nguyen T, Savard C, Mina R, Carlson LE.", "journal": "Research Square", "publication_date": "2025-08-18", "publication_year": 2025, "doi": "10.21203/rs.3.rs-6941009/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-6941009/v1", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Observational Study,Cancer Patients,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-6941009/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-6941009/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-6941009/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-6941009/v1", "doi": "10.21203/rs.3.rs-6941009/v1", "pmid": "", "publication_date": "2025-08-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 418, "title": "Exploring the therapeutic potential of psychedelics in treating substance use disorders.", "authors": "Li Y, Li H, Wang H, Wang X.", "journal": null, "publication_date": "2025-08-18", "publication_year": 2025, "doi": "10.1038/s41380-025-03168-w", "pubmed_id": "40830580", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41380-025-03168-w", "substance_tags": "psilocybin", "topic_tags": "Addiction,Neuroplasticity,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40830580", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41380-025-03168-w", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40830580", "source_url": "https://doi.org/10.1038/s41380-025-03168-w", "doi": "10.1038/s41380-025-03168-w", "pmid": "40830580", "publication_date": "2025-08-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3070, "title": "Psilocybin treatment for symptoms of depression: a living systematic review, meta-analysis, and data resource", "authors": "Singleton SP, Sevchik BL, Lahey A, Cuijpers P, Harrer M, Jones MT, Nayak SM, Strain EC, Vandekar SN, Dworkin RH, Scott JC, Satterthwaite TD.", "journal": "medRxiv", "publication_date": "2025-08-15", "publication_year": 2025, "doi": "10.1101/2025.08.13.25333530", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.08.13.25333530", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2025.08.13.25333530", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.08.13.25333530", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2025.08.13.25333530", "source_url": "https://doi.org/10.1101/2025.08.13.25333530", "doi": "10.1101/2025.08.13.25333530", "pmid": "", "publication_date": "2025-08-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 519, "title": "Therapeutic Divergence in 5-HT2A Agonism: Psilocybin and Phenalkylamines for Demoralization Syndrome.", "authors": "Kargbo RB.", "journal": null, "publication_date": "2025-08-14", "publication_year": 2025, "doi": "10.1021/acsmedchemlett.5c00475", "pubmed_id": "40959252", "openalex_id": null, "source_url": "https://doi.org/10.1021/acsmedchemlett.5c00475", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40959252", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsmedchemlett.5c00475", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40959252", "source_url": "https://doi.org/10.1021/acsmedchemlett.5c00475", "doi": "10.1021/acsmedchemlett.5c00475", "pmid": "40959252", "publication_date": "2025-08-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 598, "title": "Perspectives on Trauma Treatment, Self-Management Strategies, and Attitudes Toward Psychedelic Therapies in Individuals with Psychological Trauma Symptoms", "authors": "Nadav Liam Modlin, Jessica L. Maples-Keller, Maria Sarang, Lucie Siebenaler, Carolina Maggio, Susannah Pick, Victoria Williamson, Anthony J. Cleare, James Rucker", "journal": "Psychiatry and Clinical Psychopharmacology", "publication_date": "2025-08-13", "publication_year": 2025, "doi": "10.5152/pcp.2025.24934", "pubmed_id": "40864832", "openalex_id": "https://openalex.org/W4413381444", "source_url": "https://doi.org/10.5152/pcp.2025.24934", "substance_tags": "psilocybin", "topic_tags": "PTSD,Receptor Pharmacology,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40864832", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5152/pcp.2025.24934", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40864832", "source_url": "https://doi.org/10.5152/pcp.2025.24934", "doi": "10.5152/pcp.2025.24934", "pmid": "40864832", "publication_date": "2025-08-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 530, "title": "Psilocybin-assisted psychotherapy for depression and anxiety associated with life threatening illness: A phase 2b randomized controlled trial", "authors": "Margaret Ross, Ravi Iyer, M.L. Williams, Mark Boughey, Clare O’Callaghan, Richard Hiscock, Justin Dwyer", "journal": "General Hospital Psychiatry", "publication_date": "2025-08-11", "publication_year": 2025, "doi": "10.1016/j.genhosppsych.2025.08.001", "pubmed_id": "40858059", "openalex_id": "https://openalex.org/W4413190735", "source_url": "https://doi.org/10.1016/j.genhosppsych.2025.08.001", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Wellbeing,Spirituality,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40858059", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.genhosppsych.2025.08.001", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40858059", "source_url": "https://doi.org/10.1016/j.genhosppsych.2025.08.001", "doi": "10.1016/j.genhosppsych.2025.08.001", "pmid": "40858059", "publication_date": "2025-08-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 567, "title": "Psychedelic-Assisted Therapy: Potential Benefits and Challenges in Mental Health Treatment.", "authors": "Silczuk A, Madejek RJ, Koweszko T, Mularczyk-Tomczewska P, Adamska E, Gujski M, Szulc A.", "journal": null, "publication_date": "2025-08-08", "publication_year": 2025, "doi": "10.12659/msm.948302", "pubmed_id": "40781763", "openalex_id": null, "source_url": "https://doi.org/10.12659/msm.948302", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,OCD,Neuroplasticity,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40781763", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.12659/msm.948302", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40781763", "source_url": "https://doi.org/10.12659/msm.948302", "doi": "10.12659/msm.948302", "pmid": "40781763", "publication_date": "2025-08-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 566, "title": "Psychedelics and Headache Disorders: an Update.", "authors": "Im JJH, Sandoe CH", "journal": "Current neurology and neuroscience reports", "publication_date": "2025-08-08", "publication_year": 2025, "doi": "10.1007/s11910-025-01446-2", "pubmed_id": "40782223", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40782223/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Review Article,Case Report,Observational Study,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:40782223", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40782223/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40782223", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40782223/", "doi": "10.1007/s11910-025-01446-2", "pmid": "40782223", "publication_date": "2025-08-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 417, "title": "Between enhancement and risk: A critical review of psychedelic microdosing.", "authors": "Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC.", "journal": null, "publication_date": "2025-08-05", "publication_year": 2025, "doi": "10.1016/j.copsyc.2025.102129", "pubmed_id": "40834796", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.copsyc.2025.102129", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Microdosing,Review Article,Observational Study,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40834796", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.copsyc.2025.102129", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40834796", "source_url": "https://doi.org/10.1016/j.copsyc.2025.102129", "doi": "10.1016/j.copsyc.2025.102129", "pmid": "40834796", "publication_date": "2025-08-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 574, "title": "Neurobiology of psilocybin: a comprehensive overview and comparative analysis of experimental models", "authors": "Dotun Adeleye Adeyinka, Dayna Forsyth, Suzanne Currie, Nicoletta Faraone", "journal": "Frontiers in Systems Neuroscience", "publication_date": "2025-08-04", "publication_year": 2025, "doi": "10.3389/fnsys.2025.1585367", "pubmed_id": "40894380", "openalex_id": "https://openalex.org/W4413969371", "source_url": "https://doi.org/10.3389/fnsys.2025.1585367", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Aging,Animal Study,Safety,Drug Interactions", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40894380", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fnsys.2025.1585367", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40894380", "source_url": "https://doi.org/10.3389/fnsys.2025.1585367", "doi": "10.3389/fnsys.2025.1585367", "pmid": "40894380", "publication_date": "2025-08-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4339, "title": "204. A NOVEL, NON-HALLUCINOGENIC PSYCHEDELIC FOR THE TREATMENT OF OCD AND TIC DISORDER", "authors": "Bernard Lerer, Peretz Golding, Michal Brownstien, Adam Kozikowski, Tzuri Lifschytz", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.1093/ijnp/pyaf052.019", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413285218", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.019", "substance_tags": "psilocybin", "topic_tags": "OCD,Receptor Pharmacology,Animal Study,In Vitro Study,Safety,Toxicity", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1093/ijnp/pyaf052.019", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyaf052.019", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/ijnp/pyaf052.019", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.019", "doi": "10.1093/ijnp/pyaf052.019", "pmid": "", "publication_date": "2025-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4335, "title": "577. CLINICAL EVIDENCE AND APPLICATIONS OF PSYCHEDELICS FOR MENTAL ILLNESSES", "authors": "Hiroe Tani", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.1093/ijnp/pyaf052.377", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413284846", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.377", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1093/ijnp/pyaf052.377", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyaf052.377", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/ijnp/pyaf052.377", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.377", "doi": "10.1093/ijnp/pyaf052.377", "pmid": "", "publication_date": "2025-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4322, "title": "670. CAN WE RE-MEDICALISE THE PSYCHEDELIC EXPERIENCE?", "authors": "Guy M. Goodwin", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.1093/ijnp/pyaf052.159", "pubmed_id": null, "openalex_id": "https://openalex.org/W4413284175", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.159", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1093/ijnp/pyaf052.159", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyaf052.159", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/ijnp/pyaf052.159", "source_url": "https://doi.org/10.1093/ijnp/pyaf052.159", "doi": "10.1093/ijnp/pyaf052.159", "pmid": "", "publication_date": "2025-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3265, "title": "631. PSILOCYBIN AND KETANSERIN VS RTMS IN TREATMENT-RESISTANT DEPRESSION: ENHANCING TOLERABILITY BY MITIGATING PSYCHEDELIC EFFECTS", "authors": "", "journal": null, "publication_date": "2025-07-31", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC12359594", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC12359594", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC12359594", "source_url": "https://europepmc.org/article/PMC/PMC12359594", "doi": "", "pmid": "", "publication_date": "2025-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 582, "title": "Treatment approaches and efficacy in psychedelic-induced psychosis: A systematic review.", "authors": "Sulstarova A, Scheuerlein L, Monari S, Seragnoli F, Gabriel T, Preller K, Böge K, Sentissi O, Kaiser S, Solmi M, Kirschner M, Sabé M", "journal": "Asian journal of psychiatry", "publication_date": "2025-07-31", "publication_year": 2025, "doi": "10.1016/j.ajp.2025.104604", "pubmed_id": "40614615", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40614615/", "substance_tags": "psilocybin", "topic_tags": "Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:40614615", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40614615/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40614615", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40614615/", "doi": "10.1016/j.ajp.2025.104604", "pmid": "40614615", "publication_date": "2025-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 599, "title": "Psilocybin in the treatment of eating disorders: a systematic review of the literature and registered clinical trials.", "authors": "Bevione F, Lacidogna MC, Lavalle R, Abbate Daga G, Preti A.", "journal": null, "publication_date": "2025-07-28", "publication_year": 2025, "doi": "10.1007/s40519-025-01771-y", "pubmed_id": "40730892", "openalex_id": null, "source_url": "https://doi.org/10.1007/s40519-025-01771-y", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40730892", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40519-025-01771-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40730892", "source_url": "https://doi.org/10.1007/s40519-025-01771-y", "doi": "10.1007/s40519-025-01771-y", "pmid": "40730892", "publication_date": "2025-07-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 602, "title": "Psilocybin in alcohol use disorder and comorbid depressive symptoms: Results from a feasibility randomized clinical trial", "authors": "Amandine Luquiens, Dahbia Belahda, Carine Graux, Noe Igounenc, Chris Serrand, Paul A. Rochefort, Thibault Mura, Felix Sergent", "journal": "Addiction", "publication_date": "2025-07-23", "publication_year": 2025, "doi": "10.1111/add.70152", "pubmed_id": "40702912", "openalex_id": "https://openalex.org/W4412642858", "source_url": "https://doi.org/10.1111/add.70152", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40702912", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.70152", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40702912", "source_url": "https://doi.org/10.1111/add.70152", "doi": "10.1111/add.70152", "pmid": "40702912", "publication_date": "2025-07-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 601, "title": "Psychedelic use in individuals living with eating disorders or disordered eating: findings from the international MED-FED survey", "authors": "Sarah-Catherine Rodan, Noah Meez, Sophie Lloyd-Hurwitz, Miguel A. Bedoya-Pérez, Anastasia Suraev, Natasha Sommer, Kayla Greenstien, Sarah Maguire, Iain S. McGregor", "journal": "Journal of Eating Disorders", "publication_date": "2025-07-23", "publication_year": 2025, "doi": "10.1186/s40337-025-01328-5", "pubmed_id": "40708053", "openalex_id": "https://openalex.org/W4412645629", "source_url": "https://doi.org/10.1186/s40337-025-01328-5", "substance_tags": "psilocybin", "topic_tags": "PTSD,Eating Disorders,Microdosing,Clinical Trial,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40708053", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s40337-025-01328-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40708053", "source_url": "https://doi.org/10.1186/s40337-025-01328-5", "doi": "10.1186/s40337-025-01328-5", "pmid": "40708053", "publication_date": "2025-07-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3633, "title": "The Safety, Feasibility, and Acceptability of Psilocybin Combined With Multidisciplinary Palliative Care in Demoralized Cancer Survivors With Chronic Pain (P-PC)", "authors": "Emory University", "journal": "ClinicalTrials.gov", "publication_date": "2025-07-22", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05506982", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Chronic Pain,Mystical Experience,Clinical Trial,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05506982", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05506982", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05506982", "source_url": "https://clinicaltrials.gov/study/NCT05506982", "doi": "", "pmid": "", "publication_date": "2025-07-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 604, "title": "“I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke", "authors": "Patricia A. Cioe, Garrett S Stang, Danish Azam, Sarah Dugal", "journal": "Addiction Science & Clinical Practice", "publication_date": "2025-07-20", "publication_year": 2025, "doi": "10.1186/s13722-025-00563-0", "pubmed_id": "40691651", "openalex_id": "https://openalex.org/W4412510542", "source_url": "https://doi.org/10.1186/s13722-025-00563-0", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Safety,Adverse Events,Toxicity", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40691651", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s13722-025-00563-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40691651", "source_url": "https://doi.org/10.1186/s13722-025-00563-0", "doi": "10.1186/s13722-025-00563-0", "pmid": "40691651", "publication_date": "2025-07-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3581, "title": "Acceptability & Safety of Two Sequential Doses of Psilocybin in Bipolar Disorder II Depression and Suicidality", "authors": "The University of Texas Health Science Center, Houston", "journal": "ClinicalTrials.gov", "publication_date": "2025-07-17", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06706232", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06706232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06706232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06706232", "source_url": "https://clinicaltrials.gov/study/NCT06706232", "doi": "", "pmid": "", "publication_date": "2025-07-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4344, "title": "Rise of the Mushrooms: Effects of Psilocybin Reforms on Psychedelic Usage Patterns", "authors": "Ashutosh Bhave", "journal": "Journal of Public Policy & Marketing", "publication_date": "2025-07-15", "publication_year": 2025, "doi": "10.1177/07439156251360774", "pubmed_id": null, "openalex_id": "https://openalex.org/W4412479365", "source_url": "https://doi.org/10.1177/07439156251360774", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1177/07439156251360774", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/07439156251360774", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/07439156251360774", "source_url": "https://doi.org/10.1177/07439156251360774", "doi": "10.1177/07439156251360774", "pmid": "", "publication_date": "2025-07-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 494, "title": "Informed Consent Documents from Psychedelic Clinical Trials: A Descriptive Ethical Analysis", "authors": "Katherine Cheung, Caleigh Propes, Marianna Graziosi, Kyle Patch, David B. Yaden", "journal": "AJOB Empirical Bioethics", "publication_date": "2025-07-15", "publication_year": 2025, "doi": "10.1080/23294515.2025.2526339", "pubmed_id": "40668936", "openalex_id": "https://openalex.org/W4412488390", "source_url": "https://doi.org/10.1080/23294515.2025.2526339", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Consciousness,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40668936", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/23294515.2025.2526339", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40668936", "source_url": "https://doi.org/10.1080/23294515.2025.2526339", "doi": "10.1080/23294515.2025.2526339", "pmid": "40668936", "publication_date": "2025-07-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 535, "title": "Attitudes toward psychedelics and psychedelic-assisted psychotherapy among Australian mental healthcare providers", "authors": "Zohaib Nadeem, Stephen Parker, Hugh McGovern, Bianca Sebben, Lena Oestreich", "journal": "Australian & New Zealand Journal of Psychiatry", "publication_date": "2025-07-14", "publication_year": 2025, "doi": "10.1177/00048674251346679", "pubmed_id": "40660894", "openalex_id": "https://openalex.org/W4412418522", "source_url": "https://doi.org/10.1177/00048674251346679", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Observational Study,Treatment-Resistant Depression,Healthcare Workers,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40660894", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00048674251346679", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40660894", "source_url": "https://doi.org/10.1177/00048674251346679", "doi": "10.1177/00048674251346679", "pmid": "40660894", "publication_date": "2025-07-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 556, "title": "Examining the potential of psilocybin and 5-MeO-DMT as therapeutics for traumatic brain injury.", "authors": "Plummer Z, Allen J, Brand J, Mayo LM, Shultz SR, Christie BR.", "journal": null, "publication_date": "2025-07-13", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111448", "pubmed_id": "40669813", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111448", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Oxidative Stress,Review Article,Animal Study,Safety,Inflammation", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40669813", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2025.111448", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40669813", "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111448", "doi": "10.1016/j.pnpbp.2025.111448", "pmid": "40669813", "publication_date": "2025-07-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 537, "title": "Unequal representation? A cross-sectional analysis of age, sex, race, and ethnicity in clinical trials of classic psychedelics", "authors": "Damian Świeczkowski, Aleksander Kwaśny, Patrycja Ciurkowska, Michał Pruc, Łukasz Szarpak, Wiesław Jerzy Cubała", "journal": "Journal of Psychopharmacology", "publication_date": "2025-07-10", "publication_year": 2025, "doi": "10.1177/02698811251353250", "pubmed_id": "40643096", "openalex_id": "https://openalex.org/W4412197020", "source_url": "https://doi.org/10.1177/02698811251353250", "substance_tags": "psilocybin,psilocin", "topic_tags": "Chronic Pain,Aging,Clinical Trial,Review Article,Healthy Volunteers,Older Adults,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40643096", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811251353250", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40643096", "source_url": "https://doi.org/10.1177/02698811251353250", "doi": "10.1177/02698811251353250", "pmid": "40643096", "publication_date": "2025-07-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 536, "title": "A systematic review and narrative summary of the therapeutic potential of classic serotonergic psychedelics for smoking cessation and reduction.", "authors": "Glenn DL, Choi SH, Zimmerman RS.", "journal": null, "publication_date": "2025-07-10", "publication_year": 2025, "doi": "10.1177/02698811251353251", "pubmed_id": "40643107", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811251353251", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Receptor Pharmacology,Consciousness,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40643107", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811251353251", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40643107", "source_url": "https://doi.org/10.1177/02698811251353251", "doi": "10.1177/02698811251353251", "pmid": "40643107", "publication_date": "2025-07-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4347, "title": "The Medial PrefrontalCortex Modulates Psychedelic-likeEffects of Psilocin", "authors": "Miyuan Zhang (21677016), Haojiang Zhai (21677019), Longwei Yang (21677022), Haohong Li (5164970), Xiaohui Wang (19899)", "journal": "Figshare", "publication_date": "2025-07-07", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00324.s001", "pubmed_id": null, "openalex_id": "https://openalex.org/W7111003529", "source_url": "https://figshare.com/articles/journal_contribution/The_Medial_Prefrontal_Cortex_Modulates_Psychedelic-like_Effects_of_Psilocin/29500347", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Animal Study,Safety,Toxicity", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1021/acsptsci.5c00324.s001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://figshare.com/articles/journal_contribution/The_Medial_Prefrontal_Cortex_Modulates_Psychedelic-like_Effects_of_Psilocin/29500347", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1021/acsptsci.5c00324.s001", "source_url": "https://figshare.com/articles/journal_contribution/The_Medial_Prefrontal_Cortex_Modulates_Psychedelic-like_Effects_of_Psilocin/29500347", "doi": "10.1021/acsptsci.5c00324.s001", "pmid": "", "publication_date": "2025-07-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 569, "title": "The Medial Prefrontal Cortex Modulates Psychedelic-like Effects of Psilocin", "authors": "Miyuan Zhang, Haiyan Zhai, Longwei Yang, Haohong Li, Xiaohui Wang", "journal": "ACS Pharmacology & Translational Science", "publication_date": "2025-07-07", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00324", "pubmed_id": "40810162", "openalex_id": "https://openalex.org/W4412100010", "source_url": "https://doi.org/10.1021/acsptsci.5c00324", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40810162", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acsptsci.5c00324", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40810162", "source_url": "https://doi.org/10.1021/acsptsci.5c00324", "doi": "10.1021/acsptsci.5c00324", "pmid": "40810162", "publication_date": "2025-07-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3745, "title": "An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression", "authors": "Szigeti B.", "journal": "PsyArXiv", "publication_date": "2025-07-06", "publication_year": 2025, "doi": "10.31234/osf.io/97cqx_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/97cqx_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Safety,Adverse Events", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:18", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/97cqx_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/97cqx_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/97cqx_v1", "source_url": "https://doi.org/10.31234/osf.io/97cqx_v1", "doi": "10.31234/osf.io/97cqx_v1", "pmid": "", "publication_date": "2025-07-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3072, "title": "An open-label, dose-escalation trial of psilocybin-assisted therapy for bipolar 2 depression", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-07-06", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/97cqx_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Safety,Adverse Events", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/97cqx_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/97cqx_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/97cqx_v1", "source_url": "https://osf.io/preprints/psyarxiv/97cqx_v1", "doi": "", "pmid": "", "publication_date": "2025-07-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4348, "title": "Explore the effect of psilocybin on depression and anxiety", "authors": "Yutong Song", "journal": "Arts Culture and Language", "publication_date": "2025-07-05", "publication_year": 2025, "doi": "10.61173/rcg8me57", "pubmed_id": null, "openalex_id": "https://openalex.org/W4412054280", "source_url": "https://doi.org/10.61173/rcg8me57", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Headache / Migraine,Wellbeing,Spirituality,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.61173/rcg8me57", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.61173/rcg8me57", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.61173/rcg8me57", "source_url": "https://doi.org/10.61173/rcg8me57", "doi": "10.61173/rcg8me57", "pmid": "", "publication_date": "2025-07-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 615, "title": "Exploring Jordanian Physicians’ and Medical Students’ Perspectives on Ketamine and Psychedelic-Assisted Therapies: An Insight from the Middle East", "authors": "Khalid Ahmed, Dima Abu Nasrieh, Haneen A. Banihani, Mohammed Fadi Obaidat, Toni Mazzawi, Azzah Khalid Al-Tarawneh, Radwan Bani Mustafa, Zaid Al Kayed", "journal": "Journal of Psychoactive Drugs", "publication_date": "2025-07-05", "publication_year": 2025, "doi": "10.1080/02791072.2025.2526403", "pubmed_id": "40619866", "openalex_id": "https://openalex.org/W4412097474", "source_url": "https://doi.org/10.1080/02791072.2025.2526403", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40619866", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2025.2526403", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40619866", "source_url": "https://doi.org/10.1080/02791072.2025.2526403", "doi": "10.1080/02791072.2025.2526403", "pmid": "40619866", "publication_date": "2025-07-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4350, "title": "Beyond prohibition: A public health analysis of naturalistic psychedelic use", "authors": "Mark Haden, Sarah A. Paschall, Birgitta Woods", "journal": "Journal of Psychedelic Studies", "publication_date": "2025-07-02", "publication_year": 2025, "doi": "10.1556/2054.2025.00450", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411976075", "source_url": "https://doi.org/10.1556/2054.2025.00450", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Chronic Pain,Aging,Wellbeing,Emotional Processing,Spirituality,Psychological Flexibility,Review Article,Older Adults,Adolescents,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2025.00450", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2025.00450", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2025.00450", "source_url": "https://doi.org/10.1556/2054.2025.00450", "doi": "10.1556/2054.2025.00450", "pmid": "", "publication_date": "2025-07-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4352, "title": "Psilocybin Use in an Intercollegiate Athlete with Persisting Symptoms After Concussion: A Case Report", "authors": "David W. Lawrence, Alex P. Di Battista, Michael G. Hutchison", "journal": "Psychoactives", "publication_date": "2025-06-30", "publication_year": 2025, "doi": "10.3390/psychoactives4030022", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411885403", "source_url": "https://doi.org/10.3390/psychoactives4030022", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Receptor Pharmacology,Aging,Case Report,Healthcare Workers,Safety", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4030022", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4030022", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4030022", "source_url": "https://doi.org/10.3390/psychoactives4030022", "doi": "10.3390/psychoactives4030022", "pmid": "", "publication_date": "2025-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 640, "title": "Disentangling the acute subjective effects of classic psychedelics from their enduring therapeutic properties.", "authors": "Atiq MA, Baker MR, Voort JLV, Vargas MV, Choi DS", "journal": "Psychopharmacology", "publication_date": "2025-06-30", "publication_year": 2025, "doi": "10.1007/s00213-024-06599-5", "pubmed_id": "38743110", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38743110/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Receptor Pharmacology,Mystical Experience,Clinical Trial,Review Article,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:38743110", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38743110/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38743110", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38743110/", "doi": "10.1007/s00213-024-06599-5", "pmid": "38743110", "publication_date": "2025-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 635, "title": "Exploring serotonergic psychedelics as a treatment for personality disorders.", "authors": "Carrithers BM, Roberts DE, Weiss BM, King JD, Carhart-Harris RL, Gordon AR, Pagni BA, Moreau M, Ross S, Zeifman RJ", "journal": "Neuropharmacology", "publication_date": "2025-06-30", "publication_year": 2025, "doi": "10.1016/j.neuropharm.2025.110413", "pubmed_id": "40081794", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40081794/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mechanism of Action,Personality Change,Review Article,Observational Study,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:40081794", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40081794/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40081794", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40081794/", "doi": "10.1016/j.neuropharm.2025.110413", "pmid": "40081794", "publication_date": "2025-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 623, "title": "Exploring the Therapeutic Effects of Psychedelics Administered to Military Veterans in Naturalistic Retreat Settings", "authors": "Megan Calnan, Grace Blest-Hopley, Chris Busch, Milly Adams, Simon Ruffell, Theodore Piper, Leor Roseman, Hannes Kettner, Robin Carhart-Harris", "journal": "Brain and Behavior", "publication_date": "2025-06-30", "publication_year": 2025, "doi": "10.1002/brb3.70660", "pubmed_id": "40619953", "openalex_id": "https://openalex.org/W4412096805", "source_url": "https://doi.org/10.1002/brb3.70660", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Wellbeing,Veterans,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40619953", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/brb3.70660", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40619953", "source_url": "https://doi.org/10.1002/brb3.70660", "doi": "10.1002/brb3.70660", "pmid": "40619953", "publication_date": "2025-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 616, "title": "Caffeine, nicotine, cannabis, and psilocybin: Pharmacology, toxicology, and potential therapeutic uses of four naturally occurring psychoactive substances", "authors": "Samuel E Christen, Elias Bekka, Yasmin Schmid, Neal L. Benowitz, Evangelia Liakoni", "journal": "Swiss Medical Weekly", "publication_date": "2025-06-30", "publication_year": 2025, "doi": "10.57187/s.4346", "pubmed_id": "40811135", "openalex_id": "https://openalex.org/W4412107589", "source_url": "https://doi.org/10.57187/s.4346", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Consciousness,Emotional Processing,Review Article,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40811135", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.57187/s.4346", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40811135", "source_url": "https://doi.org/10.57187/s.4346", "doi": "10.57187/s.4346", "pmid": "40811135", "publication_date": "2025-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 595, "title": "Natural hallucinogens of fungal and animal origin: action and potentialapplications - a narrative review.", "authors": "Ciszowski K, Ziaja A, Niedzielska-Andres E, Pomierny-Chamioło L.", "journal": null, "publication_date": "2025-06-30", "publication_year": 2025, "doi": "10.24425/fmc.2025.156119", "pubmed_id": "41329968", "openalex_id": null, "source_url": "https://doi.org/10.24425/fmc.2025.156119", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Animal Study,Treatment-Resistant Depression,Safety,Toxicity,Inflammation", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:41329968", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.24425/fmc.2025.156119", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:41329968", "source_url": "https://doi.org/10.24425/fmc.2025.156119", "doi": "10.24425/fmc.2025.156119", "pmid": "41329968", "publication_date": "2025-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 644, "title": "Psychedelic-Assisted Therapies for Psychosocial Symptoms in Cancer: A Systematic Review and Meta-Analysis.", "authors": "Schuman HDM, Savard C, Mina R, Barkova S, Conradi HSW, Deleemans JM, Carlson LE.", "journal": null, "publication_date": "2025-06-29", "publication_year": 2025, "doi": "10.3390/curroncol32070380", "pubmed_id": "40710191", "openalex_id": null, "source_url": "https://doi.org/10.3390/curroncol32070380", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40710191", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/curroncol32070380", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40710191", "source_url": "https://doi.org/10.3390/curroncol32070380", "doi": "10.3390/curroncol32070380", "pmid": "40710191", "publication_date": "2025-06-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4358, "title": "Evaluating Psilocybin as a Treatment for Neuropsychiatric Symptoms in Parkinson’s Disease", "authors": "Nayiri Barton", "journal": "Global Journal of Medical Research", "publication_date": "2025-06-27", "publication_year": 2025, "doi": "10.34257/gjmravol25is1pg1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4412955867", "source_url": "https://doi.org/10.34257/gjmravol25is1pg1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Receptor Pharmacology,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:39", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.34257/gjmravol25is1pg1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.34257/gjmravol25is1pg1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.34257/gjmravol25is1pg1", "source_url": "https://doi.org/10.34257/gjmravol25is1pg1", "doi": "10.34257/gjmravol25is1pg1", "pmid": "", "publication_date": "2025-06-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 583, "title": "Australia’s psychedelic experiment: reflections from a psychiatrist clinical researcher", "authors": "Adam Bayes", "journal": "Australasian Psychiatry", "publication_date": "2025-06-25", "publication_year": 2025, "doi": "10.1177/10398562251347890", "pubmed_id": "40574457", "openalex_id": "https://openalex.org/W4411736916", "source_url": "https://doi.org/10.1177/10398562251347890", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40574457", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/10398562251347890", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40574457", "source_url": "https://doi.org/10.1177/10398562251347890", "doi": "10.1177/10398562251347890", "pmid": "40574457", "publication_date": "2025-06-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 585, "title": "Use of Psychedelic Agents in Older Adults with Treatment-Resistant Major Depressive Disorder: What the Evidence Shows.", "authors": "Vinarcsik L, Smoller C, Grossberg G.", "journal": null, "publication_date": "2025-06-23", "publication_year": 2025, "doi": "10.1007/s40266-025-01221-5", "pubmed_id": "40553322", "openalex_id": null, "source_url": "https://doi.org/10.1007/s40266-025-01221-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Aging,Review Article,Older Adults,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40553322", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40266-025-01221-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40553322", "source_url": "https://doi.org/10.1007/s40266-025-01221-5", "doi": "10.1007/s40266-025-01221-5", "pmid": "40553322", "publication_date": "2025-06-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 650, "title": "Assessing the Attitudes of Dutch Mental Health Care Professionals Toward Psychedelic-Assisted Psychotherapy: A Cross-Sectional Exploratory Study", "authors": "Martijn H.B. Koolen, Annika Wirsching, Erwin Krediet, Michiel van Elk", "journal": "Journal of Psychoactive Drugs", "publication_date": "2025-06-22", "publication_year": 2025, "doi": "10.1080/02791072.2025.2508156", "pubmed_id": "40551401", "openalex_id": "https://openalex.org/W4411571625", "source_url": "https://doi.org/10.1080/02791072.2025.2508156", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Consciousness,Observational Study,Healthcare Workers,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40551401", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2025.2508156", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40551401", "source_url": "https://doi.org/10.1080/02791072.2025.2508156", "doi": "10.1080/02791072.2025.2508156", "pmid": "40551401", "publication_date": "2025-06-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3096, "title": "The Emerging Use of Psilocybin in Adult Populations with Alcohol Use Disorder: A Scoping Review", "authors": "Daroui D, Mastrostefano A, Davini F, Giuseppe G, Terracina S.", "journal": "Preprints.org", "publication_date": "2025-06-18", "publication_year": 2025, "doi": "10.20944/preprints202506.1536.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202506.1536.v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Randomized Controlled Trial,Review Article,Case Report,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202506.1536.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202506.1536.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202506.1536.v1", "source_url": "https://doi.org/10.20944/preprints202506.1536.v1", "doi": "10.20944/preprints202506.1536.v1", "pmid": "", "publication_date": "2025-06-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 654, "title": "Long-term benefits of single-dose psilocybin in depressed patients with cancer", "authors": "Manish Agrawal, Kim Roddy, Betsy Jenkins, Celia Leeks, Ezekiel Emanuel", "journal": "Cancer", "publication_date": "2025-06-14", "publication_year": 2025, "doi": "10.1002/cncr.35889", "pubmed_id": "40518804", "openalex_id": "https://openalex.org/W4411327114", "source_url": "https://doi.org/10.1002/cncr.35889", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40518804", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cncr.35889", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40518804", "source_url": "https://doi.org/10.1002/cncr.35889", "doi": "10.1002/cncr.35889", "pmid": "40518804", "publication_date": "2025-06-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 656, "title": "Evaluation of behavioural and neurochemical effects of psilocybin in mice subjected to chronic unpredictable mild stress", "authors": "Ines Erkizia-Santamaría, Igor Horrillo, Nerea Martínez-Álvarez, Daniel Pérez-Martínez, Guadalupe Rivero, Amaia M. Erdozain, J. Javier Meana, Jorge E. Ortega", "journal": "Translational Psychiatry", "publication_date": "2025-06-13", "publication_year": 2025, "doi": "10.1038/s41398-025-03421-4", "pubmed_id": "40517150", "openalex_id": "https://openalex.org/W4411302754", "source_url": "https://doi.org/10.1038/s41398-025-03421-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40517150", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41398-025-03421-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40517150", "source_url": "https://doi.org/10.1038/s41398-025-03421-4", "doi": "10.1038/s41398-025-03421-4", "pmid": "40517150", "publication_date": "2025-06-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3482, "title": "The Safety and Tolerability of COMP360 in Participants With Post-traumatic Stress Disorder", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-12", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05312151", "substance_tags": "psilocybin", "topic_tags": "PTSD,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05312151", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05312151", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05312151", "source_url": "https://clinicaltrials.gov/study/NCT05312151", "doi": "", "pmid": "", "publication_date": "2025-06-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3611, "title": "A Phase 1 Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of MLS101 (Psilocybin) in Healthy Participants", "authors": "MycoMedica Life Sciences PBC", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-11", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06643637", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Microdosing,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06643637", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06643637", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06643637", "source_url": "https://clinicaltrials.gov/study/NCT06643637", "doi": "", "pmid": "", "publication_date": "2025-06-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3746, "title": "Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use Disorder", "authors": "Agin-Liebes G, Petridis P, Zeifman R, Link M, Cordova MJ, Bogenschutz M.", "journal": "PsyArXiv", "publication_date": "2025-06-09", "publication_year": 2025, "doi": "10.31234/osf.io/f27jm_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/f27jm_v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:18", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/f27jm_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/f27jm_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/f27jm_v1", "source_url": "https://doi.org/10.31234/osf.io/f27jm_v1", "doi": "10.31234/osf.io/f27jm_v1", "pmid": "", "publication_date": "2025-06-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3617, "title": "Comparison of the Effects of PEX20 (Oral Psilocin), PEX30 (Sublingual Psilocin), and PEX10 (Oral Psilocybin) in Healthy Adults", "authors": "University of California, San Francisco", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-09", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05317689", "substance_tags": "psilocybin,psilocin", "topic_tags": "Healthcare Workers,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05317689", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05317689", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05317689", "source_url": "https://clinicaltrials.gov/study/NCT05317689", "doi": "", "pmid": "", "publication_date": "2025-06-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3074, "title": "Psilocybin-Assisted Therapy Increases Self-Compassion in Patients with Alcohol Use Disorder", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-06-09", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/f27jm_v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/f27jm_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/f27jm_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/f27jm_v1", "source_url": "https://osf.io/preprints/psyarxiv/f27jm_v1", "doi": "", "pmid": "", "publication_date": "2025-06-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 663, "title": "Clinical conceptualisation of PTSD in psilocybin treatment: disrupting a pre-determined and over-determined maladaptive interpretive framework.", "authors": "Modlin NL, Williamson V, Maggio C, Stubley J, Kirlic N, Cleare A, Rucker J.", "journal": null, "publication_date": "2025-06-07", "publication_year": 2025, "doi": "10.1177/20451253251342319", "pubmed_id": "40492108", "openalex_id": null, "source_url": "https://doi.org/10.1177/20451253251342319", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Eating Disorders,End-of-Life Distress,Mechanism of Action,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40492108", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/20451253251342319", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40492108", "source_url": "https://doi.org/10.1177/20451253251342319", "doi": "10.1177/20451253251342319", "pmid": "40492108", "publication_date": "2025-06-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 652, "title": "Classic Psychedelics in Pain Modulation: Mechanisms, Clinical Evidence, and Future Perspectives.", "authors": "Czopek A, Jończyk J, Fryc M, Kluzik D, Zagórska A.", "journal": null, "publication_date": "2025-06-05", "publication_year": 2025, "doi": "10.1021/acschemneuro.5c00152", "pubmed_id": "40474592", "openalex_id": null, "source_url": "https://doi.org/10.1021/acschemneuro.5c00152", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Headache / Migraine,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40474592", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.5c00152", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40474592", "source_url": "https://doi.org/10.1021/acschemneuro.5c00152", "doi": "10.1021/acschemneuro.5c00152", "pmid": "40474592", "publication_date": "2025-06-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3672, "title": "Low-Income Group Psilocybin Assisted Therapy for Depression: A Feasibility Study", "authors": "Matthew Hicks", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06372197", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Consciousness,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06372197", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06372197", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06372197", "source_url": "https://clinicaltrials.gov/study/NCT06372197", "doi": "", "pmid": "", "publication_date": "2025-06-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3480, "title": "Optimizing Microdosing and Meditation", "authors": "National University of Natural Medicine", "journal": "ClinicalTrials.gov", "publication_date": "2025-06-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06560658", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Consciousness,Microdosing,Wellbeing,Clinical Trial,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06560658", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06560658", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06560658", "source_url": "https://clinicaltrials.gov/study/NCT06560658", "doi": "", "pmid": "", "publication_date": "2025-06-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 667, "title": "Leveraging psychedelic neuroscience to boost human creativity using artificial intelligence", "authors": "Brian M. Ross", "journal": "Frontiers in Artificial Intelligence", "publication_date": "2025-06-03", "publication_year": 2025, "doi": "10.3389/frai.2025.1589086", "pubmed_id": "40535200", "openalex_id": "https://openalex.org/W4411035865", "source_url": "https://doi.org/10.3389/frai.2025.1589086", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Default Mode Network,Aging,Creativity,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40535200", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/frai.2025.1589086", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40535200", "source_url": "https://doi.org/10.3389/frai.2025.1589086", "doi": "10.3389/frai.2025.1589086", "pmid": "40535200", "publication_date": "2025-06-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 541, "title": "Self-inflicted transorbital intracranial foreign body following ingestion of hallucinogenic psilocybin mushrooms", "authors": "Abigail M. Blanton, Pooja Parikh, Scott Zhou, Mohamed Mohamed, Rafael Ufret-Vincenty, Ronald Mancini", "journal": "American Journal of Ophthalmology Case Reports", "publication_date": "2025-06-01", "publication_year": 2025, "doi": "10.1016/j.ajoc.2025.102359", "pubmed_id": "40535325", "openalex_id": "https://openalex.org/W4410946123", "source_url": "https://doi.org/10.1016/j.ajoc.2025.102359", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Case Report,Safety,Toxicity", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40535325", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.ajoc.2025.102359", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40535325", "source_url": "https://doi.org/10.1016/j.ajoc.2025.102359", "doi": "10.1016/j.ajoc.2025.102359", "pmid": "40535325", "publication_date": "2025-06-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 680, "title": "The therapeutic effects of psychedelics for opioid use disorder: A systematic review of clinical studies.", "authors": "Weleff J, Pulido-Saavedra A, Aghaei AM, Ing K, Arakelian M, Fontenele R, Nero N, Barnett BS, Anand A, Bassir Nia A, Angarita GA", "journal": "Psychiatry research", "publication_date": "2025-05-31", "publication_year": 2025, "doi": "10.1016/j.psychres.2025.116446", "pubmed_id": "40147088", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40147088/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Systematic Review,Review Article,Animal Study,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:40147088", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40147088/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40147088", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40147088/", "doi": "10.1016/j.psychres.2025.116446", "pmid": "40147088", "publication_date": "2025-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 676, "title": "Innovation and inequity in psychedelic research at the Mayo Clinic.", "authors": "Klim C, VanDreese B, Meyerhoefer T, Breitinger S", "journal": "History of psychiatry", "publication_date": "2025-05-31", "publication_year": 2025, "doi": "10.1177/0957154x251318489", "pubmed_id": "40293719", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40293719/", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:35", "bibtex": null, "source_record_id": "PMID:40293719", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40293719/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40293719", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40293719/", "doi": "10.1177/0957154x251318489", "pmid": "40293719", "publication_date": "2025-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 365, "title": "Attitudes Toward Psychedelic Treatments by Individuals With Histories of Substance Use or Psychiatric Disorders: A Survey Study", "authors": "Sara Prostko, Alexander Wu, Samuel Maddams, Veronica Szpak, Naomi Rosenblum, Lori M. Hilt, Joji Suzuki", "journal": "Journal of Addiction Medicine", "publication_date": "2025-05-27", "publication_year": 2025, "doi": "10.1097/adm.0000000000001517", "pubmed_id": "40433994", "openalex_id": "https://openalex.org/W4410826214", "source_url": "https://doi.org/10.1097/adm.0000000000001517", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40433994", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/adm.0000000000001517", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40433994", "source_url": "https://doi.org/10.1097/adm.0000000000001517", "doi": "10.1097/adm.0000000000001517", "pmid": "40433994", "publication_date": "2025-05-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 690, "title": "Therapeutic emergence of dissociated traumatic memories during psilocybin treatment for anorexia nervosa", "authors": "Stéphanie Knatz Peck, Timothy D. Brewerton, Hannah M. Fisher, Julie Trim, Samantha Shao, Nadav Liam Modlin, Jessie Kim, Daphna M. Finn, Walter H. Kaye", "journal": "Journal of Eating Disorders", "publication_date": "2025-05-25", "publication_year": 2025, "doi": "10.1186/s40337-025-01274-2", "pubmed_id": "40420197", "openalex_id": "https://openalex.org/W4410748059", "source_url": "https://doi.org/10.1186/s40337-025-01274-2", "substance_tags": "psilocybin", "topic_tags": "PTSD,Eating Disorders,Chronic Pain,Mechanism of Action,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40420197", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s40337-025-01274-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40420197", "source_url": "https://doi.org/10.1186/s40337-025-01274-2", "doi": "10.1186/s40337-025-01274-2", "pmid": "40420197", "publication_date": "2025-05-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 881, "title": "Clinical pharmacology.", "authors": "Vogt SB, Liechti ME.", "journal": null, "publication_date": "2025-05-22", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.02.003", "pubmed_id": "40541320", "openalex_id": null, "source_url": "https://doi.org/10.1016/bs.irn.2025.02.003", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40541320", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/bs.irn.2025.02.003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40541320", "source_url": "https://doi.org/10.1016/bs.irn.2025.02.003", "doi": "10.1016/bs.irn.2025.02.003", "pmid": "40541320", "publication_date": "2025-05-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 588, "title": "Lessons learned from the regulatory alignment in ketamine, esketamine and arketamine clinical trials: A cross-sectional analysis of protocols from ClinicalTrials.gov.", "authors": "Swieczkowski D, Kwaśny A, Sadko K, Pruc M, Gaca Z, Szarpak L, Cubała WJ.", "journal": null, "publication_date": "2025-05-21", "publication_year": 2025, "doi": "10.1016/j.psychres.2025.116559", "pubmed_id": "40440859", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2025.116559", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40440859", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2025.116559", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40440859", "source_url": "https://doi.org/10.1016/j.psychres.2025.116559", "doi": "10.1016/j.psychres.2025.116559", "pmid": "40440859", "publication_date": "2025-05-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3762, "title": "Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments", "authors": "Basedow LA, Lottes L, Falkenberg I, Vogelbacher C, Yildiz C.", "journal": "PsyArXiv", "publication_date": "2025-05-15", "publication_year": 2025, "doi": "10.31234/osf.io/6hjkm_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/6hjkm_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/6hjkm_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/6hjkm_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/6hjkm_v1", "source_url": "https://doi.org/10.31234/osf.io/6hjkm_v1", "doi": "10.31234/osf.io/6hjkm_v1", "pmid": "", "publication_date": "2025-05-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3183, "title": "Under Pressure: Stronger depressive symptoms are associated with more positive expectations towards experimental treatments", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-05-15", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "source_url": "https://osf.io/preprints/psyarxiv/6hjkm_v1", "doi": "", "pmid": "", "publication_date": "2025-05-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 383, "title": "Effects of Psilocybin on Religious and Spiritual Attitudes and Behaviors in Clergy from Various Major World Religions", "authors": "Roland R. Griffiths, Robert L. Jesse, William A. Richards, Matthew W. Johnson, Nathan D. Sepeda, Anthony P. Bossis, Stephen Ross", "journal": "Psychedelic Medicine", "publication_date": "2025-05-15", "publication_year": 2025, "doi": "10.1089/psymed.2023.0044", "pubmed_id": "41869007", "openalex_id": "https://openalex.org/W4410448036", "source_url": "https://doi.org/10.1089/psymed.2023.0044", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Spirituality,Safety,Adverse Events", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:41869007", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0044", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:41869007", "source_url": "https://doi.org/10.1089/psymed.2023.0044", "doi": "10.1089/psymed.2023.0044", "pmid": "41869007", "publication_date": "2025-05-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 885, "title": "Serotonergic psychedelics for depression: A comprehensive overview.", "authors": "Wingert AM, Agnorelli C, Peill J, Reed S, Nutt DJ, Erritzoe D.", "journal": null, "publication_date": "2025-05-13", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.04.009", "pubmed_id": "40541312", "openalex_id": null, "source_url": "https://doi.org/10.1016/bs.irn.2025.04.009", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40541312", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/bs.irn.2025.04.009", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40541312", "source_url": "https://doi.org/10.1016/bs.irn.2025.04.009", "doi": "10.1016/bs.irn.2025.04.009", "pmid": "40541312", "publication_date": "2025-05-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 674, "title": "The pharmacological treatment of anxiety in people with eating disorders: A systematic review.", "authors": "Morris R, Keeler J, Treasure J, Himmerich H.", "journal": null, "publication_date": "2025-05-13", "publication_year": 2025, "doi": "10.1016/j.phrs.2025.107782", "pubmed_id": "40378942", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.phrs.2025.107782", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40378942", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.phrs.2025.107782", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40378942", "source_url": "https://doi.org/10.1016/j.phrs.2025.107782", "doi": "10.1016/j.phrs.2025.107782", "pmid": "40378942", "publication_date": "2025-05-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3426, "title": "A Phase 2a, Placebo-Controlled Randomized, Double-Blind Trial to Evaluate the Safety, Tolerability, and Preliminary Efficacy of Psilocybin Oral Solution in Adults With Generalized Anxiety Disorder", "authors": "Queen's University", "journal": "ClinicalTrials.gov", "publication_date": "2025-05-12", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06969170", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Brain Imaging,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06969170", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06969170", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06969170", "source_url": "https://clinicaltrials.gov/study/NCT06969170", "doi": "", "pmid": "", "publication_date": "2025-05-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 630, "title": "The effect of psychedelic microdosing on animal behavior: A review with recommendations for the field.", "authors": "Syed OA, Petranker R, Tsang B.", "journal": null, "publication_date": "2025-05-08", "publication_year": 2025, "doi": "10.1016/j.neubiorev.2025.106204", "pubmed_id": "40348309", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neubiorev.2025.106204", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,Microdosing,Wellbeing,Review Article,Animal Study,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40348309", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neubiorev.2025.106204", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40348309", "source_url": "https://doi.org/10.1016/j.neubiorev.2025.106204", "doi": "10.1016/j.neubiorev.2025.106204", "pmid": "40348309", "publication_date": "2025-05-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 703, "title": "A protocol for a scoping review of variations among psychedelic interventions for psychological suffering associated with the end-of-life.", "authors": "Kratina S, Strike C, Schwartz R, Nayfeh A, Jopling S, Lo C, Rush B.", "journal": null, "publication_date": "2025-05-05", "publication_year": 2025, "doi": "10.1371/journal.pone.0318343", "pubmed_id": "40327705", "openalex_id": null, "source_url": "https://doi.org/10.1371/journal.pone.0318343", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40327705", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0318343", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40327705", "source_url": "https://doi.org/10.1371/journal.pone.0318343", "doi": "10.1371/journal.pone.0318343", "pmid": "40327705", "publication_date": "2025-05-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 704, "title": "A landscape analysis of psychedelic retreat organizations advertising online", "authors": "Logan Neitzke-Spruill, Caroline Beit, Jill O. Robinson, Nikita Singh, Srijith Kambala, Rishi Ramesh, Amy L. McGuire", "journal": "PLoS ONE", "publication_date": "2025-05-01", "publication_year": 2025, "doi": "10.1371/journal.pone.0321648", "pubmed_id": "40315211", "openalex_id": "https://openalex.org/W4410030136", "source_url": "https://doi.org/10.1371/journal.pone.0321648", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Wellbeing,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40315211", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0321648", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40315211", "source_url": "https://doi.org/10.1371/journal.pone.0321648", "doi": "10.1371/journal.pone.0321648", "pmid": "40315211", "publication_date": "2025-05-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4381, "title": "Improving Best Practice Indicators for Psilocybin Assisted Therapy Using a Mul-tiphase Mixed Methods Delphi Study", "authors": "Kim Hoffman, Todd P. Korthuis, Kellie Pertl, David Morgan", "journal": "International Journal of Multiple Research Approaches", "publication_date": "2025-04-29", "publication_year": 2025, "doi": "10.29034/ijmra.v17n1a1", "pubmed_id": null, "openalex_id": "https://openalex.org/W7155048769", "source_url": "https://doi.org/10.29034/ijmra.v17n1a1", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.29034/ijmra.v17n1a1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.29034/ijmra.v17n1a1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.29034/ijmra.v17n1a1", "source_url": "https://doi.org/10.29034/ijmra.v17n1a1", "doi": "10.29034/ijmra.v17n1a1", "pmid": "", "publication_date": "2025-04-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4386, "title": "Psilocybin-assisted therapy shows range of benefits in cancer patients", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2025-04-28", "publication_year": 2025, "doi": "10.1002/pu.31316", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409945764", "source_url": "https://doi.org/10.1002/pu.31316", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31316", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.31316", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31316", "source_url": "https://doi.org/10.1002/pu.31316", "doi": "10.1002/pu.31316", "pmid": "", "publication_date": "2025-04-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3591, "title": "Treatment With Psilocybin for Chronic Neuropathic Pain and Depression (TRANSCEND): An Open-Label Clinical Trial", "authors": "Centre for Addiction and Mental Health", "journal": "ClinicalTrials.gov", "publication_date": "2025-04-24", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06518720", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06518720", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06518720", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06518720", "source_url": "https://clinicaltrials.gov/study/NCT06518720", "doi": "", "pmid": "", "publication_date": "2025-04-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 463, "title": "Psilocybin-assisted psychotherapy as a rapid-acting treatment for cancer-related depression and anxiety: Evidence from a network meta-analysis", "authors": "Damian Świeczkowski, Aleksander Kwaśny, Michał Pruc, Zuzanna Gaca, Łukasz Szarpak, Wiesław Jerzy Cubała", "journal": "The International Journal of Psychiatry in Medicine", "publication_date": "2025-04-24", "publication_year": 2025, "doi": "10.1177/00912174251337572", "pubmed_id": "40279353", "openalex_id": "https://openalex.org/W4409797469", "source_url": "https://doi.org/10.1177/00912174251337572", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40279353", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00912174251337572", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40279353", "source_url": "https://doi.org/10.1177/00912174251337572", "doi": "10.1177/00912174251337572", "pmid": "40279353", "publication_date": "2025-04-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 732, "title": "[Treatment with psychedelics: potential benefits in Parkinson's disease].", "authors": "Louise Penzenstadler, Sandra Baudois, Alma Lingenberg, Sabina Catalano Chiuvé, Emilie Tomkova, Vanessa Fleury", "journal": "PubMed", "publication_date": "2025-04-22", "publication_year": 2025, "doi": "10.53738/revmed.2025.21.915.47180", "pubmed_id": "40275842", "openalex_id": "https://openalex.org/W4409833807", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40275842", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Neuroplasticity,Receptor Pharmacology,Clinical Trial,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40275842", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40275842", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40275842", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40275842", "doi": "10.53738/revmed.2025.21.915.47180", "pmid": "40275842", "publication_date": "2025-04-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 500, "title": "Incremental efficacy systematic review and meta-analysis of psilocybin-for-depression RCTs.", "authors": "Borgogna NC, Owen T, Petrovitch D, Vaughn J, Johnson DAL, Pagano LA, Aita SL, Hill BD.", "journal": null, "publication_date": "2025-04-22", "publication_year": 2025, "doi": "10.1007/s00213-025-06788-w", "pubmed_id": "40266291", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00213-025-06788-w", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40266291", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-025-06788-w", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40266291", "source_url": "https://doi.org/10.1007/s00213-025-06788-w", "doi": "10.1007/s00213-025-06788-w", "pmid": "40266291", "publication_date": "2025-04-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 734, "title": "Evaluating the effectiveness of psilocybin in alleviating distress among cancer patients: A systematic review.", "authors": "Lapid MI, Pagali SR, Randall AL, Donovan KA, Bronars CA, Gauthier TA, Bock J, Lim SD, Carey EC, Sokolowski E, Ulrich AM, Hassett LC, Kung S, Whitford KJ, Olivier KR, D'Andre SD.", "journal": null, "publication_date": "2025-04-21", "publication_year": 2025, "doi": "10.1017/s147895152500032x", "pubmed_id": "40259688", "openalex_id": null, "source_url": "https://doi.org/10.1017/s147895152500032x", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Randomized Controlled Trial,Systematic Review,Review Article,Case Report,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40259688", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/s147895152500032x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40259688", "source_url": "https://doi.org/10.1017/s147895152500032x", "doi": "10.1017/s147895152500032x", "pmid": "40259688", "publication_date": "2025-04-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 708, "title": "Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.", "authors": "Falchi-Carvalho M, Palhano-Fontes F, Wießner I, Barros H, Bolcont R, Laborde S, Ruschi B Silva S, Montanini D, C Barbosa D, Teixeira E, Florence-Vilela R, Almeida R, K A de Macedo R, Arichelle F, J Pantrigo É, V Costa-Macedo J, da Cruz Nunes JA, de Araújo Costa Neto LA, Nunes Ferreira LF, Dantas Corrêa L, da Costa Bezerra RB, Arcoverde E, Galvão-Coelho N, B Araujo D.", "journal": null, "publication_date": "2025-04-21", "publication_year": 2025, "doi": "10.1038/s41386-025-02091-6", "pubmed_id": "40258990", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41386-025-02091-6", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40258990", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41386-025-02091-6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40258990", "source_url": "https://doi.org/10.1038/s41386-025-02091-6", "doi": "10.1038/s41386-025-02091-6", "pmid": "40258990", "publication_date": "2025-04-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 884, "title": "Psychedelics and substance use disorder treatment.", "authors": "DuPont CM, Johnson MW.", "journal": null, "publication_date": "2025-04-20", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.03.005", "pubmed_id": "40541314", "openalex_id": null, "source_url": "https://doi.org/10.1016/bs.irn.2025.03.005", "substance_tags": "psilocybin", "topic_tags": "Addiction,Emotional Processing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40541314", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/bs.irn.2025.03.005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40541314", "source_url": "https://doi.org/10.1016/bs.irn.2025.03.005", "doi": "10.1016/bs.irn.2025.03.005", "pmid": "40541314", "publication_date": "2025-04-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 737, "title": "Comparative Efficacy and Functional Outcomes of Psychedelic-Assisted Therapies in Treatment-Resistant Depression: A Systematic Review of Recent Clinical Trials.", "authors": "Mimms C, Sotelo K, Khaliq AS.", "journal": null, "publication_date": "2025-04-17", "publication_year": 2025, "doi": "10.7759/cureus.82532", "pubmed_id": "40385821", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.82532", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:40385821", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.82532", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40385821", "source_url": "https://doi.org/10.7759/cureus.82532", "doi": "10.7759/cureus.82532", "pmid": "40385821", "publication_date": "2025-04-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 738, "title": "Roadmap for Equitable Access and Responsible Use of Psilocybin-Assisted Psychotherapy in Palliative Care", "authors": "Michel Dorval, Sue-Ling Chang, Houman Farzin, Olivia Nguyen, Jean-François Stephan, Diane Tapp, P. Deschamps, Yann Joly, Florence Moureaux, Robert Foxman, Marianne Masse-Grenier, Jean-Sébastien Fallu", "journal": "Palliative Medicine Reports", "publication_date": "2025-04-16", "publication_year": 2025, "doi": "10.1089/pmr.2024.0108", "pubmed_id": "40385526", "openalex_id": "https://openalex.org/W4409528946", "source_url": "https://doi.org/10.1089/pmr.2024.0108", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40385526", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/pmr.2024.0108", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40385526", "source_url": "https://doi.org/10.1089/pmr.2024.0108", "doi": "10.1089/pmr.2024.0108", "pmid": "40385526", "publication_date": "2025-04-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 633, "title": "Regulatory Alignment of Psilocybin Clinical Trials in Major Depressive Disorder on ClinicalTrials.gov: A Cross-Sectional Analysis", "authors": "Damian Świeczkowski, Aleksander Kwaśny, Michał Pruc, Zuzanna Gaca, Łukasz Szarpak, Wiesław Jerzy Cubała", "journal": "Pharmacopsychiatry", "publication_date": "2025-04-16", "publication_year": 2025, "doi": "10.1055/a-2529-7029", "pubmed_id": "40245934", "openalex_id": "https://openalex.org/W4409534321", "source_url": "https://doi.org/10.1055/a-2529-7029", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40245934", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1055/a-2529-7029", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40245934", "source_url": "https://doi.org/10.1055/a-2529-7029", "doi": "10.1055/a-2529-7029", "pmid": "40245934", "publication_date": "2025-04-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3465, "title": "A Phase 2a, Open-label, Pilot Study to Assess the Safety and Efficacy of Psilocybin Administration in Concert With Psychotherapy Among Adult Patients With Fibromyalgia", "authors": "Kevin Boehnke", "journal": "ClinicalTrials.gov", "publication_date": "2025-04-15", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05128162", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Mechanism of Action,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05128162", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05128162", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05128162", "source_url": "https://clinicaltrials.gov/study/NCT05128162", "doi": "", "pmid": "", "publication_date": "2025-04-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 677, "title": "Efficacy and safety of psilocybin for the treatment of substance use disorders: A systematic review.", "authors": "Meshkat S, Malik G, Zeifman RJ, Swainson J, Balachandra K, Reichelt AC, Zhang Y, Burback L, Winkler O, Greenshaw A, Vermetten E, Mayo LM, Tanguay R, Jetly R, Bhat V.", "journal": null, "publication_date": "2025-04-14", "publication_year": 2025, "doi": "10.1016/j.neubiorev.2025.106163", "pubmed_id": "40245969", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neubiorev.2025.106163", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Aging,Microdosing,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40245969", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neubiorev.2025.106163", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40245969", "source_url": "https://doi.org/10.1016/j.neubiorev.2025.106163", "doi": "10.1016/j.neubiorev.2025.106163", "pmid": "40245969", "publication_date": "2025-04-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3612, "title": "The Role of Personal Experience for the Therapeutic Attitude in the Context of Substance-assisted Therapy Training", "authors": "Felix Mueller", "journal": "ClinicalTrials.gov", "publication_date": "2025-04-13", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05570708", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Safety,Drug Interactions", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05570708", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05570708", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05570708", "source_url": "https://clinicaltrials.gov/study/NCT05570708", "doi": "", "pmid": "", "publication_date": "2025-04-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3288, "title": "Assessing the potential cardiovascular risk of microdosing the psychedelic LSD in mice", "authors": "Effinger DP, Schalk SS, King JL, Strong JR, O’Connell CK, Calderon JR, McCorvy JD, Thompson SM.", "journal": "bioRxiv", "publication_date": "2025-04-13", "publication_year": 2025, "doi": "10.1101/2025.04.08.647757", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.04.08.647757", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Microdosing,Emotional Processing,Animal Study,Safety", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.1101/2025.04.08.647757", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.04.08.647757", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.04.08.647757", "source_url": "https://doi.org/10.1101/2025.04.08.647757", "doi": "10.1101/2025.04.08.647757", "pmid": "", "publication_date": "2025-04-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4396, "title": "13. Safety, Feasibility, and Tolerability of Psilocybin in Older Adults With Amnestic MCI: Preliminary Data From a SV2a PET Imaging Study", "authors": "Danielle Bukovsky, Aron Amaev, Jianmeng Song, Edgardo Torres Carmona, S. Lauren Kyte, Fumihiko Ueno, Vincenzo De Luca, Christopher R. Bowie, Alastair J. Flint, Muhammad Ishrat Husain, Ariel Graff-Guerrero, Philip Gerretsen", "journal": "Biological Psychiatry", "publication_date": "2025-04-08", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.250", "pubmed_id": null, "openalex_id": "https://openalex.org/W4409280654", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.250", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Receptor Pharmacology,Aging,Older Adults,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2025.02.250", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2025.02.250", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.250", "doi": "10.1016/j.biopsych.2025.02.250", "pmid": "", "publication_date": "2025-04-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 745, "title": "The Emergence of Psilocybin in Psychiatry and Neuroscience.", "authors": "Omidian H, Omidian A.", "journal": null, "publication_date": "2025-04-08", "publication_year": 2025, "doi": "10.3390/ph18040555", "pubmed_id": "40283990", "openalex_id": null, "source_url": "https://doi.org/10.3390/ph18040555", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:40283990", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ph18040555", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40283990", "source_url": "https://doi.org/10.3390/ph18040555", "doi": "10.3390/ph18040555", "pmid": "40283990", "publication_date": "2025-04-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 634, "title": "Psilocybin therapy for mood dysfunction in Parkinson’s disease: an open-label pilot trial", "authors": "Ellen Bradley, Kimberly Sakai, Gisele Fernandes-Osterhold, Balázs Szigeti, Connie Ludwig, Jill L. Ostrem, Caroline M. Tanner, Meredith Bock, Katiah Llerena, Patrick R. Finley, Aoife O’Donovan, José Rafael P. Zuzuárregui, Zachary Busby, Amber McKernan, Andrew Penn, Aliss C.C. Wang, Raymond C. Rosen, Joshua Woolley", "journal": "Neuropsychopharmacology", "publication_date": "2025-04-08", "publication_year": 2025, "doi": "10.1038/s41386-025-02097-0", "pubmed_id": "40205013", "openalex_id": "https://openalex.org/W4409286565", "source_url": "https://doi.org/10.1038/s41386-025-02097-0", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Safety,Adverse Events", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40205013", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41386-025-02097-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40205013", "source_url": "https://doi.org/10.1038/s41386-025-02097-0", "doi": "10.1038/s41386-025-02097-0", "pmid": "40205013", "publication_date": "2025-04-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4404, "title": "Harnessing neuroplasticity with psychoplastogens: the essential role of psychotherapy in psychedelic treatment optimization", "authors": "Jennifer Jones", "journal": "Frontiers in Psychiatry", "publication_date": "2025-04-07", "publication_year": 2025, "doi": "10.3389/fpsyt.2025.1565852", "pubmed_id": "40264517", "openalex_id": "https://openalex.org/W4409274889", "source_url": "https://doi.org/10.3389/fpsyt.2025.1565852", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Emotional Processing,Psychological Flexibility,Clinical Trial,Review Article,Animal Study,Veterans,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40264517", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2025.1565852", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40264517", "source_url": "https://doi.org/10.3389/fpsyt.2025.1565852", "doi": "10.3389/fpsyt.2025.1565852", "pmid": "40264517", "publication_date": "2025-04-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 886, "title": "Potential therapeutic effects of psychedelics in small doses: Is there a role for microdosing in psychiatry?", "authors": "Totomanova I, Haijen ECHM, Hurks PPM, Ramaekers JG, Kuypers KPC.", "journal": null, "publication_date": "2025-04-01", "publication_year": 2025, "doi": "10.1016/bs.irn.2025.03.002", "pubmed_id": "40541311", "openalex_id": null, "source_url": "https://doi.org/10.1016/bs.irn.2025.03.002", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Chronic Pain,Pharmacology,Microdosing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40541311", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/bs.irn.2025.03.002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40541311", "source_url": "https://doi.org/10.1016/bs.irn.2025.03.002", "doi": "10.1016/bs.irn.2025.03.002", "pmid": "40541311", "publication_date": "2025-04-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4420, "title": "Selective outcome reporting and non-reporting in trials of psychedelic drugs for mental disorders", "authors": "Ioana A. Cristea, G Tomei, Jazmín Freddi, A. Bonessio", "journal": "European Psychiatry", "publication_date": "2025-03-31", "publication_year": 2025, "doi": "10.1192/j.eurpsy.2025.393", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414208490", "source_url": "https://doi.org/10.1192/j.eurpsy.2025.393", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2025.393", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2025.393", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2025.393", "source_url": "https://doi.org/10.1192/j.eurpsy.2025.393", "doi": "10.1192/j.eurpsy.2025.393", "pmid": "", "publication_date": "2025-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4410, "title": "Reporting of psychotherapeutic methods in psychedelic treatments: on the road to ethical, professional and regulatory oversight", "authors": "A. Oliveira-Maia", "journal": "European Psychiatry", "publication_date": "2025-03-31", "publication_year": 2025, "doi": "10.1192/j.eurpsy.2025.64", "pubmed_id": null, "openalex_id": "https://openalex.org/W4414181599", "source_url": "https://doi.org/10.1192/j.eurpsy.2025.64", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2025.64", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/j.eurpsy.2025.64", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2025.64", "source_url": "https://doi.org/10.1192/j.eurpsy.2025.64", "doi": "10.1192/j.eurpsy.2025.64", "pmid": "", "publication_date": "2025-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2999, "title": "A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.", "authors": "Miller M, Meyers M, Martin A, Napolitano S, Dorsen C, Penn A, Rosa WE", "journal": "Journal of hospice and palliative nursing: JHPN: the official journal of the Hospice and Palliative Nurses Association", "publication_date": "2025-03-31", "publication_year": 2025, "doi": "10.1097/njh.0000000000001113", "pubmed_id": "40042324", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40042324/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Spirituality,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 07:01:03", "last_checked": "2026-07-01 11:20:36", "bibtex": null, "source_record_id": "PMID:40042324", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40042324/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40042324", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40042324/", "doi": "10.1097/njh.0000000000001113", "pmid": "40042324", "publication_date": "2025-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 739, "title": "Psilocybin-Assisted suppoRtive psychoTherapy IN the treatment of prolonged Grief (PARTING) trial: protocol for an open-label pilot trial for cancer-related bereavement", "authors": "Vanessa L. Beesley, Tom Kennedy, Fiona Maccallum, Margaret Ross, Renee Harvey, Susan L. Rossell, Jerome Sarris, Daniel Perkins, Rachel Ε. Neale, James Bennett-Levy, Shevaugn Johnson, Hanna Beebe, Natalie Roset, Jörg Strobel, Stephen Parker", "journal": "BMJ Open", "publication_date": "2025-03-31", "publication_year": 2025, "doi": "10.1136/bmjopen-2024-095992", "pubmed_id": "40233965", "openalex_id": "https://openalex.org/W4409449177", "source_url": "https://doi.org/10.1136/bmjopen-2024-095992", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Psychological Flexibility,Clinical Trial,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:33", "bibtex": null, "source_record_id": "PMID:40233965", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/bmjopen-2024-095992", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40233965", "source_url": "https://doi.org/10.1136/bmjopen-2024-095992", "doi": "10.1136/bmjopen-2024-095992", "pmid": "40233965", "publication_date": "2025-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3635, "title": "Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN", "authors": "Unity Health Toronto", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-29", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06731335", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06731335", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06731335", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06731335", "source_url": "https://clinicaltrials.gov/study/NCT06731335", "doi": "", "pmid": "", "publication_date": "2025-03-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4423, "title": "Psilocybin-assisted therapy leads to personality shifts in patients with alcohol use disorder", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2025-03-26", "publication_year": 2025, "doi": "10.1002/pu.31300", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408975325", "source_url": "https://doi.org/10.1002/pu.31300", "substance_tags": "psilocybin", "topic_tags": "Addiction,Personality Change,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31300", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.31300", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31300", "source_url": "https://doi.org/10.1002/pu.31300", "doi": "10.1002/pu.31300", "pmid": "", "publication_date": "2025-03-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4424, "title": "Current U.S. Approaches to Studying Psychedelic Medicines Compared to Psychedelics Use Among Indigenous Groups: What Are We Missing?", "authors": "M. Cirillo", "journal": "Journal of Humanistic Psychology", "publication_date": "2025-03-21", "publication_year": 2025, "doi": "10.1177/00221678251321040", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408724359", "source_url": "https://doi.org/10.1177/00221678251321040", "substance_tags": "psilocybin", "topic_tags": "Review Article,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 06:34:40", "bibtex": null, "source_record_id": "DOI:10.1177/00221678251321040", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00221678251321040", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/00221678251321040", "source_url": "https://doi.org/10.1177/00221678251321040", "doi": "10.1177/00221678251321040", "pmid": "", "publication_date": "2025-03-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3544, "title": "An 8-week Phase 2 Clinical Trial to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-assisted-psychotherapy in Adults With Cannabis Use Disorder: A Proof-of-Concept Study", "authors": "McMaster University", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-18", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06225232", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06225232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06225232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06225232", "source_url": "https://clinicaltrials.gov/study/NCT06225232", "doi": "", "pmid": "", "publication_date": "2025-03-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3457, "title": "Psilocybin in Alcohol Use Disorder With Comorbid Depression", "authors": "Centre Hospitalier Universitaire de Nīmes", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-18", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06235411", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Observational Study,Safety,Inflammation,Immune Function", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06235411", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06235411", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06235411", "source_url": "https://clinicaltrials.gov/study/NCT06235411", "doi": "", "pmid": "", "publication_date": "2025-03-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 778, "title": "A Modern Overview of the Potential Therapeutic Effects of Psilocybin in the Treatment of Depressive Disorders, Treatment-Resistant Depression, and End-of-Life Distress.", "authors": "Dino F.", "journal": null, "publication_date": "2025-03-16", "publication_year": 2025, "doi": "10.7759/cureus.80707", "pubmed_id": "40242672", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.80707", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Pharmacology,Review Article,Treatment-Resistant Depression,Safety,Drug Interactions,Contraindications", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:40242672", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.80707", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40242672", "source_url": "https://doi.org/10.7759/cureus.80707", "doi": "10.7759/cureus.80707", "pmid": "40242672", "publication_date": "2025-03-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 715, "title": "IUPHAR Article: Psilocybin induces long-lasting effects via 5-HT2A receptors in mouse models of chronic pain", "authors": "Eda Köşeli, Belle Buzzi, Torin Honaker, Yogesh Rakholia, Melissa J. Lewis, Maya Gaines-Smith, Alaina M. Jaster, Javier González-Maeso, M. Imad Damaj", "journal": "Pharmacological Research", "publication_date": "2025-03-16", "publication_year": 2025, "doi": "10.1016/j.phrs.2025.107699", "pubmed_id": "40107634", "openalex_id": "https://openalex.org/W4408540649", "source_url": "https://doi.org/10.1016/j.phrs.2025.107699", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Pharmacology,Receptor Pharmacology,Animal Study,Safety,Inflammation", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:40107634", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.phrs.2025.107699", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40107634", "source_url": "https://doi.org/10.1016/j.phrs.2025.107699", "doi": "10.1016/j.phrs.2025.107699", "pmid": "40107634", "publication_date": "2025-03-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 565, "title": "Current Evidence for the Role of Rapid-Acting Antidepressants in Bipolar Depression: A Perspective and Plan for Action.", "authors": "Repple J, Bayas M, Möser C, Kobayashi NF, Reif A.", "journal": null, "publication_date": "2025-03-07", "publication_year": 2025, "doi": "10.1016/j.biopsych.2025.02.903", "pubmed_id": "40064389", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.903", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40064389", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.biopsych.2025.02.903", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40064389", "source_url": "https://doi.org/10.1016/j.biopsych.2025.02.903", "doi": "10.1016/j.biopsych.2025.02.903", "pmid": "40064389", "publication_date": "2025-03-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 740, "title": "Psychedelics and Eating Disorders: Exploring the Therapeutic Potential for Anorexia Nervosa and Beyond.", "authors": "Hu S, Lin C, Wang H, Wang X.", "journal": null, "publication_date": "2025-03-06", "publication_year": 2025, "doi": "10.1021/acsptsci.5c00094", "pubmed_id": "40242584", "openalex_id": null, "source_url": "https://doi.org/10.1021/acsptsci.5c00094", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Wellbeing,Emotional Processing,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40242584", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsptsci.5c00094", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40242584", "source_url": "https://doi.org/10.1021/acsptsci.5c00094", "doi": "10.1021/acsptsci.5c00094", "pmid": "40242584", "publication_date": "2025-03-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4432, "title": "Psychedelics for Substance Use Disorders: Updates for the Psychiatric Trainee", "authors": "Lauren Wilseck, Preet Chatha, Lawrence Canale, Dhvanit Raval, Jeremy Weleff", "journal": "American Journal of Psychiatry Residents Journal", "publication_date": "2025-03-05", "publication_year": 2025, "doi": "10.1176/appi.ajp-rj.2025.200301", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408204973", "source_url": "https://doi.org/10.1176/appi.ajp-rj.2025.200301", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Aging,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1176/appi.ajp-rj.2025.200301", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.ajp-rj.2025.200301", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.ajp-rj.2025.200301", "source_url": "https://doi.org/10.1176/appi.ajp-rj.2025.200301", "doi": "10.1176/appi.ajp-rj.2025.200301", "pmid": "", "publication_date": "2025-03-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4431, "title": "Risks of using psilocybin in treatment of treatment-resistant depression", "authors": "Michał Orzechowski, Joanna Orzechowska, Paulina Fijałek, Jan Karczmarz, Aleksandra Paprocka, Marika Gutowska, Agnieszka Kosińska, Urszula Świrk, Wiktoria Belcarz, Katarzyna Kalinowska", "journal": "Journal of Education Health and Sport", "publication_date": "2025-03-05", "publication_year": 2025, "doi": "10.12775/jehs.2025.79.58319", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408197223", "source_url": "https://doi.org/10.12775/jehs.2025.79.58319", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2025.79.58319", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/jehs.2025.79.58319", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2025.79.58319", "source_url": "https://doi.org/10.12775/jehs.2025.79.58319", "doi": "10.12775/jehs.2025.79.58319", "pmid": "", "publication_date": "2025-03-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3666, "title": "Acute Effects of 2C-B Compared With MDMA and Psilocybin in Healthy Subjects", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2025-03-04", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05523401", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,PTSD,Pharmacology,Receptor Pharmacology,Clinical Trial,In Vitro Study,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05523401", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05523401", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05523401", "source_url": "https://clinicaltrials.gov/study/NCT05523401", "doi": "", "pmid": "", "publication_date": "2025-03-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 787, "title": "Vermont Primary Care Provider Perspectives on Psychedelics - A Cross-Sectional Study", "authors": "Josephine Yalovitser, jonah levine, Cole Zweber, Lauren Tien, Mallory Stultz, Henry Mitchell, Elizabeth Cote, Charles D. MacLean", "journal": "Journal of Psychoactive Drugs", "publication_date": "2025-03-04", "publication_year": 2025, "doi": "10.1080/02791072.2025.2474246", "pubmed_id": "40045530", "openalex_id": "https://openalex.org/W4408177956", "source_url": "https://doi.org/10.1080/02791072.2025.2474246", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Observational Study,Adolescents,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:40045530", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2025.2474246", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40045530", "source_url": "https://doi.org/10.1080/02791072.2025.2474246", "doi": "10.1080/02791072.2025.2474246", "pmid": "40045530", "publication_date": "2025-03-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4433, "title": "Could psilocin rescue chronic, stress-accelerated, transcriptional aging in brain?", "authors": "Craig, Danny R, Blalock, Eric M.", "journal": "UKnowledge (University of Kentucky)", "publication_date": "2025-03-03", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110662772", "source_url": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Aging,Cellular Senescence,Resilience,Clinical Trial,Randomized Controlled Trial,Animal Study,Older Adults,Adolescents,Treatment-Resistant Depression,Safety,Drug Interactions,Transcriptomics,Inflammation", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:40", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "source_url": "https://uknowledge.uky.edu/jpns/vol2/iss1/1", "doi": "", "pmid": "", "publication_date": "2025-03-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 797, "title": "Psychedelics for Cancer Pain and Associated Psychological Distress: A Narrative Review of a Potential Strategy.", "authors": "Belitzky E, Ravani Carvalho LV, Taylor M, Ortiz CN, Baum L, Fiellin DA, Lustberg MB.", "journal": null, "publication_date": "2025-02-28", "publication_year": 2025, "doi": "10.1002/cam4.70586", "pubmed_id": "40052631", "openalex_id": null, "source_url": "https://doi.org/10.1002/cam4.70586", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Review Article,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40052631", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/cam4.70586", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40052631", "source_url": "https://doi.org/10.1002/cam4.70586", "doi": "10.1002/cam4.70586", "pmid": "40052631", "publication_date": "2025-02-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3748, "title": "Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms", "authors": "Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P.", "journal": "PsyArXiv", "publication_date": "2025-02-27", "publication_year": 2025, "doi": "10.31234/osf.io/93x5h_v3", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/93x5h_v3", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Spirituality,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:18", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/93x5h_v3", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/93x5h_v3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/93x5h_v3", "source_url": "https://doi.org/10.31234/osf.io/93x5h_v3", "doi": "10.31234/osf.io/93x5h_v3", "pmid": "", "publication_date": "2025-02-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3110, "title": "Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms", "authors": "Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P.", "journal": "PsyArXiv", "publication_date": "2025-02-27", "publication_year": 2025, "doi": "10.31234/osf.io/93x5h_v2", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/93x5h_v2", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Spirituality,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/93x5h_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/93x5h_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/93x5h_v2", "source_url": "https://doi.org/10.31234/osf.io/93x5h_v2", "doi": "10.31234/osf.io/93x5h_v2", "pmid": "", "publication_date": "2025-02-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3109, "title": "Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-02-27", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/93x5h_v3", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Spirituality,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/93x5h_v3", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/93x5h_v3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/93x5h_v3", "source_url": "https://osf.io/preprints/psyarxiv/93x5h_v3", "doi": "", "pmid": "", "publication_date": "2025-02-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 793, "title": "A Field-Wide Review and Analysis of Study Materials Used in Psilocybin Trials: Assessment of Two Decades of Research.", "authors": "Yaden DB, Graziosi M, Owen AM, Agin-Liebes G, Aaronson ST, Allen KE, Barrett FS, Bogenschutz MP, Carhart-Harris R, Ching THW, Cosimano MP, Danforth A, Davis AK, Garcia-Romeu A, Griffiths R, Grob CS, Gründer G, Gukasyan N, Heinzerling KG, Hendricks PS, Holze F, Horton DM, Johnson MW, Kelmendi B, Knatz Peck S, Koslowski M, Liechti ME, Mertens LJ, Moreno FA, Nayak SM, Nicholas CR, Preller KH, Rieser NM, Ross S, Sergi K, Sloshower J, Smigielski L, Stenbæk DS, Vollenweider FX, Weiss B, Wolff M, Yaden ME.", "journal": null, "publication_date": "2025-02-26", "publication_year": 2025, "doi": "10.1089/psymed.2024.0019", "pubmed_id": "40351554", "openalex_id": null, "source_url": "https://doi.org/10.1089/psymed.2024.0019", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Consciousness,Wellbeing,Review Article,Safety,Adverse Events,Contraindications", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:40351554", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1089/psymed.2024.0019", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40351554", "source_url": "https://doi.org/10.1089/psymed.2024.0019", "doi": "10.1089/psymed.2024.0019", "pmid": "40351554", "publication_date": "2025-02-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 815, "title": "A review of psychedelics trials completed in depression, informed by European regulatory perspectives.", "authors": "Silva F, Butlen-Ducuing F, Guizzaro L, Balabanov P.", "journal": null, "publication_date": "2025-02-25", "publication_year": 2025, "doi": "10.1016/j.nsa.2025.105516", "pubmed_id": "40654583", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.nsa.2025.105516", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40654583", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.nsa.2025.105516", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40654583", "source_url": "https://doi.org/10.1016/j.nsa.2025.105516", "doi": "10.1016/j.nsa.2025.105516", "pmid": "40654583", "publication_date": "2025-02-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3077, "title": "The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.", "authors": "Hitchins K, Reynolds J.", "journal": "PsyArXiv", "publication_date": "2025-02-24", "publication_year": 2025, "doi": "10.31234/osf.io/48yg7_v2", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/48yg7_v2", "substance_tags": "psilocybin", "topic_tags": "Longevity,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/48yg7_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/48yg7_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/48yg7_v2", "source_url": "https://doi.org/10.31234/osf.io/48yg7_v2", "doi": "10.31234/osf.io/48yg7_v2", "pmid": "", "publication_date": "2025-02-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 532, "title": "The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.", "authors": "", "journal": "PsyArXiv", "publication_date": "2025-02-24", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/48yg7_v2", "substance_tags": "psilocybin", "topic_tags": "Longevity,Personality Change,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/48yg7_v2", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/48yg7_v2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/48yg7_v2", "source_url": "https://osf.io/preprints/psyarxiv/48yg7_v2", "doi": "", "pmid": "", "publication_date": "2025-02-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3080, "title": "The Impact of Communicating the Benefits and Safety of Psilocybin on Policy Support: A Survey Based Experiment.", "authors": "Hitchins K, Reynolds J.", "journal": "PsyArXiv", "publication_date": "2025-02-23", "publication_year": 2025, "doi": "10.31234/osf.io/48yg7_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/48yg7_v1", "substance_tags": "psilocybin", "topic_tags": "Longevity,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/48yg7_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/48yg7_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/48yg7_v1", "source_url": "https://doi.org/10.31234/osf.io/48yg7_v1", "doi": "10.31234/osf.io/48yg7_v1", "pmid": "", "publication_date": "2025-02-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 816, "title": "Psychedelics and Suicide-Related Outcomes: A Systematic Review.", "authors": "Meshkat S, Malik T, Zeifman R, Swainson J, Zhang Y, Burback L, Winkler O, Greenshaw AJ, Claire Reichelt A, Vermetten E, Erritzoe D, Jha MK, Dunn W, Jetly R, Husain MI, Bhat V.", "journal": null, "publication_date": "2025-02-19", "publication_year": 2025, "doi": "10.3390/jcm14051416", "pubmed_id": "40094838", "openalex_id": null, "source_url": "https://doi.org/10.3390/jcm14051416", "substance_tags": "psilocybin", "topic_tags": "PTSD,Mechanism of Action,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:40094838", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/jcm14051416", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40094838", "source_url": "https://doi.org/10.3390/jcm14051416", "doi": "10.3390/jcm14051416", "pmid": "40094838", "publication_date": "2025-02-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 720, "title": "Anaesthetic implications of psilocybin and lysergic acid diethylamide: what is old is now new: A narrative review on psychedelics and anaesthesia.", "authors": "Dave M, Shore R, Cupido T, Haley C, Clinkard D.", "journal": null, "publication_date": "2025-02-17", "publication_year": 2025, "doi": "10.1097/eja.0000000000002138", "pubmed_id": "39967455", "openalex_id": null, "source_url": "https://doi.org/10.1097/eja.0000000000002138", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Receptor Pharmacology,Aging,Review Article,Safety,Adverse Events,Contraindications", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39967455", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/eja.0000000000002138", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39967455", "source_url": "https://doi.org/10.1097/eja.0000000000002138", "doi": "10.1097/eja.0000000000002138", "pmid": "39967455", "publication_date": "2025-02-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 682, "title": "Psychedelics and chronic pain: self-reported outcomes on changed substance use patterns and health following naturalistic psychedelic use", "authors": "Nicolas G. Glynos, Anne Baker, Jacob S. Aday, Daniel J. Kruger, Kevin F. Boehnke, Stephanie Lake, Philippe Lucas", "journal": "British Journal of Pain", "publication_date": "2025-02-10", "publication_year": 2025, "doi": "10.1177/20494637251319497", "pubmed_id": "39944237", "openalex_id": "https://openalex.org/W4407380636", "source_url": "https://doi.org/10.1177/20494637251319497", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39944237", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20494637251319497", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39944237", "source_url": "https://doi.org/10.1177/20494637251319497", "doi": "10.1177/20494637251319497", "pmid": "39944237", "publication_date": "2025-02-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4441, "title": "Psychedelics for Moral Bioenhancement in Healthy Individuals-A Violation of the Non-Maleficence Principle?", "authors": "Bor Luen Tang", "journal": "Psychoactives", "publication_date": "2025-02-05", "publication_year": 2025, "doi": "10.3390/psychoactives4010005", "pubmed_id": null, "openalex_id": "https://openalex.org/W4407194293", "source_url": "https://doi.org/10.3390/psychoactives4010005", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives4010005", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives4010005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives4010005", "source_url": "https://doi.org/10.3390/psychoactives4010005", "doi": "10.3390/psychoactives4010005", "pmid": "", "publication_date": "2025-02-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 820, "title": "Psilocybin as a Treatment for Repetitive Mild Head Injury: Evidence from Neuroradiology and Molecular Biology", "authors": "Brengel EK, Axe B, Maheswari A, Abeer MI, Ortiz RJ, Woodward TJ, Walhof R, Utama R, Sawada C, Balaji S, Kulkarni PP, Bradshaw HB, Gitcho MA, Ferris CF.", "journal": "bioRxiv", "publication_date": "2025-02-05", "publication_year": 2025, "doi": "10.1101/2025.02.03.636248", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.02.03.636248", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Safety,Inflammation", "study_type": "Other", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2025.02.03.636248", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.02.03.636248", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.02.03.636248", "source_url": "https://doi.org/10.1101/2025.02.03.636248", "doi": "10.1101/2025.02.03.636248", "pmid": "", "publication_date": "2025-02-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4443, "title": "Psilocybin mushroom stewardship: A qualitative inquiry into practices and priorities of “underground” psilocybin mushroom practitioners", "authors": "Shannon Hughes, Lucia Terpak, Reilly Capps, Pam Peters, Nicole Lilly, Dylan Rivard", "journal": "Journal of Psychedelic Studies", "publication_date": "2025-02-04", "publication_year": 2025, "doi": "10.1556/2054.2025.00375", "pubmed_id": null, "openalex_id": "https://openalex.org/W4407157019", "source_url": "https://doi.org/10.1556/2054.2025.00375", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Receptor Pharmacology,Personality Change,Mystical Experience,Safety", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2025.00375", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2025.00375", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2025.00375", "source_url": "https://doi.org/10.1556/2054.2025.00375", "doi": "10.1556/2054.2025.00375", "pmid": "", "publication_date": "2025-02-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 827, "title": "Psychedelics assisting therapy, or therapy assisting psychedelics? The importance of psychotherapy in psychedelic-assisted therapy", "authors": "Joseph A. Zamaria, Gisele Fernandes-Osterhold, Jonathan Shedler, Rachel Yehuda", "journal": "Frontiers in Psychology", "publication_date": "2025-02-04", "publication_year": 2025, "doi": "10.3389/fpsyg.2025.1505894", "pubmed_id": "39973948", "openalex_id": "https://openalex.org/W4407181198", "source_url": "https://doi.org/10.3389/fpsyg.2025.1505894", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Consciousness,Emotional Processing,Clinical Trial,Observational Study,Treatment-Resistant Depression,Healthcare Workers,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39973948", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyg.2025.1505894", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39973948", "source_url": "https://doi.org/10.3389/fpsyg.2025.1505894", "doi": "10.3389/fpsyg.2025.1505894", "pmid": "39973948", "publication_date": "2025-02-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 836, "title": "Evaluating the value and risks of psychedelics for psychiatric medicine: a clinical perspective.", "authors": "Marazziti D, Weiss F, Gurrieri R, Russomanno G, Gambini M, Magnesa A, Coccoglioniti A, Perugi G", "journal": "Expert review of neurotherapeutics", "publication_date": "2025-01-31", "publication_year": 2025, "doi": "10.1080/14737175.2024.2445016", "pubmed_id": "39699299", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39699299/", "substance_tags": "psilocybin,psilocin", "topic_tags": "Receptor Pharmacology,Emotional Processing,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:36", "bibtex": null, "source_record_id": "PMID:39699299", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39699299/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39699299", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39699299/", "doi": "10.1080/14737175.2024.2445016", "pmid": "39699299", "publication_date": "2025-01-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 832, "title": "The Acceptability of Psychedelic-Assisted Therapy Amongst Mental Health Consumers: Utilising the Theory of Planned Behaviour", "authors": "Eva Louie, Ellen Towers, Alyssa R. Morse, Joshua Watt, Zachary Bryant, Paul Haber, Kirsten C. Morley", "journal": "International Journal of Mental Health Nursing", "publication_date": "2025-01-31", "publication_year": 2025, "doi": "10.1111/inm.70010", "pubmed_id": "39952893", "openalex_id": "https://openalex.org/W4407570589", "source_url": "https://doi.org/10.1111/inm.70010", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39952893", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/inm.70010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39952893", "source_url": "https://doi.org/10.1111/inm.70010", "doi": "10.1111/inm.70010", "pmid": "39952893", "publication_date": "2025-01-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 846, "title": "Psychedelic-assisted treatment for substance use disorder: A narrative systematic review.", "authors": "Piper T, Small F, Brown S, Kelleher M, Mitcheson L, Rucker J, Young AH, Marsden J.", "journal": null, "publication_date": "2025-01-29", "publication_year": 2025, "doi": "10.1111/add.16762", "pubmed_id": "39887551", "openalex_id": null, "source_url": "https://doi.org/10.1111/add.16762", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:39887551", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/add.16762", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39887551", "source_url": "https://doi.org/10.1111/add.16762", "doi": "10.1111/add.16762", "pmid": "39887551", "publication_date": "2025-01-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4461, "title": "Experiential dimension of psilocybin-assisted therapy training: Necessity or hindrance to wider accessibility?", "authors": "Louis Plourde, Sue-Ling Chang, Houman Farzin, Jean-François Stephan, Jean-Sébastien Fallu, Michel Dorval", "journal": "Journal of Psychedelic Studies", "publication_date": "2025-01-20", "publication_year": 2025, "doi": "10.1556/2054.2024.00431", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406667242", "source_url": "https://doi.org/10.1556/2054.2024.00431", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2024.00431", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2024.00431", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2024.00431", "source_url": "https://doi.org/10.1556/2054.2024.00431", "doi": "10.1556/2054.2024.00431", "pmid": "", "publication_date": "2025-01-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3679, "title": "A Phase II Randomized, Double-blind, Active Placebo-controlled Parallel Group Trial to Examine the Efficacy and Safety of Psilocybin in Treatment-resistant Major Depression", "authors": "Central Institute of Mental Health, Mannheim", "journal": "ClinicalTrials.gov", "publication_date": "2025-01-19", "publication_year": 2025, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04670081", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04670081", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04670081", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04670081", "source_url": "https://clinicaltrials.gov/study/NCT04670081", "doi": "", "pmid": "", "publication_date": "2025-01-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 854, "title": "Uncovering Psychedelics: From Neural Circuits to Therapeutic Applications.", "authors": "Melani A, Bonaso M, Biso L, Zucchini B, Conversano C, Scarselli M.", "journal": null, "publication_date": "2025-01-18", "publication_year": 2025, "doi": "10.3390/ph18010130", "pubmed_id": "39861191", "openalex_id": null, "source_url": "https://doi.org/10.3390/ph18010130", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Brain Imaging,Mechanism of Action,Default Mode Network,Consciousness,Aging,Emotional Processing,Spirituality,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39861191", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ph18010130", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39861191", "source_url": "https://doi.org/10.3390/ph18010130", "doi": "10.3390/ph18010130", "pmid": "39861191", "publication_date": "2025-01-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 855, "title": "Psilocybin-assisted massed cognitive processing therapy for chronic posttraumatic stress disorder: Protocol for an open-label pilot feasibility trial", "authors": "Shakila Meshkat, Richard J. Zeifman, Kathleen E. Stewart, Reinhard Janssen-Aguilar, Wendy Lou, Rakesh Jetly, Candice M. Monson, Venkat Bhat", "journal": "PLoS ONE", "publication_date": "2025-01-16", "publication_year": 2025, "doi": "10.1371/journal.pone.0313741", "pubmed_id": "39823496", "openalex_id": "https://openalex.org/W4406512218", "source_url": "https://doi.org/10.1371/journal.pone.0313741", "substance_tags": "psilocybin", "topic_tags": "PTSD,Chronic Pain,Mechanism of Action,Wellbeing,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39823496", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0313741", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39823496", "source_url": "https://doi.org/10.1371/journal.pone.0313741", "doi": "10.1371/journal.pone.0313741", "pmid": "39823496", "publication_date": "2025-01-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 857, "title": "Exploring the Potential of Psychedelics in the Treatment of Headache Disorders: Clinical Considerations and Exploratory Insights.", "authors": "Henderson I, Elsaadany R, Chan G, Bajaj V, Duarte D, Goodman S, Grunstein M, Vadhan NP, Duarte RA.", "journal": null, "publication_date": "2025-01-15", "publication_year": 2025, "doi": "10.1007/s11916-024-01321-8", "pubmed_id": "39820774", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11916-024-01321-8", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Mechanism of Action,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39820774", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11916-024-01321-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39820774", "source_url": "https://doi.org/10.1007/s11916-024-01321-8", "doi": "10.1007/s11916-024-01321-8", "pmid": "39820774", "publication_date": "2025-01-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 856, "title": "Self-reported experiences and perspectives on using psychedelics to manage opioid use among participants of two Reddit communities.", "authors": "Krawczyk N, Miller M, Gu EY, Irvine N, Ramirez E, Santaella-Tenorio J, Lippincott T, Bogenschutz M, Bunting AM, Meacham MC", "journal": "Addiction (Abingdon, England)", "publication_date": "2025-01-15", "publication_year": 2025, "doi": "10.1111/add.16767", "pubmed_id": "39821493", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39821493/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Wellbeing,Safety", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:36", "bibtex": null, "source_record_id": "PMID:39821493", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39821493/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39821493", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39821493/", "doi": "10.1111/add.16767", "pmid": "39821493", "publication_date": "2025-01-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3086, "title": "Age- and estrous-dependent effects of psilocybin in rats", "authors": "Zylko A, Rakoczy R, Roberts B, Wilson M, Powell A, Page A, Heitkamp M, Fiest D, Jones J, McMurray M.", "journal": "bioRxiv", "publication_date": "2025-01-13", "publication_year": 2025, "doi": "10.1101/2025.01.10.632408", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2025.01.10.632408", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Receptor Pharmacology,Animal Study,Adolescents,Safety", "study_type": "Clinical Trial", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2025.01.10.632408", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2025.01.10.632408", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2025.01.10.632408", "source_url": "https://doi.org/10.1101/2025.01.10.632408", "doi": "10.1101/2025.01.10.632408", "pmid": "", "publication_date": "2025-01-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4463, "title": "Study finds encouraging results in psilocybin treatment for TRD patients", "authors": "Valerie A. Canady", "journal": "Mental Health Weekly", "publication_date": "2025-01-09", "publication_year": 2025, "doi": "10.1002/mhw.34292", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406243180", "source_url": "https://doi.org/10.1002/mhw.34292", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Aging,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.34292", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/mhw.34292", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/mhw.34292", "source_url": "https://doi.org/10.1002/mhw.34292", "doi": "10.1002/mhw.34292", "pmid": "", "publication_date": "2025-01-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4464, "title": "PSYCHEDELICS IN THE TREATMENT OF MENTAL DISORDERS", "authors": "Eduardo d’Avila Lins Lacerda, Bianca Medeiros Ferraz da Nóbrega, Yasmin Mesquita Dias Franca Gadelha, Liliane Reis Teixeira, Manolo Altieri Espinar, Bruna Trigueiro Carlini, Gabriel Santa Cruz Lins, Anthonielly Leinat Lima, Isabel Azevedo, Paulo Heinrich Soares Bomtempo", "journal": "Health and Society", "publication_date": "2025-01-07", "publication_year": 2025, "doi": "10.51249/hs.v5i01.2377", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406161181", "source_url": "https://doi.org/10.51249/hs.v5i01.2377", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Receptor Pharmacology,Review Article,Safety,Drug Interactions", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.51249/hs.v5i01.2377", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.51249/hs.v5i01.2377", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.51249/hs.v5i01.2377", "source_url": "https://doi.org/10.51249/hs.v5i01.2377", "doi": "10.51249/hs.v5i01.2377", "pmid": "", "publication_date": "2025-01-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 869, "title": "Pain and Perception: Exploring Psychedelics as Novel Therapeutic Agents in Chronic Pain Management.", "authors": "Strand NH, Whitney M, Johnson B, Dunn T, Attanti S, Maloney J, Misra L, Gomez D, Viswanath O, Emami E, Leathem J.", "journal": null, "publication_date": "2025-01-06", "publication_year": 2025, "doi": "10.1007/s11916-024-01353-0", "pubmed_id": "39775134", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11916-024-01353-0", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Headache / Migraine,Neuroplasticity,Mechanism of Action,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39775134", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11916-024-01353-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39775134", "source_url": "https://doi.org/10.1007/s11916-024-01353-0", "doi": "10.1007/s11916-024-01353-0", "pmid": "39775134", "publication_date": "2025-01-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 863, "title": "Clinical and preclinical evidence of psilocybin as antidepressant. A narrative review.", "authors": "Erkizia-Santamaría I, Horrillo I, Meana JJ, Ortega JE.", "journal": null, "publication_date": "2025-01-05", "publication_year": 2025, "doi": "10.1016/j.pnpbp.2025.111249", "pubmed_id": "39778644", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111249", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Animal Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39778644", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2025.111249", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39778644", "source_url": "https://doi.org/10.1016/j.pnpbp.2025.111249", "doi": "10.1016/j.pnpbp.2025.111249", "pmid": "39778644", "publication_date": "2025-01-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 761, "title": "Psychedelic Treatments in Adolescent Psychopharmacology: Considering Safety, Ethics, and Scientific Rigor.", "authors": "Sutherland I, Ho MF, Croarkin PE.", "journal": null, "publication_date": "2025-01-05", "publication_year": 2025, "doi": "10.1089/cap.2024.0082", "pubmed_id": "39761065", "openalex_id": null, "source_url": "https://doi.org/10.1089/cap.2024.0082", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Pharmacology,Adolescents,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39761065", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1089/cap.2024.0082", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39761065", "source_url": "https://doi.org/10.1089/cap.2024.0082", "doi": "10.1089/cap.2024.0082", "pmid": "39761065", "publication_date": "2025-01-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4465, "title": "From Safe Touch to Sexual Abuse: Walking the Tightrope of Patient Safety in Psychedelic Therapy", "authors": "Y. Tony Yang", "journal": "The American Journal of Bioethics", "publication_date": "2025-01-01", "publication_year": 2025, "doi": "10.1080/15265161.2024.2433418", "pubmed_id": "39804319", "openalex_id": "https://openalex.org/W4406325093", "source_url": "https://doi.org/10.1080/15265161.2024.2433418", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39804319", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/15265161.2024.2433418", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39804319", "source_url": "https://doi.org/10.1080/15265161.2024.2433418", "doi": "10.1080/15265161.2024.2433418", "pmid": "39804319", "publication_date": "2025-01-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4498, "title": "Additional file 1 of “I’ve learned that I’m open-minded to this possibility”: A qualitative study to evaluate the acceptability of a psilocybin-aided smoking cessation treatment for people with HIV who smoke", "authors": "Patricia A. Cioe, Garrett S Stang, Danish Azam, Sarah Dugal", "journal": "Figshare", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.6084/m9.figshare.29615217", "pubmed_id": null, "openalex_id": "https://openalex.org/W7130712582", "source_url": "https://doi.org/10.6084/m9.figshare.29615217", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.6084/m9.figshare.29615217", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.6084/m9.figshare.29615217", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.6084/m9.figshare.29615217", "source_url": "https://doi.org/10.6084/m9.figshare.29615217", "doi": "10.6084/m9.figshare.29615217", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4488, "title": "Psilocybin-Assisted Therapy for Trauma-Related Disorders: A Scoping Review of a Depression-Dominated Evidence Base with Implications for Intimate Partner Violence-Related PTSD", "authors": "Hancock, Mackenzie, Shambhu Prasad Adhikari, Getz, Nicole", "journal": "Open Science Framework", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.17605/osf.io/ar2s4", "pubmed_id": null, "openalex_id": "https://openalex.org/W7106330185", "source_url": "https://doi.org/10.17605/osf.io/ar2s4", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.17605/osf.io/ar2s4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17605/osf.io/ar2s4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17605/osf.io/ar2s4", "source_url": "https://doi.org/10.17605/osf.io/ar2s4", "doi": "10.17605/osf.io/ar2s4", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4484, "title": "Alternative therapy for neurological and psychiatric disorders using psilocybin", "authors": "Henrique Tofoli Vieira Machado, GEOVANA MENDES DE SEIXAS, L. Silva, Mariana Duarte Garcia Brito, Gabriella Assink de Castro", "journal": null, "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.5327/1516-3180.cpn.1123", "pubmed_id": null, "openalex_id": "https://openalex.org/W4417514861", "source_url": "https://doi.org/10.5327/1516-3180.cpn.1123", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Chronic Pain,Mechanism of Action,Wellbeing,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.5327/1516-3180.cpn.1123", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5327/1516-3180.cpn.1123", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5327/1516-3180.cpn.1123", "source_url": "https://doi.org/10.5327/1516-3180.cpn.1123", "doi": "10.5327/1516-3180.cpn.1123", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4477, "title": "Neurotoxic and Neuroprotective Effects of Psychedelics in a Human Neuroblastoma Cell Model", "authors": "Andreia Machado Brito da Costa, Ricardo Jorge Dinis-Oliveira, Áurea Madureira-Carvalho, Diana Dias-da-Silva", "journal": "RevSALUS - Revista Científica da Rede Académica das Ciências da Saúde da Lusofonia", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.51126/revsalus.v7isup.1031", "pubmed_id": null, "openalex_id": "https://openalex.org/W4411369954", "source_url": "https://doi.org/10.51126/revsalus.v7isup.1031", "substance_tags": "psilocybin,psilocin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Mitochondrial Function,In Vitro Study,Safety,Toxicity", "study_type": "In Vitro Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.51126/revsalus.v7isup.1031", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.51126/revsalus.v7isup.1031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.51126/revsalus.v7isup.1031", "source_url": "https://doi.org/10.51126/revsalus.v7isup.1031", "doi": "10.51126/revsalus.v7isup.1031", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3687, "title": "Psilocybin Therapy for Depression and Anxiety in Parkinson's Disease: a Pilot Study", "authors": "Joshua Woolley, MD, PhD", "journal": "ClinicalTrials.gov", "publication_date": "2024-12-31", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04932434", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Safety,Adverse Events", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04932434", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04932434", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04932434", "source_url": "https://clinicaltrials.gov/study/NCT04932434", "doi": "", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 902, "title": "Single-Dose Psilocybin for Depression With Severe Treatment Resistance: An Open-Label Trial", "authors": "Scott T. Aaronson, Andrew van der Vaart, Tammy Miller, Jeffrey LaPratt, Kimberly Swartz, Audrey Shoultz, Margo Lauterbach, Trisha Suppes, Harold A. Sackeïm", "journal": "American Journal of Psychiatry", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1176/appi.ajp.20231063", "pubmed_id": "39741440", "openalex_id": "https://openalex.org/W4405955624", "source_url": "https://doi.org/10.1176/appi.ajp.20231063", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Clinical Trial,Treatment-Resistant Depression,Safety,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39741440", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.20231063", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39741440", "source_url": "https://doi.org/10.1176/appi.ajp.20231063", "doi": "10.1176/appi.ajp.20231063", "pmid": "39741440", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 900, "title": "Multidimensional Personality Changes Following Psilocybin-Assisted Therapy in Patients With Alcohol Use Disorder: Results From a Double-Blind, Placebo-Controlled Clinical Trial", "authors": "Broc A. Pagni, Richard J. Zeifman, Sarah E. Mennenga, Brennan M. Carrithers, Noam Goldway, Snehal Bhatt, Kelley C. O’Donnell, Stephen Ross, Michael P. Bogenschutz", "journal": "American Journal of Psychiatry", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1176/appi.ajp.20230887", "pubmed_id": "39741446", "openalex_id": "https://openalex.org/W4405955644", "source_url": "https://doi.org/10.1176/appi.ajp.20230887", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Personality Change,Clinical Trial,Randomized Controlled Trial,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39741446", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.20230887", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39741446", "source_url": "https://doi.org/10.1176/appi.ajp.20230887", "doi": "10.1176/appi.ajp.20230887", "pmid": "39741446", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 899, "title": "Exploring Psychedelics Pharmacology: A Scoping Review Charting the Course of Psilocybin Pharmacokinetics.", "authors": "Manzano-Nunez R, Gomez DA, Toledo-Mendoza C, Perez-Otero M, Matilla IL, Prats C, Perez-Lopez E, Pardo H, Díaz-Pellicer P, De La Torre-Fornell R, Aldea AM.", "journal": null, "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1097/wnf.0000000000000617", "pubmed_id": "39787428", "openalex_id": null, "source_url": "https://doi.org/10.1097/wnf.0000000000000617", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,End-of-Life Distress,Pharmacology,Clinical Trial,Review Article,Healthy Volunteers,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39787428", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/wnf.0000000000000617", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39787428", "source_url": "https://doi.org/10.1097/wnf.0000000000000617", "doi": "10.1097/wnf.0000000000000617", "pmid": "39787428", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 898, "title": "Psilocybin-Assisted Group Psychotherapy + Mindfulness Based Stress Reduction (MBSR) for Frontline Healthcare Provider COVID-19 Related Depression and Burnout: A Randomized Clinical Trial", "authors": "Lewis BR, Hendrick J, Byrne K, Odette M, Wu C, Garland EL.", "journal": "medRxiv", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1101/2024.12.31.24319806", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.12.31.24319806", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Observational Study,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2024.12.31.24319806", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.12.31.24319806", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2024.12.31.24319806", "source_url": "https://doi.org/10.1101/2024.12.31.24319806", "doi": "10.1101/2024.12.31.24319806", "pmid": "", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 875, "title": "\"\" A Qualitative Analysis of Patient Perspectives on Psychedelic-Assisted Therapy for Cancer-Related Psychosocial Symptoms.", "authors": "D M Schuman H, Barkova S, Mina R, Deleemans JM, Nguyen T, Carlson LE", "journal": "Integrative cancer therapies", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1177/15347354251370982", "pubmed_id": "41013977", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/41013977/", "substance_tags": "psilocybin", "topic_tags": "Emotional Processing,Spirituality,Observational Study,Cancer Patients,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:20:36", "bibtex": null, "source_record_id": "PMID:41013977", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/41013977/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:41013977", "source_url": "https://pubmed.ncbi.nlm.nih.gov/41013977/", "doi": "10.1177/15347354251370982", "pmid": "41013977", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 597, "title": "Psychedelic Treatment with Psilocybin: Addressing Medical Malpractice Risk and Physicians’ Concerns", "authors": "Katherine Cheung, Maxwell Brodie, Sue-Ling Chang, P. Deschamps, Jean-Sébastien Fallu, Houman Farzin, Johanne Hébert, Jean-François Stephan, Michel Dorval, Yann Joly, for the P3A Study Group", "journal": "The Journal of Law Medicine & Ethics", "publication_date": "2024-12-31", "publication_year": 2024, "doi": "10.1017/jme.2025.10109", "pubmed_id": "40739983", "openalex_id": "https://openalex.org/W4412810429", "source_url": "https://doi.org/10.1017/jme.2025.10109", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:40739983", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/jme.2025.10109", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40739983", "source_url": "https://doi.org/10.1017/jme.2025.10109", "doi": "10.1017/jme.2025.10109", "pmid": "40739983", "publication_date": "2024-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4505, "title": "Psychedelic-Assisted Therapy: The Emerging Role of the Psychiatric-Mental Health Nurse", "authors": "Khalaud Naseeb Alhajry, Zahra Mohammed Sukairi, Hamidah Abdullah Lajami, Safiah Anber Bin Ali Ibrahim, Nawal Obaid Alanazi, Eman Ali Alsafwani, Ashwag Saad Hnif Albishi, Nada Naser Alomi, Zahrh Ahmed Ali Al-Hamadah, Anwar Mehdaf Akash Alrowaly", "journal": "Saudi Journal of Medicine and Public Health", "publication_date": "2024-12-30", "publication_year": 2024, "doi": "10.64483/20251153", "pubmed_id": null, "openalex_id": "https://openalex.org/W7104738164", "source_url": "https://doi.org/10.64483/20251153", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.64483/20251153", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.64483/20251153", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.64483/20251153", "source_url": "https://doi.org/10.64483/20251153", "doi": "10.64483/20251153", "pmid": "", "publication_date": "2024-12-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 921, "title": "Exploring the neurobiological correlates of psilocybin-assisted psychotherapy in eating disorders: a review of potential methodologies and implications for the psychedelic study design.", "authors": "Koning E, Chaves C, Kirkpatrick RH, Brietzke E.", "journal": null, "publication_date": "2024-12-26", "publication_year": 2024, "doi": "10.1186/s40337-024-01185-8", "pubmed_id": "39731144", "openalex_id": null, "source_url": "https://doi.org/10.1186/s40337-024-01185-8", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Neuroplasticity,Brain Imaging,Mechanism of Action,Biomarkers,Aging,Emotional Processing,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39731144", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1186/s40337-024-01185-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39731144", "source_url": "https://doi.org/10.1186/s40337-024-01185-8", "doi": "10.1186/s40337-024-01185-8", "pmid": "39731144", "publication_date": "2024-12-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 833, "title": "Efficacy and safety of psilocybin in the treatment of Major Depressive Disorder (MDD): A dose-response network meta-analysis of randomized placebo-controlled clinical trials.", "authors": "Swieczkowski D, Kwaśny A, Pruc M, Gaca Z, Szarpak L, Cubała WJ.", "journal": null, "publication_date": "2024-12-22", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.116337", "pubmed_id": "39754904", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2024.116337", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39754904", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2024.116337", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39754904", "source_url": "https://doi.org/10.1016/j.psychres.2024.116337", "doi": "10.1016/j.psychres.2024.116337", "pmid": "39754904", "publication_date": "2024-12-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 723, "title": "ALSUntangled #77: Psilocybin.", "authors": "Bakshi B, Yerraguntla S, Armon C, Barkhaus P, Bertorini T, Bowser R, Breevoort S, Bromberg M, Brown A, Carter GT, Chang V, Crayle J, Fullam T, Greene M, Heiman-Patterson T, Jackson C, Jhooty S, Mallon E, Cadavid JM, Mcdermott CJ, Pattee G, Pierce K, Ratner D, Sun Y, Wang O, Wicks P, Wiedau M, Bedlack R.", "journal": null, "publication_date": "2024-12-21", "publication_year": 2024, "doi": "10.1080/21678421.2024.2441274", "pubmed_id": "39709547", "openalex_id": null, "source_url": "https://doi.org/10.1080/21678421.2024.2441274", "substance_tags": "psilocybin", "topic_tags": "Neurogenesis,Mechanism of Action,Review Article,Case Report,Safety,Adverse Events,Inflammation", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39709547", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/21678421.2024.2441274", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39709547", "source_url": "https://doi.org/10.1080/21678421.2024.2441274", "doi": "10.1080/21678421.2024.2441274", "pmid": "39709547", "publication_date": "2024-12-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 835, "title": "Therapeutic Potential of MDMA- and Psychedelic-Assisted Psychotherapy for Adolescent Depression and Trauma.", "authors": "Geller J, Whitney E.", "journal": null, "publication_date": "2024-12-18", "publication_year": 2024, "doi": "10.1007/s11920-024-01577-2", "pubmed_id": "39699759", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11920-024-01577-2", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Aging,Clinical Trial,Review Article,Adolescents,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39699759", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11920-024-01577-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39699759", "source_url": "https://doi.org/10.1007/s11920-024-01577-2", "doi": "10.1007/s11920-024-01577-2", "pmid": "39699759", "publication_date": "2024-12-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 757, "title": "A Rapid Review of Psychedelic-Assisted Therapy in the Context of Palliative Care.", "authors": "Miller M, Meyers M, Martin A, Napolitano S, Dorsen C, Penn A, Rosa WE.", "journal": null, "publication_date": "2024-12-18", "publication_year": 2024, "doi": "10.1097/njh.0000000000001096", "pubmed_id": "39699865", "openalex_id": null, "source_url": "https://doi.org/10.1097/njh.0000000000001096", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Spirituality,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39699865", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/njh.0000000000001096", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39699865", "source_url": "https://doi.org/10.1097/njh.0000000000001096", "doi": "10.1097/njh.0000000000001096", "pmid": "39699865", "publication_date": "2024-12-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 637, "title": "Psychedelic Therapeutics for Adolescents: Ethics, Safety, Opportunities, and Equipoise.", "authors": "Croarkin PE, Sutherland I, Ho MF.", "journal": null, "publication_date": "2024-12-18", "publication_year": 2024, "doi": "10.1016/j.jaac.2024.12.003", "pubmed_id": "39709009", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jaac.2024.12.003", "substance_tags": "psilocybin", "topic_tags": "Adolescents,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39709009", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jaac.2024.12.003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39709009", "source_url": "https://doi.org/10.1016/j.jaac.2024.12.003", "doi": "10.1016/j.jaac.2024.12.003", "pmid": "39709009", "publication_date": "2024-12-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 834, "title": "Exploring the role of psychedelic-assisted therapy in enhancing spirituality and mystical experiences in patients with life-threatening illnesses: A systematic review.", "authors": "Ferreira AE, Reis-Pina P.", "journal": null, "publication_date": "2024-12-16", "publication_year": 2024, "doi": "10.1016/j.jpsychores.2024.112020", "pubmed_id": "39705901", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jpsychores.2024.112020", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Mechanism of Action,Wellbeing,Spirituality,Mystical Experience,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39705901", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jpsychores.2024.112020", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39705901", "source_url": "https://doi.org/10.1016/j.jpsychores.2024.112020", "doi": "10.1016/j.jpsychores.2024.112020", "pmid": "39705901", "publication_date": "2024-12-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4508, "title": "Disentangling debate about therapeutic and recreational use of psychedelics", "authors": "Christina M. Andrews, Wayne Hall, Keith Humphreys, John Marsden", "journal": "Addiction", "publication_date": "2024-12-14", "publication_year": 2024, "doi": "10.1111/add.16744", "pubmed_id": "39676069", "openalex_id": "https://openalex.org/W4405412696", "source_url": "https://doi.org/10.1111/add.16744", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39676069", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.16744", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39676069", "source_url": "https://doi.org/10.1111/add.16744", "doi": "10.1111/add.16744", "pmid": "39676069", "publication_date": "2024-12-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 837, "title": "The safety of psilocybin-assisted psychotherapy: A systematic review.", "authors": "Freitas RR, Gotsis ES, Gallo AT, Fitzgibbon BM, Bailey NW, Fitzgerald PB.", "journal": null, "publication_date": "2024-12-12", "publication_year": 2024, "doi": "10.1177/00048674241289024", "pubmed_id": "39670342", "openalex_id": null, "source_url": "https://doi.org/10.1177/00048674241289024", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39670342", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/00048674241289024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39670342", "source_url": "https://doi.org/10.1177/00048674241289024", "doi": "10.1177/00048674241289024", "pmid": "39670342", "publication_date": "2024-12-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4510, "title": "Chronic pain education: past, present, and future of psychedelics for the management of chronic pain", "authors": "Christopher L. Robinson, Pawan Solanki, S Snyder, Adam Amir, Antje M. Barreveld, Rory Vu Mather, Ivo H. Cerda, Michael Motoc, Harman Chopra, R. Jason Yong, Joel Castellanos, Timothy Furnish, Alan D. Kaye, Vwaire Orhurhu, Trent Emerick", "journal": "Pain Medicine", "publication_date": "2024-12-09", "publication_year": 2024, "doi": "10.1093/pm/pnae124", "pubmed_id": "39658247", "openalex_id": "https://openalex.org/W4405231848", "source_url": "https://doi.org/10.1093/pm/pnae124", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Neuroplasticity,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Microdosing,Spirituality,Review Article,Animal Study,Healthcare Workers,Safety,Adverse Events,Drug Interactions,Inflammation", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:41", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39658247", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/pm/pnae124", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39658247", "source_url": "https://doi.org/10.1093/pm/pnae124", "doi": "10.1093/pm/pnae124", "pmid": "39658247", "publication_date": "2024-12-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 942, "title": "The revival of psilocybin between scientific excitement, evidence of efficacy, and real-world challenges.", "authors": "Scala M, Fabbri C, Fusar-Poli P, Di Lorenzo G, Ferrara M, Amerio A, Fusar-Poli L, Pichiecchio A, Asteggiano C, Menchetti M, De Ronchi D, MNESYS - Mood and Psychosis Sub-Project (Spoke 5), Fanelli G, Serretti A.", "journal": null, "publication_date": "2024-12-09", "publication_year": 2024, "doi": "10.1017/s1092852924002268", "pubmed_id": "39655426", "openalex_id": null, "source_url": "https://doi.org/10.1017/s1092852924002268", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39655426", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/s1092852924002268", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39655426", "source_url": "https://doi.org/10.1017/s1092852924002268", "doi": "10.1017/s1092852924002268", "pmid": "39655426", "publication_date": "2024-12-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 368, "title": "Psychedelics as an intervention for psychological, existential distress in terminally ill patients: A systematic review and network meta-analysis.", "authors": "Marchi M, Farina R, Rachedi K, Laonigro F, Žuljević MF, Pingani L, Ferrari S, Somers M, Boks MPM, Galeazzi GM.", "journal": null, "publication_date": "2024-12-09", "publication_year": 2024, "doi": "10.1177/02698811241303594", "pubmed_id": "39655749", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811241303594", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Spirituality,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39655749", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811241303594", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39655749", "source_url": "https://doi.org/10.1177/02698811241303594", "doi": "10.1177/02698811241303594", "pmid": "39655749", "publication_date": "2024-12-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 908, "title": "Quality of reporting on psychological interventions in psychedelic treatments: a systematic review.", "authors": "Seybert C, Schimmers N, Silva L, Breeksema JJ, Veraart J, Bessa BS, d'Orsi D, Schoevers RA, Oliveira-Maia AJ.", "journal": null, "publication_date": "2024-12-08", "publication_year": 2024, "doi": "10.1016/s2215-0366(24)00333-x", "pubmed_id": "39667373", "openalex_id": null, "source_url": "https://doi.org/10.1016/s2215-0366(24)00333-x", "substance_tags": "psilocybin", "topic_tags": "Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39667373", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/s2215-0366(24)00333-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39667373", "source_url": "https://doi.org/10.1016/s2215-0366(24)00333-x", "doi": "10.1016/s2215-0366(24)00333-x", "pmid": "39667373", "publication_date": "2024-12-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 928, "title": "Psilocybin-assisted psychotherapy for methamphetamine dependence: a case report involving daily methamphetamine use", "authors": "Jonathan Brett, Elizabeth Knock, Kathy Watson, Steven M. Albert, Krista J. Siefried, Jeffrey Guss", "journal": "Frontiers in Psychiatry", "publication_date": "2024-12-05", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1490907", "pubmed_id": "39713770", "openalex_id": "https://openalex.org/W4405122998", "source_url": "https://doi.org/10.3389/fpsyt.2024.1490907", "substance_tags": "psilocybin", "topic_tags": "Addiction,Pharmacology,Receptor Pharmacology,Aging,Emotional Processing,Clinical Trial,Case Report,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39713770", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1490907", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39713770", "source_url": "https://doi.org/10.3389/fpsyt.2024.1490907", "doi": "10.3389/fpsyt.2024.1490907", "pmid": "39713770", "publication_date": "2024-12-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3689, "title": "Efficacy and Safety of COMP360 Psilocybin Therapy in Anorexia Nervosa: a Proof-of-concept Study", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2024-12-03", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05481736", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05481736", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05481736", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05481736", "source_url": "https://clinicaltrials.gov/study/NCT05481736", "doi": "", "pmid": "", "publication_date": "2024-12-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 932, "title": "Synergistic, multi-level understanding of psychedelics: three systematic reviews and meta-analyses of their pharmacology, neuroimaging and phenomenology.", "authors": "Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML.", "journal": null, "publication_date": "2024-12-03", "publication_year": 2024, "doi": "10.1038/s41398-024-03187-1", "pubmed_id": "39632810", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41398-024-03187-1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Brain Imaging,Pharmacology,Receptor Pharmacology,Consciousness,Aging,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39632810", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41398-024-03187-1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39632810", "source_url": "https://doi.org/10.1038/s41398-024-03187-1", "doi": "10.1038/s41398-024-03187-1", "pmid": "39632810", "publication_date": "2024-12-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 931, "title": "Comparative antidepressant effects and safety of intravenous racemic ketamine, psilocybin and theta burst stimulation for major depressive disorder: A systematic review and network meta-analyses of randomized controlled trials.", "authors": "Terao I, Kodama W.", "journal": null, "publication_date": "2024-12-03", "publication_year": 2024, "doi": "10.1002/pcn5.70042", "pubmed_id": "39641126", "openalex_id": null, "source_url": "https://doi.org/10.1002/pcn5.70042", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39641126", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/pcn5.70042", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39641126", "source_url": "https://doi.org/10.1002/pcn5.70042", "doi": "10.1002/pcn5.70042", "pmid": "39641126", "publication_date": "2024-12-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 915, "title": "Therapeutic Potential of Psychedelic Drugs: Navigating High Hopes, Strong Claims, Weak Evidence, and Big Money.", "authors": "Humphreys K, Todd Korthuis P, Stjepanović D, Hall W.", "journal": null, "publication_date": "2024-12-02", "publication_year": 2024, "doi": "10.1146/annurev-psych-020124-023532", "pubmed_id": "39094057", "openalex_id": null, "source_url": "https://doi.org/10.1146/annurev-psych-020124-023532", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39094057", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1146/annurev-psych-020124-023532", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39094057", "source_url": "https://doi.org/10.1146/annurev-psych-020124-023532", "doi": "10.1146/annurev-psych-020124-023532", "pmid": "39094057", "publication_date": "2024-12-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 724, "title": "Randomized Controlled Trials of Psilocybin-Assisted Therapy in the Treatment of Major Depressive Disorder: Systematic Review and Meta-Analysis.", "authors": "Menon V, Ramamurthy P, Venu S, Andrade C.", "journal": null, "publication_date": "2024-12-02", "publication_year": 2024, "doi": "10.1111/acps.13778", "pubmed_id": "39627679", "openalex_id": null, "source_url": "https://doi.org/10.1111/acps.13778", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39627679", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/acps.13778", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39627679", "source_url": "https://doi.org/10.1111/acps.13778", "doi": "10.1111/acps.13778", "pmid": "39627679", "publication_date": "2024-12-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5701, "title": "Psilocybin Microdosing for Anxiety Relief in Young Adults: A Comparative Review of Emerging Evidence", "authors": "Shabir Kanwal", "journal": "Premier Journal of Science", "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.70389/pjs.100036", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.70389/pjs.100036", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Aging,Microdosing,Wellbeing,Resilience,Emotional Processing,Review Article,Safety", "study_type": "Review Article", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-07-11 19:28:11", "bibtex": null, "source_record_id": "DOI:10.70389/pjs.100036", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.70389/pjs.100036", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.70389/pjs.100036", "source_url": "https://doi.org/10.70389/pjs.100036", "doi": "10.70389/pjs.100036", "pmid": "", "publication_date": "2024-12-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 933, "title": "Protective Behavioral Strategies for Psychedelic Use: A Mini Review of the Evidence.", "authors": "Piercey CJ, Gray B, Sung A, Henry D, Karoly HC.", "journal": null, "publication_date": "2024-12-01", "publication_year": 2024, "doi": "10.1089/psymed.2023.0052", "pubmed_id": "40051484", "openalex_id": null, "source_url": "https://doi.org/10.1089/psymed.2023.0052", "substance_tags": "psilocybin", "topic_tags": "Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:40051484", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0052", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40051484", "source_url": "https://doi.org/10.1089/psymed.2023.0052", "doi": "10.1089/psymed.2023.0052", "pmid": "40051484", "publication_date": "2024-12-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4515, "title": "Exploring Therapeutic Potentials and Pathways of Psychedelics in Alzheimer’s Disease-Related Dementia", "authors": "Jitendra Kumar Sinha, Shampa Ghosh, Krishna Kumar Singh, M. P. Singh, Manchala Raghunath", "journal": "Alzheimer s & Dementia", "publication_date": "2024-11-30", "publication_year": 2024, "doi": "10.1002/alz.084413", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406224088", "source_url": "https://doi.org/10.1002/alz.084413", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Spirituality,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1002/alz.084413", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/alz.084413", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/alz.084413", "source_url": "https://doi.org/10.1002/alz.084413", "doi": "10.1002/alz.084413", "pmid": "", "publication_date": "2024-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 951, "title": "Adverse Events in Studies of Classic Psychedelics: A Systematic Review and Meta-Analysis.", "authors": "Hinkle JT, Graziosi M, Nayak SM, Yaden DB.", "journal": null, "publication_date": "2024-11-30", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2024.2546", "pubmed_id": "39230883", "openalex_id": null, "source_url": "https://doi.org/10.1001/jamapsychiatry.2024.2546", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Meta-Analysis,Systematic Review,Review Article,Healthy Volunteers,Safety,Adverse Events", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39230883", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2024.2546", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39230883", "source_url": "https://doi.org/10.1001/jamapsychiatry.2024.2546", "doi": "10.1001/jamapsychiatry.2024.2546", "pmid": "39230883", "publication_date": "2024-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 941, "title": "Psilocybin and hallucinogenic mushrooms.", "authors": "Fradet M, Kelly CM, Donnelly AJ, Suppes T.", "journal": null, "publication_date": "2024-11-30", "publication_year": 2024, "doi": "10.1017/s1092852924002487", "pubmed_id": "39789676", "openalex_id": null, "source_url": "https://doi.org/10.1017/s1092852924002487", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Aging,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39789676", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/s1092852924002487", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39789676", "source_url": "https://doi.org/10.1017/s1092852924002487", "doi": "10.1017/s1092852924002487", "pmid": "39789676", "publication_date": "2024-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 838, "title": "Effects of psychoplastogens on blood levels of brain-derived neurotrophic factor (BDNF) in humans: a systematic review and meta-analysis.", "authors": "Calder AE, Hase A, Hasler G.", "journal": null, "publication_date": "2024-11-28", "publication_year": 2024, "doi": "10.1038/s41380-024-02830-z", "pubmed_id": "39613915", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41380-024-02830-z", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Brain Imaging,Biomarkers,Aging,Meta-Analysis,Systematic Review,Review Article,Animal Study,Safety", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:39613915", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41380-024-02830-z", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39613915", "source_url": "https://doi.org/10.1038/s41380-024-02830-z", "doi": "10.1038/s41380-024-02830-z", "pmid": "39613915", "publication_date": "2024-11-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3157, "title": "Synergistic Behavioral and Neuroplastic Effects of Psilocybin-NMDAR Modulator Administration", "authors": "Ben-Tal T, Pogodin I, Botvinnik A, Lifschytz T, Heresco-Levy U, Lerer B.", "journal": "bioRxiv", "publication_date": "2024-11-27", "publication_year": 2024, "doi": "10.1101/2024.11.28.625811", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.11.28.625811", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2024.11.28.625811", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.11.28.625811", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.11.28.625811", "source_url": "https://doi.org/10.1101/2024.11.28.625811", "doi": "10.1101/2024.11.28.625811", "pmid": "", "publication_date": "2024-11-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 811, "title": "Reconsidering evidence for psychedelic-induced psychosis: an overview of reviews, a systematic review, and meta-analysis of human studies.", "authors": "Sabé M, Sulstarova A, Glangetas A, De Pieri M, Mallet L, Curtis L, Richard-Lepouriel H, Penzenstadler L, Seragnoli F, Thorens G, Zullino D, Preller K, Böge K, Leucht S, Correll CU, Solmi M, Kaiser S, Kirschner M.", "journal": null, "publication_date": "2024-11-26", "publication_year": 2024, "doi": "10.1038/s41380-024-02800-5", "pubmed_id": "39592825", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41380-024-02800-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39592825", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41380-024-02800-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39592825", "source_url": "https://doi.org/10.1038/s41380-024-02800-5", "doi": "10.1038/s41380-024-02800-5", "pmid": "39592825", "publication_date": "2024-11-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 795, "title": "Participants’ Experience of Psychedelic Integration Groups and Processes: A Qualitative Thematic Analysis", "authors": "Nadav Liam Modlin, Tyler McPhee, Nira Zazon, Maria Sarang, Rebecca Hignett, Susannah Pick, Anthony J. Cleare, Victoria Williamson, James Rucker", "journal": "Psychedelic Medicine", "publication_date": "2024-11-25", "publication_year": 2024, "doi": "10.1089/psymed.2024.0027", "pubmed_id": "40337755", "openalex_id": "https://openalex.org/W4404743266", "source_url": "https://doi.org/10.1089/psymed.2024.0027", "substance_tags": "psilocybin", "topic_tags": "Aging,Clinical Trial,Observational Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:40337755", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2024.0027", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40337755", "source_url": "https://doi.org/10.1089/psymed.2024.0027", "doi": "10.1089/psymed.2024.0027", "pmid": "40337755", "publication_date": "2024-11-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4520, "title": "Pattern of psychedelic substance use: a comparison between populations in Spain and South America using the Psychedelic Use Scale (PUS)", "authors": "Jaime Rojas-Hernández, Lucas F. Borkel, Domingo Jesús Quintana Hernández, Ángelo Santana del Pino, Luis Alberto Henríquez-Hernández", "journal": "Current Psychology", "publication_date": "2024-11-20", "publication_year": 2024, "doi": "10.1007/s12144-024-07017-x", "pubmed_id": null, "openalex_id": "https://openalex.org/W4404599367", "source_url": "https://doi.org/10.1007/s12144-024-07017-x", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.1007/s12144-024-07017-x", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s12144-024-07017-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s12144-024-07017-x", "source_url": "https://doi.org/10.1007/s12144-024-07017-x", "doi": "10.1007/s12144-024-07017-x", "pmid": "", "publication_date": "2024-11-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 955, "title": "Strategies for resolving challenging psychedelic experiences: insights from a mixed-methods study", "authors": "Maximillian J. Wood, Rosalind McAlpine, Sunjeev K. Kamboj", "journal": "Scientific Reports", "publication_date": "2024-11-20", "publication_year": 2024, "doi": "10.1038/s41598-024-79931-w", "pubmed_id": "39572645", "openalex_id": "https://openalex.org/W4404604989", "source_url": "https://doi.org/10.1038/s41598-024-79931-w", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Emotional Processing,Observational Study,Safety,Drug Interactions", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39572645", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-024-79931-w", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39572645", "source_url": "https://doi.org/10.1038/s41598-024-79931-w", "doi": "10.1038/s41598-024-79931-w", "pmid": "39572645", "publication_date": "2024-11-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3512, "title": "A Phase 2a Safety and Feasibility Study Evaluating Psilocybin (TRP-8802) Administration in Concert With Psychotherapy in the Treatment of Binge Eating Disorder", "authors": "TRYP Therapeutics", "journal": "ClinicalTrials.gov", "publication_date": "2024-11-18", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05035927", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Pharmacology,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05035927", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05035927", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05035927", "source_url": "https://clinicaltrials.gov/study/NCT05035927", "doi": "", "pmid": "", "publication_date": "2024-11-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 794, "title": "Psilocybin-Assisted Psychotherapy for Treatment-Resistant Depression in Bipolar II Disorder", "authors": "Shakila Meshkat, Erica Kaczmarek, Zoe Doyle, Ryan M. Brudner, Fabiano A. Gomes, Marc G. Blainey, Geneva Weiglein, Roger S McIntyre, Rodrigo B. Mansur, Joshua D. Rosenblat", "journal": "Psychedelic Medicine", "publication_date": "2024-11-17", "publication_year": 2024, "doi": "10.1089/psymed.2024.0032", "pubmed_id": "40337756", "openalex_id": "https://openalex.org/W4404460385", "source_url": "https://doi.org/10.1089/psymed.2024.0032", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:40337756", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2024.0032", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40337756", "source_url": "https://doi.org/10.1089/psymed.2024.0032", "doi": "10.1089/psymed.2024.0032", "pmid": "40337756", "publication_date": "2024-11-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 958, "title": "Knowledge, attitudes, and concerns about psilocybin and MDMA as novel therapies among U.S. healthcare professionals", "authors": "Erin Y. Wang, David S. Mathai, Natalie Gukasyan, Sandeep M. Nayak, Albert Garcia-Romeu", "journal": "Scientific Reports", "publication_date": "2024-11-13", "publication_year": 2024, "doi": "10.1038/s41598-024-78736-1", "pubmed_id": "39543323", "openalex_id": "https://openalex.org/W4404374254", "source_url": "https://doi.org/10.1038/s41598-024-78736-1", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Observational Study,Safety,Contraindications", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39543323", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-024-78736-1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39543323", "source_url": "https://doi.org/10.1038/s41598-024-78736-1", "doi": "10.1038/s41598-024-78736-1", "pmid": "39543323", "publication_date": "2024-11-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 910, "title": "Associations between psychedelic use and cannabis use disorder in a nationally representative sample.", "authors": "Zech JM, Yaden DB, Jones GM.", "journal": null, "publication_date": "2024-11-13", "publication_year": 2024, "doi": "10.1016/j.drugalcdep.2024.112502", "pubmed_id": "39586127", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.drugalcdep.2024.112502", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Adolescents,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39586127", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.drugalcdep.2024.112502", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39586127", "source_url": "https://doi.org/10.1016/j.drugalcdep.2024.112502", "doi": "10.1016/j.drugalcdep.2024.112502", "pmid": "39586127", "publication_date": "2024-11-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 961, "title": "Prospective Preference Assessment for the Psilocybin for Enhanced Analgesia in Chronic nEuropathic PAIN (PEACE-PAIN) Trial", "authors": "Jiwon Lee, Kaylyssa Philip, Duminda N. Wijeysundera, Hance Clarke, Cheryl Pritlove, Joel Katz, Paul Ritvo, Akash Goel, Muhammad Ishrat Husain, Karim S. Ladha", "journal": "Canadian Journal of Pain", "publication_date": "2024-11-07", "publication_year": 2024, "doi": "10.1080/24740527.2024.2406285", "pubmed_id": "39529994", "openalex_id": "https://openalex.org/W4404189888", "source_url": "https://doi.org/10.1080/24740527.2024.2406285", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Aging,Randomized Controlled Trial,Observational Study,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39529994", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/24740527.2024.2406285", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39529994", "source_url": "https://doi.org/10.1080/24740527.2024.2406285", "doi": "10.1080/24740527.2024.2406285", "pmid": "39529994", "publication_date": "2024-11-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3128, "title": "Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms", "authors": "Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P.", "journal": "PsyArXiv", "publication_date": "2024-11-06", "publication_year": 2024, "doi": "10.31234/osf.io/93x5h", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/93x5h", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Spirituality,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/93x5h", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/93x5h", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/93x5h", "source_url": "https://doi.org/10.31234/osf.io/93x5h", "doi": "10.31234/osf.io/93x5h", "pmid": "", "publication_date": "2024-11-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3127, "title": "Tū Wairua: Development of an Indigenous Rongoā Māori Approach to Healing with Psilocybin Containing Mushrooms", "authors": "Hodge A, Forsyth A, Noorani T, Muthukumaraswamy S, Rolleston A, McHugh P.", "journal": "PsyArXiv", "publication_date": "2024-11-06", "publication_year": 2024, "doi": "10.31234/osf.io/93x5h_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/93x5h_v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Spirituality,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/93x5h_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/93x5h_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/93x5h_v1", "source_url": "https://doi.org/10.31234/osf.io/93x5h_v1", "doi": "10.31234/osf.io/93x5h_v1", "pmid": "", "publication_date": "2024-11-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4524, "title": "Why N,N-dimethyltryptamine matters: unique features and therapeutic potential beyond classical psychedelics", "authors": "Cristiano Chaves, Rafael G. dos Santos, Serdar Dursun, Massimo Tusconi, Mauro Giovanni Carta, Elisa Brietzke, Jaime E. C. Hallak", "journal": "Frontiers in Psychiatry", "publication_date": "2024-11-05", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1485337", "pubmed_id": "39568756", "openalex_id": "https://openalex.org/W4404119543", "source_url": "https://doi.org/10.3389/fpsyt.2024.1485337", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Neurogenesis,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Mitochondrial Function,Oxidative Stress,Emotional Processing,Mystical Experience,Review Article,Observational Study,Animal Study,Healthy Volunteers,Treatment-Resistant Depression,Safety,Toxicity,Drug Interactions,Inflammation,Immune Function", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39568756", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1485337", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39568756", "source_url": "https://doi.org/10.3389/fpsyt.2024.1485337", "doi": "10.3389/fpsyt.2024.1485337", "pmid": "39568756", "publication_date": "2024-11-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3669, "title": "PsilOCD: Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity (A Pharmacological-Challenge Feasibility Study)", "authors": "Imperial College London", "journal": "ClinicalTrials.gov", "publication_date": "2024-11-05", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06258031", "substance_tags": "psilocybin", "topic_tags": "OCD,Neuroplasticity,Brain Imaging,Receptor Pharmacology,Biomarkers,Observational Study,Safety,Inflammation", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06258031", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06258031", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06258031", "source_url": "https://clinicaltrials.gov/study/NCT06258031", "doi": "", "pmid": "", "publication_date": "2024-11-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 912, "title": "Australian psychologists' attitudes towards psychedelic-assisted therapy and training following a world-first drug down-scheduling", "authors": "Jordan J. Negrine, Cheneal Puljević, Jason Ferris, Paul Liknaitzky, Christopher M. Perlman, Timothy Piatkowski", "journal": "Drug and Alcohol Review", "publication_date": "2024-11-04", "publication_year": 2024, "doi": "10.1111/dar.13973", "pubmed_id": "39499579", "openalex_id": "https://openalex.org/W4404059132", "source_url": "https://doi.org/10.1111/dar.13973", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39499579", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/dar.13973", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39499579", "source_url": "https://doi.org/10.1111/dar.13973", "doi": "10.1111/dar.13973", "pmid": "39499579", "publication_date": "2024-11-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 893, "title": "Psilocybin Mushrooms and Public Health in Brazil: Insights from a Retrospective Analysis of Adverse Events and Their Implications for Regulatory Discussions", "authors": "Marcel Nogueira, Solimary García-Hernández, Gleicy Sotéro Roberto, Leonardo Zanella Marques", "journal": "International journal of medicinal mushrooms", "publication_date": "2024-11-04", "publication_year": 2024, "doi": "10.1615/intjmedmushrooms.2024057053", "pubmed_id": "40096533", "openalex_id": "https://openalex.org/W4404063451", "source_url": "https://doi.org/10.1615/intjmedmushrooms.2024057053", "substance_tags": "psilocybin", "topic_tags": "Addiction,Pharmacology,Safety,Adverse Events", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:40096533", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1615/intjmedmushrooms.2024057053", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40096533", "source_url": "https://doi.org/10.1615/intjmedmushrooms.2024057053", "doi": "10.1615/intjmedmushrooms.2024057053", "pmid": "40096533", "publication_date": "2024-11-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3134, "title": "Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trial", "authors": "Aday JS, McAfee J, Conroy DA, Hosanagar A, Tarnal V, Weston C, Scott K, Horowitz D, Harte SE, Pouyan N, Glynos NG, Baker AK, Guss J, Davis AK, Burgess HJ, Mashour GA, Clauw DJ, Boehnke KF.", "journal": "PsyArXiv", "publication_date": "2024-11-03", "publication_year": 2024, "doi": "10.31234/osf.io/j8zb5", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/j8zb5", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/j8zb5", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/j8zb5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/j8zb5", "source_url": "https://doi.org/10.31234/osf.io/j8zb5", "doi": "10.31234/osf.io/j8zb5", "pmid": "", "publication_date": "2024-11-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 776, "title": "Preliminary safety and effectiveness of psilocybin-assisted therapy in adults with fibromyalgia: An open-label, pilot clinical trial", "authors": "", "journal": "PsyArXiv", "publication_date": "2024-11-03", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "source_url": "https://osf.io/preprints/psyarxiv/j8zb5_v1", "doi": "", "pmid": "", "publication_date": "2024-11-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3136, "title": "Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts", "authors": "Luoma JB, Wilson-Poe A, Pertl K, Hoffman K, Bazinet A, Stauffer C, McCarty D, Korthuis P.", "journal": "PsyArXiv", "publication_date": "2024-10-30", "publication_year": 2024, "doi": "10.31234/osf.io/dwhcu_v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/dwhcu_v1", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/dwhcu_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/dwhcu_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/dwhcu_v1", "source_url": "https://doi.org/10.31234/osf.io/dwhcu_v1", "doi": "10.31234/osf.io/dwhcu_v1", "pmid": "", "publication_date": "2024-10-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 551, "title": "Personal Psychedelic Experience as a Training Qualification for Facilitators: A Thematic Analysis of Qualitative Interviews with Psilocybin Experts", "authors": "", "journal": "PsyArXiv", "publication_date": "2024-10-30", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "source_url": "https://osf.io/preprints/psyarxiv/dwhcu_v1", "doi": "", "pmid": "", "publication_date": "2024-10-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3584, "title": "A Registered Clinical Trial of PEX010-Assisted Therapy for Stimulant Use Disorder: A Safety, Feasibility and Efficacy Study", "authors": "Filament Health Corp.", "journal": "ClinicalTrials.gov", "publication_date": "2024-10-29", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06666010", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06666010", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06666010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06666010", "source_url": "https://clinicaltrials.gov/study/NCT06666010", "doi": "", "pmid": "", "publication_date": "2024-10-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 986, "title": "A narrative exploration of psilocybin's potential in mental health.", "authors": "Min H, Park SY, Park J, Na S, Lee HS, Kim T, Ham J, Park YT.", "journal": null, "publication_date": "2024-10-29", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1429373", "pubmed_id": "39540010", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2024.1429373", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:39540010", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1429373", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39540010", "source_url": "https://doi.org/10.3389/fpsyt.2024.1429373", "doi": "10.3389/fpsyt.2024.1429373", "pmid": "39540010", "publication_date": "2024-10-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 988, "title": "Critical appraisal of evidence supporting prescription of psychedelics from clinic websites in Ontario, Canada", "authors": "K S Kim, Abban Yusuf, Abhimanyu Sud, Nav Persaud, Abirami Kirubarajan, Monique Moller, Taryn Lloyd, Braden O’Neill", "journal": "PLoS ONE", "publication_date": "2024-10-23", "publication_year": 2024, "doi": "10.1371/journal.pone.0309911", "pubmed_id": "39446753", "openalex_id": "https://openalex.org/W4403721028", "source_url": "https://doi.org/10.1371/journal.pone.0309911", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Healthcare Workers,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39446753", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0309911", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39446753", "source_url": "https://doi.org/10.1371/journal.pone.0309911", "doi": "10.1371/journal.pone.0309911", "pmid": "39446753", "publication_date": "2024-10-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 865, "title": "Psychedelic-related deaths in England, Wales and Northern Ireland (1997-2022)", "authors": "Emma I Kopra, Jenni Penttinen, James Rucker, Caroline S. Copeland", "journal": "Progress in Neuro-Psychopharmacology and Biological Psychiatry", "publication_date": "2024-10-19", "publication_year": 2024, "doi": "10.1016/j.pnpbp.2024.111177", "pubmed_id": "39437962", "openalex_id": "https://openalex.org/W4403579240", "source_url": "https://doi.org/10.1016/j.pnpbp.2024.111177", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39437962", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2024.111177", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39437962", "source_url": "https://doi.org/10.1016/j.pnpbp.2024.111177", "doi": "10.1016/j.pnpbp.2024.111177", "pmid": "39437962", "publication_date": "2024-10-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 954, "title": "Moving psychedelic-assisted therapies from promising research into routine clinical practice: Lessons from the field of implementation science", "authors": "Danielle R. Adams, Heidi Allen, Ginger E. Nicol, Leopoldo J. Cabassa", "journal": "Translational Behavioral Medicine", "publication_date": "2024-10-16", "publication_year": 2024, "doi": "10.1093/tbm/ibae053", "pubmed_id": "39419768", "openalex_id": "https://openalex.org/W4403502370", "source_url": "https://doi.org/10.1093/tbm/ibae053", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39419768", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/tbm/ibae053", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39419768", "source_url": "https://doi.org/10.1093/tbm/ibae053", "doi": "10.1093/tbm/ibae053", "pmid": "39419768", "publication_date": "2024-10-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4537, "title": "The therapeutic potential and mechanisms of action of psilocybin-assisted therapy in anorexia nervosa treatment", "authors": "Hannah Douglass", "journal": "Open MIND", "publication_date": "2024-10-09", "publication_year": 2024, "doi": "10.25560/118978", "pubmed_id": null, "openalex_id": "https://openalex.org/W7166080670", "source_url": "https://hdl.handle.net/10044/1/118978", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Consciousness,Aging,Resilience,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.25560/118978", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://hdl.handle.net/10044/1/118978", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.25560/118978", "source_url": "https://hdl.handle.net/10044/1/118978", "doi": "10.25560/118978", "pmid": "", "publication_date": "2024-10-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3469, "title": "A Phase 1 Dose Escalation Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of MLS101 (psilocybin) in Healthy Participants", "authors": "MycoMedica Life Sciences PBC", "journal": "ClinicalTrials.gov", "publication_date": "2024-10-08", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06326606", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Microdosing,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06326606", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06326606", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06326606", "source_url": "https://clinicaltrials.gov/study/NCT06326606", "doi": "", "pmid": "", "publication_date": "2024-10-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4542, "title": "Rapid and Prolonged Antidepressant and Antianxiety Effects of Psychedelics and 3,4-Methylenedioxy-methamphetamine-A Systematic Review and Meta-Analysis", "authors": "Dimy Fluyau, Vasanth Kattalai Kailasam, Neelambika Revadigar", "journal": "Psychoactives", "publication_date": "2024-10-03", "publication_year": 2024, "doi": "10.3390/psychoactives3040029", "pubmed_id": null, "openalex_id": "https://openalex.org/W4403113128", "source_url": "https://doi.org/10.3390/psychoactives3040029", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Headache / Migraine,Pharmacology,Aging,Personality Change,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives3040029", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives3040029", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives3040029", "source_url": "https://doi.org/10.3390/psychoactives3040029", "doi": "10.3390/psychoactives3040029", "pmid": "", "publication_date": "2024-10-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 947, "title": "Impact of psilocybin on cognitive function: A systematic review.", "authors": "Meshkat S, Tello-Gerez TJ, Gholaminezhad F, Dunkley BT, Reichelt AC, Erritzoe D, Vermetten E, Zhang Y, Greenshaw A, Burback L, Winkler O, Jetly R, Mayo LM, Bhat V.", "journal": null, "publication_date": "2024-09-30", "publication_year": 2024, "doi": "10.1111/pcn.13741", "pubmed_id": "39354706", "openalex_id": null, "source_url": "https://doi.org/10.1111/pcn.13741", "substance_tags": "psilocybin", "topic_tags": "Depression,Emotional Processing,Creativity,Systematic Review,Review Article,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:39354706", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/pcn.13741", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39354706", "source_url": "https://doi.org/10.1111/pcn.13741", "doi": "10.1111/pcn.13741", "pmid": "39354706", "publication_date": "2024-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1015, "title": "Beyond the numbers: reimagining healing with psychedelics for eating disorders.", "authors": "Lafrance A, Spriggs MJ, Gukasyan N, Peck SK", "journal": "Journal of eating disorders", "publication_date": "2024-09-29", "publication_year": 2024, "doi": "10.1186/s40337-024-01111-y", "pubmed_id": "39350242", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/39350242/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:36", "bibtex": null, "source_record_id": "PMID:39350242", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/39350242/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:39350242", "source_url": "https://pubmed.ncbi.nlm.nih.gov/39350242/", "doi": "10.1186/s40337-024-01111-y", "pmid": "39350242", "publication_date": "2024-09-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 914, "title": "Harnessing Pharmacogenomics in Clinical Research on Psychedelic-Assisted Therapy.", "authors": "Halman A, Conyers R, Moore C, Khatri D, Sarris J, Perkins D.", "journal": null, "publication_date": "2024-09-29", "publication_year": 2024, "doi": "10.1002/cpt.3459", "pubmed_id": "39345195", "openalex_id": null, "source_url": "https://doi.org/10.1002/cpt.3459", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Review Article,Animal Study,Safety,Genomics", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39345195", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/cpt.3459", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39345195", "source_url": "https://doi.org/10.1002/cpt.3459", "doi": "10.1002/cpt.3459", "pmid": "39345195", "publication_date": "2024-09-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3592, "title": "An Open-Label Pilot Study Examining the Feasibility, Safety, and Effectiveness of Psilocybin Therapy for Depression in Bipolar II Disorder", "authors": "University of California, San Francisco", "journal": "ClinicalTrials.gov", "publication_date": "2024-09-24", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05065294", "substance_tags": "psilocybin", "topic_tags": "Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05065294", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05065294", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05065294", "source_url": "https://clinicaltrials.gov/study/NCT05065294", "doi": "", "pmid": "", "publication_date": "2024-09-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1017, "title": "Psilocybin for major depressive disorder: a systematic review of randomized controlled studies.", "authors": "Li LJ, Mo Y, Shi ZM, Huang XB, Ning YP, Wu HW, Yang XH, Zheng W.", "journal": null, "publication_date": "2024-09-22", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1416420", "pubmed_id": "39376971", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2024.1416420", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39376971", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1416420", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39376971", "source_url": "https://doi.org/10.3389/fpsyt.2024.1416420", "doi": "10.3389/fpsyt.2024.1416420", "pmid": "39376971", "publication_date": "2024-09-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 997, "title": "Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial", "authors": "David Erritzøe, Tommaso Barba, Kyle T. Greenway, Roberta Murphy, Jonny Martell, Bruna Giribaldi, Christopher Timmermann, Ashleigh Murphy-Beiner, Michelle Baker Jones, David Nutt, Brandon Weiss, Robin Carhart-Harris", "journal": "EClinicalMedicine", "publication_date": "2024-09-22", "publication_year": 2024, "doi": "10.1016/j.eclinm.2024.102799", "pubmed_id": "39764567", "openalex_id": "https://openalex.org/W4402747955", "source_url": "https://doi.org/10.1016/j.eclinm.2024.102799", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Observational Study,Safety,Contraindications", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39764567", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.eclinm.2024.102799", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39764567", "source_url": "https://doi.org/10.1016/j.eclinm.2024.102799", "doi": "10.1016/j.eclinm.2024.102799", "pmid": "39764567", "publication_date": "2024-09-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 974, "title": "Low-dose psilocybin in short-lasting unilateral neuralgiform headache attacks: results from an open-label phase Ib ascending dose study", "authors": "James Rucker, Matthew Butler, Sadie Hambleton, Catherine Bird, Mathieu Seynaeve, Sanjay Cheema, Kete Campbell-Coker, Carolina Maggio, Fiona Dunbar, Giorgio Lambru, Manjit Matharu", "journal": "Headache The Journal of Head and Face Pain", "publication_date": "2024-09-19", "publication_year": 2024, "doi": "10.1111/head.14837", "pubmed_id": "39301810", "openalex_id": "https://openalex.org/W4402697828", "source_url": "https://doi.org/10.1111/head.14837", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39301810", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/head.14837", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39301810", "source_url": "https://doi.org/10.1111/head.14837", "doi": "10.1111/head.14837", "pmid": "39301810", "publication_date": "2024-09-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3528, "title": "Psilocybin-assisted Psychotherapy in the Treatment of Patients Hospitalized for Treatment-resistant Depression: an Open-label Feasibility Study with an Experiential and Systemic Focus", "authors": "University Hospital, Ghent", "journal": "ClinicalTrials.gov", "publication_date": "2024-09-18", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06378229", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Brain Imaging,Observational Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06378229", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06378229", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06378229", "source_url": "https://clinicaltrials.gov/study/NCT06378229", "doi": "", "pmid": "", "publication_date": "2024-09-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1018, "title": "Psychedelic research at a crossroads.", "authors": "Armstrong SB, Davis AK.", "journal": null, "publication_date": "2024-09-18", "publication_year": 2024, "doi": "10.1126/science.adt1024", "pubmed_id": "39298596", "openalex_id": null, "source_url": "https://doi.org/10.1126/science.adt1024", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Consciousness,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39298596", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1126/science.adt1024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39298596", "source_url": "https://doi.org/10.1126/science.adt1024", "doi": "10.1126/science.adt1024", "pmid": "39298596", "publication_date": "2024-09-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 465, "title": "Going Underground: Demographics, Services, and Best Practices Endorsed by Practitioners Providing Support for Naturalistic Psychedelic Use", "authors": "Nicolas G. Glynos, Anne Baker, Jacob S. Aday, Niloufar Pouyan, Julie Barron, Moss Herberholz, Daniel J. Kruger, Kevin F. Boehnke", "journal": "Journal of Psychoactive Drugs", "publication_date": "2024-09-18", "publication_year": 2024, "doi": "10.1080/02791072.2024.2405685", "pubmed_id": "39297183", "openalex_id": "https://openalex.org/W4402649875", "source_url": "https://doi.org/10.1080/02791072.2024.2405685", "substance_tags": "psilocybin", "topic_tags": "Addiction,Personality Change,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "PMID:39297183", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2024.2405685", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39297183", "source_url": "https://doi.org/10.1080/02791072.2024.2405685", "doi": "10.1080/02791072.2024.2405685", "pmid": "39297183", "publication_date": "2024-09-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3122, "title": "Exploring U.K. cancer doctors’ attitudes toward psilocybin-assisted psychotherapy for cancer-related distress", "authors": "Mageean S, Daniel A, Tai S.", "journal": "Research Square", "publication_date": "2024-09-17", "publication_year": 2024, "doi": "10.21203/rs.3.rs-4862438/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-4862438/v1", "substance_tags": "psilocybin", "topic_tags": "Cancer Patients,Safety,Drug Interactions", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-4862438/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-4862438/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-4862438/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-4862438/v1", "doi": "10.21203/rs.3.rs-4862438/v1", "pmid": "", "publication_date": "2024-09-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4551, "title": "Use of Psilocybin in the Treatment of Mental Disorders: Systematic Review of Clinal Trials", "authors": "Danielle B Rodrigues", "journal": "Journal of Complementary Medicine & Alternative Healthcare", "publication_date": "2024-09-16", "publication_year": 2024, "doi": "10.19080/jcmah.2024.13.555852", "pubmed_id": null, "openalex_id": "https://openalex.org/W4408545862", "source_url": "https://doi.org/10.19080/jcmah.2024.13.555852", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:34", "bibtex": null, "source_record_id": "DOI:10.19080/jcmah.2024.13.555852", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.19080/jcmah.2024.13.555852", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.19080/jcmah.2024.13.555852", "source_url": "https://doi.org/10.19080/jcmah.2024.13.555852", "doi": "10.19080/jcmah.2024.13.555852", "pmid": "", "publication_date": "2024-09-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1020, "title": "Psychedelics as a potential treatment for tobacco use disorder: a systematic review.", "authors": "Spoelstra SK, Schoevers RA, Venema SD, Knegtering H.", "journal": null, "publication_date": "2024-09-16", "publication_year": 2024, "doi": "10.1007/s44192-024-00095-0", "pubmed_id": "39289250", "openalex_id": null, "source_url": "https://doi.org/10.1007/s44192-024-00095-0", "substance_tags": "psilocybin", "topic_tags": "Addiction,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39289250", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s44192-024-00095-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39289250", "source_url": "https://doi.org/10.1007/s44192-024-00095-0", "doi": "10.1007/s44192-024-00095-0", "pmid": "39289250", "publication_date": "2024-09-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 949, "title": "Exploring the regulatory framework of psychedelics in the US & Europe.", "authors": "Behera HK, Joga R, Yerram S, Karnati P, Mergu T, Gandhi K, M S, Nathiya D, Singh RP, Srivastava S, Kumar S.", "journal": null, "publication_date": "2024-09-16", "publication_year": 2024, "doi": "10.1016/j.ajp.2024.104242", "pubmed_id": null, "openalex_id": "https://openalex.org/W39305768", "source_url": "https://doi.org/10.1016/j.ajp.2024.104242", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "DOI:10.1016/j.ajp.2024.104242", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.ajp.2024.104242", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.1016/j.ajp.2024.104242", "source_url": "https://doi.org/10.1016/j.ajp.2024.104242", "doi": "10.1016/j.ajp.2024.104242", "pmid": "", "publication_date": "2024-09-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1025, "title": "Psychedelic-assisted therapy for treating anxiety, depression, and existential distress in people with life-threatening diseases.", "authors": "Schipper S, Nigam K, Schmid Y, Piechotta V, Ljuslin M, Beaussant Y, Schwarzer G, Boehlke C.", "journal": null, "publication_date": "2024-09-11", "publication_year": 2024, "doi": "10.1002/14651858.cd015383.pub2", "pubmed_id": "39260823", "openalex_id": null, "source_url": "https://doi.org/10.1002/14651858.cd015383.pub2", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Headache / Migraine,Emotional Processing,Spirituality,Randomized Controlled Trial,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39260823", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/14651858.cd015383.pub2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39260823", "source_url": "https://doi.org/10.1002/14651858.cd015383.pub2", "doi": "10.1002/14651858.cd015383.pub2", "pmid": "39260823", "publication_date": "2024-09-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 867, "title": "The immunomodulatory effects of classical psychedelics: A systematic review of preclinical studies.", "authors": "Low ZXB, Ng WS, Lim ESY, Goh BH, Kumari Y.", "journal": null, "publication_date": "2024-09-06", "publication_year": 2024, "doi": "10.1016/j.pnpbp.2024.111139", "pubmed_id": "39251080", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2024.111139", "substance_tags": "psilocybin,psilocin", "topic_tags": "Biomarkers,Clinical Trial,Systematic Review,Review Article,Animal Study,In Vitro Study,Safety,Inflammation,Immune Function", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39251080", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2024.111139", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39251080", "source_url": "https://doi.org/10.1016/j.pnpbp.2024.111139", "doi": "10.1016/j.pnpbp.2024.111139", "pmid": "39251080", "publication_date": "2024-09-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 977, "title": "Psychoactive substances for the treatment of neuropsychiatric disorders.", "authors": "Zhen Z, Sun X, Yuan S, Zhang J.", "journal": null, "publication_date": "2024-09-02", "publication_year": 2024, "doi": "10.1016/j.ajp.2024.104193", "pubmed_id": "39243659", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.ajp.2024.104193", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Receptor Pharmacology,Resilience,Emotional Processing,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39243659", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.ajp.2024.104193", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39243659", "source_url": "https://doi.org/10.1016/j.ajp.2024.104193", "doi": "10.1016/j.ajp.2024.104193", "pmid": "39243659", "publication_date": "2024-09-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4560, "title": "G33 Psychedelic drugs for the treatment of chronic pain: is ketamine included?", "authors": "Amany E. Ayad", "journal": null, "publication_date": "2024-08-31", "publication_year": 2024, "doi": "10.1136/rapm-2024-esra.582", "pubmed_id": null, "openalex_id": "https://openalex.org/W4402766768", "source_url": "https://doi.org/10.1136/rapm-2024-esra.582", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Chronic Pain,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Consciousness,Emotional Processing,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1136/rapm-2024-esra.582", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/rapm-2024-esra.582", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1136/rapm-2024-esra.582", "source_url": "https://doi.org/10.1136/rapm-2024-esra.582", "doi": "10.1136/rapm-2024-esra.582", "pmid": "", "publication_date": "2024-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4558, "title": "Rosalind Franklin Society Proudly Announces the 2023 Award Recipient for Psychedelic Medicine", "authors": "Albert Garcia-Romeu", "journal": "Psychedelic Medicine", "publication_date": "2024-08-31", "publication_year": 2024, "doi": "10.1089/psymed.2024.65789.rfs2023", "pubmed_id": null, "openalex_id": "https://openalex.org/W4402269098", "source_url": "https://doi.org/10.1089/psymed.2024.65789.rfs2023", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Consciousness,Wellbeing,Spirituality,Healthy Volunteers,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1089/psymed.2024.65789.rfs2023", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2024.65789.rfs2023", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1089/psymed.2024.65789.rfs2023", "source_url": "https://doi.org/10.1089/psymed.2024.65789.rfs2023", "doi": "10.1089/psymed.2024.65789.rfs2023", "pmid": "", "publication_date": "2024-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1027, "title": "Traditional Medicine, Culture, and Psychedelic Science: New Pathways for Recovery From Substance Use Disorders.", "authors": "Loizaga-Velder A, Loizaga Pazzi A.", "journal": null, "publication_date": "2024-08-31", "publication_year": 2024, "doi": "10.15288/jsad.23-00011", "pubmed_id": "39400118", "openalex_id": null, "source_url": "https://doi.org/10.15288/jsad.23-00011", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Consciousness,Review Article,Observational Study,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39400118", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.15288/jsad.23-00011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39400118", "source_url": "https://doi.org/10.15288/jsad.23-00011", "doi": "10.15288/jsad.23-00011", "pmid": "39400118", "publication_date": "2024-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1026, "title": "Understanding Psychedelic-Assisted Psychotherapy Providers' Perspective and Insights: A Qualitative Analysis.", "authors": "Smith CL, Sackett N, Stark BC, Dinh V, Romesburg EW, Roll J", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2024-08-31", "publication_year": 2024, "doi": "10.1089/psymed.2023.0074", "pubmed_id": "40051684", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051684/", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:36", "bibtex": null, "source_record_id": "PMID:40051684", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40051684/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40051684", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40051684/", "doi": "10.1089/psymed.2023.0074", "pmid": "40051684", "publication_date": "2024-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1029, "title": "Psychedelic-assisted therapy for palliative care within a home treatment setting: A case report", "authors": "Federico Seragnoli, Martignoni Geo, Martignoni Entela, Silke Bachmann, Elisa Rabitti, Silvio Cavuto, Dubus Zoë, Penzenstadler Louise, Gabriel Thorens, Joël Billieux, Zullino Daniele", "journal": "Clinical Case Reports", "publication_date": "2024-08-29", "publication_year": 2024, "doi": "10.1002/ccr3.9305", "pubmed_id": "39219779", "openalex_id": "https://openalex.org/W4402098372", "source_url": "https://doi.org/10.1002/ccr3.9305", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Case Report,Safety", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:39219779", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/ccr3.9305", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39219779", "source_url": "https://doi.org/10.1002/ccr3.9305", "doi": "10.1002/ccr3.9305", "pmid": "39219779", "publication_date": "2024-08-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1030, "title": "[Psychedelic and dissociative agents in psychiatry: challenges in the treatment].", "authors": "Jungwirth J, Bavato F, Quednow BB.", "journal": null, "publication_date": "2024-08-27", "publication_year": 2024, "doi": "10.1007/s00115-024-01727-0", "pubmed_id": "39196383", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00115-024-01727-0", "substance_tags": "psilocybin", "topic_tags": "Depression,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39196383", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00115-024-01727-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39196383", "source_url": "https://doi.org/10.1007/s00115-024-01727-0", "doi": "10.1007/s00115-024-01727-0", "pmid": "39196383", "publication_date": "2024-08-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1003, "title": "The role of psilocybin in depressive disorders.", "authors": "Najib J.", "journal": null, "publication_date": "2024-08-27", "publication_year": 2024, "doi": "10.1080/03007995.2024.2396536", "pubmed_id": "39177339", "openalex_id": null, "source_url": "https://doi.org/10.1080/03007995.2024.2396536", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39177339", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/03007995.2024.2396536", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39177339", "source_url": "https://doi.org/10.1080/03007995.2024.2396536", "doi": "10.1080/03007995.2024.2396536", "pmid": "39177339", "publication_date": "2024-08-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3141, "title": "The phenomenology of psilocybin’s experience mediates subsequent persistent psychological effects independently of sex, previous experience or setting", "authors": "Klučková T, Nikolič M, Tylš F, Viktorin V, Vejmola Č, Viktorinová M, Bravermanová A, Androvičová R, Andrashko V, Korčák J, Zach P, Hájková K, Kuchař M, Balíková M, Brunovský M, Horáček J, Páleníček T.", "journal": "medRxiv", "publication_date": "2024-08-25", "publication_year": 2024, "doi": "10.1101/2024.08.26.24311611", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.08.26.24311611", "substance_tags": "psilocybin,psilocin", "topic_tags": "Anxiety,Brain Imaging,Consciousness,Emotional Processing,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2024.08.26.24311611", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.08.26.24311611", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2024.08.26.24311611", "source_url": "https://doi.org/10.1101/2024.08.26.24311611", "doi": "10.1101/2024.08.26.24311611", "pmid": "", "publication_date": "2024-08-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3075, "title": "­­­­Single-Dose Psilocybin Therapy for Alcohol Use Disorder: Pharmacokinetics, Feasibility, Safety, and Efficacy in an Open-Label Study", "authors": "Jensen ME, Stenbæk DS, Messell CD, Poulsen ED, Varga TV, Fisher PM, Nielsen MKK, Johansen SS, Volkow ND, Knudsen GM, Fink-Jensen A.", "journal": "Research Square", "publication_date": "2024-08-22", "publication_year": 2024, "doi": "10.21203/rs.3.rs-4947184/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-4947184/v1", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Pharmacology,Receptor Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-4947184/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-4947184/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-4947184/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-4947184/v1", "doi": "10.21203/rs.3.rs-4947184/v1", "pmid": "", "publication_date": "2024-08-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4565, "title": "Tripping on Utopia: Margaret Mead, the Cold War, and the troubled birth of psychedelic science By BenjaminBreen. New York: Grand Central Publishing, 2024. 384 pp.", "authors": "Jim Weil", "journal": "American Anthropologist", "publication_date": "2024-08-18", "publication_year": 2024, "doi": "10.1111/aman.28009", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401690921", "source_url": "http://dx.doi.org/10.1111/aman.28009", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Personality Change,Mystical Experience,Observational Study,Veterans,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1111/aman.28009", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1111/aman.28009", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1111/aman.28009", "source_url": "http://dx.doi.org/10.1111/aman.28009", "doi": "10.1111/aman.28009", "pmid": "", "publication_date": "2024-08-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4567, "title": "Psychedelic use and psychological flexibility: The role of meaningful intention and decentering", "authors": "William M. Campo, Ann Marie Yali", "journal": "Journal of Psychedelic Studies", "publication_date": "2024-08-15", "publication_year": 2024, "doi": "10.1556/2054.2024.00350", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401710092", "source_url": "https://doi.org/10.1556/2054.2024.00350", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Wellbeing,Mystical Experience,Psychological Flexibility,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2024.00350", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2024.00350", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2024.00350", "source_url": "https://doi.org/10.1556/2054.2024.00350", "doi": "10.1556/2054.2024.00350", "pmid": "", "publication_date": "2024-08-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3428, "title": "A24-Week, Multicentre, Randomised, Double-Blind, Placebo-Controlled, Parallel-Group, Phase 2 Clinical Trial to Evaluate Efficacy and Safety of Psilocybin-Assisted Psychotherapy in Adults With Alcohol Use Disorder (AUD)", "authors": "Clairvoyant Therapeutics", "journal": "ClinicalTrials.gov", "publication_date": "2024-08-14", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05646303", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05646303", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05646303", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05646303", "source_url": "https://clinicaltrials.gov/study/NCT05646303", "doi": "", "pmid": "", "publication_date": "2024-08-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 842, "title": "A clinical research perspective on the regulation of medical and non-medical use of psychedelic drugs", "authors": "Michael P. Bogenschutz", "journal": "Addiction", "publication_date": "2024-08-11", "publication_year": 2024, "doi": "10.1111/add.16647", "pubmed_id": "39129581", "openalex_id": "https://openalex.org/W4401521492", "source_url": "https://doi.org/10.1111/add.16647", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Chronic Pain,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:39129581", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.16647", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39129581", "source_url": "https://doi.org/10.1111/add.16647", "doi": "10.1111/add.16647", "pmid": "39129581", "publication_date": "2024-08-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3609, "title": "An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD)", "authors": "Sheppard Pratt Health System", "journal": "ClinicalTrials.gov", "publication_date": "2024-08-08", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04433858", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04433858", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04433858", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04433858", "source_url": "https://clinicaltrials.gov/study/NCT04433858", "doi": "", "pmid": "", "publication_date": "2024-08-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3438, "title": "Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Feasibility, Clinical Efficacy & (Neuro)Cognitive Mechanisms", "authors": "Brugmann University Hospital", "journal": "ClinicalTrials.gov", "publication_date": "2024-08-06", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06160232", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Mechanism of Action,Biomarkers,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06160232", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06160232", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06160232", "source_url": "https://clinicaltrials.gov/study/NCT06160232", "doi": "", "pmid": "", "publication_date": "2024-08-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1055, "title": "Psilocybin-assisted therapy and HIV-related shame", "authors": "Nicky J. Mehtani, Mallory O. Johnson, Peter S. Hendricks, Jennifer Mitchell, B. Anderson", "journal": "Scientific Reports", "publication_date": "2024-08-01", "publication_year": 2024, "doi": "10.1038/s41598-024-68908-4", "pubmed_id": "39095420", "openalex_id": "https://openalex.org/W4401257064", "source_url": "https://doi.org/10.1038/s41598-024-68908-4", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:39095420", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-024-68908-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39095420", "source_url": "https://doi.org/10.1038/s41598-024-68908-4", "doi": "10.1038/s41598-024-68908-4", "pmid": "39095420", "publication_date": "2024-08-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1065, "title": "Psychedelic-assisted psychotherapy: where is the psychotherapy research?", "authors": "Aday JS, Horton D, Fernandes-Osterhold G, O'Donovan A, Bradley ER, Rosen RC, Woolley JD", "journal": "Psychopharmacology", "publication_date": "2024-07-31", "publication_year": 2024, "doi": "10.1007/s00213-024-06620-x", "pubmed_id": "38782821", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38782821/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:36", "bibtex": null, "source_record_id": "PMID:38782821", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38782821/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38782821", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38782821/", "doi": "10.1007/s00213-024-06620-x", "pmid": "38782821", "publication_date": "2024-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1072, "title": "Psilocybin and Motor Function: A Triple-Blind, Dose-Finding Study in Healthy Participants", "authors": "Chiranth Bhagavan, Richard Kanaan, Olivia Carter, Glenn Nielsen, David J. Berlowitz, Sara Issak, Sabine Braat, Sophie Zaloumis, Zachary Attard, Georgina Oliver, Deanne Mayne, David McKernon, Greg Roebuck, James Rucker, Matthew Butler, Alexander Bryson", "journal": "Psychiatric Research and Clinical Practice", "publication_date": "2024-07-22", "publication_year": 2024, "doi": "10.1176/appi.prcp.20240047", "pubmed_id": "39669539", "openalex_id": "https://openalex.org/W4400913466", "source_url": "https://doi.org/10.1176/appi.prcp.20240047", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Brain Imaging,Aging,Healthy Volunteers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:39669539", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.prcp.20240047", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39669539", "source_url": "https://doi.org/10.1176/appi.prcp.20240047", "doi": "10.1176/appi.prcp.20240047", "pmid": "39669539", "publication_date": "2024-07-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1008, "title": "Current Perspectives on the Clinical Research and Medicalization of Psychedelic Drugs for Addiction Treatments: Safety, Efficacy, Limitations and Challenges.", "authors": "Gomez-Escolar A, Folch-Sanchez D, Stefaniuk J, Swithenbank Z, Nisa A, Braddick F, Idrees Chaudhary N, van der Meer PB, Batalla A.", "journal": null, "publication_date": "2024-07-19", "publication_year": 2024, "doi": "10.1007/s40263-024-01101-3", "pubmed_id": "39033264", "openalex_id": null, "source_url": "https://doi.org/10.1007/s40263-024-01101-3", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:39033264", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40263-024-01101-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39033264", "source_url": "https://doi.org/10.1007/s40263-024-01101-3", "doi": "10.1007/s40263-024-01101-3", "pmid": "39033264", "publication_date": "2024-07-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4586, "title": "Psychedelic trip sitting, dosages and intensities: Supplementing clinical studies with anecdotal reports", "authors": "Liam Engel, Sascha Thal, Stephen Bright, Mitchell Low", "journal": "Journal of Psychedelic Studies", "publication_date": "2024-07-16", "publication_year": 2024, "doi": "10.1556/2054.2024.00377", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400732567", "source_url": "https://doi.org/10.1556/2054.2024.00377", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:42", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2024.00377", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2024.00377", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2024.00377", "source_url": "https://doi.org/10.1556/2054.2024.00377", "doi": "10.1556/2054.2024.00377", "pmid": "", "publication_date": "2024-07-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1076, "title": "Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report", "authors": "André Do, Vanessa Michaud, Jean-François Stephan, Miltiadis Moreau, Élise Benoît, Felix-Antoine Berubé, Antoine Bibaud-De Serres, Alain Taillefer, Philippe Vincent", "journal": "Frontiers in Psychiatry", "publication_date": "2024-07-15", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1394962", "pubmed_id": "39086732", "openalex_id": "https://openalex.org/W4400695899", "source_url": "https://doi.org/10.3389/fpsyt.2024.1394962", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Pharmacology,Receptor Pharmacology,Clinical Trial,Case Report,Safety,Adverse Events,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:39086732", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1394962", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39086732", "source_url": "https://doi.org/10.3389/fpsyt.2024.1394962", "doi": "10.3389/fpsyt.2024.1394962", "pmid": "39086732", "publication_date": "2024-07-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3638, "title": "Psilocybin for Treatment of Alcohol Use Disorder: a Feasibility Study", "authors": "Anders Fink-Jensen, MD, DMSci", "journal": "ClinicalTrials.gov", "publication_date": "2024-07-11", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04718792", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Pharmacology,Receptor Pharmacology,Safety,Adverse Events", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04718792", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04718792", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04718792", "source_url": "https://clinicaltrials.gov/study/NCT04718792", "doi": "", "pmid": "", "publication_date": "2024-07-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3132, "title": "Psilocybin mushrooms and public health in Brazil: a low-risk adverse event profile calls for evidence-based regulatory discussions", "authors": "Nogueira M, García-Hernández S, Roberto GS, Marques LZ.", "journal": "medRxiv", "publication_date": "2024-07-11", "publication_year": 2024, "doi": "10.1101/2024.07.11.24310147", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.07.11.24310147", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety,Adverse Events", "study_type": "Other", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.1101/2024.07.11.24310147", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.07.11.24310147", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2024.07.11.24310147", "source_url": "https://doi.org/10.1101/2024.07.11.24310147", "doi": "10.1101/2024.07.11.24310147", "pmid": "", "publication_date": "2024-07-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1077, "title": "Psilocybin for the treatment of Alzheimer's disease.", "authors": "Zheng S, Ma R, Yang Y, Li G.", "journal": null, "publication_date": "2024-07-09", "publication_year": 2024, "doi": "10.3389/fnins.2024.1420601", "pubmed_id": "39050672", "openalex_id": null, "source_url": "https://doi.org/10.3389/fnins.2024.1420601", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Creativity,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:39050672", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fnins.2024.1420601", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39050672", "source_url": "https://doi.org/10.3389/fnins.2024.1420601", "doi": "10.3389/fnins.2024.1420601", "pmid": "39050672", "publication_date": "2024-07-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 554, "title": "Magic of the Mushrooms: Effects of Psilocybin Decriminalization", "authors": "Ashutosh Bhave", "journal": "Journal of Psychoactive Drugs", "publication_date": "2024-07-09", "publication_year": 2024, "doi": "10.1080/02791072.2024.2376755", "pubmed_id": "38984875", "openalex_id": "https://openalex.org/W4400495765", "source_url": "https://doi.org/10.1080/02791072.2024.2376755", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38984875", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2024.2376755", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38984875", "source_url": "https://doi.org/10.1080/02791072.2024.2376755", "doi": "10.1080/02791072.2024.2376755", "pmid": "38984875", "publication_date": "2024-07-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1052, "title": "Addressing a major interference in the quantification of psilocin in mouse plasma: Development of a validated liquid chromatography tandem mass spectrometry method", "authors": "Amir Khajavinia, Déborah Michel, Udoka C. Ezeaka, Randy W. Purves, Robert B. Laprairie, Anas El-Aneed", "journal": "Journal of Chromatography A", "publication_date": "2024-07-03", "publication_year": 2024, "doi": "10.1016/j.chroma.2024.465123", "pubmed_id": "38981146", "openalex_id": "https://openalex.org/W4400333801", "source_url": "https://doi.org/10.1016/j.chroma.2024.465123", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Pharmacology,Receptor Pharmacology,Animal Study,Safety,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38981146", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.chroma.2024.465123", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38981146", "source_url": "https://doi.org/10.1016/j.chroma.2024.465123", "doi": "10.1016/j.chroma.2024.465123", "pmid": "38981146", "publication_date": "2024-07-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2993, "title": "Psilocybin Therapy for Females With Anorexia Nervosa: A Phase 1, Open-Label Feasibility Study", "authors": "Stéphanie Knatz Peck, Samantha Shao, Tessa Gruen, Kevin H. Yang, Alexandra Babakanian, Julie Trim, Daphna M. Finn, Walter H. Kaye", "journal": "FOCUS The Journal of Lifelong Learning in Psychiatry", "publication_date": "2024-06-30", "publication_year": 2024, "doi": "10.1176/appi.focus.24022013", "pubmed_id": "38988455", "openalex_id": "https://openalex.org/W4400572892", "source_url": "http://dx.doi.org/10.1176/appi.focus.24022013", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 07:01:03", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38988455", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.focus.24022013", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38988455", "source_url": "http://dx.doi.org/10.1176/appi.focus.24022013", "doi": "10.1176/appi.focus.24022013", "pmid": "38988455", "publication_date": "2024-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1079, "title": "The Black Book of Psychotropic Dosing and Monitoring.", "authors": "DeBattista C, Schatzberg AF.", "journal": null, "publication_date": "2024-06-30", "publication_year": 2024, "doi": "10.64719/pb.4493", "pubmed_id": "38993656", "openalex_id": null, "source_url": "https://doi.org/10.64719/pb.4493", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Brain Imaging,Pharmacology,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:38993656", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.64719/pb.4493", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38993656", "source_url": "https://doi.org/10.64719/pb.4493", "doi": "10.64719/pb.4493", "pmid": "38993656", "publication_date": "2024-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4601, "title": "IS PSYCHEDELIC TREATMENT OF MENTAL HEALTH DISORDERS READY FOR PRIME TIME?", "authors": "Nauman Ashraf", "journal": "Journal of Pakistan Psychiatric Society", "publication_date": "2024-06-29", "publication_year": 2024, "doi": "10.63050/jpps.21.02.935", "pubmed_id": null, "openalex_id": "https://openalex.org/W4400219530", "source_url": "http://dx.doi.org/10.63050/jpps.21.02.935", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Consciousness,Emotional Processing,Spirituality,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.63050/jpps.21.02.935", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.63050/jpps.21.02.935", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.63050/jpps.21.02.935", "source_url": "http://dx.doi.org/10.63050/jpps.21.02.935", "doi": "10.63050/jpps.21.02.935", "pmid": "", "publication_date": "2024-06-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1011, "title": "Attitudes toward psychedelics and psychedelic-assisted therapy among potential mental health service users and the general population in Australia", "authors": "Zohaib Nadeem, Stephen Parker, Hugh McGovern, Lena Oestreich", "journal": "Australian & New Zealand Journal of Psychiatry", "publication_date": "2024-06-21", "publication_year": 2024, "doi": "10.1177/00048674241261779", "pubmed_id": "38907608", "openalex_id": "https://openalex.org/W4399918457", "source_url": "https://doi.org/10.1177/00048674241261779", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 06:34:43", "bibtex": null, "source_record_id": "PMID:38907608", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00048674241261779", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38907608", "source_url": "https://doi.org/10.1177/00048674241261779", "doi": "10.1177/00048674241261779", "pmid": "38907608", "publication_date": "2024-06-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3184, "title": "Rapid and prolonged antidepressant and antianxiety effects of psilocybin, lysergic acid diethylamide, ayahuasca, and 3, 4-methylenedioxy-methamphetamine. A systematic review and meta-analysis of randomized controlled trials", "authors": "Fluyau D, Kailasam VK, Revadigar N.", "journal": "medRxiv", "publication_date": "2024-06-19", "publication_year": 2024, "doi": "10.1101/2024.06.17.24308787", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.06.17.24308787", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,End-of-Life Distress,Headache / Migraine,Aging,Personality Change,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2024.06.17.24308787", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.06.17.24308787", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2024.06.17.24308787", "source_url": "https://doi.org/10.1101/2024.06.17.24308787", "doi": "10.1101/2024.06.17.24308787", "pmid": "", "publication_date": "2024-06-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1062, "title": "The cyclical revival of psychedelics in psychiatric treatment.", "authors": "Appiani FJ, Caroff SN.", "journal": null, "publication_date": "2024-06-19", "publication_year": 2024, "doi": "10.1080/03007995.2024.2368725", "pubmed_id": "38880945", "openalex_id": null, "source_url": "https://doi.org/10.1080/03007995.2024.2368725", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38880945", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/03007995.2024.2368725", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38880945", "source_url": "https://doi.org/10.1080/03007995.2024.2368725", "doi": "10.1080/03007995.2024.2368725", "pmid": "38880945", "publication_date": "2024-06-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1034, "title": "Efficacy and safety of eight enhanced therapies for treatment-resistant depression: A systematic review and network meta-analysis of RCTs.", "authors": "Guo Q, Guo L, Wang Y, Shang S.", "journal": null, "publication_date": "2024-06-19", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.116018", "pubmed_id": "38924903", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2024.116018", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38924903", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2024.116018", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38924903", "source_url": "https://doi.org/10.1016/j.psychres.2024.116018", "doi": "10.1016/j.psychres.2024.116018", "pmid": "38924903", "publication_date": "2024-06-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1061, "title": "Developing the Open Psychedelic Evaluation Nexus consensus measures for assessment of supervised psilocybin services: An e-Delphi study", "authors": "P. Todd Korthuis, Kim Hoffman, Adrianne R. Wilson-Poe, Jason B. Luoma, Alissa Bazinet, Kellie Pertl, David L. Morgan, Ryan Cook, Sarann Bielavitz, Renae Myers, R. Cameron Wolf, Dennis McCarty, Christopher S. Stauffer", "journal": "Journal of Psychopharmacology", "publication_date": "2024-06-17", "publication_year": 2024, "doi": "10.1177/02698811241257839", "pubmed_id": "38888164", "openalex_id": "https://openalex.org/W4399780176", "source_url": "https://doi.org/10.1177/02698811241257839", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Observational Study,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38888164", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811241257839", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38888164", "source_url": "https://doi.org/10.1177/02698811241257839", "doi": "10.1177/02698811241257839", "pmid": "38888164", "publication_date": "2024-06-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1106, "title": "A Plea for Nuance: Should People with a Family History of Bipolar Disorder Be Excluded from Clinical Trials of Psilocybin Therapy?", "authors": "Downey AE, Bradley ER, Lerche AS, O'Donovan A, Krystal AD, Woolley J.", "journal": null, "publication_date": "2024-06-16", "publication_year": 2024, "doi": "10.1089/psymed.2023.0051", "pubmed_id": "40051581", "openalex_id": null, "source_url": "https://doi.org/10.1089/psymed.2023.0051", "substance_tags": "psilocybin", "topic_tags": "Aging,Clinical Trial,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:40051581", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0051", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40051581", "source_url": "https://doi.org/10.1089/psymed.2023.0051", "doi": "10.1089/psymed.2023.0051", "pmid": "40051581", "publication_date": "2024-06-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1037, "title": "Commentary on Darkeet al.: Expanded psychedelic access requires new safety monitoring systems", "authors": "P. Todd Korthuis, Adrianne R. Wilson-Poe, Joshua C. Black, Andrew A. Monte", "journal": "Addiction", "publication_date": "2024-06-16", "publication_year": 2024, "doi": "10.1111/add.16589", "pubmed_id": "38881433", "openalex_id": "https://openalex.org/W4399750332", "source_url": "http://dx.doi.org/10.1111/add.16589", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Aging,Spirituality,Clinical Trial,Review Article,Adolescents,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38881433", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1111/add.16589", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38881433", "source_url": "http://dx.doi.org/10.1111/add.16589", "doi": "10.1111/add.16589", "pmid": "38881433", "publication_date": "2024-06-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1063, "title": "Is microdosing a placebo? A rapid review of low-dose LSD and psilocybin research.", "authors": "Polito V, Liknaitzky P.", "journal": null, "publication_date": "2024-06-13", "publication_year": 2024, "doi": "10.1177/02698811241254831", "pubmed_id": "38877715", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811241254831", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:38877715", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811241254831", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38877715", "source_url": "https://doi.org/10.1177/02698811241254831", "doi": "10.1177/02698811241254831", "pmid": "38877715", "publication_date": "2024-06-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4605, "title": "Psychedelics’ Use as Medicine Hits Significant Roadblock", "authors": "Linda M. Richmond", "journal": "Psychiatric News", "publication_date": "2024-06-11", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.07.7.54", "pubmed_id": null, "openalex_id": "https://openalex.org/W4399577191", "source_url": "https://doi.org/10.1176/appi.pn.2024.07.7.54", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Mechanism of Action,Aging,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.07.7.54", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2024.07.7.54", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.07.7.54", "source_url": "https://doi.org/10.1176/appi.pn.2024.07.7.54", "doi": "10.1176/appi.pn.2024.07.7.54", "pmid": "", "publication_date": "2024-06-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1110, "title": "Unlocking the healing power of psilocybin: an overview of the role of psilocybin therapy in major depressive disorder, obsessive-compulsive disorder and substance use disorder", "authors": "Sandra Szafoni, Piotr Gręblowski, Klaudia Grabowska, Gniewko Więckiewicz", "journal": "Frontiers in Psychiatry", "publication_date": "2024-06-10", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1406888", "pubmed_id": "38919636", "openalex_id": "https://openalex.org/W4399572299", "source_url": "https://doi.org/10.3389/fpsyt.2024.1406888", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38919636", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1406888", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38919636", "source_url": "https://doi.org/10.3389/fpsyt.2024.1406888", "doi": "10.3389/fpsyt.2024.1406888", "pmid": "38919636", "publication_date": "2024-06-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3791, "title": "Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies", "authors": "Petrovitch D, Mitchell SM, Van Allen J, Littlefield AK.", "journal": "PsyArXiv", "publication_date": "2024-06-09", "publication_year": 2024, "doi": "10.31234/osf.io/adnpg", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/adnpg", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/adnpg", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/adnpg", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/adnpg", "source_url": "https://doi.org/10.31234/osf.io/adnpg", "doi": "10.31234/osf.io/adnpg", "pmid": "", "publication_date": "2024-06-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3445, "title": "A Multi-centre, Double-blinded, Placebo-controlled, Randomised, Phase II Clinical Trial for Psilocybin-assisted Therapy for Alcohol Use Disorder", "authors": "University of Sydney", "journal": "ClinicalTrials.gov", "publication_date": "2024-06-09", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06444243", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Wellbeing,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06444243", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06444243", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06444243", "source_url": "https://clinicaltrials.gov/study/NCT06444243", "doi": "", "pmid": "", "publication_date": "2024-06-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3355, "title": "Who believes psychedelic-assisted therapies work? Risky cannabis use and other factors are associated with positive treatment-outcome expectancies", "authors": "", "journal": "PsyArXiv", "publication_date": "2024-06-09", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/adnpg_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/adnpg_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/adnpg_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/adnpg_v1", "source_url": "https://osf.io/preprints/psyarxiv/adnpg_v1", "doi": "", "pmid": "", "publication_date": "2024-06-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3341, "title": "Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA", "authors": "Calder A, Hasler G.", "journal": "PsyArXiv", "publication_date": "2024-06-06", "publication_year": 2024, "doi": "10.31234/osf.io/um2cy", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/um2cy", "substance_tags": "psilocybin", "topic_tags": "Safety,Adverse Events", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/um2cy", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/um2cy", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/um2cy", "source_url": "https://doi.org/10.31234/osf.io/um2cy", "doi": "10.31234/osf.io/um2cy", "pmid": "", "publication_date": "2024-06-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 956, "title": "Validation of the Swiss Psychedelic Side Effects Inventory: Standardized assessment of adverse effects in studies of psychedelics and MDMA", "authors": "", "journal": "PsyArXiv", "publication_date": "2024-06-06", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/um2cy_v1", "substance_tags": "psilocybin", "topic_tags": "Safety,Adverse Events", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/um2cy_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/um2cy_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/um2cy_v1", "source_url": "https://osf.io/preprints/psyarxiv/um2cy_v1", "doi": "", "pmid": "", "publication_date": "2024-06-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1012, "title": "Pharmacological and behavioural effects of tryptamines present in psilocybin-containing mushrooms", "authors": "Ryan J. Rakoczy, Grace N. Runge, Abhishek K. Sen, Oscar Sandoval, Hunter G. Wells, Quynh Nguyen, B. Roberts, Jon H. Sciortino, William J. Gibbons, Lucas M. Friedberg, J. Andrew Jones, Matthew S. McMurray", "journal": "British Journal of Pharmacology", "publication_date": "2024-06-01", "publication_year": 2024, "doi": "10.1111/bph.16466", "pubmed_id": "38825326", "openalex_id": "https://openalex.org/W4399276098", "source_url": "https://doi.org/10.1111/bph.16466", "substance_tags": "psilocybin,psilocin", "topic_tags": "Brain Imaging,Pharmacology,Receptor Pharmacology,Biomarkers,Aging,In Vitro Study,Safety,Toxicity", "study_type": "In Vitro Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38825326", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/bph.16466", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38825326", "source_url": "https://doi.org/10.1111/bph.16466", "doi": "10.1111/bph.16466", "pmid": "38825326", "publication_date": "2024-06-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4614, "title": "Therapeutic Implications of Psilocybin in the Wake of Decriminalization", "authors": "Nikola Lash, George Tadros, Eman Tadros", "journal": "Integrative and Complementary Therapies", "publication_date": "2024-05-31", "publication_year": 2024, "doi": "10.1089/ict.2024.27206.nl", "pubmed_id": null, "openalex_id": "https://openalex.org/W4399645755", "source_url": "http://dx.doi.org/10.1089/ict.2024.27206.nl", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1089/ict.2024.27206.nl", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1089/ict.2024.27206.nl", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1089/ict.2024.27206.nl", "source_url": "http://dx.doi.org/10.1089/ict.2024.27206.nl", "doi": "10.1089/ict.2024.27206.nl", "pmid": "", "publication_date": "2024-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1123, "title": "Single-Dose Synthetic Psilocybin With Psychotherapy for Treatment-Resistant Bipolar Type II Major Depressive Episodes: A Nonrandomized Open-Label Trial.", "authors": "Aaronson ST, van der Vaart A, Miller T, LaPratt J, Swartz K, Shoultz A, Lauterbach M, Sackeim HA, Suppes T.", "journal": null, "publication_date": "2024-05-31", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2023.4685", "pubmed_id": "38055270", "openalex_id": null, "source_url": "https://doi.org/10.1001/jamapsychiatry.2023.4685", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38055270", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2023.4685", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38055270", "source_url": "https://doi.org/10.1001/jamapsychiatry.2023.4685", "doi": "10.1001/jamapsychiatry.2023.4685", "pmid": "38055270", "publication_date": "2024-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1119, "title": "Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety-Reply.", "authors": "Aaronson ST, van der Vaart A, Sackeim HA.", "journal": null, "publication_date": "2024-05-31", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2024.0423", "pubmed_id": "38598225", "openalex_id": null, "source_url": "https://doi.org/10.1001/jamapsychiatry.2024.0423", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:38598225", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38598225", "source_url": "https://doi.org/10.1001/jamapsychiatry.2024.0423", "doi": "10.1001/jamapsychiatry.2024.0423", "pmid": "38598225", "publication_date": "2024-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1064, "title": "Protocols and practices in psilocybin assisted psychotherapy for depression: A systematic review.", "authors": "Chisamore N, Johnson D, Chen MJQ, Offman H, Chen-Li D, Kaczmarek ES, Doyle Z, McIntyre RS, Rosenblat JD.", "journal": null, "publication_date": "2024-05-30", "publication_year": 2024, "doi": "10.1016/j.jpsychires.2024.05.051", "pubmed_id": "38850581", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jpsychires.2024.05.051", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:38850581", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jpsychires.2024.05.051", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38850581", "source_url": "https://doi.org/10.1016/j.jpsychires.2024.05.051", "doi": "10.1016/j.jpsychires.2024.05.051", "pmid": "38850581", "publication_date": "2024-05-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1114, "title": "Long-COVID symptoms improved after MDMA and psilocybin therapy: A case report", "authors": "Harman Chopra, Timothy Furnish, Monica Verduzco-Gutierrez, David S. Jevotovsky, Joel Castellanos", "journal": "Clinical Case Reports", "publication_date": "2024-05-27", "publication_year": 2024, "doi": "10.1002/ccr3.8791", "pubmed_id": "38813452", "openalex_id": "https://openalex.org/W4399135187", "source_url": "https://doi.org/10.1002/ccr3.8791", "substance_tags": "psilocybin", "topic_tags": "Case Report,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38813452", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/ccr3.8791", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38813452", "source_url": "https://doi.org/10.1002/ccr3.8791", "doi": "10.1002/ccr3.8791", "pmid": "38813452", "publication_date": "2024-05-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 939, "title": "Narrative review of the potential for psychedelics to treat Prolonged Grief Disorder.", "authors": "Ehrenkranz R, Agrawal M, Penberthy JK, Yaden DB.", "journal": null, "publication_date": "2024-05-22", "publication_year": 2024, "doi": "10.1080/09540261.2024.2357668", "pubmed_id": "39980217", "openalex_id": null, "source_url": "https://doi.org/10.1080/09540261.2024.2357668", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mystical Experience,Clinical Trial,Review Article,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39980217", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/09540261.2024.2357668", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39980217", "source_url": "https://doi.org/10.1080/09540261.2024.2357668", "doi": "10.1080/09540261.2024.2357668", "pmid": "39980217", "publication_date": "2024-05-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1091, "title": "Efficacy and safety of psilocybin on treatment-resistant depression: A systematic review and meta-analysis.", "authors": "Fang Q, Chan VKY, Chan SSM, Jiao Y, Wang J, Li X.", "journal": null, "publication_date": "2024-05-21", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.115960", "pubmed_id": "38781672", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2024.115960", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:38781672", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38781672", "source_url": "https://doi.org/10.1016/j.psychres.2024.115960", "doi": "10.1016/j.psychres.2024.115960", "pmid": "38781672", "publication_date": "2024-05-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 953, "title": "A Case Report of Psilocybin-induced Psychosis in a Predisposed Patient", "authors": "S Morris", "journal": "Clinical Psychopharmacology and Neuroscience", "publication_date": "2024-05-20", "publication_year": 2024, "doi": "10.9758/cpn.24.1180", "pubmed_id": "39420616", "openalex_id": "https://openalex.org/W4398182074", "source_url": "http://dx.doi.org/10.9758/cpn.24.1180", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Personality Change,Review Article,Case Report,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:39420616", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.9758/cpn.24.1180", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39420616", "source_url": "http://dx.doi.org/10.9758/cpn.24.1180", "doi": "10.9758/cpn.24.1180", "pmid": "39420616", "publication_date": "2024-05-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4623, "title": "Psychedelic renaissance: A renewed focus on the clinical utility of hallucinogens", "authors": "Shunichiro Ikeda, Toshihiko Kinoshita", "journal": "Psychiatry and Clinical Neurosciences Reports", "publication_date": "2024-05-15", "publication_year": 2024, "doi": "10.1002/pcn5.196", "pubmed_id": null, "openalex_id": "https://openalex.org/W4397013596", "source_url": "https://doi.org/10.1002/pcn5.196", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1002/pcn5.196", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pcn5.196", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pcn5.196", "source_url": "https://doi.org/10.1002/pcn5.196", "doi": "10.1002/pcn5.196", "pmid": "", "publication_date": "2024-05-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4624, "title": "Psilocybin as a new way for depression treatment", "authors": "Mateusz Pawlicki, Aleksandra Kłos, Karol Stachyrak, Dawid Mika, Bartosz Mazur, Kamila Turek, Maciej Lambach, Anna Gregułą, Aleksandra Mazurek, Wiktoria Wilanowska", "journal": "Journal of Education Health and Sport", "publication_date": "2024-05-14", "publication_year": 2024, "doi": "10.12775/jehs.2024.68.50168", "pubmed_id": null, "openalex_id": "https://openalex.org/W4396937684", "source_url": "http://dx.doi.org/10.12775/jehs.2024.68.50168", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Safety,Adverse Events", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2024.68.50168", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.12775/jehs.2024.68.50168", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2024.68.50168", "source_url": "http://dx.doi.org/10.12775/jehs.2024.68.50168", "doi": "10.12775/jehs.2024.68.50168", "pmid": "", "publication_date": "2024-05-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3350, "title": "Psychedelics Use and the Risk of Reduced Formal Mental Health Care", "authors": "Viña S.", "journal": "Research Square", "publication_date": "2024-05-12", "publication_year": 2024, "doi": "10.21203/rs.3.rs-4378944/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-4378944/v1", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Safety,Drug Interactions", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-4378944/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-4378944/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-4378944/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-4378944/v1", "doi": "10.21203/rs.3.rs-4378944/v1", "pmid": "", "publication_date": "2024-05-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4628, "title": "Calls to Poison Centers Involving Psilocybin Rising in Youth", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2024-05-09", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.06.6.2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4396797833", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.06.6.2", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Adolescents,Healthcare Workers,Safety,Adverse Events,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.06.6.2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.06.6.2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.06.6.2", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.06.6.2", "doi": "10.1176/appi.pn.2024.06.6.2", "pmid": "", "publication_date": "2024-05-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 952, "title": "Clinical Research Trials of Psychedelic-Assisted Therapy in Adolescents Aged 16 to 17 Years: Rationale Balanced With Caution.", "authors": "Jeffrey JK, Weintraub MJ, Grob CS.", "journal": null, "publication_date": "2024-05-08", "publication_year": 2024, "doi": "10.1016/j.jaac.2024.03.021", "pubmed_id": "38734406", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jaac.2024.03.021", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Clinical Trial,Adolescents,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38734406", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jaac.2024.03.021", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38734406", "source_url": "https://doi.org/10.1016/j.jaac.2024.03.021", "doi": "10.1016/j.jaac.2024.03.021", "pmid": "38734406", "publication_date": "2024-05-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 934, "title": "Evolving Guidelines for the Use of Touch During a Clinical Trial of Group Psilocybin-Assisted Therapy", "authors": "Anthony L. Back, Susanna Myers, John Guy, Juliana Pérez, Leslie Lazar Thorn, Bonnie A. McGregor", "journal": "Psychedelic Medicine", "publication_date": "2024-05-07", "publication_year": 2024, "doi": "10.1089/psymed.2023.0069", "pubmed_id": "40051480", "openalex_id": "https://openalex.org/W4396720923", "source_url": "https://doi.org/10.1089/psymed.2023.0069", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:40051480", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0069", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40051480", "source_url": "https://doi.org/10.1089/psymed.2023.0069", "doi": "10.1089/psymed.2023.0069", "pmid": "40051480", "publication_date": "2024-05-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4633, "title": "From Venerable Cultural Practices to Modern Psychological Solutions: Enter Entheogens into Mainstream Medicine", "authors": "Nicholas A Kerna, Kevin D. Pruitt, N.D. Victor Carsrud, Kyle Kadivi, Dabeluchi C. Ngwu, Hilary M. Holets, John V. Flores, Ijeoma Nnake, Cornelius I. Azi, Joseph Anderson, Fatimah A. Olunlade, Uzoamaka Nwokorie", "journal": "European Journal of Arts Humanities and Social Sciences", "publication_date": "2024-04-30", "publication_year": 2024, "doi": "10.59324/ejahss.2024.1(3).10", "pubmed_id": null, "openalex_id": "https://openalex.org/W4399259513", "source_url": "https://doi.org/10.59324/ejahss.2024.1(3).10", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Chronic Pain,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Spirituality,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.59324/ejahss.2024.1(3).10", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.59324/ejahss.2024.1(3).10", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.59324/ejahss.2024.1(3).10", "source_url": "https://doi.org/10.59324/ejahss.2024.1(3).10", "doi": "10.59324/ejahss.2024.1(3).10", "pmid": "", "publication_date": "2024-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1146, "title": "Safety and risk assessment of psychedelic psychotherapy: A meta-analysis and systematic review.", "authors": "Romeo B, Kervadec E, Fauvel B, Strika-Bruneau L, Amirouche A, Verroust V, Piolino P, Benyamina A", "journal": "Psychiatry research", "publication_date": "2024-04-30", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.115880", "pubmed_id": "38579460", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38579460/", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Headache / Migraine,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Meta-Analysis", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:37", "bibtex": null, "source_record_id": "PMID:38579460", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38579460/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38579460", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38579460/", "doi": "10.1016/j.psychres.2024.115880", "pmid": "38579460", "publication_date": "2024-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1142, "title": "Efficacy of psilocybin for treating symptoms of depression: systematic review and meta-analysis.", "authors": "Metaxa AM, Clarke M.", "journal": null, "publication_date": "2024-04-30", "publication_year": 2024, "doi": "10.1136/bmj-2023-078084", "pubmed_id": "38692686", "openalex_id": null, "source_url": "https://doi.org/10.1136/bmj-2023-078084", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38692686", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1136/bmj-2023-078084", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38692686", "source_url": "https://doi.org/10.1136/bmj-2023-078084", "doi": "10.1136/bmj-2023-078084", "pmid": "38692686", "publication_date": "2024-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3362, "title": "Do undergraduates’ views of psychedelics relate to the context for psychedelic use?", "authors": "Petrovitch D, Van Allen J, Mitchell SM, Littlefield AK.", "journal": "PsyArXiv", "publication_date": "2024-04-23", "publication_year": 2024, "doi": "10.31234/osf.io/xnu5c", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/xnu5c", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/xnu5c", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/xnu5c", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/xnu5c", "source_url": "https://doi.org/10.31234/osf.io/xnu5c", "doi": "10.31234/osf.io/xnu5c", "pmid": "", "publication_date": "2024-04-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1162, "title": "Psilocybin therapy and anorexia nervosa: a narrative review of safety considerations for researchers and clinicians.", "authors": "Downey AE, Chaphekar AV, Woolley J, Raymond-Flesch M.", "journal": null, "publication_date": "2024-04-23", "publication_year": 2024, "doi": "10.1186/s40337-024-01005-z", "pubmed_id": "38659049", "openalex_id": null, "source_url": "https://doi.org/10.1186/s40337-024-01005-z", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Headache / Migraine,Clinical Trial,Review Article,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38659049", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1186/s40337-024-01005-z", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38659049", "source_url": "https://doi.org/10.1186/s40337-024-01005-z", "doi": "10.1186/s40337-024-01005-z", "pmid": "38659049", "publication_date": "2024-04-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 527, "title": "Do undergraduates’ views of psychedelics relate to the context for psychedelic use?", "authors": "", "journal": "PsyArXiv", "publication_date": "2024-04-23", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/xnu5c_v1", "substance_tags": "psilocybin", "topic_tags": "Addiction,Microdosing,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/xnu5c_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/xnu5c_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/xnu5c_v1", "source_url": "https://osf.io/preprints/psyarxiv/xnu5c_v1", "doi": "", "pmid": "", "publication_date": "2024-04-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4638, "title": "MedCheck: Psilocybin for Depression, LSD for Anxiety, Donanemab, LSD, and More", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2024-04-22", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.05.5.1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4395032120", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.05.5.1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.05.5.1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.05.5.1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.05.5.1", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.05.5.1", "doi": "10.1176/appi.pn.2024.05.5.1", "pmid": "", "publication_date": "2024-04-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3434, "title": "The Effect of Psilocybin on MDD Symptom Severity and Synaptic Density - A Single Dose Randomized, Double Blind, Placebo- Controlled Phase 2 Positron Emission Tomography Study", "authors": "Section for Affective Disorders; Northern Stockholm Psychiatry", "journal": "ClinicalTrials.gov", "publication_date": "2024-04-18", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04630964", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Brain Imaging,Aging,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04630964", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04630964", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04630964", "source_url": "https://clinicaltrials.gov/study/NCT04630964", "doi": "", "pmid": "", "publication_date": "2024-04-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1164, "title": "Palliative care patients’ attitudes and openness towards psilocybin-assisted psychotherapy for existential distress", "authors": "Julia R. Wang, Samuel J. Mendez Araque, Gina Micciche, Andrew McMillan, Emily Coughlin, Rosalie Mattiola, Diana P. English, Kristopher Kaliebe", "journal": "Frontiers in Psychiatry", "publication_date": "2024-04-17", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1301960", "pubmed_id": "38699449", "openalex_id": "https://openalex.org/W4394924908", "source_url": "https://doi.org/10.3389/fpsyt.2024.1301960", "substance_tags": "psilocybin", "topic_tags": "Anxiety,End-of-Life Distress,Chronic Pain,Wellbeing,Observational Study,Healthcare Workers,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38699449", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1301960", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38699449", "source_url": "https://doi.org/10.3389/fpsyt.2024.1301960", "doi": "10.3389/fpsyt.2024.1301960", "pmid": "38699449", "publication_date": "2024-04-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4639, "title": "Mind the Psychedelic Hype: Characterizing the Risks and Benefits of Psychedelics for Depression", "authors": "Daniel Meling, Rebecca Ehrenkranz, Sandeep M. Nayak, Helena Aicher, Xaver Funk, Michiel van Elk, Marianna Graziosi, Prisca R. Bauer, Milan Scheidegger, David B. Yaden", "journal": "Psychoactives", "publication_date": "2024-04-15", "publication_year": 2024, "doi": "10.3390/psychoactives3020014", "pubmed_id": null, "openalex_id": "https://openalex.org/W4394855468", "source_url": "https://doi.org/10.3390/psychoactives3020014", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 06:34:43", "bibtex": null, "source_record_id": "DOI:10.3390/psychoactives3020014", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3390/psychoactives3020014", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3390/psychoactives3020014", "source_url": "https://doi.org/10.3390/psychoactives3020014", "doi": "10.3390/psychoactives3020014", "pmid": "", "publication_date": "2024-04-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1120, "title": "Treating Bipolar Depression Using Psilocybin-Validity Threats Regarding Efficacy and Safety", "authors": "Eiko I. Fried, Ioana A. Cristea, Florian Naudet", "journal": "JAMA Psychiatry", "publication_date": "2024-04-09", "publication_year": 2024, "doi": "10.1001/jamapsychiatry.2024.0420", "pubmed_id": "38598200", "openalex_id": "https://openalex.org/W4394676727", "source_url": "https://doi.org/10.1001/jamapsychiatry.2024.0420", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38598200", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jamapsychiatry.2024.0420", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38598200", "source_url": "https://doi.org/10.1001/jamapsychiatry.2024.0420", "doi": "10.1001/jamapsychiatry.2024.0420", "pmid": "38598200", "publication_date": "2024-04-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3724, "title": "Psilocybin for dementia prevention? The potential role of psilocybin to alter mechanisms associated with major depression and neurodegenerative diseases.", "authors": "Haniff ZR, Bocharova M, Mantingh T, Rucker JJ, Velayudhan L, Taylor DM, Young AH, Aarsland D, Vernon AC, Thuret S.", "journal": null, "publication_date": "2024-04-05", "publication_year": 2024, "doi": "10.1016/j.pharmthera.2024.108641", "pubmed_id": "38583670", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pharmthera.2024.108641", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Neurogenesis,Mechanism of Action,Biomarkers,Review Article,Animal Study,Safety,Immune Function", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:08:41", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38583670", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pharmthera.2024.108641", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38583670", "source_url": "https://doi.org/10.1016/j.pharmthera.2024.108641", "doi": "10.1016/j.pharmthera.2024.108641", "pmid": "38583670", "publication_date": "2024-04-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4644, "title": "A double-edged sword: Insights from practitioners on the short and long-term negative effects of psilocybin-assisted psychological interventions", "authors": "M. Nordin, Jón Ingi Hlynsson, Jakob Håkansson Eklund, Per Carlbring", "journal": "Journal of Psychedelic Studies", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1556/2054.2024.00337", "pubmed_id": null, "openalex_id": "https://openalex.org/W4393547236", "source_url": "https://doi.org/10.1556/2054.2024.00337", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2024.00337", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2024.00337", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2024.00337", "source_url": "https://doi.org/10.1556/2054.2024.00337", "doi": "10.1556/2054.2024.00337", "pmid": "", "publication_date": "2024-04-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1170, "title": "The psychedelic call: analysis of Australian Poisons Information Centre calls associated with classic psychedelics", "authors": "Rachael Wilkes, Darren M. Roberts, Paul Liknaitzky, Jonathan Brett", "journal": "Clinical Toxicology", "publication_date": "2024-04-01", "publication_year": 2024, "doi": "10.1080/15563650.2024.2346612", "pubmed_id": "38753585", "openalex_id": "https://openalex.org/W4396977515", "source_url": "https://doi.org/10.1080/15563650.2024.2346612", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Observational Study,Healthcare Workers,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38753585", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/15563650.2024.2346612", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38753585", "source_url": "https://doi.org/10.1080/15563650.2024.2346612", "doi": "10.1080/15563650.2024.2346612", "pmid": "38753585", "publication_date": "2024-04-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4658, "title": "Current situation regarding psychedelics and magic mushroom in Korea", "authors": "J. S. Seo", "journal": "European Psychiatry", "publication_date": "2024-03-31", "publication_year": 2024, "doi": "10.1192/j.eurpsy.2024.1695", "pubmed_id": null, "openalex_id": "https://openalex.org/W4401921810", "source_url": "http://dx.doi.org/10.1192/j.eurpsy.2024.1695", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1192/j.eurpsy.2024.1695", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1192/j.eurpsy.2024.1695", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/j.eurpsy.2024.1695", "source_url": "http://dx.doi.org/10.1192/j.eurpsy.2024.1695", "doi": "10.1192/j.eurpsy.2024.1695", "pmid": "", "publication_date": "2024-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1172, "title": "Acute Adverse Effects of Therapeutic Doses of Psilocybin: A Systematic Review and Meta-Analysis.", "authors": "Yerubandi A, Thomas JE, Bhuiya NMMA, Harrington C, Villa Zapata L, Caballero J.", "journal": null, "publication_date": "2024-03-31", "publication_year": 2024, "doi": "10.1001/jamanetworkopen.2024.5960", "pubmed_id": "38598236", "openalex_id": null, "source_url": "https://doi.org/10.1001/jamanetworkopen.2024.5960", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38598236", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1001/jamanetworkopen.2024.5960", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38598236", "source_url": "https://doi.org/10.1001/jamanetworkopen.2024.5960", "doi": "10.1001/jamanetworkopen.2024.5960", "pmid": "38598236", "publication_date": "2024-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1147, "title": "Efficacy and safety of psychedelics for the treatment of mental disorders: A systematic review and meta-analysis.", "authors": "Yao Y, Guo D, Lu TS, Liu FL, Huang SH, Diao MQ, Li SX, Zhang XJ, Kosten TR, Shi J, Bao YP, Lu L, Han Y.", "journal": null, "publication_date": "2024-03-27", "publication_year": 2024, "doi": "10.1016/j.psychres.2024.115886", "pubmed_id": "38574699", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2024.115886", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,Headache / Migraine,Personality Change,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38574699", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2024.115886", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38574699", "source_url": "https://doi.org/10.1016/j.psychres.2024.115886", "doi": "10.1016/j.psychres.2024.115886", "pmid": "38574699", "publication_date": "2024-03-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4660, "title": "MedCheck; Psilocybin, Roluperidone, Latozinemab, Lacosamide", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2024-03-25", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.04.4.1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4393210403", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.1", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Pharmacology,Clinical Trial,Review Article,Safety,Immune Function", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.1", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.1", "doi": "10.1176/appi.pn.2024.04.4.1", "pmid": "", "publication_date": "2024-03-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1148, "title": "Effects of discontinuation of serotonergic antidepressants prior to psilocybin therapy versus escitalopram for major depression", "authors": "David Erritzøe, Tommaso Barba, Meg J. Spriggs, Fernando E. Rosas, David Nutt, Robin Carhart-Harris", "journal": "Journal of Psychopharmacology", "publication_date": "2024-03-21", "publication_year": 2024, "doi": "10.1177/02698811241237870", "pubmed_id": "38520045", "openalex_id": "https://openalex.org/W4393118291", "source_url": "https://doi.org/10.1177/02698811241237870", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Receptor Pharmacology,Wellbeing,Clinical Trial,Safety,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38520045", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811241237870", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38520045", "source_url": "https://doi.org/10.1177/02698811241237870", "doi": "10.1177/02698811241237870", "pmid": "38520045", "publication_date": "2024-03-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4663, "title": "Psychedelic Renaissance: Evidence and Culture", "authors": "Adrian Preda", "journal": "Psychiatric News", "publication_date": "2024-03-20", "publication_year": 2024, "doi": "10.1176/appi.pn.2024.04.4.39", "pubmed_id": null, "openalex_id": "https://openalex.org/W4393030764", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.39", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Neuroplasticity,Emotional Processing,Spirituality,Clinical Trial,Animal Study,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.39", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.39", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2024.04.4.39", "source_url": "http://dx.doi.org/10.1176/appi.pn.2024.04.4.39", "doi": "10.1176/appi.pn.2024.04.4.39", "pmid": "", "publication_date": "2024-03-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3697, "title": "A Pilot Study of Psilocybin Enhanced Group Psychotherapy in Patients With Cancer", "authors": "University of Utah", "journal": "ClinicalTrials.gov", "publication_date": "2024-03-19", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04522804", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04522804", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04522804", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04522804", "source_url": "https://clinicaltrials.gov/study/NCT04522804", "doi": "", "pmid": "", "publication_date": "2024-03-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4664, "title": "Psychedelic drugs and the law: What’s next?", "authors": "Ben Seal", "journal": "Knowable Magazine", "publication_date": "2024-03-13", "publication_year": 2024, "doi": "10.1146/knowable-031424-2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392794286", "source_url": "http://dx.doi.org/10.1146/knowable-031424-2", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Mechanism of Action,Receptor Pharmacology,Spirituality,Clinical Trial,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:43", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "DOI:10.1146/knowable-031424-2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1146/knowable-031424-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1146/knowable-031424-2", "source_url": "http://dx.doi.org/10.1146/knowable-031424-2", "doi": "10.1146/knowable-031424-2", "pmid": "", "publication_date": "2024-03-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1211, "title": "Screening and confirmation of psilocin, mitragynine, phencyclidine, ketamine and ketamine metabolites by liquid chromatography-tandem mass spectrometry.", "authors": "Wood ME, Brown GJ, Karschner EL, Seither JZ, Brown JT, Knittel JL, Walterscheid JP.", "journal": null, "publication_date": "2024-02-29", "publication_year": 2024, "doi": "10.1093/jat/bkae002", "pubmed_id": "38287693", "openalex_id": "https://openalex.org/W4391462932", "source_url": "https://doi.org/10.1093/jat/bkae002", "substance_tags": "psilocybin,psilocin", "topic_tags": "Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38287693", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1093/jat/bkae002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38287693", "source_url": "https://doi.org/10.1093/jat/bkae002", "doi": "10.1093/jat/bkae002", "pmid": "38287693", "publication_date": "2024-02-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1209, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians-Psilocybin", "authors": "Burton J. Tabaac, Kenneth Shinozuka, Alejandro Arenas, Bryce D. Beutler, Kirsten Cherian, Viviana D. Evans, Chelsey Fasano, Owen S. Muir", "journal": "American Journal of Therapeutics", "publication_date": "2024-02-29", "publication_year": 2024, "doi": "10.1097/mjt.0000000000001724", "pubmed_id": "38518269", "openalex_id": "https://openalex.org/W4393098899", "source_url": "https://doi.org/10.1097/mjt.0000000000001724", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Headache / Migraine,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38518269", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/mjt.0000000000001724", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38518269", "source_url": "https://doi.org/10.1097/mjt.0000000000001724", "doi": "10.1097/mjt.0000000000001724", "pmid": "38518269", "publication_date": "2024-02-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1221, "title": "Development of a digital intervention for psychedelic preparation (DIPP)", "authors": "Rosalind McAlpine, Matthew D. Sacchet, Otto Simonsson, Maisha M. Khan, Katarina Krajnović, Larisa Morometescu, Sunjeev K. Kamboj", "journal": "Scientific Reports", "publication_date": "2024-02-18", "publication_year": 2024, "doi": "10.1038/s41598-024-54642-4", "pubmed_id": "38374177", "openalex_id": "https://openalex.org/W4391926727", "source_url": "https://doi.org/10.1038/s41598-024-54642-4", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Consciousness,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38374177", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-024-54642-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38374177", "source_url": "https://doi.org/10.1038/s41598-024-54642-4", "doi": "10.1038/s41598-024-54642-4", "pmid": "38374177", "publication_date": "2024-02-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1222, "title": "Corrigendum: Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings.", "authors": "Ching THW, Amoroso L, Bohner C, D'Amico E, Eilbott J, Entezar T, Fitzpatrick M, Fram G, Grazioplene R, Hokanson J, Jankovsky A, Kichuk SA, Martins B, Patel P, Schaer H, Shnayder S, Witherow C, Pittenger C, Kelmendi B.", "journal": null, "publication_date": "2024-02-15", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1372373", "pubmed_id": "38435972", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2024.1372373", "substance_tags": "psilocybin", "topic_tags": "OCD,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:38435972", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1372373", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38435972", "source_url": "https://doi.org/10.3389/fpsyt.2024.1372373", "doi": "10.3389/fpsyt.2024.1372373", "pmid": "38435972", "publication_date": "2024-02-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1225, "title": "Efficacy and acceptability of psilocybin for primary or secondary depression: A systematic review and meta-analysis of randomized controlled trials.", "authors": "Fang S, Yang X, Zhang W.", "journal": null, "publication_date": "2024-02-14", "publication_year": 2024, "doi": "10.3389/fpsyt.2024.1359088", "pubmed_id": "38426002", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2024.1359088", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38426002", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2024.1359088", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38426002", "source_url": "https://doi.org/10.3389/fpsyt.2024.1359088", "doi": "10.3389/fpsyt.2024.1359088", "pmid": "38426002", "publication_date": "2024-02-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1228, "title": "The Effects of Psychedelics on Neuronal Physiology.", "authors": "Hatzipantelis CJ, Olson DE", "journal": "Annual review of physiology", "publication_date": "2024-02-11", "publication_year": 2024, "doi": "10.1146/annurev-physiol-042022-020923", "pubmed_id": "37931171", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37931171/", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:37", "bibtex": null, "source_record_id": "PMID:37931171", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37931171/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37931171", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37931171/", "doi": "10.1146/annurev-physiol-042022-020923", "pmid": "37931171", "publication_date": "2024-02-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1235, "title": "Patient perspectives and experiences with psilocybin treatment for treatment-resistant depression: a qualitative study", "authors": "Joost J. Breeksema, Alistair Niemeijer, Erwin Krediet, T.L. Karsten, Jeanine Kamphuis, Eric Vermetten, Wim van den Brink, Robert A. Schoevers", "journal": "Scientific Reports", "publication_date": "2024-02-04", "publication_year": 2024, "doi": "10.1038/s41598-024-53188-9", "pubmed_id": "38316896", "openalex_id": "https://openalex.org/W4391540455", "source_url": "https://doi.org/10.1038/s41598-024-53188-9", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Aging,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38316896", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-024-53188-9", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38316896", "source_url": "https://doi.org/10.1038/s41598-024-53188-9", "doi": "10.1038/s41598-024-53188-9", "pmid": "38316896", "publication_date": "2024-02-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1247, "title": "The development of psilocybin therapy for treatment-resistant depression: an update.", "authors": "Borissova A, Rucker JJ.", "journal": null, "publication_date": "2024-01-31", "publication_year": 2024, "doi": "10.1192/bjb.2023.25", "pubmed_id": "37357767", "openalex_id": null, "source_url": "https://doi.org/10.1192/bjb.2023.25", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37357767", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1192/bjb.2023.25", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37357767", "source_url": "https://doi.org/10.1192/bjb.2023.25", "doi": "10.1192/bjb.2023.25", "pmid": "37357767", "publication_date": "2024-01-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1245, "title": "The impact of psychedelics on patients with alcohol use disorder: a systematic review with meta-analysis.", "authors": "Sicignano D, Hernandez AV, Schiff B, Elmahy N, White CM", "journal": "Current medical research and opinion", "publication_date": "2024-01-31", "publication_year": 2024, "doi": "10.1080/03007995.2023.2296968", "pubmed_id": "38111216", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38111216/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:37", "bibtex": null, "source_record_id": "PMID:38111216", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38111216/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38111216", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38111216/", "doi": "10.1080/03007995.2023.2296968", "pmid": "38111216", "publication_date": "2024-01-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1176, "title": "Psychedelics for alzheimer's disease-related dementia: Unveiling therapeutic possibilities and pathways", "authors": "Jitendra Kumar Sinha, Anchal Trisal, Shampa Ghosh, Saurabh Gupta, Krishna Kumar Singh, Sung Soo Han, Madhumita Mahapatra, Mosleh Mohammad Abomughaid, Ali M. Abomughayedh, Abdulmajeed G. Almutary, Danish Iqbal, Rakesh Bhaskar, Prabhu Chandra Mishra, Saurabh Kumar Jha, Niraj Kumar Jha, Abhishek Kumar Singh", "journal": "Ageing Research Reviews", "publication_date": "2024-01-31", "publication_year": 2024, "doi": "10.1016/j.arr.2024.102211", "pubmed_id": "38307424", "openalex_id": "https://openalex.org/W4391451768", "source_url": "https://doi.org/10.1016/j.arr.2024.102211", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Spirituality,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:35", "bibtex": null, "source_record_id": "PMID:38307424", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.arr.2024.102211", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38307424", "source_url": "https://doi.org/10.1016/j.arr.2024.102211", "doi": "10.1016/j.arr.2024.102211", "pmid": "38307424", "publication_date": "2024-01-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1154, "title": "Serotonergic Psychedelics: A Comparative Review of Efficacy, Safety, Pharmacokinetics, and Binding Profile.", "authors": "Holze F, Singh N, Liechti ME, D'Souza DC.", "journal": null, "publication_date": "2024-01-31", "publication_year": 2024, "doi": "10.1016/j.bpsc.2024.01.007", "pubmed_id": "38301886", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.bpsc.2024.01.007", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38301886", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.bpsc.2024.01.007", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38301886", "source_url": "https://doi.org/10.1016/j.bpsc.2024.01.007", "doi": "10.1016/j.bpsc.2024.01.007", "pmid": "38301886", "publication_date": "2024-01-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4681, "title": "Psilocybin-assisted psychotherapy for cancer patients", "authors": "Houman Farzin", "journal": "International Journal of Whole Person Care", "publication_date": "2024-01-28", "publication_year": 2024, "doi": "10.26443/ijwpc.v11i1.390", "pubmed_id": null, "openalex_id": "https://openalex.org/W4391329406", "source_url": "http://dx.doi.org/10.26443/ijwpc.v11i1.390", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Consciousness,Spirituality,Clinical Trial,Case Report,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.26443/ijwpc.v11i1.390", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.26443/ijwpc.v11i1.390", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.26443/ijwpc.v11i1.390", "source_url": "http://dx.doi.org/10.26443/ijwpc.v11i1.390", "doi": "10.26443/ijwpc.v11i1.390", "pmid": "", "publication_date": "2024-01-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4685, "title": "Pharmacotherapy of Psychological Disorders Using Psychedelic Drugs: A Treatise for Psychiatrists", "authors": "Payal Ghosh, Debjeet Sur", "journal": "Current Psychiatry Research and Reviews", "publication_date": "2024-01-20", "publication_year": 2024, "doi": "10.2174/0126660822258502231120074036", "pubmed_id": null, "openalex_id": "https://openalex.org/W4391067287", "source_url": "https://doi.org/10.2174/0126660822258502231120074036", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.2174/0126660822258502231120074036", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.2174/0126660822258502231120074036", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.2174/0126660822258502231120074036", "source_url": "https://doi.org/10.2174/0126660822258502231120074036", "doi": "10.2174/0126660822258502231120074036", "pmid": "", "publication_date": "2024-01-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1252, "title": "Trauma-Informed Care in Psychedelic Therapy Research: A Qualitative Literature Review of Evidence-Based Psychotherapy Interventions in PTSD and Psychedelic Therapy Across Conditions.", "authors": "Modlin NL, Creed M, Sarang M, Maggio C, Rucker JJ, Williamson V.", "journal": null, "publication_date": "2024-01-19", "publication_year": 2024, "doi": "10.2147/ndt.s432537", "pubmed_id": "38268571", "openalex_id": null, "source_url": "https://doi.org/10.2147/ndt.s432537", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:38268571", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.2147/ndt.s432537", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38268571", "source_url": "https://doi.org/10.2147/ndt.s432537", "doi": "10.2147/ndt.s432537", "pmid": "38268571", "publication_date": "2024-01-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1272, "title": "Older adults in psychedelic-assisted therapy trials: A systematic review.", "authors": "Bouchet L, Sager Z, Yrondi A, Nigam KB, Anderson BT, Ross S, Petridis PD, Beaussant Y.", "journal": null, "publication_date": "2024-01-18", "publication_year": 2024, "doi": "10.1177/02698811231215420", "pubmed_id": "38240068", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811231215420", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Aging,Clinical Trial,Systematic Review,Review Article,Older Adults,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:38240068", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811231215420", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38240068", "source_url": "https://doi.org/10.1177/02698811231215420", "doi": "10.1177/02698811231215420", "pmid": "38240068", "publication_date": "2024-01-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4687, "title": "Abstract C001: A pilot study of palliadelic treatment with psilocybin to reduce psychological distress and improve quality of life in patients with advanced pancreatic adenocarcinoma", "authors": "Kelsey Klute, Lou Lukas, Soonjo Hwang, Yeongjin Gwon, Mridula Krishnan, Jean L. Grem, Sunil R. Hingorani, Jody Koenig Kellas", "journal": "Cancer Research", "publication_date": "2024-01-15", "publication_year": 2024, "doi": "10.1158/1538-7445.panca2023-c001", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390915346", "source_url": "https://doi.org/10.1158/1538-7445.panca2023-c001", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Brain Imaging,Cancer Patients,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1158/1538-7445.panca2023-c001", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1158/1538-7445.panca2023-c001", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1158/1538-7445.panca2023-c001", "source_url": "https://doi.org/10.1158/1538-7445.panca2023-c001", "doi": "10.1158/1538-7445.panca2023-c001", "pmid": "", "publication_date": "2024-01-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1254, "title": "Modern Psychedelic Microdosing Research on Mental Health", "authors": "David F. Lo, Hasan Zia, Pranetha Rajkumar, Adarsh Thakur, Heather O’Donnell", "journal": "The Primary Care Companion For CNS Disorders", "publication_date": "2024-01-11", "publication_year": 2024, "doi": "10.4088/pcc.23r03581", "pubmed_id": "38228068", "openalex_id": "https://openalex.org/W4390802651", "source_url": "https://doi.org/10.4088/pcc.23r03581", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Chronic Pain,Microdosing,Wellbeing,Review Article,Observational Study,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38228068", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4088/pcc.23r03581", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38228068", "source_url": "https://doi.org/10.4088/pcc.23r03581", "doi": "10.4088/pcc.23r03581", "pmid": "38228068", "publication_date": "2024-01-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1212, "title": "Microdosing psychedelics and the risk of cardiac fibrosis and valvulopathy: Comparison to known cardiotoxins.", "authors": "Rouaud A, Calder AE, Hasler G.", "journal": null, "publication_date": "2024-01-11", "publication_year": 2024, "doi": "10.1177/02698811231225609", "pubmed_id": "38214279", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811231225609", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Microdosing,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:38214279", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811231225609", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38214279", "source_url": "https://doi.org/10.1177/02698811231225609", "doi": "10.1177/02698811231225609", "pmid": "38214279", "publication_date": "2024-01-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1261, "title": "Safety, feasibility, tolerability, and clinical effects of repeated psilocybin dosing combined with non-directive support in the treatment of obsessive-compulsive disorder: protocol for a randomized, waitlist-controlled trial with blinded ratings", "authors": "Terence H. W. Ching, Lucia Amoroso, Calvin Bohner, Elizabeth J. D’Amico, Jeffrey Eilbott, Tara Entezar, Madison Fitzpatrick, Geena Fram, Rachael Grazioplene, Jamila Hokanson, Anastasia Jankovsky, Stephen A. Kichuk, Bradford Martins, Prerana Patel, Henry Schaer, Sarah Shnayder, Chelsea Witherow, Christopher Pittenger, Benjamin Kelmendi", "journal": "Frontiers in Psychiatry", "publication_date": "2024-01-08", "publication_year": 2024, "doi": "10.3389/fpsyt.2023.1278823", "pubmed_id": "38264632", "openalex_id": "https://openalex.org/W4390753253", "source_url": "https://doi.org/10.3389/fpsyt.2023.1278823", "substance_tags": "psilocybin", "topic_tags": "OCD,Chronic Pain,Pharmacology,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38264632", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1278823", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38264632", "source_url": "https://doi.org/10.3389/fpsyt.2023.1278823", "doi": "10.3389/fpsyt.2023.1278823", "pmid": "38264632", "publication_date": "2024-01-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3623, "title": "Safety and Tolerability of Psilocybin in Post-Traumatic Stress Disorder", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2024-01-04", "publication_year": 2024, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05562973", "substance_tags": "psilocybin", "topic_tags": "PTSD,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05562973", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05562973", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05562973", "source_url": "https://clinicaltrials.gov/study/NCT05562973", "doi": "", "pmid": "", "publication_date": "2024-01-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3066, "title": "Behavioural Investigations of Psilocybin in Animals 1962-2021: A Scoping Review", "authors": "Shore R, Dobson K, Thomson N, Barnim N, Bergman H, Rideout K, McKeown S, Olmstead MC, Goldie C, Dumont E.", "journal": "bioRxiv", "publication_date": "2024-01-04", "publication_year": 2024, "doi": "10.1101/2024.01.04.574146", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2024.01.04.574146", "substance_tags": "psilocybin,psilocin", "topic_tags": "Mechanism of Action,Review Article,Safety,Adverse Events,Toxicity", "study_type": "Review Article", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2024.01.04.574146", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2024.01.04.574146", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2024.01.04.574146", "source_url": "https://doi.org/10.1101/2024.01.04.574146", "doi": "10.1101/2024.01.04.574146", "pmid": "", "publication_date": "2024-01-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3174, "title": "Psilocybin-Assisted Therapy for Severe Alcohol Use Disorder: Protocol for a Double-Blind, Randomized, Placebo-Controlled, 7-month Parallel-Group Phase II Superiority Trial", "authors": "Vanderijst L, Hever F, Buot A, Dauré C, Benoit J, Hanak C, Veeser J, Morgiève M, Campanella S, Kornreich C, Mallet L, Leys C, Noël X.", "journal": "Research Square", "publication_date": "2024-01-03", "publication_year": 2024, "doi": "10.21203/rs.3.rs-3829237/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3829237/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3829237/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3829237/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3829237/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3829237/v1", "doi": "10.21203/rs.3.rs-3829237/v1", "pmid": "", "publication_date": "2024-01-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4722, "title": "Psilocybin’s Role in Major Depressive Disorder: A Scoping Review", "authors": "Barajas, Carlos", "journal": "Digital Commons - George Fox University (George Fox University)", "publication_date": "2023-12-31", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W7110533292", "source_url": "https://digitalcommons.georgefox.edu/dmsc/31", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Receptor Pharmacology,Consciousness,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "https://digitalcommons.georgefox.edu/dmsc/31", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://digitalcommons.georgefox.edu/dmsc/31", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://digitalcommons.georgefox.edu/dmsc/31", "source_url": "https://digitalcommons.georgefox.edu/dmsc/31", "doi": "", "pmid": "", "publication_date": "2023-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4705, "title": "Government-funded trial will test psilocybin as treatment for opioid use disorder", "authors": "", "journal": "Pharmaceutical journal/˜The œpharmaceutical journal", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1211/pj.2024.1.335169", "pubmed_id": null, "openalex_id": "https://openalex.org/W4403684433", "source_url": "https://doi.org/10.1211/pj.2024.1.335169", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1211/pj.2024.1.335169", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1211/pj.2024.1.335169", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1211/pj.2024.1.335169", "source_url": "https://doi.org/10.1211/pj.2024.1.335169", "doi": "10.1211/pj.2024.1.335169", "pmid": "", "publication_date": "2023-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4698, "title": "Introduction to the Special Section on Psychedelics Research and Treatment", "authors": "Dominic Sisti", "journal": "Perspectives in biology and medicine", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1353/pbm.2024.a919714", "pubmed_id": "38662067", "openalex_id": "https://openalex.org/W4391959887", "source_url": "http://dx.doi.org/10.1353/pbm.2024.a919714", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Spirituality,Mystical Experience,Healthcare Workers,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38662067", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1353/pbm.2024.a919714", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38662067", "source_url": "http://dx.doi.org/10.1353/pbm.2024.a919714", "doi": "10.1353/pbm.2024.a919714", "pmid": "38662067", "publication_date": "2023-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4697, "title": "Psychedelic Mushrooms: The Use of Psilocybin in the Treatment of Mental Disorders", "authors": "Correa RMS", "journal": "Annals of Bioethics & Clinical Applications", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.23880/abca-16000266", "pubmed_id": null, "openalex_id": "https://openalex.org/W4391147144", "source_url": "https://doi.org/10.23880/abca-16000266", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.23880/abca-16000266", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.23880/abca-16000266", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.23880/abca-16000266", "source_url": "https://doi.org/10.23880/abca-16000266", "doi": "10.23880/abca-16000266", "pmid": "", "publication_date": "2023-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4695, "title": "Psilocybin for the treatment of posttraumatic stress disorder: A magic to treat a harmony of illusions?", "authors": "Rakesh Khanna", "journal": "Journal of Indira Gandhi Institute Of Medical Sciences", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.4103/jigims.jigims_60_23", "pubmed_id": null, "openalex_id": "https://openalex.org/W4392948774", "source_url": "https://doi.org/10.4103/jigims.jigims_60_23", "substance_tags": "psilocybin", "topic_tags": "PTSD,Review Article,Safety,Drug Interactions", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.4103/jigims.jigims_60_23", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.4103/jigims.jigims_60_23", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.4103/jigims.jigims_60_23", "source_url": "https://doi.org/10.4103/jigims.jigims_60_23", "doi": "10.4103/jigims.jigims_60_23", "pmid": "", "publication_date": "2023-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1279, "title": "Longitudinal associations between psychedelic use and unusual visual experiences in the United States and the United Kingdom.", "authors": "Simonsson O, Hendricks PS, Stenfors CU, Goldberg SB, Honk L, Osika W", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1177/02698811231218931", "pubmed_id": "38140891", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38140891/", "substance_tags": "psilocybin", "topic_tags": "Case Report,Observational Study,Safety,Drug Interactions", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:37", "bibtex": null, "source_record_id": "PMID:38140891", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38140891/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38140891", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38140891/", "doi": "10.1177/02698811231218931", "pmid": "38140891", "publication_date": "2023-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1277, "title": "Is Poorly Assisted Psilocybin Treatment an Increasing Risk?", "authors": "Schenberg EE, King F, da Fonseca JE, Roseman L.", "journal": null, "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1176/appi.ajp.20230664", "pubmed_id": "38161296", "openalex_id": null, "source_url": "https://doi.org/10.1176/appi.ajp.20230664", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:38161296", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38161296", "source_url": "https://doi.org/10.1176/appi.ajp.20230664", "doi": "10.1176/appi.ajp.20230664", "pmid": "38161296", "publication_date": "2023-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1274, "title": "The safety of supported psilocybin use in Oregon.", "authors": "Smith WR, Sisti DA, Appelbaum PS.", "journal": null, "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1038/s41591-023-02727-4", "pubmed_id": "38238619", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41591-023-02727-4", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:38238619", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38238619", "source_url": "https://doi.org/10.1038/s41591-023-02727-4", "doi": "10.1038/s41591-023-02727-4", "pmid": "38238619", "publication_date": "2023-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1271, "title": "The Psychedelic Future of Post-Traumatic Stress Disorder Treatment.", "authors": "Zaretsky TG, Jagodnik KM, Barsic R, Antonio JH, Bonanno PA, MacLeod C, Pierce C, Carney H, Morrison MT, Saylor C, Danias G, Lepow L, Yehuda R.", "journal": null, "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.2174/1570159x22666231027111147", "pubmed_id": "38284341", "openalex_id": null, "source_url": "https://doi.org/10.2174/1570159x22666231027111147", "substance_tags": "psilocybin", "topic_tags": "PTSD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:38284341", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.2174/1570159x22666231027111147", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38284341", "source_url": "https://doi.org/10.2174/1570159x22666231027111147", "doi": "10.2174/1570159x22666231027111147", "pmid": "38284341", "publication_date": "2023-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1268, "title": "Efficacy, Safety, and Tolerability of Psychedelics in Treatment-Resistant Depression (TRD).", "authors": "Olivier B, Olivier JDA.", "journal": null, "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1007/978-981-97-4402-2_3", "pubmed_id": "39261423", "openalex_id": null, "source_url": "https://doi.org/10.1007/978-981-97-4402-2_3", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:39261423", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/978-981-97-4402-2_3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:39261423", "source_url": "https://doi.org/10.1007/978-981-97-4402-2_3", "doi": "10.1007/978-981-97-4402-2_3", "pmid": "39261423", "publication_date": "2023-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1234, "title": "Keeping the promise: a critique of the current state of microdosing research.", "authors": "Petranker R, Anderson T, Fewster EC, Aberman Y, Hazan M, Gaffrey M, Seli P", "journal": "Frontiers in psychiatry", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.3389/fpsyt.2024.1217102", "pubmed_id": "38374976", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38374976/", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Creativity,Review Article,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:37", "bibtex": null, "source_record_id": "PMID:38374976", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/38374976/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38374976", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38374976/", "doi": "10.3389/fpsyt.2024.1217102", "pmid": "38374976", "publication_date": "2023-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1196, "title": "Safety pharmacology of acute psilocybin administration in healthy participants", "authors": "Isabelle Straumann, Friederike Holze, A. Becker, Laura Ley, Nepomuk Halter, Matthias E. Liechti", "journal": "Neuroscience Applied", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1016/j.nsa.2024.104060", "pubmed_id": "40656108", "openalex_id": "https://openalex.org/W4392888270", "source_url": "https://doi.org/10.1016/j.nsa.2024.104060", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Receptor Pharmacology,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:40656108", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.nsa.2024.104060", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40656108", "source_url": "https://doi.org/10.1016/j.nsa.2024.104060", "doi": "10.1016/j.nsa.2024.104060", "pmid": "40656108", "publication_date": "2023-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1054, "title": "Exploring psychedelic use in athletes and their attitudes toward psilocybin-assisted therapy in concussion recovery", "authors": "Baeleigh VanderZwaag, Albert Garcia-Romeu, Mauricio A. García-Barrera", "journal": "Therapeutic Advances in Psychopharmacology", "publication_date": "2023-12-31", "publication_year": 2023, "doi": "10.1177/20451253241264812", "pubmed_id": "39132012", "openalex_id": "https://openalex.org/W4401432739", "source_url": "https://doi.org/10.1177/20451253241264812", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Aging,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:39132012", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20451253241264812", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:39132012", "source_url": "https://doi.org/10.1177/20451253241264812", "doi": "10.1177/20451253241264812", "pmid": "39132012", "publication_date": "2023-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5702, "title": "Psilocybin Therapy for Depression: A Review of Current Molecular Knowledge", "authors": "Verheijen Marcha C.T.", "journal": "Journal of the Netherlands Society of Toxicology", "publication_date": "2023-12-30", "publication_year": 2023, "doi": "10.61833/jnst.2024.0002", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.61833/jnst.2024.0002", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "Crossref", "publication_status": "published", "date_added": "2026-07-11 19:28:11", "last_checked": "2026-07-11 19:28:11", "bibtex": null, "source_record_id": "DOI:10.61833/jnst.2024.0002", "abstract_available": true, "abstract_source": "Crossref", "abstract_source_url": "https://doi.org/10.61833/jnst.2024.0002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Crossref", "source_record_id": "DOI:10.61833/jnst.2024.0002", "source_url": "https://doi.org/10.61833/jnst.2024.0002", "doi": "10.61833/jnst.2024.0002", "pmid": "", "publication_date": "2023-12-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4723, "title": "Psilocybin - new remedy for patients with psychiatric disorders? Critical analysis of the current state of knowledge", "authors": "Karolina Wąsik, Sebastian Tomaszuk, Magda Wojtuś", "journal": "Journal of Education Health and Sport", "publication_date": "2023-12-29", "publication_year": 2023, "doi": "10.12775/jehs.2023.50.01.005", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390439845", "source_url": "http://dx.doi.org/10.12775/jehs.2023.50.01.005", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Pharmacology,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2023.50.01.005", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.12775/jehs.2023.50.01.005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2023.50.01.005", "source_url": "http://dx.doi.org/10.12775/jehs.2023.50.01.005", "doi": "10.12775/jehs.2023.50.01.005", "pmid": "", "publication_date": "2023-12-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3751, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin", "authors": "Tabaac BJ, Shinozuka K, Arenas A, Beutler BD, Cherian K, Evans VD, Fasano C, Muir OS.", "journal": "PsyArXiv", "publication_date": "2023-12-25", "publication_year": 2023, "doi": "10.31234/osf.io/a8xwk", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/a8xwk", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:18", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/a8xwk", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/a8xwk", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/a8xwk", "source_url": "https://doi.org/10.31234/osf.io/a8xwk", "doi": "10.31234/osf.io/a8xwk", "pmid": "", "publication_date": "2023-12-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3572, "title": "Psilocybin-assisted Psychotherapy in the Management of Anxiety Associated With Stage IV Melanoma.", "authors": "Multidisciplinary Association for Psychedelic Studies", "journal": "ClinicalTrials.gov", "publication_date": "2023-12-25", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT00979693", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Spirituality,Mystical Experience,Safety,Immune Function", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT00979693", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT00979693", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT00979693", "source_url": "https://clinicaltrials.gov/study/NCT00979693", "doi": "", "pmid": "", "publication_date": "2023-12-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3133, "title": "Psychedelic Therapy: A Primer for Primary Care Clinicians - Part IV. Psilocybin", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-12-25", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "source_url": "https://osf.io/preprints/psyarxiv/a8xwk_v1", "doi": "", "pmid": "", "publication_date": "2023-12-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1324, "title": "Potential use of psilocybin drugs in the treatment of depression.", "authors": "Śladowska K, Kawalec P, Brzostek T, Pilc A.", "journal": null, "publication_date": "2023-12-25", "publication_year": 2023, "doi": "10.1080/14728214.2023.2264180", "pubmed_id": "37817501", "openalex_id": null, "source_url": "https://doi.org/10.1080/14728214.2023.2264180", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37817501", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/14728214.2023.2264180", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37817501", "source_url": "https://doi.org/10.1080/14728214.2023.2264180", "doi": "10.1080/14728214.2023.2264180", "pmid": "37817501", "publication_date": "2023-12-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1183, "title": "Acceptability of psilocybin-assisted group therapy in patients with cancer and major depressive disorder: Qualitative analysis", "authors": "Yvan Beaussant, Elise C. Tarbi, Kabir Nigam, Skye A. Miner, Zachary Sager, Justin J. Sanders, Michael Ljuslin, Benjamin Guérin, Paul Thambi, James A. Tulsky, Manish Agrawal", "journal": "Cancer", "publication_date": "2023-12-17", "publication_year": 2023, "doi": "10.1002/cncr.35024", "pubmed_id": "38105653", "openalex_id": "https://openalex.org/W4389895437", "source_url": "https://doi.org/10.1002/cncr.35024", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Aging,Clinical Trial,Cancer Patients,Safety,Toxicity,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38105653", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cncr.35024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38105653", "source_url": "https://doi.org/10.1002/cncr.35024", "doi": "10.1002/cncr.35024", "pmid": "38105653", "publication_date": "2023-12-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1181, "title": "Psilocybin-assisted group therapy in patients with cancer diagnosed with a major depressive disorder", "authors": "Manish Agrawal, William A. Richards, Yvan Beaussant, Sarah Shnayder, Rezvan Ameli, Kimberly Roddy, Norma Stevens, Brian D. Richards, Nick Schor, Heather Honstein, Betsy Jenkins, Mark Bates, Paul Thambi", "journal": "Cancer", "publication_date": "2023-12-17", "publication_year": 2023, "doi": "10.1002/cncr.35010", "pubmed_id": "38105655", "openalex_id": "https://openalex.org/W4389900078", "source_url": "https://doi.org/10.1002/cncr.35010", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Headache / Migraine,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38105655", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cncr.35010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38105655", "source_url": "https://doi.org/10.1002/cncr.35010", "doi": "10.1002/cncr.35010", "pmid": "38105655", "publication_date": "2023-12-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3549, "title": "Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2023-12-14", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT02981173", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT02981173", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT02981173", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT02981173", "source_url": "https://clinicaltrials.gov/study/NCT02981173", "doi": "", "pmid": "", "publication_date": "2023-12-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1308, "title": "A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions.", "authors": "Brennan W, Kelman AR, Belser AB.", "journal": null, "publication_date": "2023-12-12", "publication_year": 2023, "doi": "10.1089/psymed.2023.0007", "pubmed_id": "40046864", "openalex_id": null, "source_url": "https://doi.org/10.1089/psymed.2023.0007", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:40046864", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0007", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40046864", "source_url": "https://doi.org/10.1089/psymed.2023.0007", "doi": "10.1089/psymed.2023.0007", "pmid": "40046864", "publication_date": "2023-12-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1311, "title": "Drugs for depressionr.", "authors": "", "journal": "The Medical letter on drugs and therapeutics", "publication_date": "2023-12-10", "publication_year": 2023, "doi": "10.58347/tml.2023.1691a", "pubmed_id": "38133585", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/38133585/", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:37", "bibtex": null, "source_record_id": "PMID:38133585", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:38133585", "source_url": "https://pubmed.ncbi.nlm.nih.gov/38133585/", "doi": "10.58347/tml.2023.1691a", "pmid": "38133585", "publication_date": "2023-12-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1124, "title": "Psilocybin in Bipolar II Study Provides Preliminary Data on Safety", "authors": "David B. Yaden, Natalie Gukasyan, Sandeep M. Nayak", "journal": "JAMA Psychiatry", "publication_date": "2023-12-05", "publication_year": 2023, "doi": "10.1001/jamapsychiatry.2023.4680", "pubmed_id": "38055240", "openalex_id": "https://openalex.org/W4389397300", "source_url": "http://dx.doi.org/10.1001/jamapsychiatry.2023.4680", "substance_tags": "psilocybin", "topic_tags": "Cancer Patients,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38055240", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1001/jamapsychiatry.2023.4680", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38055240", "source_url": "http://dx.doi.org/10.1001/jamapsychiatry.2023.4680", "doi": "10.1001/jamapsychiatry.2023.4680", "pmid": "38055240", "publication_date": "2023-12-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4730, "title": "Studying classic psychedelics for the management of headache disorders: Considerations for Veterans", "authors": "Emmanuelle A. D. Schindler, Jason J. Sico", "journal": "Journal of Military Veteran and Family Health", "publication_date": "2023-11-30", "publication_year": 2023, "doi": "10.3138/jmvfh-2023-0006", "pubmed_id": null, "openalex_id": "https://openalex.org/W4389613923", "source_url": "https://doi.org/10.3138/jmvfh-2023-0006", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Receptor Pharmacology,Aging,Veterans,Safety,Adverse Events", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.3138/jmvfh-2023-0006", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3138/jmvfh-2023-0006", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3138/jmvfh-2023-0006", "source_url": "https://doi.org/10.3138/jmvfh-2023-0006", "doi": "10.3138/jmvfh-2023-0006", "pmid": "", "publication_date": "2023-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1307, "title": "Psilocybin for Opioid Use Disorder in Two Adults Stabilized on Buprenorphine: A Technical Report on Study Modifications and Preliminary Findings", "authors": "Christopher R. Nicholas, David Horton, Julia Malicki, Amelia Baltes, Paul R. Hutson, Randall Brown", "journal": "Psychedelic Medicine", "publication_date": "2023-11-30", "publication_year": 2023, "doi": "10.1089/psymed.2023.0012", "pubmed_id": "40046866", "openalex_id": "https://openalex.org/W4389304198", "source_url": "https://doi.org/10.1089/psymed.2023.0012", "substance_tags": "psilocybin", "topic_tags": "Addiction,Pharmacology,Receptor Pharmacology,Safety,Adverse Events,Toxicity,Drug Interactions", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:40046866", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40046866", "source_url": "https://doi.org/10.1089/psymed.2023.0012", "doi": "10.1089/psymed.2023.0012", "pmid": "40046866", "publication_date": "2023-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1127, "title": "Current Understanding on Psilocybin for Major Depressive Disorder: A Review Focusing on Clinical Trials.", "authors": "Wang SM, Kim S, Choi WS, Lim HK, Woo YS, Pae CU, Bahk WM.", "journal": null, "publication_date": "2023-11-29", "publication_year": 2023, "doi": "10.9758/cpn.23.1134", "pubmed_id": "38627070", "openalex_id": null, "source_url": "https://doi.org/10.9758/cpn.23.1134", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Default Mode Network,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38627070", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.9758/cpn.23.1134", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38627070", "source_url": "https://doi.org/10.9758/cpn.23.1134", "doi": "10.9758/cpn.23.1134", "pmid": "38627070", "publication_date": "2023-11-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3629, "title": "A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Safety, Tolerability and Efficacy of Psilocybin-Assisted Psychotherapy in Treating Severe Depression Among Adults With Post-Traumatic Stress Disorder (PTSD).", "authors": "Apex Labs Ltd.", "journal": "ClinicalTrials.gov", "publication_date": "2023-11-28", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06141876", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06141876", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06141876", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06141876", "source_url": "https://clinicaltrials.gov/study/NCT06141876", "doi": "", "pmid": "", "publication_date": "2023-11-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3781, "title": "Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approach", "authors": "McAlpine R, Krajnović K, Khan M, Morometescu L, Simonsson O, Sacchet M, Kamboj S.", "journal": "PsyArXiv", "publication_date": "2023-11-21", "publication_year": 2023, "doi": "10.31234/osf.io/9ev27", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/9ev27", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:21", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/9ev27", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/9ev27", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/9ev27", "source_url": "https://doi.org/10.31234/osf.io/9ev27", "doi": "10.31234/osf.io/9ev27", "pmid": "", "publication_date": "2023-11-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3304, "title": "Development of a Digital Intervention for Psychedelic Preparation (DIPP): a theory- and person-centred approach", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-11-21", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/9ev27_v1", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Safety", "study_type": "Qualitative Study", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:50", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/9ev27_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/9ev27_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/9ev27_v1", "source_url": "https://osf.io/preprints/psyarxiv/9ev27_v1", "doi": "", "pmid": "", "publication_date": "2023-11-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4733, "title": "Altered stakes: Identifying gaps in the informed consent process for psychedelic-assisted therapy trials", "authors": "Tahlia R. Harrison", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-11-19", "publication_year": 2023, "doi": "10.1556/2054.2023.00267", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388822593", "source_url": "https://doi.org/10.1556/2054.2023.00267", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2023.00267", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2023.00267", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2023.00267", "source_url": "https://doi.org/10.1556/2054.2023.00267", "doi": "10.1556/2054.2023.00267", "pmid": "", "publication_date": "2023-11-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4735, "title": "Psychedelic Integration: Psychotherapy for non-ordinary states of consciousness", "authors": "Danelle Jones", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-11-15", "publication_year": 2023, "doi": "10.1556/2054.2023.00306", "pubmed_id": null, "openalex_id": "https://openalex.org/W4388730617", "source_url": "http://dx.doi.org/10.1556/2054.2023.00306", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Chronic Pain,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:44", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2023.00306", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1556/2054.2023.00306", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2023.00306", "source_url": "http://dx.doi.org/10.1556/2054.2023.00306", "doi": "10.1556/2054.2023.00306", "pmid": "", "publication_date": "2023-11-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 919, "title": "Efficacy and Safety of Four Psychedelic-Assisted Therapies for Adults with Symptoms of Depression, Anxiety, and Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis.", "authors": "Bahji A, Lunsky I, Gutierrez G, Vazquez G.", "journal": null, "publication_date": "2023-11-14", "publication_year": 2023, "doi": "10.1080/02791072.2023.2278586", "pubmed_id": "37968944", "openalex_id": null, "source_url": "https://doi.org/10.1080/02791072.2023.2278586", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Aging,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:37968944", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2023.2278586", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37968944", "source_url": "https://doi.org/10.1080/02791072.2023.2278586", "doi": "10.1080/02791072.2023.2278586", "pmid": "37968944", "publication_date": "2023-11-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3364, "title": "Aesthetic Chills Mitigate Maladaptive Cognition In Depression", "authors": "Schoeller F, Jain A, Adrien V, Maes P, Reggente N.", "journal": "Research Square", "publication_date": "2023-11-13", "publication_year": 2023, "doi": "10.21203/rs.3.rs-3582420/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3582420/v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Consciousness,Emotional Processing,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3582420/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3582420/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3582420/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3582420/v1", "doi": "10.21203/rs.3.rs-3582420/v1", "pmid": "", "publication_date": "2023-11-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1335, "title": "Epidemiology of classic psychedelic substances: results from a Norwegian internet convenience sample", "authors": "Tor-Morten Kvam, Malin V. Uthaug, Kristoffer Andreas Aamodt Andersen, Birk Berggrav Refsum, Paula Aarseth Tunstad, Lowan H. Stewart, Henrik Børsting Jacobsen, Cato Grønnerød", "journal": "Frontiers in Psychiatry", "publication_date": "2023-11-12", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1287196", "pubmed_id": "38025484", "openalex_id": "https://openalex.org/W4388646562", "source_url": "https://doi.org/10.3389/fpsyt.2023.1287196", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Clinical Trial,Observational Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38025484", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1287196", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38025484", "source_url": "https://doi.org/10.3389/fpsyt.2023.1287196", "doi": "10.3389/fpsyt.2023.1287196", "pmid": "38025484", "publication_date": "2023-11-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3680, "title": "The Safety and Efficacy Of Psilocybin as an Adjunctive Therapy in Participants With Treatment Resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2023-11-08", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04739865", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04739865", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04739865", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04739865", "source_url": "https://clinicaltrials.gov/study/NCT04739865", "doi": "", "pmid": "", "publication_date": "2023-11-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1288, "title": "Synergistic psychedelic - NMDAR modulator treatment for neuropsychiatric disorders.", "authors": "Heresco-Levy U, Lerer B.", "journal": null, "publication_date": "2023-11-08", "publication_year": 2023, "doi": "10.1038/s41380-023-02312-8", "pubmed_id": "37945694", "openalex_id": null, "source_url": "https://doi.org/10.1038/s41380-023-02312-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Safety,Drug Interactions", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37945694", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1038/s41380-023-02312-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37945694", "source_url": "https://doi.org/10.1038/s41380-023-02312-8", "doi": "10.1038/s41380-023-02312-8", "pmid": "37945694", "publication_date": "2023-11-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1321, "title": "Psychedelic renaissance: Revitalized potential therapies for psychiatric disorders.", "authors": "Rhee TG, Davoudian PA, Sanacora G, Wilkinson ST.", "journal": null, "publication_date": "2023-11-01", "publication_year": 2023, "doi": "10.1016/j.drudis.2023.103818", "pubmed_id": "37925136", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.drudis.2023.103818", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:37925136", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.drudis.2023.103818", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37925136", "source_url": "https://doi.org/10.1016/j.drudis.2023.103818", "doi": "10.1016/j.drudis.2023.103818", "pmid": "37925136", "publication_date": "2023-11-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1340, "title": "Determination of amanita peptide and tryptamine toxins in wild mushrooms by high performance liquid chromatography-tandem mass spectrometry", "authors": "Leiqi LIU, Jing-Ze Chen, Wusheng Fu, Cui-Ying Tang", "journal": "Chinese Journal of Chromatography", "publication_date": "2023-10-31", "publication_year": 2023, "doi": "10.3724/sp.j.1123.2023.07013", "pubmed_id": "37968816", "openalex_id": "https://openalex.org/W4388737296", "source_url": "http://dx.doi.org/10.3724/sp.j.1123.2023.07013", "substance_tags": "psilocybin", "topic_tags": "Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37968816", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.3724/sp.j.1123.2023.07013", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37968816", "source_url": "http://dx.doi.org/10.3724/sp.j.1123.2023.07013", "doi": "10.3724/sp.j.1123.2023.07013", "pmid": "37968816", "publication_date": "2023-10-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1336, "title": "Beyond the 5-HT2A Receptor: Classic and Nonclassic Targets in Psychedelic Drug Action.", "authors": "Cameron LP, Benetatos J, Lewis V, Bonniwell EM, Jaster AM, Moliner R, Castrén E, McCorvy JD, Palner M, Aguilar-Valles A.", "journal": null, "publication_date": "2023-10-31", "publication_year": 2023, "doi": "10.1523/jneurosci.1384-23.2023", "pubmed_id": "37940583", "openalex_id": null, "source_url": "https://doi.org/10.1523/jneurosci.1384-23.2023", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Review Article,Safety,Drug Interactions", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37940583", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1523/jneurosci.1384-23.2023", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37940583", "source_url": "https://doi.org/10.1523/jneurosci.1384-23.2023", "doi": "10.1523/jneurosci.1384-23.2023", "pmid": "37940583", "publication_date": "2023-10-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1069, "title": "The Tolerability and Safety of Psilocybin in Psychiatric and Substance-Dependence Conditions: A Systematic Review.", "authors": "Kaminski D, Reinert JP.", "journal": null, "publication_date": "2023-10-29", "publication_year": 2023, "doi": "10.1177/10600280231205645", "pubmed_id": "37902038", "openalex_id": null, "source_url": "https://doi.org/10.1177/10600280231205645", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37902038", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/10600280231205645", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37902038", "source_url": "https://doi.org/10.1177/10600280231205645", "doi": "10.1177/10600280231205645", "pmid": "37902038", "publication_date": "2023-10-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3798, "title": "A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues", "authors": "Kratina S, Lo C, Schwartz R, Strike C, Jopling S, Nayfeh A, Rush B.", "journal": "PsyArXiv", "publication_date": "2023-10-26", "publication_year": 2023, "doi": "10.31234/osf.io/4gfyd", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/4gfyd", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/4gfyd", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/4gfyd", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/4gfyd", "source_url": "https://doi.org/10.31234/osf.io/4gfyd", "doi": "10.31234/osf.io/4gfyd", "pmid": "", "publication_date": "2023-10-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3369, "title": "A protocol for a scoping review of psychedelic interventions to alleviate psychological suffering in populations coping with end-of-life issues", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-10-26", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Mechanism of Action,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "source_url": "https://osf.io/preprints/psyarxiv/4gfyd_v1", "doi": "", "pmid": "", "publication_date": "2023-10-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4747, "title": "Extended difficulties following the use of psychedelic drugs: A mixed methods study", "authors": "Jules Evans, Oliver Robinson, Eirini K. Argyri, Shayam Suseelan, Ashleigh Murphy-Beiner, Rosalind McAlpine, David Luke, Katrina Michelle, Ed Prideaux", "journal": "PLoS ONE", "publication_date": "2023-10-23", "publication_year": 2023, "doi": "10.1371/journal.pone.0293349", "pubmed_id": "37874826", "openalex_id": "https://openalex.org/W4387902564", "source_url": "https://doi.org/10.1371/journal.pone.0293349", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Receptor Pharmacology,Emotional Processing,Safety", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 06:34:45", "bibtex": null, "source_record_id": "PMID:37874826", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0293349", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37874826", "source_url": "https://doi.org/10.1371/journal.pone.0293349", "doi": "10.1371/journal.pone.0293349", "pmid": "37874826", "publication_date": "2023-10-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1323, "title": "Cardiovascular safety of psychedelic medicine: current status and future directions.", "authors": "Wsół A.", "journal": null, "publication_date": "2023-10-23", "publication_year": 2023, "doi": "10.1007/s43440-023-00539-4", "pubmed_id": "37874530", "openalex_id": null, "source_url": "https://doi.org/10.1007/s43440-023-00539-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Microdosing,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37874530", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s43440-023-00539-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37874530", "source_url": "https://doi.org/10.1007/s43440-023-00539-4", "doi": "10.1007/s43440-023-00539-4", "pmid": "37874530", "publication_date": "2023-10-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3094, "title": "Pharmacological and behavioral effects of tryptamines present in psilocybin-containing mushrooms", "authors": "Rakoczy RJ, Runge GN, Sen AK, Sandoval O, Nguyen Q, Roberts BR, Sciortino JH, Gibbons WJ, Friedberg LM, Andrew Jones J, McMurray MS.", "journal": "bioRxiv", "publication_date": "2023-10-22", "publication_year": 2023, "doi": "10.1101/2023.10.19.563138", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.10.19.563138", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Receptor Pharmacology,Biomarkers,Animal Study,In Vitro Study,Safety", "study_type": "Animal Study", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:46", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "DOI:10.1101/2023.10.19.563138", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.10.19.563138", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2023.10.19.563138", "source_url": "https://doi.org/10.1101/2023.10.19.563138", "doi": "10.1101/2023.10.19.563138", "pmid": "", "publication_date": "2023-10-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1218, "title": "Psilocybin, an Effective Treatment for Major Depressive Disorder in Adults - A Systematic Review.", "authors": "Watford T, Masood N.", "journal": null, "publication_date": "2023-10-15", "publication_year": 2023, "doi": "10.9758/cpn.23.1120", "pubmed_id": "38247407", "openalex_id": null, "source_url": "https://doi.org/10.9758/cpn.23.1120", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:38247407", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.9758/cpn.23.1120", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38247407", "source_url": "https://doi.org/10.9758/cpn.23.1120", "doi": "10.9758/cpn.23.1120", "pmid": "38247407", "publication_date": "2023-10-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3619, "title": "Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study II", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2023-10-11", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03806985", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03806985", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03806985", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03806985", "source_url": "https://clinicaltrials.gov/study/NCT03806985", "doi": "", "pmid": "", "publication_date": "2023-10-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3569, "title": "Safety and Efficacy of Psilocybin for the Treatment of Headache Disorders: Sub-Study I", "authors": "Yale University", "journal": "ClinicalTrials.gov", "publication_date": "2023-10-11", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03341689", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03341689", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03341689", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03341689", "source_url": "https://clinicaltrials.gov/study/NCT03341689", "doi": "", "pmid": "", "publication_date": "2023-10-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 985, "title": "Therapeutic Potential of Psilocybin for Treating Psychological Distress among Survivors of Adverse Childhood Experiences: Evidence on Acceptability and Potential Efficacy of Psilocybin Use", "authors": "Kiffer G. Card, Ashmita Grewal, Kalysha Closson, Gina Martin, Laura Baracaldo, Sandra Allison, Daniel J. Kruger, Zach Walsh", "journal": "Journal of Psychoactive Drugs", "publication_date": "2023-10-09", "publication_year": 2023, "doi": "10.1080/02791072.2023.2268640", "pubmed_id": "37815125", "openalex_id": "https://openalex.org/W4387473380", "source_url": "https://doi.org/10.1080/02791072.2023.2268640", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37815125", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2023.2268640", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37815125", "source_url": "https://doi.org/10.1080/02791072.2023.2268640", "doi": "10.1080/02791072.2023.2268640", "pmid": "37815125", "publication_date": "2023-10-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3188, "title": "Synergistic, Multi-level Understanding of Psychedelics: Three Systematic Reviews and Meta-analyses of Their Pharmacology, Neuroimaging and Phenomenology", "authors": "Shinozuka K, Jerotic K, Mediano P, Zhao AT, Preller KH, Carhart-Harris R, Kringelbach ML.", "journal": "bioRxiv", "publication_date": "2023-10-06", "publication_year": 2023, "doi": "10.1101/2023.10.06.561183", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.10.06.561183", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Brain Imaging,Pharmacology,Receptor Pharmacology,Consciousness,Aging,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "bioRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2023.10.06.561183", "abstract_available": true, "abstract_source": "bioRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.10.06.561183", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "bioRxiv", "source_record_id": "DOI:10.1101/2023.10.06.561183", "source_url": "https://doi.org/10.1101/2023.10.06.561183", "doi": "10.1101/2023.10.06.561183", "pmid": "", "publication_date": "2023-10-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4754, "title": "Psychedelics and Psychotherapy: Is the Whole Greater than the Sum of its Parts?", "authors": "Robert H. Dworkin, Michael McDermott, Sandeep M. Nayak, Eric C. Strain", "journal": "Clinical Pharmacology & Therapeutics", "publication_date": "2023-10-04", "publication_year": 2023, "doi": "10.1002/cpt.3050", "pubmed_id": "37795632", "openalex_id": "https://openalex.org/W4387357883", "source_url": "https://doi.org/10.1002/cpt.3050", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Headache / Migraine,Neuroplasticity,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Microdosing,Wellbeing,Clinical Trial,Healthcare Workers,Safety,Adverse Events,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37795632", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/cpt.3050", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37795632", "source_url": "https://doi.org/10.1002/cpt.3050", "doi": "10.1002/cpt.3050", "pmid": "37795632", "publication_date": "2023-10-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1360, "title": "An open-label pilot trial assessing tolerability and feasibility of LSD microdosing in patients with major depressive disorder (LSDDEP1)", "authors": "C Donegan, Dimitri Daldegan-Bueno, Rachael L. Sumner, David B Menkes, William J. Evans, Nicholas Hoeh, Frederick Sundram, Lisa Reynolds, Rhys Ponton, Alana Cavadino, Todd Smith, Partha S. Roop, Nathan Allen, Binu Abeysinghe, Darren Svirskis, Anna Forsyth, Mahima Bansal, Suresh Muthukumaraswamy", "journal": "Pilot and Feasibility Studies", "publication_date": "2023-10-04", "publication_year": 2023, "doi": "10.1186/s40814-023-01399-8", "pubmed_id": "37798662", "openalex_id": "https://openalex.org/W4387372869", "source_url": "https://doi.org/10.1186/s40814-023-01399-8", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Microdosing,Clinical Trial,Randomized Controlled Trial,Observational Study,Healthy Volunteers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37798662", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s40814-023-01399-8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37798662", "source_url": "https://doi.org/10.1186/s40814-023-01399-8", "doi": "10.1186/s40814-023-01399-8", "pmid": "37798662", "publication_date": "2023-10-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4755, "title": "Psilocybin shows promising results in subjects continuing to use an antidepressant", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2023-10-03", "publication_year": 2023, "doi": "10.1002/pu.31089", "pubmed_id": null, "openalex_id": "https://openalex.org/W4387361294", "source_url": "http://dx.doi.org/10.1002/pu.31089", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1002/pu.31089", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1002/pu.31089", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.31089", "source_url": "http://dx.doi.org/10.1002/pu.31089", "doi": "10.1002/pu.31089", "pmid": "", "publication_date": "2023-10-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1368, "title": "Exploring the Potential Utility of Psychedelic Therapy for Patients With Amyotrophic Lateral Sclerosis.", "authors": "Gold ND, Mallard AJ, Hermann JC, Zeifman RJ, Pagni BA, Bogenschutz MP, Ross S", "journal": "Journal of palliative medicine", "publication_date": "2023-09-30", "publication_year": 2023, "doi": "10.1089/jpm.2022.0604", "pubmed_id": "37167080", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37167080/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Mechanism of Action,Spirituality,Clinical Trial,Review Article,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:37167080", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37167080/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37167080", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37167080/", "doi": "10.1089/jpm.2022.0604", "pmid": "37167080", "publication_date": "2023-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3667, "title": "Effects and Therapeutic Potential of Psilocybin in Alcohol Dependence", "authors": "University of New Mexico", "journal": "ClinicalTrials.gov", "publication_date": "2023-09-25", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT01534494", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Spirituality,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT01534494", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT01534494", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT01534494", "source_url": "https://clinicaltrials.gov/study/NCT01534494", "doi": "", "pmid": "", "publication_date": "2023-09-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1370, "title": "Manic episode following psilocybin use in a man with bipolar II disorder: a case report", "authors": "Haniya J. Halim, Bradley G. Burk, Rachel E. Fargason, Badari Birur", "journal": "Frontiers in Psychiatry", "publication_date": "2023-09-21", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1221131", "pubmed_id": "37810598", "openalex_id": "https://openalex.org/W4386961159", "source_url": "https://doi.org/10.3389/fpsyt.2023.1221131", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,OCD,End-of-Life Distress,Receptor Pharmacology,Case Report,Treatment-Resistant Depression,Safety", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37810598", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1221131", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37810598", "source_url": "https://doi.org/10.3389/fpsyt.2023.1221131", "doi": "10.3389/fpsyt.2023.1221131", "pmid": "37810598", "publication_date": "2023-09-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3573, "title": "Phase II, Randomized, Double Blind, Placebo Controlled, Parallel Group, Single Center Study of Psilocybin Efficacy and Mechanism in Alcohol Use Disorder", "authors": "University of Zurich", "journal": "ClinicalTrials.gov", "publication_date": "2023-09-20", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04141501", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Receptor Pharmacology,Aging,Emotional Processing,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04141501", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04141501", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04141501", "source_url": "https://clinicaltrials.gov/study/NCT04141501", "doi": "", "pmid": "", "publication_date": "2023-09-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1371, "title": "Lifeboat ethics, risk, and therapeutic opportunity: an appeal for equitable psychedelic therapy access in the “high-risk” addiction patient", "authors": "Taylor Black", "journal": "Frontiers in Psychiatry", "publication_date": "2023-09-19", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1159843", "pubmed_id": "37799400", "openalex_id": "https://openalex.org/W4386931181", "source_url": "https://doi.org/10.3389/fpsyt.2023.1159843", "substance_tags": "psilocybin", "topic_tags": "Addiction,Wellbeing,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37799400", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1159843", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37799400", "source_url": "https://doi.org/10.3389/fpsyt.2023.1159843", "doi": "10.3389/fpsyt.2023.1159843", "pmid": "37799400", "publication_date": "2023-09-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1373, "title": "Nature-themed video intervention may improve cardiovascular safety of psilocybin-assisted therapy for alcohol use disorder", "authors": "Keith G. Heinzerling, Karina Sergi, Micah Linton, Rhianna Rich, Brittany Youssef, Inez Bentancourt, Jennifer E. Bramen, Prabha Siddarth, L. Schwartzberg, Daniel F. Kelly", "journal": "Frontiers in Psychiatry", "publication_date": "2023-09-17", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1215972", "pubmed_id": "37795513", "openalex_id": "https://openalex.org/W4386849390", "source_url": "https://doi.org/10.3389/fpsyt.2023.1215972", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Chronic Pain,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37795513", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1215972", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37795513", "source_url": "https://doi.org/10.3389/fpsyt.2023.1215972", "doi": "10.3389/fpsyt.2023.1215972", "pmid": "37795513", "publication_date": "2023-09-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1201, "title": "American Psychiatrists' Opinions About Classic Hallucinogens and Their Potential Therapeutic Applications: A7-Year Follow-Up Survey", "authors": "Brian S. Barnett, Miranda Arakelian, David S. Beebe, Jared Ontko, Connor Riegal, Willie O. Siu, Jeremy Weleff, Harrison G. Pope", "journal": "Psychedelic Medicine", "publication_date": "2023-09-17", "publication_year": 2023, "doi": "10.1089/psymed.2023.0036", "pubmed_id": "40051760", "openalex_id": "https://openalex.org/W4386824127", "source_url": "https://doi.org/10.1089/psymed.2023.0036", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Clinical Trial,Observational Study,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:40051760", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0036", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40051760", "source_url": "https://doi.org/10.1089/psymed.2023.0036", "doi": "10.1089/psymed.2023.0036", "pmid": "40051760", "publication_date": "2023-09-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4769, "title": "The psychedelic experience and treatment-resistant depression", "authors": "Guy M. Goodwin", "journal": "World Psychiatry", "publication_date": "2023-09-14", "publication_year": 2023, "doi": "10.1002/wps.21140", "pubmed_id": "37713542", "openalex_id": "https://openalex.org/W4386765441", "source_url": "http://dx.doi.org/10.1002/wps.21140", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Consciousness,Personality Change,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Review Article,Healthy Volunteers,Treatment-Resistant Depression,Safety,Adverse Events,Drug Interactions", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37713542", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1002/wps.21140", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37713542", "source_url": "http://dx.doi.org/10.1002/wps.21140", "doi": "10.1002/wps.21140", "pmid": "37713542", "publication_date": "2023-09-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3543, "title": "Phase 1, Open-Label, One-Treatment, Single-Dose, One-Period, Pharmacokinetic Study of Psilocin 4 mg as Its Mucic Acid Salt (L-130) Form, in Healthy Subjects Under Fasted Conditions", "authors": "Lobe Sciences Ltd.", "journal": "ClinicalTrials.gov", "publication_date": "2023-09-12", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT06035900", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT06035900", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT06035900", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT06035900", "source_url": "https://clinicaltrials.gov/study/NCT06035900", "doi": "", "pmid": "", "publication_date": "2023-09-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1377, "title": "Predictors of Pharmacy Students' Attitudes About the Therapeutic Use of Psilocybin", "authors": "NM Mahmudul Alam Bhuiya, Robin J. Jacobs, Karina Wang, Yiqun Sun, Brenda Nava, Luke Sampiere, Akhila Yerubandi, Joshua Caballero", "journal": "Cureus", "publication_date": "2023-09-12", "publication_year": 2023, "doi": "10.7759/cureus.45169", "pubmed_id": "37842360", "openalex_id": "https://openalex.org/W4386702998", "source_url": "http://dx.doi.org/10.7759/cureus.45169", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,OCD,Pharmacology,Review Article,Observational Study,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37842360", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.7759/cureus.45169", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37842360", "source_url": "http://dx.doi.org/10.7759/cureus.45169", "doi": "10.7759/cureus.45169", "pmid": "37842360", "publication_date": "2023-09-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1364, "title": "Psychedelic-Assisted Therapy in Military and Veterans Healthcare Systems: Clinical, Legal, and Implementation Considerations.", "authors": "Wolfgang AS, Hoge CW.", "journal": null, "publication_date": "2023-09-07", "publication_year": 2023, "doi": "10.1007/s11920-023-01446-4", "pubmed_id": "37682446", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11920-023-01446-4", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Clinical Trial,Review Article,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:37682446", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11920-023-01446-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37682446", "source_url": "https://doi.org/10.1007/s11920-023-01446-4", "doi": "10.1007/s11920-023-01446-4", "pmid": "37682446", "publication_date": "2023-09-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1363, "title": "The zebrafish for preclinical psilocybin research.", "authors": "Syed OA, Tsang B, Gerlai R.", "journal": null, "publication_date": "2023-09-06", "publication_year": 2023, "doi": "10.1016/j.neubiorev.2023.105381", "pubmed_id": "37689090", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neubiorev.2023.105381", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Mechanism of Action,Review Article,Animal Study,Safety,Toxicity", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37689090", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neubiorev.2023.105381", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37689090", "source_url": "https://doi.org/10.1016/j.neubiorev.2023.105381", "doi": "10.1016/j.neubiorev.2023.105381", "pmid": "37689090", "publication_date": "2023-09-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1309, "title": "Psilocybin-Assisted Cognitive Behavioral Therapy for Adults with Major Depressive Disorder: Rationale and Treatment Development", "authors": "Marc J. Weintraub, Jessica Jeffrey, Charles S. Grob, Megan Ichinose, R. Lindsey Bergman, Ziva D. Cooper, David J. Miklowitz", "journal": "Psychedelic Medicine", "publication_date": "2023-09-05", "publication_year": 2023, "doi": "10.1089/psymed.2023.0018", "pubmed_id": "40046861", "openalex_id": "https://openalex.org/W4386469528", "source_url": "https://doi.org/10.1089/psymed.2023.0018", "substance_tags": "psilocybin", "topic_tags": "Depression,Chronic Pain,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:40046861", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0018", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:40046861", "source_url": "https://doi.org/10.1089/psymed.2023.0018", "doi": "10.1089/psymed.2023.0018", "pmid": "40046861", "publication_date": "2023-09-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1381, "title": "Self-administration of Psilocybin for the Acute Treatment of Migraine: A Case Report.", "authors": "David W. Lawrence", "journal": "PubMed", "publication_date": "2023-08-31", "publication_year": 2023, "doi": null, "pubmed_id": "37817818", "openalex_id": "https://openalex.org/W4387516129", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37817818", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Pharmacology,Receptor Pharmacology,Case Report,Safety,Toxicity", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37817818", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37817818", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37817818", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37817818", "doi": "", "pmid": "37817818", "publication_date": "2023-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1380, "title": "Psychedelics for treatment resistant depression: are they game changers?", "authors": "Kalfas M, Taylor RH, Tsapekos D, Young AH.", "journal": null, "publication_date": "2023-08-31", "publication_year": 2023, "doi": "10.1080/14656566.2023.2281582", "pubmed_id": "37947195", "openalex_id": null, "source_url": "https://doi.org/10.1080/14656566.2023.2281582", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Receptor Pharmacology,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:37947195", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/14656566.2023.2281582", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37947195", "source_url": "https://doi.org/10.1080/14656566.2023.2281582", "doi": "10.1080/14656566.2023.2281582", "pmid": "37947195", "publication_date": "2023-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1378, "title": "Psilocybin for anorexia nervosa: If it helps, let’s learn how", "authors": "Evelyn Attia, Joanna Steinglass", "journal": "Med", "publication_date": "2023-08-31", "publication_year": 2023, "doi": "10.1016/j.medj.2023.08.003", "pubmed_id": "37689054", "openalex_id": "https://openalex.org/W4386541001", "source_url": "https://doi.org/10.1016/j.medj.2023.08.003", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Pharmacology,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37689054", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37689054", "source_url": "https://doi.org/10.1016/j.medj.2023.08.003", "doi": "10.1016/j.medj.2023.08.003", "pmid": "37689054", "publication_date": "2023-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1435, "title": "Adapting psychedelic medicine for headache and chronic pain disorders", "authors": "Emmanuelle A. D. Schindler, Peter S. Hendricks", "journal": "Expert Review of Neurotherapeutics", "publication_date": "2023-08-30", "publication_year": 2023, "doi": "10.1080/14737175.2023.2246655", "pubmed_id": "37652000", "openalex_id": "https://openalex.org/W4386317658", "source_url": "https://doi.org/10.1080/14737175.2023.2246655", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Headache / Migraine,Mechanism of Action,Clinical Trial,Review Article,Case Report,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37652000", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/14737175.2023.2246655", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37652000", "source_url": "https://doi.org/10.1080/14737175.2023.2246655", "doi": "10.1080/14737175.2023.2246655", "pmid": "37652000", "publication_date": "2023-08-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1387, "title": "Psilocybin history, action and reaction: A narrative clinical review.", "authors": "Sharma P, Nguyen QA, Matthews SJ, Carpenter E, Mathews DB, Patten CA, Hammond CJ.", "journal": null, "publication_date": "2023-08-30", "publication_year": 2023, "doi": "10.1177/02698811231190858", "pubmed_id": "37650489", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811231190858", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Clinical Trial,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37650489", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811231190858", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37650489", "source_url": "https://doi.org/10.1177/02698811231190858", "doi": "10.1177/02698811231190858", "pmid": "37650489", "publication_date": "2023-08-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1379, "title": "Single-Dose Psilocybin Treatment for Major Depressive Disorder", "authors": "Charles L. Raison, Gerard Sanacora, Joshua Woolley, Keith G. Heinzerling, Boadie W. Dunlop, Randall Brown, Rishi Kakar, Michael Hassman, Rupal Trivedi, Reid Robison, Natalie Gukasyan, Sandeep M. Nayak, Xiaojue Hu, Kelley C. O’Donnell, Benjamin Kelmendi, Jordan Sloshower, Andrew Penn, Ellen Bradley, Daniel F. Kelly, Tanja Mletzko, Christopher R. Nicholas, Paul R. Hutson, Gary Tarpley, Malynn Utzinger, Kelsey Lenoch, Kasia Warchol, Theraysa Gapasin, Mike C. Davis, Courtney Nelson-Douthit, Steffanie H Wilson, Carrie Brown, William Linton, Matthew W. Johnson, Stephen Ross, Roland R. Griffiths", "journal": "JAMA", "publication_date": "2023-08-30", "publication_year": 2023, "doi": "10.1001/jama.2023.14530", "pubmed_id": "37651119", "openalex_id": "https://openalex.org/W4386305655", "source_url": "https://doi.org/10.1001/jama.2023.14530", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Clinical Trial,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37651119", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1001/jama.2023.14530", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37651119", "source_url": "https://doi.org/10.1001/jama.2023.14530", "doi": "10.1001/jama.2023.14530", "pmid": "37651119", "publication_date": "2023-08-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1315, "title": "Double-Blind Comparison of the Two Hallucinogens Dextromethorphan and Psilocybin: Experience-Dependent and Enduring Psychological Effects in Healthy Volunteers", "authors": "David S. Mathai, Samantha Hilbert, Nathan D. Sepeda, Justin C. Strickland, Roland R. Griffiths, Albert Garcia-Romeu", "journal": "Psychedelic Medicine", "publication_date": "2023-08-29", "publication_year": 2023, "doi": "10.1089/psymed.2023.0035", "pubmed_id": "38152462", "openalex_id": "https://openalex.org/W4386285211", "source_url": "https://doi.org/10.1089/psymed.2023.0035", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Receptor Pharmacology,Consciousness,Wellbeing,Spirituality,Healthy Volunteers,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:38152462", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1089/psymed.2023.0035", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38152462", "source_url": "https://doi.org/10.1089/psymed.2023.0035", "doi": "10.1089/psymed.2023.0035", "pmid": "38152462", "publication_date": "2023-08-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1246, "title": "The changing outlook of psychedelic drugs: The importance of risk assessment and occupational exposure limits", "authors": "Natália Bernardi Videira, Vijayalekshmi Nair, Valérie Paquet, Dean Calhoun", "journal": "Journal of Applied Toxicology", "publication_date": "2023-08-29", "publication_year": 2023, "doi": "10.1002/jat.4533", "pubmed_id": "37646119", "openalex_id": "https://openalex.org/W4386272089", "source_url": "https://doi.org/10.1002/jat.4533", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37646119", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/jat.4533", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37646119", "source_url": "https://doi.org/10.1002/jat.4533", "doi": "10.1002/jat.4533", "pmid": "37646119", "publication_date": "2023-08-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1405, "title": "Race and ethnicity moderate the associations between lifetime psilocybin use and crime arrests", "authors": "Grant Jones, Maha Al-Suwaidi, Franchesca Castro-Ramirez, Taylor C. McGuire, Patrick Mair, Matthew K. Nock", "journal": "Frontiers in Psychiatry", "publication_date": "2023-08-23", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1169692", "pubmed_id": "37692301", "openalex_id": "https://openalex.org/W4386165916", "source_url": "https://doi.org/10.3389/fpsyt.2023.1169692", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37692301", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1169692", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37692301", "source_url": "https://doi.org/10.3389/fpsyt.2023.1169692", "doi": "10.3389/fpsyt.2023.1169692", "pmid": "37692301", "publication_date": "2023-08-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1042, "title": "Beyond Psilocybin: Reviewing the Therapeutic Potential of Other Serotonergic Psychedelics in Mental and Substance Use Disorders.", "authors": "Wong S, Yu AY, Fabiano N, Finkelstein O, Pasricha A, Jones BDM, Rosenblat JD, Blumberger DM, Mulsant BH, Husain MI.", "journal": null, "publication_date": "2023-08-23", "publication_year": 2023, "doi": "10.1080/02791072.2023.2251133", "pubmed_id": "37615379", "openalex_id": null, "source_url": "https://doi.org/10.1080/02791072.2023.2251133", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Receptor Pharmacology,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:37615379", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2023.2251133", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37615379", "source_url": "https://doi.org/10.1080/02791072.2023.2251133", "doi": "10.1080/02791072.2023.2251133", "pmid": "37615379", "publication_date": "2023-08-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1407, "title": "Co-use of MDMA with psilocybin/LSD may buffer against challenging experiences and enhance positive experiences", "authors": "Richard J. Zeifman, Hannes Kettner, Broc A. Pagni, Austin J. Mallard, Daniel E. Roberts, David Erritzøe, Stephen Ross, Robin Carhart-Harris", "journal": "Scientific Reports", "publication_date": "2023-08-21", "publication_year": 2023, "doi": "10.1038/s41598-023-40856-5", "pubmed_id": "37608057", "openalex_id": "https://openalex.org/W4386069067", "source_url": "https://doi.org/10.1038/s41598-023-40856-5", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Mystical Experience,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37608057", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-023-40856-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37608057", "source_url": "https://doi.org/10.1038/s41598-023-40856-5", "doi": "10.1038/s41598-023-40856-5", "pmid": "37608057", "publication_date": "2023-08-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4785, "title": "Exploring the relationship between mental health, drug use, personality, and attitudes towards psilocybin-assisted therapy", "authors": "Benjamin M. Ross, James T. Neill", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-08-20", "publication_year": 2023, "doi": "10.1556/2054.2023.00264", "pubmed_id": null, "openalex_id": "https://openalex.org/W4386021261", "source_url": "https://doi.org/10.1556/2054.2023.00264", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Receptor Pharmacology,Personality Change,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2023.00264", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2023.00264", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2023.00264", "source_url": "https://doi.org/10.1556/2054.2023.00264", "doi": "10.1556/2054.2023.00264", "pmid": "", "publication_date": "2023-08-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1043, "title": "Seasonal Variation of Use of Common Psychedelics and Party Drugs Among Nightclub/Festival Attendees in New York City", "authors": "Joseph J. Palamar, Caroline Rutherford, Austin Le, Katherine M. Keyes", "journal": "Journal of Psychoactive Drugs", "publication_date": "2023-08-20", "publication_year": 2023, "doi": "10.1080/02791072.2023.2240322", "pubmed_id": "37605471", "openalex_id": "https://openalex.org/W4386046815", "source_url": "https://doi.org/10.1080/02791072.2023.2240322", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37605471", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2023.2240322", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37605471", "source_url": "https://doi.org/10.1080/02791072.2023.2240322", "doi": "10.1080/02791072.2023.2240322", "pmid": "37605471", "publication_date": "2023-08-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1292, "title": "Potential analgesic effects of psychedelics on select chronic pain conditions: A survey study", "authors": "Mauro Cavarra, Natasha L. Mason, Kim P. C. Kuypers, Valérie Bonnelle, William Smith, Amanda Feilding, Pamela Kryskow, Johannes G. Ramaekers", "journal": "European Journal of Pain", "publication_date": "2023-08-19", "publication_year": 2023, "doi": "10.1002/ejp.2171", "pubmed_id": "37599279", "openalex_id": "https://openalex.org/W4386019370", "source_url": "https://doi.org/10.1002/ejp.2171", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Microdosing,Observational Study,Healthy Volunteers,Safety,Adverse Events,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37599279", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/ejp.2171", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37599279", "source_url": "https://doi.org/10.1002/ejp.2171", "doi": "10.1002/ejp.2171", "pmid": "37599279", "publication_date": "2023-08-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1347, "title": "A Proposal to Study the Safety and Efficacy of Psilocybe cubensis in Preclinical and Clinical Studies as a Therapeutic Alternative for Major Depressive Disorder", "authors": "Raúl Escamilla, María Eva González-Trujano, Jesús M. González Mariscal, J. Martı́n Torres-Valencia, Héctor Guzmán-González, José Luis Vega, Anja Loizaga-Velder", "journal": "Journal of Psychoactive Drugs", "publication_date": "2023-08-17", "publication_year": 2023, "doi": "10.1080/02791072.2023.2246459", "pubmed_id": "37594163", "openalex_id": "https://openalex.org/W4385969211", "source_url": "https://doi.org/10.1080/02791072.2023.2246459", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Animal Study,Safety,Toxicity", "study_type": "Animal Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37594163", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2023.2246459", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37594163", "source_url": "https://doi.org/10.1080/02791072.2023.2246459", "doi": "10.1080/02791072.2023.2246459", "pmid": "37594163", "publication_date": "2023-08-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4786, "title": "Australia Legalizes Psychedelics for Use in Depression, PTSD Therapy", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2023-08-14", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.09.9.20", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385829163", "source_url": "https://doi.org/10.1176/appi.pn.2023.09.9.20", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Mechanism of Action,Consciousness,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.09.9.20", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.09.9.20", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.09.9.20", "source_url": "https://doi.org/10.1176/appi.pn.2023.09.9.20", "doi": "10.1176/appi.pn.2023.09.9.20", "pmid": "", "publication_date": "2023-08-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1388, "title": "The risk of chronic psychedelic and MDMA microdosing for valvular heart disease.", "authors": "Tagen M, Mantuani D, van Heerden L, Holstein A, Klumpers LE, Knowles R.", "journal": null, "publication_date": "2023-08-11", "publication_year": 2023, "doi": "10.1177/02698811231190865", "pubmed_id": "37572027", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811231190865", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Microdosing,In Vitro Study,Safety", "study_type": "In Vitro Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37572027", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811231190865", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37572027", "source_url": "https://doi.org/10.1177/02698811231190865", "doi": "10.1177/02698811231190865", "pmid": "37572027", "publication_date": "2023-08-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1326, "title": "Associations between individual hallucinogens and hallucinogen misuse among U.S. Adults who recently initiated hallucinogen use", "authors": "Grant Jones, Felipe Herrmann, Erica Wang", "journal": "Addictive Behaviors Reports", "publication_date": "2023-08-10", "publication_year": 2023, "doi": "10.1016/j.abrep.2023.100513", "pubmed_id": "37649653", "openalex_id": "https://openalex.org/W4385777618", "source_url": "https://doi.org/10.1016/j.abrep.2023.100513", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37649653", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.abrep.2023.100513", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37649653", "source_url": "https://doi.org/10.1016/j.abrep.2023.100513", "doi": "10.1016/j.abrep.2023.100513", "pmid": "37649653", "publication_date": "2023-08-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4788, "title": "Psilocybin's Emerging Role in Combating Depressive Disorder", "authors": "Anna Jaremek, Joanna Kępa, Norbert Kandefer, Michał Wyszkowski, Aleksandra Grabarczyk, Anna Pawlak, Sylwia Grad, Małgorzata Gregorek, Paweł Gregorek", "journal": "Journal of Education Health and Sport", "publication_date": "2023-08-07", "publication_year": 2023, "doi": "10.12775/jehs.2023.40.01.011", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385658334", "source_url": "https://doi.org/10.12775/jehs.2023.40.01.011", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Neurogenesis,Mechanism of Action,Default Mode Network,Aging,Emotional Processing,Clinical Trial,Review Article,Animal Study,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.12775/jehs.2023.40.01.011", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.12775/jehs.2023.40.01.011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.12775/jehs.2023.40.01.011", "source_url": "https://doi.org/10.12775/jehs.2023.40.01.011", "doi": "10.12775/jehs.2023.40.01.011", "pmid": "", "publication_date": "2023-08-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1349, "title": "“But the reality is it's happening”: A qualitative study of eating disorder providers about psilocybin-assisted psychotherapy", "authors": "Amanda E. Downey, Maxine Boyd, Anita V. Chaphekar, Joshua Woolley, Marissa Raymond-Flesch", "journal": "International Journal of Eating Disorders", "publication_date": "2023-08-07", "publication_year": 2023, "doi": "10.1002/eat.24041", "pubmed_id": "37551650", "openalex_id": "https://openalex.org/W4385664009", "source_url": "https://doi.org/10.1002/eat.24041", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Chronic Pain,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37551650", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/eat.24041", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37551650", "source_url": "https://doi.org/10.1002/eat.24041", "doi": "10.1002/eat.24041", "pmid": "37551650", "publication_date": "2023-08-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1348, "title": "Psilocybin-assisted therapy for depression: A systematic review and dose-response meta-analysis of human studies.", "authors": "Perez N, Langlest F, Mallet L, De Pieri M, Sentissi O, Thorens G, Seragnoli F, Zullino D, Kirschner M, Kaiser S, Solmi M, Sabé M.", "journal": null, "publication_date": "2023-08-06", "publication_year": 2023, "doi": "10.1016/j.euroneuro.2023.07.011", "pubmed_id": "37557019", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.euroneuro.2023.07.011", "substance_tags": "psilocybin", "topic_tags": "Depression,Headache / Migraine,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:37557019", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.euroneuro.2023.07.011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37557019", "source_url": "https://doi.org/10.1016/j.euroneuro.2023.07.011", "doi": "10.1016/j.euroneuro.2023.07.011", "pmid": "37557019", "publication_date": "2023-08-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1416, "title": "Slouching towards engagement: interactions between people using psychedelics naturalistically and their healthcare providers", "authors": "Kevin F. Boehnke, Kasey Cox, Cody Weston, Moss Herberholz, Nicolas Glynos, Nicholas Kolbman, Christopher W. Fields, Julie Barron, Daniel J. Kruger", "journal": "Frontiers in Psychiatry", "publication_date": "2023-08-03", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1224551", "pubmed_id": "37599880", "openalex_id": "https://openalex.org/W4385581517", "source_url": "https://doi.org/10.3389/fpsyt.2023.1224551", "substance_tags": "psilocybin", "topic_tags": "Safety,Adverse Events,Drug Interactions", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 06:34:45", "bibtex": null, "source_record_id": "PMID:37599880", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1224551", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37599880", "source_url": "https://doi.org/10.3389/fpsyt.2023.1224551", "doi": "10.3389/fpsyt.2023.1224551", "pmid": "37599880", "publication_date": "2023-08-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1389, "title": "The Potential of Psychedelics for the Treatment of Episodic Migraine.", "authors": "Schindler EAD.", "journal": null, "publication_date": "2023-08-03", "publication_year": 2023, "doi": "10.1007/s11916-023-01145-y", "pubmed_id": "37540398", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11916-023-01145-y", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:37540398", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11916-023-01145-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37540398", "source_url": "https://doi.org/10.1007/s11916-023-01145-y", "doi": "10.1007/s11916-023-01145-y", "pmid": "37540398", "publication_date": "2023-08-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1014, "title": "Prevalence of psilocybin use in vaping and associated factors: a study among amphetamine-type stimulants (ATS) use disorder in Malaysia", "authors": "Ruzmayuddin Mamat, Rusdi Abd Rashid, Maw Shin Sim, Baharudin Ibrahim, Suzaily Wahab, Azmir Ahmad", "journal": "Journal of Addictive Diseases", "publication_date": "2023-08-03", "publication_year": 2023, "doi": "10.1080/10550887.2023.2240932", "pubmed_id": "37540000", "openalex_id": "https://openalex.org/W4385564685", "source_url": "http://dx.doi.org/10.1080/10550887.2023.2240932", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37540000", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1080/10550887.2023.2240932", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37540000", "source_url": "http://dx.doi.org/10.1080/10550887.2023.2240932", "doi": "10.1080/10550887.2023.2240932", "pmid": "37540000", "publication_date": "2023-08-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1420, "title": "Psychedelic medicines for end-of-life care: Pipeline clinical trial review 2022.", "authors": "Jing X, Hoeh NR, Menkes DB.", "journal": null, "publication_date": "2023-07-31", "publication_year": 2023, "doi": "10.1017/s147895152300069x", "pubmed_id": "37334486", "openalex_id": null, "source_url": "https://doi.org/10.1017/s147895152300069x", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Clinical Trial,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37334486", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/s147895152300069x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37334486", "source_url": "https://doi.org/10.1017/s147895152300069x", "doi": "10.1017/s147895152300069x", "pmid": "37334486", "publication_date": "2023-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1413, "title": "Psychedelic drugs in the treatment of psychiatric disorders.", "authors": "Ibrahim IB, Videbech P, Straszek SPV.", "journal": null, "publication_date": "2023-07-31", "publication_year": 2023, "doi": null, "pubmed_id": "37615227", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/37615227", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Randomized Controlled Trial,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:37615227", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/37615227", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37615227", "source_url": "https://europepmc.org/article/MED/37615227", "doi": "", "pmid": "37615227", "publication_date": "2023-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4791, "title": "Med Check: FDA, Anti-Amyloid Beta Vaccine, Clinical Trials of Psychedelics, and Lumryz", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2023-07-26", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.08.8.3", "pubmed_id": null, "openalex_id": "https://openalex.org/W4385324763", "source_url": "https://doi.org/10.1176/appi.pn.2023.08.8.3", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Clinical Trial,Review Article,Observational Study,Safety,Immune Function", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.08.8.3", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.08.8.3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.08.8.3", "source_url": "https://doi.org/10.1176/appi.pn.2023.08.8.3", "doi": "10.1176/appi.pn.2023.08.8.3", "pmid": "", "publication_date": "2023-07-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3519, "title": "The Efficacy and Tolerability of Psilocybin in Participants With Treatment-Resistant Depression: a Phase 2, Randomized Feasibility Study", "authors": "Brain and Cognition Discovery Foundation", "journal": "ClinicalTrials.gov", "publication_date": "2023-07-26", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05029466", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05029466", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05029466", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05029466", "source_url": "https://clinicaltrials.gov/study/NCT05029466", "doi": "", "pmid": "", "publication_date": "2023-07-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3279, "title": "“Why would you open someone’s brain up?” Lived experience insights inform a psilocybin-assisted psychotherapy treatment manual for body image disturbance", "authors": "Finkelstein C, Soha O, Roy A, Phillipou A, Rossell S.", "journal": "Research Square", "publication_date": "2023-07-26", "publication_year": 2023, "doi": "10.21203/rs.3.rs-3189970/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3189970/v1", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Aging,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3189970/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3189970/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3189970/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3189970/v1", "doi": "10.21203/rs.3.rs-3189970/v1", "pmid": "", "publication_date": "2023-07-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3470, "title": "An Open Label Pragmatic Feasibility Study on a Resilience Focused Community of Practice Program With Psilocybin-assisted Therapy (PaT) for End-of-Life Patients.", "authors": "The Roots to Thrive Society for Psychedelic Therapy", "journal": "ClinicalTrials.gov", "publication_date": "2023-07-24", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05958758", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Wellbeing,Resilience,Observational Study,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05958758", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05958758", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05958758", "source_url": "https://clinicaltrials.gov/study/NCT05958758", "doi": "", "pmid": "", "publication_date": "2023-07-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1390, "title": "Assessing the risk of symptom worsening in psilocybin-assisted therapy for depression: A systematic review and individual participant data meta-analysis.", "authors": "Simonsson O, Carlbring P, Carhart-Harris R, Davis AK, Nutt DJ, Griffiths RR, Erritzoe D, Goldberg SB.", "journal": null, "publication_date": "2023-07-22", "publication_year": 2023, "doi": "10.1016/j.psychres.2023.115349", "pubmed_id": "37523886", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2023.115349", "substance_tags": "psilocybin", "topic_tags": "Depression,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37523886", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2023.115349", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37523886", "source_url": "https://doi.org/10.1016/j.psychres.2023.115349", "doi": "10.1016/j.psychres.2023.115349", "pmid": "37523886", "publication_date": "2023-07-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3143, "title": "Psilocybin as an antidepressant strategy - a review of safety aspects", "authors": "Zeiss R.", "journal": null, "publication_date": "2023-07-18", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC10405689", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC10405689", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC10405689", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC10405689", "source_url": "https://europepmc.org/article/PMC/PMC10405689", "doi": "", "pmid": "", "publication_date": "2023-07-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4793, "title": "Pharmacognostic, Forensic and Pharmaceutical, Organizational and Legal, Clinical and Pharmacological Multidisciplinary Study with an Assessment of Peculiarities of Circulation (Use) of Smoking Mixtures of Spices and Entheogens of Amanita Muscaria Mushroom", "authors": "Вікторія Шаповалова, Alina Osyntseva, Валерій Шаповалов, Serhii Nehretskii", "journal": "SSP Modern Pharmacy and Medicine", "publication_date": "2023-07-17", "publication_year": 2023, "doi": "10.53933/sspmpm.v3i3.105", "pubmed_id": null, "openalex_id": "https://openalex.org/W4384694190", "source_url": "https://doi.org/10.53933/sspmpm.v3i3.105", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Pharmacology,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.53933/sspmpm.v3i3.105", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.53933/sspmpm.v3i3.105", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.53933/sspmpm.v3i3.105", "source_url": "https://doi.org/10.53933/sspmpm.v3i3.105", "doi": "10.53933/sspmpm.v3i3.105", "pmid": "", "publication_date": "2023-07-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3422, "title": "A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-07-17", "publication_year": 2023, "doi": "10.1089/psymed.2023.00071", "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/2ab59_v1", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:04:24", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "DOI:10.1089/psymed.2023.00071", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/2ab59_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.1089/psymed.2023.00071", "source_url": "https://osf.io/preprints/psyarxiv/2ab59_v1", "doi": "10.1089/psymed.2023.00071", "pmid": "", "publication_date": "2023-07-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3380, "title": "A Systematic Review of Reporting Practices in Psychedelic Clinical Trials: Psychological Support, Therapy, and Psychosocial Interventions", "authors": "Brennan B, Kelman A, Belser AB.", "journal": "PsyArXiv", "publication_date": "2023-07-17", "publication_year": 2023, "doi": "10.31234/osf.io/2ab59", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/2ab59", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/2ab59", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/2ab59", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/2ab59", "source_url": "https://doi.org/10.31234/osf.io/2ab59", "doi": "10.31234/osf.io/2ab59", "pmid": "", "publication_date": "2023-07-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3217, "title": "Administration effects of four psilocybin mushroom extracts on serotonin levels and endothelial nitric oxide synthase activity levels in vivo and in vitro after one hour", "authors": "Nkadimeng SM, Hay L, Steinmann CM, Eloff JN.", "journal": "Research Square", "publication_date": "2023-07-17", "publication_year": 2023, "doi": "10.21203/rs.3.rs-3088850/v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.21203/rs.3.rs-3088850/v1", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Animal Study,In Vitro Study,Safety", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.21203/rs.3.rs-3088850/v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.21203/rs.3.rs-3088850/v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.21203/rs.3.rs-3088850/v1", "source_url": "https://doi.org/10.21203/rs.3.rs-3088850/v1", "doi": "10.21203/rs.3.rs-3088850/v1", "pmid": "", "publication_date": "2023-07-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1393, "title": "Psilocybin for treatment resistant depression in patients taking a concomitant SSRI medication", "authors": "Guy M. Goodwin, Megan Croal, David Feifel, John R. Kelly, Lindsey Marwood, Sunil Mistry, Veronica O’Keane, Stéphanie Knatz Peck, Hollie Simmons, Claudia Sisa, S. C. Stansfield, Joyce Tsai, Sam Williams, Ekaterina Malievskaia", "journal": "Neuropsychopharmacology", "publication_date": "2023-07-12", "publication_year": 2023, "doi": "10.1038/s41386-023-01648-7", "pubmed_id": "37443386", "openalex_id": "https://openalex.org/W4384130479", "source_url": "https://doi.org/10.1038/s41386-023-01648-7", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37443386", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41386-023-01648-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37443386", "source_url": "https://doi.org/10.1038/s41386-023-01648-7", "doi": "10.1038/s41386-023-01648-7", "pmid": "37443386", "publication_date": "2023-07-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4795, "title": "Leveraging psychedelic therapies for binge eating disorder", "authors": "Jim Gilligan", "journal": "Open Access Government", "publication_date": "2023-07-09", "publication_year": 2023, "doi": "10.56367/oag-039-10936", "pubmed_id": null, "openalex_id": "https://openalex.org/W4384523308", "source_url": "http://dx.doi.org/10.56367/oag-039-10936", "substance_tags": "psilocybin,psilocin", "topic_tags": "Eating Disorders,Pharmacology,Receptor Pharmacology,Aging,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.56367/oag-039-10936", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.56367/oag-039-10936", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.56367/oag-039-10936", "source_url": "http://dx.doi.org/10.56367/oag-039-10936", "doi": "10.56367/oag-039-10936", "pmid": "", "publication_date": "2023-07-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3755, "title": "Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin", "authors": "Tetem J, Fischmann T, Möller TJ.", "journal": "PsyArXiv", "publication_date": "2023-07-05", "publication_year": 2023, "doi": "10.31234/osf.io/ztyxh", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/ztyxh", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/ztyxh", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/ztyxh", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/ztyxh", "source_url": "https://doi.org/10.31234/osf.io/ztyxh", "doi": "10.31234/osf.io/ztyxh", "pmid": "", "publication_date": "2023-07-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3161, "title": "Psychoactive substances in psychotherapy - A vision for the future? - A systematic review on Psilocybin", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-07-05", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Systematic Review,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "source_url": "https://osf.io/preprints/psyarxiv/ztyxh_v1", "doi": "", "pmid": "", "publication_date": "2023-07-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1438, "title": "Risk of bias in randomized clinical trials on psychedelic medicine: A systematic review.", "authors": "Hovmand OR, Poulsen ED, Arnfred S, Storebø OJ.", "journal": null, "publication_date": "2023-07-03", "publication_year": 2023, "doi": "10.1177/02698811231180276", "pubmed_id": "37403379", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811231180276", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37403379", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811231180276", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37403379", "source_url": "https://doi.org/10.1177/02698811231180276", "doi": "10.1177/02698811231180276", "pmid": "37403379", "publication_date": "2023-07-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1439, "title": "Psilocybin's effects on cognition and creativity: A scoping review.", "authors": "Bonnieux JN, VanderZwaag B, Premji Z, Garcia-Romeu A, Garcia-Barrera MA.", "journal": null, "publication_date": "2023-07-02", "publication_year": 2023, "doi": "10.1177/02698811231179801", "pubmed_id": "37395359", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811231179801", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Creativity,Review Article,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:37395359", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811231179801", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37395359", "source_url": "https://doi.org/10.1177/02698811231179801", "doi": "10.1177/02698811231179801", "pmid": "37395359", "publication_date": "2023-07-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1434, "title": "Assessing potential of psilocybin for depressive disorders.", "authors": "Kozak Z, Johnson MW, Aaronson ST.", "journal": null, "publication_date": "2023-06-30", "publication_year": 2023, "doi": "10.1080/13543784.2023.2273493", "pubmed_id": "37869790", "openalex_id": null, "source_url": "https://doi.org/10.1080/13543784.2023.2273493", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37869790", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/13543784.2023.2273493", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37869790", "source_url": "https://doi.org/10.1080/13543784.2023.2273493", "doi": "10.1080/13543784.2023.2273493", "pmid": "37869790", "publication_date": "2023-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1427, "title": "Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial", "authors": "Muhammad Ishrat Husain, Daniel M. Blumberger, David Castle, Nicole Ledwos, Elise Fellows, Brett D. M. Jones, Abigail Ortiz, Stefan Kloiber, Wei Wang, Joshua D. Rosenblat, Benoit H. Mulsant", "journal": "BJPsych Open", "publication_date": "2023-06-30", "publication_year": 2023, "doi": "10.1192/bjo.2023.535", "pubmed_id": "37489299", "openalex_id": "https://openalex.org/W4385230722", "source_url": "https://doi.org/10.1192/bjo.2023.535", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Pharmacology,Receptor Pharmacology,Consciousness,Randomized Controlled Trial,Animal Study,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37489299", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2023.535", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37489299", "source_url": "https://doi.org/10.1192/bjo.2023.535", "doi": "10.1192/bjo.2023.535", "pmid": "37489299", "publication_date": "2023-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4801, "title": "FDA issues first draft guidance on psychedelic research", "authors": "Valerie A. Canady", "journal": "Mental Health Weekly", "publication_date": "2023-06-29", "publication_year": 2023, "doi": "10.1002/mhw.33697", "pubmed_id": null, "openalex_id": "https://openalex.org/W4382680172", "source_url": "http://dx.doi.org/10.1002/mhw.33697", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1002/mhw.33697", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1002/mhw.33697", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/mhw.33697", "source_url": "http://dx.doi.org/10.1002/mhw.33697", "doi": "10.1002/mhw.33697", "pmid": "", "publication_date": "2023-06-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1394, "title": "Clinical specificity profile for novel rapid acting antidepressant drugs.", "authors": "Scala M, Fanelli G, De Ronchi D, Serretti A, Fabbri C.", "journal": null, "publication_date": "2023-06-29", "publication_year": 2023, "doi": "10.1097/yic.0000000000000488", "pubmed_id": "37381161", "openalex_id": null, "source_url": "https://doi.org/10.1097/yic.0000000000000488", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37381161", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/yic.0000000000000488", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37381161", "source_url": "https://doi.org/10.1097/yic.0000000000000488", "doi": "10.1097/yic.0000000000000488", "pmid": "37381161", "publication_date": "2023-06-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3538, "title": "Investigating the Therapeutic Effects of Psilocybin in Treatment-Resistant Post-Traumatic Stress Disorder", "authors": "Halucenex Life Sciences Inc.", "journal": "ClinicalTrials.gov", "publication_date": "2023-06-28", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05243329", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Neuroplasticity,Neurogenesis,Receptor Pharmacology,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05243329", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05243329", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05243329", "source_url": "https://clinicaltrials.gov/study/NCT05243329", "doi": "", "pmid": "", "publication_date": "2023-06-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4803, "title": "Experts Offer Tips on Talking With Patients About Psychedelics", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2023-06-27", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.07.7.51", "pubmed_id": null, "openalex_id": "https://openalex.org/W4382360061", "source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.51", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.07.7.51", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.51", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.07.7.51", "source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.51", "doi": "10.1176/appi.pn.2023.07.7.51", "pmid": "", "publication_date": "2023-06-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4802, "title": "Psychedelic Therapy Requires Enhanced Consent Discussions", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2023-06-27", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.07.7.46", "pubmed_id": null, "openalex_id": "https://openalex.org/W4382360046", "source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.46", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Receptor Pharmacology,Consciousness,Spirituality,Observational Study,Healthcare Workers,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.07.7.46", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.46", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.07.7.46", "source_url": "https://doi.org/10.1176/appi.pn.2023.07.7.46", "doi": "10.1176/appi.pn.2023.07.7.46", "pmid": "", "publication_date": "2023-06-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1365, "title": "Psychedelics in the treatment of eating disorders: Rationale and potential mechanisms.", "authors": "Calder A, Mock S, Friedli N, Pasi P, Hasler G.", "journal": null, "publication_date": "2023-06-20", "publication_year": 2023, "doi": "10.1016/j.euroneuro.2023.05.008", "pubmed_id": "37352816", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.euroneuro.2023.05.008", "substance_tags": "psilocybin", "topic_tags": "PTSD,Addiction,Eating Disorders,Mechanism of Action,Review Article,Case Report,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37352816", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.euroneuro.2023.05.008", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37352816", "source_url": "https://doi.org/10.1016/j.euroneuro.2023.05.008", "doi": "10.1016/j.euroneuro.2023.05.008", "pmid": "37352816", "publication_date": "2023-06-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4806, "title": "A regulatory framework review of Schedule I psychedelics in the United States", "authors": "Kevin Herkenham", "journal": "JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY", "publication_date": "2023-06-11", "publication_year": 2023, "doi": "10.1002/jac5.1841", "pubmed_id": null, "openalex_id": "https://openalex.org/W4380357539", "source_url": "https://doi.org/10.1002/jac5.1841", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Review Article,Healthcare Workers,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:45", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1002/jac5.1841", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/jac5.1841", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/jac5.1841", "source_url": "https://doi.org/10.1002/jac5.1841", "doi": "10.1002/jac5.1841", "pmid": "", "publication_date": "2023-06-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1329, "title": "Hallucinogen use among young adults ages 19-30 in the United States: Changes from 2018 to 2021", "authors": "Katherine M. Keyes, Megan E. Patrick", "journal": "Addiction", "publication_date": "2023-06-06", "publication_year": 2023, "doi": "10.1111/add.16259", "pubmed_id": "37287110", "openalex_id": "https://openalex.org/W4379769663", "source_url": "https://doi.org/10.1111/add.16259", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37287110", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.16259", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37287110", "source_url": "https://doi.org/10.1111/add.16259", "doi": "10.1111/add.16259", "pmid": "37287110", "publication_date": "2023-06-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3190, "title": "Cardioprotective Potential of the Ethanol and Water Extracts of Four Psilocybin Mushrooms on Angiotensin II-Induced Hypertrophy and Oxidative Stress on H9C2 Cardiomyocytes", "authors": "Nkadimeng SM, Steinmann CM, Eloff JN.", "journal": "Preprints.org", "publication_date": "2023-06-05", "publication_year": 2023, "doi": "10.20944/preprints202306.0362.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202306.0362.v1", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Mitochondrial Function,Oxidative Stress,Safety,Toxicity,Inflammation", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202306.0362.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202306.0362.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202306.0362.v1", "source_url": "https://doi.org/10.20944/preprints202306.0362.v1", "doi": "10.20944/preprints202306.0362.v1", "pmid": "", "publication_date": "2023-06-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4808, "title": "Psilocybin therapy: A novel approach to treating depression", "authors": "Tooba Noor, Areej Shakil, Aimen Waqar Khan, Syeda Mahrukh Fatima Zaidi, Hussain Sohail Rangwala, Burhanuddin Sohail Rangwala", "journal": "International Journal of Surgery Global Health", "publication_date": "2023-06-01", "publication_year": 2023, "doi": "10.1097/gh9.0000000000000175", "pubmed_id": null, "openalex_id": "https://openalex.org/W4379142909", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000175", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Headache / Migraine,Brain Imaging,Pharmacology,Receptor Pharmacology,Default Mode Network,Consciousness,Aging,Wellbeing,Emotional Processing,Clinical Trial,Review Article,Adolescents,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1097/gh9.0000000000000175", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1097/gh9.0000000000000175", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/gh9.0000000000000175", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000175", "doi": "10.1097/gh9.0000000000000175", "pmid": "", "publication_date": "2023-06-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1466, "title": "Examining the Rationale for Studying Psychedelic-Assisted Psychotherapy for the Treatment of Caregiver Distress.", "authors": "Gold ND, Podrebarac SK, White LA, Marini C, Simon NM, Mittelman MS, Ross S, Bogenschutz MP, Petridis PD", "journal": "Psychedelic medicine (New Rochelle, N.Y.)", "publication_date": "2023-05-31", "publication_year": 2023, "doi": "10.1089/psymed.2022.0011", "pubmed_id": "40046728", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046728/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Spirituality,Clinical Trial,Review Article,Cancer Patients,Safety,Inflammation", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:40046728", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/40046728/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:40046728", "source_url": "https://pubmed.ncbi.nlm.nih.gov/40046728/", "doi": "10.1089/psymed.2022.0011", "pmid": "40046728", "publication_date": "2023-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1194, "title": "Ethical considerations for psychedelic-assisted therapy in military clinical settings", "authors": "Scott Hoener, Aaron Wolfgang, David A. Nissan, Edmund G. Howe", "journal": "Journal of Medical Ethics", "publication_date": "2023-05-29", "publication_year": 2023, "doi": "10.1136/jme-2023-108943", "pubmed_id": "37253556", "openalex_id": "https://openalex.org/W4378782490", "source_url": "http://dx.doi.org/10.1136/jme-2023-108943", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37253556", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1136/jme-2023-108943", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37253556", "source_url": "http://dx.doi.org/10.1136/jme-2023-108943", "doi": "10.1136/jme-2023-108943", "pmid": "37253556", "publication_date": "2023-05-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3475, "title": "Evaluation of the Acceptability, Safety, Feasibility, and Efficacy of Psilocybin-assisted Psychotherapy (PaP) for the Treatment of Post-traumatic Stress Disorder (PTSD) in Military Veterans", "authors": "Combat Stress", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-24", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05876481", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Treatment-Resistant Depression,Veterans,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05876481", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05876481", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05876481", "source_url": "https://clinicaltrials.gov/study/NCT05876481", "doi": "", "pmid": "", "publication_date": "2023-05-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1367, "title": "Comparative acute effects of mescaline, lysergic acid diethylamide, and psilocybin in a randomized, double-blind, placebo-controlled cross-over study in healthy participants", "authors": "Laura Ley, Friederike Holze, Denis Arikci, A. Becker, Isabelle Straumann, Aaron Klaiber, Fabio Coviello, Sophie Dierbach, Jan Thomann, Urs Duthaler, Dino Luethi, Nimmy Varghese, Anne Eckert, Matthias E. Liechti", "journal": "Neuropsychopharmacology", "publication_date": "2023-05-24", "publication_year": 2023, "doi": "10.1038/s41386-023-01607-2", "pubmed_id": "37231080", "openalex_id": "https://openalex.org/W4378174725", "source_url": "https://doi.org/10.1038/s41386-023-01607-2", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Receptor Pharmacology,Consciousness,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37231080", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41386-023-01607-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37231080", "source_url": "https://doi.org/10.1038/s41386-023-01607-2", "doi": "10.1038/s41386-023-01607-2", "pmid": "37231080", "publication_date": "2023-05-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1481, "title": "Neurobiological Correlates of Psilocybin Response in Depression.", "authors": "Qasim S, Zaheer Z, Jawad MY, Shad MU.", "journal": null, "publication_date": "2023-05-22", "publication_year": 2023, "doi": "10.4088/pcc.22r03419", "pubmed_id": "37230065", "openalex_id": null, "source_url": "https://doi.org/10.4088/pcc.22r03419", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37230065", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.4088/pcc.22r03419", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37230065", "source_url": "https://doi.org/10.4088/pcc.22r03419", "doi": "10.4088/pcc.22r03419", "pmid": "37230065", "publication_date": "2023-05-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3683, "title": "Recall of Experience and Conscious Awareness in Psilocybin Treatment of Depression (The RECAP Study): Pilot Phase in Healthy Adult Volunteers", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-18", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04842045", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Clinical Trial,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04842045", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04842045", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04842045", "source_url": "https://clinicaltrials.gov/study/NCT04842045", "doi": "", "pmid": "", "publication_date": "2023-05-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3634, "title": "A Phase 1 Study Comparing the Pharmacokinetics and Safety of Intravenous and Oral Psilocybin", "authors": "University of Wisconsin, Madison", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-14", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05467761", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05467761", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05467761", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05467761", "source_url": "https://clinicaltrials.gov/study/NCT05467761", "doi": "", "pmid": "", "publication_date": "2023-05-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3463, "title": "Effects of Psilocybin in Anorexia Nervosa", "authors": "Johns Hopkins University", "journal": "ClinicalTrials.gov", "publication_date": "2023-05-05", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04052568", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04052568", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04052568", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04052568", "source_url": "https://clinicaltrials.gov/study/NCT04052568", "doi": "", "pmid": "", "publication_date": "2023-05-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1491, "title": "Study protocol of an open-label proof-of-concept trial examining the safety and clinical efficacy of psilocybin-assisted therapy for veterans with PTSD", "authors": "Alan K. Davis, Adam W. Levin, Paul Nagib, Stacey B. Armstrong, Rafael Lancelotta", "journal": "BMJ Open", "publication_date": "2023-04-30", "publication_year": 2023, "doi": "10.1136/bmjopen-2022-068884", "pubmed_id": "37142308", "openalex_id": "https://openalex.org/W4372336620", "source_url": "https://doi.org/10.1136/bmjopen-2022-068884", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Chronic Pain,Clinical Trial,Review Article,Veterans,Healthcare Workers,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37142308", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/bmjopen-2022-068884", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37142308", "source_url": "https://doi.org/10.1136/bmjopen-2022-068884", "doi": "10.1136/bmjopen-2022-068884", "pmid": "37142308", "publication_date": "2023-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4819, "title": "A suicide attempt following psilocybin ingestion in a patient with no prior psychiatric history", "authors": "Eric N. Kramer, Kalyn Reddy, Bryan Shapiro", "journal": "Psychiatry Research Case Reports", "publication_date": "2023-04-25", "publication_year": 2023, "doi": "10.1016/j.psycr.2023.100118", "pubmed_id": null, "openalex_id": "https://openalex.org/W4367043450", "source_url": "https://doi.org/10.1016/j.psycr.2023.100118", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Pharmacology,Safety,Adverse Events,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "DOI:10.1016/j.psycr.2023.100118", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.psycr.2023.100118", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.psycr.2023.100118", "source_url": "https://doi.org/10.1016/j.psycr.2023.100118", "doi": "10.1016/j.psycr.2023.100118", "pmid": "", "publication_date": "2023-04-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1499, "title": "Safety, tolerability, and clinical and neural effects of single-dose psilocybin in obsessive-compulsive disorder: protocol for a randomized, double-blind, placebo-controlled, non-crossover trial", "authors": "Terence H. W. Ching, Rachael Grazioplene, Calvin Bohner, Stephen A. Kichuk, Giuliana DePalmer, Elizabeth J. D’Amico, Jeffrey Eilbott, Anastasia Jankovsky, Michelle Burke, Jamila Hokanson, Brad Martins, Chelsea Witherow, Prerana Patel, Lucia Amoroso, Henry Schaer, Christopher Pittenger, Benjamin Kelmendi", "journal": "Frontiers in Psychiatry", "publication_date": "2023-04-24", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1178529", "pubmed_id": "37181888", "openalex_id": "https://openalex.org/W4366989647", "source_url": "https://doi.org/10.3389/fpsyt.2023.1178529", "substance_tags": "psilocybin", "topic_tags": "OCD,Chronic Pain,Brain Imaging,Pharmacology,Mechanism of Action,Aging,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:36", "bibtex": null, "source_record_id": "PMID:37181888", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1178529", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:37181888", "source_url": "https://doi.org/10.3389/fpsyt.2023.1178529", "doi": "10.3389/fpsyt.2023.1178529", "pmid": "37181888", "publication_date": "2023-04-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3563, "title": "The Safety and Efficacy of Psilocybin in Participants With Treatment Resistant Depression", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2023-04-23", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03775200", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03775200", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03775200", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03775200", "source_url": "https://clinicaltrials.gov/study/NCT03775200", "doi": "", "pmid": "", "publication_date": "2023-04-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3176, "title": "A Phase I trial to inform clinical protocols for the safe administration of psilocybin-assisted psychotherapy", "authors": "Bennett JN, Blough MD, Mitchell I, Galloway L, Bains R.", "journal": "medRxiv", "publication_date": "2023-04-18", "publication_year": 2023, "doi": "10.1101/2023.04.12.23288325", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2023.04.12.23288325", "substance_tags": "psilocybin", "topic_tags": "Mystical Experience,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:47", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2023.04.12.23288325", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2023.04.12.23288325", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2023.04.12.23288325", "source_url": "https://doi.org/10.1101/2023.04.12.23288325", "doi": "10.1101/2023.04.12.23288325", "pmid": "", "publication_date": "2023-04-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1593, "title": "Psilocybin in Palliative Care: An Update.", "authors": "Whinkin E, Opalka M, Watters C, Jaffe A, Aggarwal S.", "journal": null, "publication_date": "2023-04-13", "publication_year": 2023, "doi": "10.1007/s13670-023-00383-7", "pubmed_id": "37305379", "openalex_id": null, "source_url": "https://doi.org/10.1007/s13670-023-00383-7", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Aging,Emotional Processing,Spirituality,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:37305379", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s13670-023-00383-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37305379", "source_url": "https://doi.org/10.1007/s13670-023-00383-7", "doi": "10.1007/s13670-023-00383-7", "pmid": "37305379", "publication_date": "2023-04-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1506, "title": "Use of Selective Alternative Therapies for Treatment of OCD.", "authors": "Khan I, Jaura TA, Tukruna A, Arif A, Tebha SS, Nasir S, Mukherjee D, Masroor N, Yosufi A.", "journal": null, "publication_date": "2023-04-04", "publication_year": 2023, "doi": "10.2147/ndt.s403997", "pubmed_id": "37041856", "openalex_id": null, "source_url": "https://doi.org/10.2147/ndt.s403997", "substance_tags": "psilocybin", "topic_tags": "OCD,Mechanism of Action,Clinical Trial,Systematic Review,Review Article,Observational Study,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:37041856", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.2147/ndt.s403997", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37041856", "source_url": "https://doi.org/10.2147/ndt.s403997", "doi": "10.2147/ndt.s403997", "pmid": "37041856", "publication_date": "2023-04-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1424, "title": "Are psychedelic medicines the reset for chronic pain? Preliminary findings and research needs.", "authors": "Zia FZ, Baumann MH, Belouin SJ, Dworkin RH, Ghauri MH, Hendricks PS, Henningfield JE, Lanier RK, Ross S, Berger A.", "journal": null, "publication_date": "2023-04-01", "publication_year": 2023, "doi": "10.1016/j.neuropharm.2023.109528", "pubmed_id": "37015315", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neuropharm.2023.109528", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Chronic Pain,Pharmacology,Mechanism of Action,Spirituality,Clinical Trial,Safety,Adverse Events,Inflammation", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37015315", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2023.109528", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37015315", "source_url": "https://doi.org/10.1016/j.neuropharm.2023.109528", "doi": "10.1016/j.neuropharm.2023.109528", "pmid": "37015315", "publication_date": "2023-04-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1512, "title": "Prevalence and associations of challenging, difficult or distressing experiences using classic psychedelics.", "authors": "Simonsson O, Hendricks PS, Chambers R, Osika W, Goldberg SB", "journal": "Journal of affective disorders", "publication_date": "2023-03-31", "publication_year": 2023, "doi": "10.1016/j.jad.2023.01.073", "pubmed_id": "36720405", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36720405/", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36720405", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36720405/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36720405", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36720405/", "doi": "10.1016/j.jad.2023.01.073", "pmid": "36720405", "publication_date": "2023-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1451, "title": "The need for establishing best practices and gold standards in psychedelic medicine.", "authors": "Feduccia A, Agin-Liebes G, Price CM, Grinsell N, Paradise S, Rabin DM.", "journal": null, "publication_date": "2023-03-29", "publication_year": 2023, "doi": "10.1016/j.jad.2023.03.083", "pubmed_id": "37003433", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2023.03.083", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:37003433", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2023.03.083", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37003433", "source_url": "https://doi.org/10.1016/j.jad.2023.03.083", "doi": "10.1016/j.jad.2023.03.083", "pmid": "37003433", "publication_date": "2023-03-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1526, "title": "Psychedelic Targeting of Metabotropic Glutamate Receptor 2 and Its Implications for the Treatment of Alcoholism.", "authors": "Domanegg K, Sommer WH, Meinhardt MW.", "journal": null, "publication_date": "2023-03-21", "publication_year": 2023, "doi": "10.3390/cells12060963", "pubmed_id": "36980303", "openalex_id": null, "source_url": "https://doi.org/10.3390/cells12060963", "substance_tags": "psilocybin", "topic_tags": "Addiction,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Aging,Epigenetics,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36980303", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/cells12060963", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36980303", "source_url": "https://doi.org/10.3390/cells12060963", "doi": "10.3390/cells12060963", "pmid": "36980303", "publication_date": "2023-03-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3433, "title": "Mood and Cognitive Effects of Low Doses of Psilocybin Observed in Healthy Subjects (\"MELO\"): A Blinded, Placebo-Controlled, Dose-Finding Study", "authors": "Optimi Health Corporation", "journal": "ClinicalTrials.gov", "publication_date": "2023-03-19", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05252598", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Microdosing,Wellbeing,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05252598", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05252598", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05252598", "source_url": "https://clinicaltrials.gov/study/NCT05252598", "doi": "", "pmid": "", "publication_date": "2023-03-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3763, "title": "Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD", "authors": "Ching THW, Grazioplene R, Pittenger C, Kelmendi B.", "journal": "PsyArXiv", "publication_date": "2023-03-16", "publication_year": 2023, "doi": "10.31234/osf.io/ba42z", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/ba42z", "substance_tags": "psilocybin", "topic_tags": "OCD,Mechanism of Action,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/ba42z", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/ba42z", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/ba42z", "source_url": "https://doi.org/10.31234/osf.io/ba42z", "doi": "10.31234/osf.io/ba42z", "pmid": "", "publication_date": "2023-03-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3186, "title": "Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin Combined with Non-Directive Support in the Treatment of OCD", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-03-16", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/ba42z_v1", "substance_tags": "psilocybin", "topic_tags": "OCD,Pharmacology,Mechanism of Action,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/ba42z_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/ba42z_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/ba42z_v1", "source_url": "https://osf.io/preprints/psyarxiv/ba42z_v1", "doi": "", "pmid": "", "publication_date": "2023-03-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3524, "title": "Safety and Efficacy of Psilocybin for Body Dysmorphic Disorder", "authors": "New York State Psychiatric Institute", "journal": "ClinicalTrials.gov", "publication_date": "2023-03-12", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04656301", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Receptor Pharmacology,Aging,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04656301", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04656301", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04656301", "source_url": "https://clinicaltrials.gov/study/NCT04656301", "doi": "", "pmid": "", "publication_date": "2023-03-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3772, "title": "Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study", "authors": "Turkia M.", "journal": "PsyArXiv", "publication_date": "2023-03-09", "publication_year": 2023, "doi": "10.31234/osf.io/wupvy", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/wupvy", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Treatment-Resistant Depression,Healthcare Workers,Safety,Drug Interactions", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:20", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/wupvy", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/wupvy", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/wupvy", "source_url": "https://doi.org/10.31234/osf.io/wupvy", "doi": "10.31234/osf.io/wupvy", "pmid": "", "publication_date": "2023-03-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3233, "title": "Self-treatment of depression and complex post-traumatic stress disorder with psilocybin and LSD-A retrospective case study", "authors": "", "journal": "PsyArXiv", "publication_date": "2023-03-09", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/wupvy_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Treatment-Resistant Depression,Healthcare Workers,Safety,Drug Interactions", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/wupvy_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/wupvy_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/wupvy_v1", "source_url": "https://osf.io/preprints/psyarxiv/wupvy_v1", "doi": "", "pmid": "", "publication_date": "2023-03-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4833, "title": "Psychedelics for Medicinal Use: How Will This Alter the Collective Laboratory Consciousness?", "authors": "Steven W. Cotten, Frederick G. Strathmann, Frederick S. Barrett, Laura Labay, James Mullally, Alexander M. Sherwood, Frank Wiegand", "journal": "Clinical Chemistry", "publication_date": "2023-03-06", "publication_year": 2023, "doi": "10.1093/clinchem/hvad016", "pubmed_id": "36881769", "openalex_id": "https://openalex.org/W4323351497", "source_url": "http://dx.doi.org/10.1093/clinchem/hvad016", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36881769", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1093/clinchem/hvad016", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36881769", "source_url": "http://dx.doi.org/10.1093/clinchem/hvad016", "doi": "10.1093/clinchem/hvad016", "pmid": "36881769", "publication_date": "2023-03-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1536, "title": "Inhibition of Microglial GSK3β Activity Is Common to Different Kinds of Antidepressants: A Proposal for an In Vitro Screen to Detect Novel Antidepressant Principles.", "authors": "Kalkman HO", "journal": "Biomedicines", "publication_date": "2023-03-06", "publication_year": 2023, "doi": "10.3390/biomedicines11030806", "pubmed_id": "36979785", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36979785/", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,In Vitro Study,Safety,Inflammation", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36979785", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36979785/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36979785", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36979785/", "doi": "10.3390/biomedicines11030806", "pmid": "36979785", "publication_date": "2023-03-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1548, "title": "Research into Psychedelic-Assisted Psychotherapy for Anorexia Nervosa Should be Funded.", "authors": "Otterman LS", "journal": "Journal of bioethical inquiry", "publication_date": "2023-02-28", "publication_year": 2023, "doi": "10.1007/s11673-022-10220-9", "pubmed_id": "36534233", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36534233/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36534233", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36534233/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36534233", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36534233/", "doi": "10.1007/s11673-022-10220-9", "pmid": "36534233", "publication_date": "2023-02-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1542, "title": "Pharmacotherapies for Treatment-Resistant Depression: How Antipsychotics Fit in the Rapidly Evolving Therapeutic Landscape.", "authors": "Jha MK, Mathew SJ.", "journal": null, "publication_date": "2023-02-28", "publication_year": 2023, "doi": "10.1176/appi.ajp.20230025", "pubmed_id": "36855876", "openalex_id": null, "source_url": "https://doi.org/10.1176/appi.ajp.20230025", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36855876", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1176/appi.ajp.20230025", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36855876", "source_url": "https://doi.org/10.1176/appi.ajp.20230025", "doi": "10.1176/appi.ajp.20230025", "pmid": "36855876", "publication_date": "2023-02-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1553, "title": "Effect of psilocybin on decision-making and motivation in the healthy rat.", "authors": "飯倉 洋治, 馬場 實, 三河 春樹, 西間 三馨, 前田 和一, 赤坂 徹, 正木 拓朗, 有田 昌彦", "journal": "PubMed", "publication_date": "2023-02-24", "publication_year": 2023, "doi": "10.1016/j.bbr.2022.114262", "pubmed_id": "36529299", "openalex_id": "https://openalex.org/W36529299", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36529299", "substance_tags": "psilocybin,psilocin", "topic_tags": "Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36529299", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36529299", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36529299", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36529299", "doi": "10.1016/j.bbr.2022.114262", "pmid": "36529299", "publication_date": "2023-02-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4846, "title": "Psychedelic Renaissance: Clinical Health Justice, Patient Safety, and Equity Need to Be Put First", "authors": "Jacques Ambrose, J.S. Zabinski", "journal": "Psychiatric News", "publication_date": "2023-02-15", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.03.3.43", "pubmed_id": null, "openalex_id": "https://openalex.org/W4321033113", "source_url": "https://doi.org/10.1176/appi.pn.2023.03.3.43", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.03.3.43", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.03.3.43", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.03.3.43", "source_url": "https://doi.org/10.1176/appi.pn.2023.03.3.43", "doi": "10.1176/appi.pn.2023.03.3.43", "pmid": "", "publication_date": "2023-02-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4845, "title": "Psychedelics Legislation Gains Momentum", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2023-02-15", "publication_year": 2023, "doi": "10.1176/appi.pn.2023.03.3.4", "pubmed_id": null, "openalex_id": "https://openalex.org/W4321017755", "source_url": "https://doi.org/10.1176/appi.pn.2023.03.3.4", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Safety,Drug Interactions", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2023.03.3.4", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2023.03.3.4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2023.03.3.4", "source_url": "https://doi.org/10.1176/appi.pn.2023.03.3.4", "doi": "10.1176/appi.pn.2023.03.3.4", "pmid": "", "publication_date": "2023-02-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1564, "title": "Hofmann vs. Paracelsus: Do Psychedelics Defy the Basics of Toxicology?-A Systematic Review of the Main Ergolamines, Simple Tryptamines, and Phenylethylamines.", "authors": "Henríquez-Hernández LA, Rojas-Hernández J, Quintana-Hernández DJ, Borkel LF.", "journal": null, "publication_date": "2023-02-02", "publication_year": 2023, "doi": "10.3390/toxics11020148", "pubmed_id": "36851023", "openalex_id": null, "source_url": "https://doi.org/10.3390/toxics11020148", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Systematic Review,Review Article,Safety,Toxicity", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36851023", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/toxics11020148", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36851023", "source_url": "https://doi.org/10.3390/toxics11020148", "doi": "10.3390/toxics11020148", "pmid": "36851023", "publication_date": "2023-02-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1514, "title": "Psychedelics: Science sabotaged by Social Media.", "authors": "Sellers EM, Romach MK.", "journal": null, "publication_date": "2023-01-20", "publication_year": 2023, "doi": "10.1016/j.neuropharm.2023.109426", "pubmed_id": "36693562", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neuropharm.2023.109426", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36693562", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2023.109426", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36693562", "source_url": "https://doi.org/10.1016/j.neuropharm.2023.109426", "doi": "10.1016/j.neuropharm.2023.109426", "pmid": "36693562", "publication_date": "2023-01-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1574, "title": "Classic psychedelics do not affect T cell and monocyte immune responses", "authors": "Deborah Rudin, Alexander Areesanan, Matthias E. Liechti, Carsten Gründemann", "journal": "Frontiers in Psychiatry", "publication_date": "2023-01-19", "publication_year": 2023, "doi": "10.3389/fpsyt.2023.1042440", "pubmed_id": "36741125", "openalex_id": "https://openalex.org/W4317631458", "source_url": "https://doi.org/10.3389/fpsyt.2023.1042440", "substance_tags": "psilocin", "topic_tags": "End-of-Life Distress,Pharmacology,Receptor Pharmacology,In Vitro Study,Safety,Immune Function", "study_type": "In Vitro Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36741125", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2023.1042440", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36741125", "source_url": "https://doi.org/10.3389/fpsyt.2023.1042440", "doi": "10.3389/fpsyt.2023.1042440", "pmid": "36741125", "publication_date": "2023-01-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4855, "title": "Group format psychedelic-assisted therapy interventions: Observations and impressions from the HOPE trial", "authors": "Benjamin R. Lewis, Kevin Byrne, John Hendrick, Eric L. Garland, Paul Thielking, Anna C. Beck", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-01-17", "publication_year": 2023, "doi": "10.1556/2054.2022.00222", "pubmed_id": null, "openalex_id": "https://openalex.org/W4317355030", "source_url": "https://doi.org/10.1556/2054.2022.00222", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Clinical Trial,Observational Study,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2022.00222", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2022.00222", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2022.00222", "source_url": "https://doi.org/10.1556/2054.2022.00222", "doi": "10.1556/2054.2022.00222", "pmid": "", "publication_date": "2023-01-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4856, "title": "Therapeutic potential of psilocybin: a promising agent in treating major depressive disorder", "authors": "Dragana Marković, Eleonora Čapelja", "journal": "AIDASCO Reviews", "publication_date": "2023-01-16", "publication_year": 2023, "doi": "10.59783/aire.2023.15", "pubmed_id": null, "openalex_id": "https://openalex.org/W4406142619", "source_url": "https://doi.org/10.59783/aire.2023.15", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,PTSD,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.59783/aire.2023.15", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.59783/aire.2023.15", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.59783/aire.2023.15", "source_url": "https://doi.org/10.59783/aire.2023.15", "doi": "10.59783/aire.2023.15", "pmid": "", "publication_date": "2023-01-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3568, "title": "Pilot Trial of Visual Healing®, a Nature-themed Virtual Immersive Experience, to Optimize Set and Setting in Psilocybin-assisted Therapy for Alcohol Use Disorder", "authors": "Keith Heinzerling", "journal": "ClinicalTrials.gov", "publication_date": "2023-01-16", "publication_year": 2023, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04410913", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Mystical Experience,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04410913", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04410913", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04410913", "source_url": "https://clinicaltrials.gov/study/NCT04410913", "doi": "", "pmid": "", "publication_date": "2023-01-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4858, "title": "Recruitment discrimination of lifetime classic psychedelic users is unjustified: Evidence from employees' motivation-based workplace absenteeism", "authors": "Benjamin A. Korman", "journal": "Journal of Psychedelic Studies", "publication_date": "2023-01-15", "publication_year": 2023, "doi": "10.1556/2054.2022.00240", "pubmed_id": null, "openalex_id": "https://openalex.org/W4316511320", "source_url": "https://doi.org/10.1556/2054.2022.00240", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2022.00240", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2022.00240", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2022.00240", "source_url": "https://doi.org/10.1556/2054.2022.00240", "doi": "10.1556/2054.2022.00240", "pmid": "", "publication_date": "2023-01-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1569, "title": "5-HT2ARs Mediate Therapeutic Behavioral Effects of Psychedelic Tryptamines", "authors": "Lindsay P. Cameron, Seona D. Patel, Maxemiliano V. Vargas, Eden V. Barragan, Hannah N. Saeger, Hunter T. Warren, Winston L. Chow, J.A. Gray, David E. Olson", "journal": "ACS Chemical Neuroscience", "publication_date": "2023-01-10", "publication_year": 2023, "doi": "10.1021/acschemneuro.2c00718", "pubmed_id": "36630260", "openalex_id": "https://openalex.org/W4315620747", "source_url": "https://doi.org/10.1021/acschemneuro.2c00718", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 06:34:46", "bibtex": null, "source_record_id": "PMID:36630260", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.2c00718", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36630260", "source_url": "https://doi.org/10.1021/acschemneuro.2c00718", "doi": "10.1021/acschemneuro.2c00718", "pmid": "36630260", "publication_date": "2023-01-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1516, "title": "Are psychedelics the answer to chronic pain: A review of current literature.", "authors": "Kooijman NI, Willegers T, Reuser A, Mulleners WM, Kramers C, Vissers KCP, van der Wal SEI.", "journal": null, "publication_date": "2023-01-10", "publication_year": 2023, "doi": "10.1111/papr.13203", "pubmed_id": "36597700", "openalex_id": null, "source_url": "https://doi.org/10.1111/papr.13203", "substance_tags": "psilocybin", "topic_tags": "Addiction,End-of-Life Distress,Chronic Pain,Headache / Migraine,Receptor Pharmacology,Randomized Controlled Trial,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:36597700", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/papr.13203", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36597700", "source_url": "https://doi.org/10.1111/papr.13203", "doi": "10.1111/papr.13203", "pmid": "36597700", "publication_date": "2023-01-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4862, "title": "Cognitive liberty and the constitutionality of criminalising psilocybin mushrooms in South Africa", "authors": "Sebastian William Foster", "journal": "South African Journal on Human Rights", "publication_date": "2023-01-01", "publication_year": 2023, "doi": "10.1080/02587203.2023.2202875", "pubmed_id": null, "openalex_id": "https://openalex.org/W4376279288", "source_url": "http://dx.doi.org/10.1080/02587203.2023.2202875", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1080/02587203.2023.2202875", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1080/02587203.2023.2202875", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/02587203.2023.2202875", "source_url": "http://dx.doi.org/10.1080/02587203.2023.2202875", "doi": "10.1080/02587203.2023.2202875", "pmid": "", "publication_date": "2023-01-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4887, "title": "The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a long-term observational follow-up study", "authors": "Guy M. Goodwin, Lindsey Marwood, S. Mistry, Anna Nowakowska, Zainib Shabir, H. Clifton Simmons, E.K. Teoh, Jeng-Yu Tsai, E. Malievskaia", "journal": "Neuroscience Applied", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.nsa.2023.102906", "pubmed_id": null, "openalex_id": "https://openalex.org/W4390223380", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.102906", "substance_tags": "psilocybin", "topic_tags": "Depression,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2023.102906", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2023.102906", "source_url": "http://dx.doi.org/10.1016/j.nsa.2023.102906", "doi": "10.1016/j.nsa.2023.102906", "pmid": "", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4868, "title": "The right to privacy in the decriminalisation of psilocybin mushrooms in South Africa", "authors": "Sebastian William Foster", "journal": "Law Democracy & Development", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.17159/2077-4907/2023/ldd.v27.1", "pubmed_id": null, "openalex_id": "https://openalex.org/W4366774867", "source_url": "https://doi.org/10.17159/2077-4907/2023/ldd.v27.1", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:46", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.17159/2077-4907/2023/ldd.v27.1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.17159/2077-4907/2023/ldd.v27.1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.17159/2077-4907/2023/ldd.v27.1", "source_url": "https://doi.org/10.17159/2077-4907/2023/ldd.v27.1", "doi": "10.17159/2077-4907/2023/ldd.v27.1", "pmid": "", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1614, "title": "Linkages between Psychedelics and Meditation in a Population-Based Sample in the United States.", "authors": "Simonsson O, Goldberg SB", "journal": "Journal of psychoactive drugs", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1080/02791072.2021.2022816", "pubmed_id": "35000559", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35000559/", "substance_tags": "psilocybin", "topic_tags": "Randomized Controlled Trial,Observational Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:35000559", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35000559/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35000559", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35000559/", "doi": "10.1080/02791072.2021.2022816", "pmid": "35000559", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1595, "title": "Psychedelic drug abuse potential assessment for new drug applications and controlled substance scheduling: A United States perspective", "authors": "Jack E. Henningfield, Judy Ashworth, David J. Heal, Sharon L. Smith", "journal": "Journal of Psychopharmacology", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1177/02698811221140004", "pubmed_id": "36588452", "openalex_id": "https://openalex.org/W4313424238", "source_url": "https://doi.org/10.1177/02698811221140004", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Mechanism of Action,Receptor Pharmacology,Clinical Trial,In Vitro Study,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36588452", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811221140004", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36588452", "source_url": "https://doi.org/10.1177/02698811221140004", "doi": "10.1177/02698811221140004", "pmid": "36588452", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1585, "title": "Efficacy and Safety of Psychedelics in Treating Anxiety Disorders", "authors": "Leah Feulner, Thanpicha Sermchaiwong, Nathan Rodland, David Galarneau", "journal": "Ochsner Journal", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.31486/toj.23.0076", "pubmed_id": "38143548", "openalex_id": "https://openalex.org/W4389868195", "source_url": "https://doi.org/10.31486/toj.23.0076", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Aging,Clinical Trial,Review Article,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:38143548", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.31486/toj.23.0076", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38143548", "source_url": "https://doi.org/10.31486/toj.23.0076", "doi": "10.31486/toj.23.0076", "pmid": "38143548", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1584, "title": "Past Is Prologue: Ethical Issues in Pediatric Psychedelics Research and Treatment", "authors": "Gail A. Edelsohn, Dominic Sisti", "journal": "Perspectives in biology and medicine", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1353/pbm.2023.0007", "pubmed_id": "38662012", "openalex_id": "https://openalex.org/W4324007078", "source_url": "https://doi.org/10.1353/pbm.2023.0007", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Personality Change,Clinical Trial,Adolescents,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:38662012", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1353/pbm.2023.0007", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:38662012", "source_url": "https://doi.org/10.1353/pbm.2023.0007", "doi": "10.1353/pbm.2023.0007", "pmid": "38662012", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1577, "title": "On blinding and suicide risk in a recent trial of psilocybin-assisted therapy for treatment-resistant depression", "authors": "Natalie Gukasyan", "journal": "Med", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.medj.2022.12.003", "pubmed_id": "36640755", "openalex_id": "https://openalex.org/W4315874306", "source_url": "https://doi.org/10.1016/j.medj.2022.12.003", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36640755", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36640755", "source_url": "https://doi.org/10.1016/j.medj.2022.12.003", "doi": "10.1016/j.medj.2022.12.003", "pmid": "36640755", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1576, "title": "Is psilocybin an effective antidepressant and what is its Mechanism of action?", "authors": "Mann JJ.", "journal": null, "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1016/j.xcrm.2022.100906", "pubmed_id": "36652915", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.xcrm.2022.100906", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:36652915", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.xcrm.2022.100906", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36652915", "source_url": "https://doi.org/10.1016/j.xcrm.2022.100906", "doi": "10.1016/j.xcrm.2022.100906", "pmid": "36652915", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1523, "title": "Magic Mushroom Use: A Qualitative Interview Study of Post-Trip Impacts and Strategies for Optimizing Experiences.", "authors": "Shaw L, Rea K, Lachowsky NJ, Roth EA", "journal": "Journal of psychoactive drugs", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1080/02791072.2022.2054746", "pubmed_id": "35315749", "openalex_id": "https://openalex.org/W4220816548", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35315749/", "substance_tags": "psilocybin", "topic_tags": "Aging,Safety", "study_type": "Qualitative Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:35315749", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35315749/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35315749", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35315749/", "doi": "10.1080/02791072.2022.2054746", "pmid": "35315749", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1509, "title": "The Impact of Psilocybin on Patients Experiencing Psychiatric Symptoms: A Systematic Review of Randomized Clinical Trials.", "authors": "IsHak WW, Garcia P, Pearl R, Dang J, William C, Totlani J, Danovitch I.", "journal": null, "publication_date": "2022-12-31", "publication_year": 2022, "doi": null, "pubmed_id": "37387703", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/37387703", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:37387703", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/37387703", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:37387703", "source_url": "https://europepmc.org/article/MED/37387703", "doi": "", "pmid": "37387703", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1485, "title": "Editorial: Appropriateness and safety of using cannabinoid and psychedelic medicines as treatments for psychiatric disorders.", "authors": "Blest-Hopley G, Amit BH, O'Neill A, Ruffell SGD", "journal": "Frontiers in psychiatry", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.3389/fpsyt.2023.1191970", "pubmed_id": "37252138", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37252138/", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:37252138", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37252138", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37252138/", "doi": "10.3389/fpsyt.2023.1191970", "pmid": "37252138", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1461, "title": "Systematic review and rationale of using psychedelics in the treatment of cannabis use disorder.", "authors": "Phan AN, Terry GE", "journal": "Frontiers in psychiatry", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.3389/fpsyt.2023.1144276", "pubmed_id": "37435402", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37435402/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Systematic Review,Review Article,Observational Study,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:37435402", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37435402/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37435402", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37435402/", "doi": "10.3389/fpsyt.2023.1144276", "pmid": "37435402", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1458, "title": "Medical student attitudes and perceptions of psychedelic-assisted therapies.", "authors": "Li I, Fong R, Hagen M, Tabaac B", "journal": "Frontiers in psychiatry", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.3389/fpsyt.2023.1190507", "pubmed_id": "37441143", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37441143/", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:37441143", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37441143/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37441143", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37441143/", "doi": "10.3389/fpsyt.2023.1190507", "pmid": "37441143", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1457, "title": "Case report: Psychedelic-induced seizures captured by intracranial electrocorticography.", "authors": "Blond BN, Schindler EAD", "journal": "Frontiers in neurology", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.3389/fneur.2023.1214969", "pubmed_id": "37456653", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37456653/", "substance_tags": "psilocybin", "topic_tags": "Case Report,Safety", "study_type": "Case Report", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:37456653", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37456653/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37456653", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37456653/", "doi": "10.3389/fneur.2023.1214969", "pmid": "37456653", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1355, "title": "Editorial: Psychedelics as treatments for substance use disorders: exploring therapeutic potential, risks, underlying mechanisms of action, and implementation challenges.", "authors": "Barnett BS, Bassir Nia A, Sackett NB, Weleff J", "journal": "Frontiers in psychiatry", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.3389/fpsyt.2023.1305478", "pubmed_id": "37928914", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37928914/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:37928914", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37928914", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37928914/", "doi": "10.3389/fpsyt.2023.1305478", "pmid": "37928914", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1351, "title": "\"How Do I Learn More About this?\": Utilization and Trust of Psychedelic Information Sources Among People Naturalistically Using Psychedelics.", "authors": "Kruger DJ, Enghoff O, Herberholz M, Barron J, Boehnke KF", "journal": "Journal of psychoactive drugs", "publication_date": "2022-12-31", "publication_year": 2022, "doi": "10.1080/02791072.2023.2201263", "pubmed_id": "37078418", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/37078418/", "substance_tags": "psilocybin", "topic_tags": "Review Article,Observational Study,Safety", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:37", "bibtex": null, "source_record_id": "PMID:37078418", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/37078418/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:37078418", "source_url": "https://pubmed.ncbi.nlm.nih.gov/37078418/", "doi": "10.1080/02791072.2023.2201263", "pmid": "37078418", "publication_date": "2022-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1549, "title": "Experimental strategies to discover and develop the next generation of psychedelics and entactogens as medicines.", "authors": "Heal DJ, Gosden J, Smith SL, Atterwill CK.", "journal": null, "publication_date": "2022-12-15", "publication_year": 2022, "doi": "10.1016/j.neuropharm.2022.109375", "pubmed_id": "36529260", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neuropharm.2022.109375", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Receptor Pharmacology,Animal Study,Safety,Toxicity,Drug Interactions,Inflammation", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36529260", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2022.109375", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36529260", "source_url": "https://doi.org/10.1016/j.neuropharm.2022.109375", "doi": "10.1016/j.neuropharm.2022.109375", "pmid": "36529260", "publication_date": "2022-12-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1620, "title": "“A sense of the bigger picture:” A qualitative analysis of follow-up interviews with people with bipolar disorder who self-reported psilocybin use", "authors": "Meghan DellaCrosse, Mollie Pleet, Emma Morton, Amir Ashtari, Kimberly Sakai, Josh Woolley, Erin E. Michalak", "journal": "PLoS ONE", "publication_date": "2022-12-13", "publication_year": 2022, "doi": "10.1371/journal.pone.0279073", "pubmed_id": "36516137", "openalex_id": "https://openalex.org/W4311439362", "source_url": "https://doi.org/10.1371/journal.pone.0279073", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Emotional Processing,Clinical Trial,Observational Study,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36516137", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0279073", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36516137", "source_url": "https://doi.org/10.1371/journal.pone.0279073", "doi": "10.1371/journal.pone.0279073", "pmid": "36516137", "publication_date": "2022-12-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1597, "title": "Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption", "authors": "Emma Morton, Kimberly Sakai, Amir Ashtari, Mollie Pleet, Erin E. Michalak, Josh Woolley", "journal": "Journal of Psychopharmacology", "publication_date": "2022-12-13", "publication_year": 2022, "doi": "10.1177/02698811221131997", "pubmed_id": "36515370", "openalex_id": "https://openalex.org/W4311477082", "source_url": "https://doi.org/10.1177/02698811221131997", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Clinical Trial,Observational Study,Safety,Adverse Events,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36515370", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/02698811221131997", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:36515370", "source_url": "https://doi.org/10.1177/02698811221131997", "doi": "10.1177/02698811221131997", "pmid": "36515370", "publication_date": "2022-12-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4897, "title": "History of epilepsy increases risk of psychedelic-induced seizures", "authors": "", "journal": "The Brown University Psychopharmacology Update", "publication_date": "2022-12-09", "publication_year": 2022, "doi": "10.1002/pu.30967", "pubmed_id": null, "openalex_id": "https://openalex.org/W4312063948", "source_url": "https://doi.org/10.1002/pu.30967", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Receptor Pharmacology,Observational Study,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:34:47", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1002/pu.30967", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/pu.30967", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1002/pu.30967", "source_url": "https://doi.org/10.1002/pu.30967", "doi": "10.1002/pu.30967", "pmid": "", "publication_date": "2022-12-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1517, "title": "Psychedelic-Assisted Therapy and Psychedelic Science: A Review and Perspective on Opportunities in Neurosurgery and Neuro-Oncology.", "authors": "Kelly DF, Kelly DF, Heinzerling K, Sharma A, Gowrinathan S, Sergi K, Mallari RJ.", "journal": null, "publication_date": "2022-12-07", "publication_year": 2022, "doi": "10.1227/neu.0000000000002275", "pubmed_id": "36512813", "openalex_id": null, "source_url": "https://doi.org/10.1227/neu.0000000000002275", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Chronic Pain,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:36512813", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1227/neu.0000000000002275", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36512813", "source_url": "https://doi.org/10.1227/neu.0000000000002275", "doi": "10.1227/neu.0000000000002275", "pmid": "36512813", "publication_date": "2022-12-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1627, "title": "Psychedelic-Assisted Therapy for People with Eating Disorders.", "authors": "Gukasyan N, Schreyer CC, Griffiths RR, Guarda AS", "journal": "Current psychiatry reports", "publication_date": "2022-11-30", "publication_year": 2022, "doi": "10.1007/s11920-022-01394-5", "pubmed_id": "36374357", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36374357/", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36374357", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36374357/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36374357", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36374357/", "doi": "10.1007/s11920-022-01394-5", "pmid": "36374357", "publication_date": "2022-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1625, "title": "Therapeutic use of psilocybin: Practical considerations for dosing and administration.", "authors": "MacCallum CA, Lo LA, Pistawka CA, Deol JK.", "journal": null, "publication_date": "2022-11-30", "publication_year": 2022, "doi": "10.3389/fpsyt.2022.1040217", "pubmed_id": "36532184", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2022.1040217", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Review Article,Safety,Adverse Events,Drug Interactions,Contraindications", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:36532184", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2022.1040217", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36532184", "source_url": "https://doi.org/10.3389/fpsyt.2022.1040217", "doi": "10.3389/fpsyt.2022.1040217", "pmid": "36532184", "publication_date": "2022-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1635, "title": "Psilocybin as a Treatment for Psychiatric Illness: A Meta-Analysis.", "authors": "Irizarry R, Winczura A, Dimassi O, Dhillon N, Minhas A, Larice J.", "journal": null, "publication_date": "2022-11-21", "publication_year": 2022, "doi": "10.7759/cureus.31796", "pubmed_id": "36569662", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.31796", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,Microdosing,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:01", "bibtex": null, "source_record_id": "PMID:36569662", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.31796", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36569662", "source_url": "https://doi.org/10.7759/cureus.31796", "doi": "10.7759/cureus.31796", "pmid": "36569662", "publication_date": "2022-11-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1638, "title": "Extensive Collection of Psychotropic Mushrooms with Determination of Their Tryptamine Alkaloids.", "authors": "Gotvaldová K, Borovička J, Hájková K, Cihlářová P, Rockefeller A, Kuchař M.", "journal": "International Journal of Molecular Sciences", "publication_date": "2022-11-14", "publication_year": 2022, "doi": "10.3390/ijms232214068", "pubmed_id": "36430546", "openalex_id": "https://openalex.org/W4309210963", "source_url": "https://doi.org/10.3390/ijms232214068", "substance_tags": "psilocybin,psilocin", "topic_tags": "Microdosing,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36430546", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ijms232214068", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36430546", "source_url": "https://doi.org/10.3390/ijms232214068", "doi": "10.3390/ijms232214068", "pmid": "36430546", "publication_date": "2022-11-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3442, "title": "A Double-Blind Trial of Psilocybin-Assisted Treatment of Alcohol Dependence", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2022-11-07", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT02061293", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Spirituality,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT02061293", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT02061293", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT02061293", "source_url": "https://clinicaltrials.gov/study/NCT02061293", "doi": "", "pmid": "", "publication_date": "2022-11-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1630, "title": "Psilocybin for alcohol use disorder: Rationale and design considerations for a randomized controlled trial.", "authors": "O'Donnell KC, Mennenga SE, Owens LT, Podrebarac SK, Baron T, Rotrosen J, Ross S, Forcehimes AA, Bogenschutz MP.", "journal": "Contemporary Clinical Trials", "publication_date": "2022-11-01", "publication_year": 2022, "doi": "10.1016/j.cct.2022.106976", "pubmed_id": "36332827", "openalex_id": "https://openalex.org/W4308040950", "source_url": "https://doi.org/10.1016/j.cct.2022.106976", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36332827", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.cct.2022.106976", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36332827", "source_url": "https://doi.org/10.1016/j.cct.2022.106976", "doi": "10.1016/j.cct.2022.106976", "pmid": "36332827", "publication_date": "2022-11-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4910, "title": "The psychedelic renaissance: can psilocybin possibly combat depression?", "authors": "Hamna Raheel, Unaiza Naeem, Asim Shaikh, Omer Ahmed Shaikh", "journal": "International Journal of Surgery Global Health", "publication_date": "2022-10-31", "publication_year": 2022, "doi": "10.1097/gh9.0000000000000089", "pubmed_id": null, "openalex_id": "https://openalex.org/W4318965036", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000089", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Headache / Migraine,Mechanism of Action,Wellbeing,Personality Change,Emotional Processing,Clinical Trial,Systematic Review,Review Article,Observational Study,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events,Toxicity", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:56", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1097/gh9.0000000000000089", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://dx.doi.org/10.1097/gh9.0000000000000089", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/gh9.0000000000000089", "source_url": "http://dx.doi.org/10.1097/gh9.0000000000000089", "doi": "10.1097/gh9.0000000000000089", "pmid": "", "publication_date": "2022-10-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1644, "title": "[Treatment-resistant depression. From classification to new therapies.]", "authors": "Paganin W, Signorini S, Signorini S, Leccese V, Sciarretta A.", "journal": "Rivista di psichiatria", "publication_date": "2022-10-31", "publication_year": 2022, "doi": "10.1708/3922.39072", "pubmed_id": "36503940", "openalex_id": "https://openalex.org/W4311667760", "source_url": "https://doi.org/10.1708/3922.39072", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36503940", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1708/3922.39072", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36503940", "source_url": "https://doi.org/10.1708/3922.39072", "doi": "10.1708/3922.39072", "pmid": "36503940", "publication_date": "2022-10-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3461, "title": "The Safety and Efficacy of Psilocybin in Participants With Type 2 Bipolar Disorder (BP-II) Depression.", "authors": "Sheppard Pratt Health System", "journal": "ClinicalTrials.gov", "publication_date": "2022-10-24", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04433845", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04433845", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04433845", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04433845", "source_url": "https://clinicaltrials.gov/study/NCT04433845", "doi": "", "pmid": "", "publication_date": "2022-10-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3685, "title": "An Exploratory Open-Label, Phase 1b, Ascending Dose Study to Evaluate the Effects of Oral 3-[2-(Dimethylamino)Ethyl]-1h-indol-4-yl Dihydrogen Phosphate (Psilocybin, BPL-PSILO) on Cognition in Patients With Chronic Short-Lasting Unilateral Neuralgiform Headache Attacks (SUNHA)", "authors": "Beckley Psytech Limited", "journal": "ClinicalTrials.gov", "publication_date": "2022-10-11", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04905121", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04905121", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04905121", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04905121", "source_url": "https://clinicaltrials.gov/study/NCT04905121", "doi": "", "pmid": "", "publication_date": "2022-10-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1661, "title": "A proposed mechanism for the MDMA-mediated extinction of traumatic memories in PTSD patients treated with MDMA-assisted therapy.", "authors": "Sottile RJ, Vida T.", "journal": null, "publication_date": "2022-10-11", "publication_year": 2022, "doi": "10.3389/fpsyt.2022.991753", "pubmed_id": "36311515", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2022.991753", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Mechanism of Action,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36311515", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2022.991753", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36311515", "source_url": "https://doi.org/10.3389/fpsyt.2022.991753", "doi": "10.3389/fpsyt.2022.991753", "pmid": "36311515", "publication_date": "2022-10-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3765, "title": "Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin-OCD Session Monitors for Protocol HIC: 2000020355", "authors": "Ching THW, Kichuk S, DePalmer G, Pittenger C, Kelmendi B.", "journal": "PsyArXiv", "publication_date": "2022-10-04", "publication_year": 2022, "doi": "10.31234/osf.io/85s9p", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/85s9p", "substance_tags": "psilocybin", "topic_tags": "OCD,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:19", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/85s9p", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/85s9p", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/85s9p", "source_url": "https://doi.org/10.31234/osf.io/85s9p", "doi": "10.31234/osf.io/85s9p", "pmid": "", "publication_date": "2022-10-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3204, "title": "Yale Program for Psychedelic Science (YPPS) Manual for Psilocybin-OCD Session Monitors for Protocol HIC: 2000020355", "authors": "", "journal": "PsyArXiv", "publication_date": "2022-10-04", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/85s9p_v1", "substance_tags": "psilocybin", "topic_tags": "OCD,Pharmacology,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/85s9p_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/85s9p_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/85s9p_v1", "source_url": "https://osf.io/preprints/psyarxiv/85s9p_v1", "doi": "", "pmid": "", "publication_date": "2022-10-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1649, "title": "A Critical Appraisal of Evidence on the Efficacy and Safety of Serotonergic Psychedelic Drugs as Emerging Antidepressants: Mind the Evidence Gap.", "authors": "Ledwos N, Rosenblat JD, Blumberger DM, Castle DJ, McIntyre RS, Mulsant BH, Husain MI.", "journal": null, "publication_date": "2022-10-02", "publication_year": 2022, "doi": "10.1097/jcp.0000000000001608", "pubmed_id": "36193898", "openalex_id": null, "source_url": "https://doi.org/10.1097/jcp.0000000000001608", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Review Article,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36193898", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/jcp.0000000000001608", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36193898", "source_url": "https://doi.org/10.1097/jcp.0000000000001608", "doi": "10.1097/jcp.0000000000001608", "pmid": "36193898", "publication_date": "2022-10-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1690, "title": "Towards psychedelic apprenticeship: Developing a gentle touch for the mediation and validation of psychedelic-induced insights and revelations.", "authors": "Timmermann C, Watts R, Dupuis D", "journal": "Transcultural psychiatry", "publication_date": "2022-09-30", "publication_year": 2022, "doi": "10.1177/13634615221082796", "pubmed_id": "35313754", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35313754/", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:35313754", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35313754/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35313754", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35313754/", "doi": "10.1177/13634615221082796", "pmid": "35313754", "publication_date": "2022-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1689, "title": "If the Doors of Perception Were Cleansed, Would Chronic Pain be Relieved? Evaluating the Benefits and Risks of Psychedelics.", "authors": "Dworkin RH, Anderson BT, Andrews N, Edwards RR, Grob CS, Ross S, Satterthwaite TD, Strain EC", "journal": "The journal of pain", "publication_date": "2022-09-30", "publication_year": 2022, "doi": "10.1016/j.jpain.2022.05.003", "pubmed_id": "35643270", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35643270/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Mechanism of Action,Consciousness,Spirituality,Mystical Experience,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:35643270", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35643270/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35643270", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35643270/", "doi": "10.1016/j.jpain.2022.05.003", "pmid": "35643270", "publication_date": "2022-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1682, "title": "Prevalence and associations of classic psychedelic-related seizures in a population-based sample.", "authors": "Simonsson O, Goldberg SB, Chambers R, Osika W, Long DM, Hendricks PS", "journal": "Drug and alcohol dependence", "publication_date": "2022-09-30", "publication_year": 2022, "doi": "10.1016/j.drugalcdep.2022.109586", "pubmed_id": "35981469", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35981469/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:35981469", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35981469/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35981469", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35981469/", "doi": "10.1016/j.drugalcdep.2022.109586", "pmid": "35981469", "publication_date": "2022-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3244, "title": "Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing", "authors": "Dougherty RF, Clarke P, Alti M, Kuc J, Schlosser D, Dunlop BW, Hellerstein DJ, Aaronson ST, Zisook S, Young AH, Carhart-Harris R, Goodwin G, Ryslik GA.", "journal": "PsyArXiv", "publication_date": "2022-09-29", "publication_year": 2022, "doi": "10.31234/osf.io/kh3cx", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/kh3cx", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/kh3cx", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/kh3cx", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/kh3cx", "source_url": "https://doi.org/10.31234/osf.io/kh3cx", "doi": "10.31234/osf.io/kh3cx", "pmid": "", "publication_date": "2022-09-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 643, "title": "Psilocybin Therapy for Treatment Resistant Depression: Prediction of Clinical Outcome by Natural Language Processing", "authors": "", "journal": "PsyArXiv", "publication_date": "2022-09-29", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Emotional Processing,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:48:04", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "source_url": "https://osf.io/preprints/psyarxiv/kh3cx_v1", "doi": "", "pmid": "", "publication_date": "2022-09-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3477, "title": "Multicentre Study To Assess Safety And Efficacy Of Psilocybin In Patients With Treatment-Resistant Depression Following Completion Of COMP001 And COMP003 Trials (P-TRD LTFU)", "authors": "COMPASS Pathways", "journal": "ClinicalTrials.gov", "publication_date": "2022-09-21", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04519957", "substance_tags": "psilocybin", "topic_tags": "Depression,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04519957", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04519957", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04519957", "source_url": "https://clinicaltrials.gov/study/NCT04519957", "doi": "", "pmid": "", "publication_date": "2022-09-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1695, "title": "Association between Lifetime Classic Psychedelic Use and Sick Leave in a Population-Based Sample.", "authors": "Mellner C, Dahlen M, Simonsson O", "journal": "International journal of environmental research and public health", "publication_date": "2022-09-08", "publication_year": 2022, "doi": "10.3390/ijerph191811353", "pubmed_id": "36141631", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/36141631/", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:36141631", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/36141631/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:36141631", "source_url": "https://pubmed.ncbi.nlm.nih.gov/36141631/", "doi": "10.3390/ijerph191811353", "pmid": "36141631", "publication_date": "2022-09-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1606, "title": "The Safety and Efficacy of Psychedelic-Assisted Therapies for Older Adults: Knowns and Unknowns.", "authors": "Johnston CB, Mangini M, Grob C, Anderson B.", "journal": null, "publication_date": "2022-09-05", "publication_year": 2022, "doi": "10.1016/j.jagp.2022.08.007", "pubmed_id": "36184377", "openalex_id": "https://openalex.org/W4294723946", "source_url": "https://doi.org/10.1016/j.jagp.2022.08.007", "substance_tags": "psilocybin", "topic_tags": "PTSD,Receptor Pharmacology,Aging,Clinical Trial,Older Adults,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36184377", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jagp.2022.08.007", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36184377", "source_url": "https://doi.org/10.1016/j.jagp.2022.08.007", "doi": "10.1016/j.jagp.2022.08.007", "pmid": "36184377", "publication_date": "2022-09-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3383, "title": "Therapeutic potential of serotoninergic psychedelic substances in the treatment of Obsessive Compulsive Disorder", "authors": "Rodrigues J, Nombora O, Ribeiro L.", "journal": null, "publication_date": "2022-08-31", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9567436", "substance_tags": "psilocybin", "topic_tags": "OCD,Mechanism of Action,Receptor Pharmacology,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9567436", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9567436", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9567436", "source_url": "https://europepmc.org/article/PMC/PMC9567436", "doi": "", "pmid": "", "publication_date": "2022-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3376, "title": "Exploring Psychedelics and Entactogens as Treatments for Psychiatric Disorders: Proceedings of a Workshop", "authors": "National Academies of Sciences, Engineering, and Medicine; Health and Medicine Division; Board on Health Sciences Policy; Forum on Neuroscience and Nervous System Disorders.", "journal": "National Academies Press (US), Washington (DC)", "publication_date": "2022-08-31", "publication_year": 2022, "doi": null, "pubmed_id": "36049038", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/36049038", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Mechanism of Action,Healthcare Workers,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36049038", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/36049038", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36049038", "source_url": "https://europepmc.org/article/MED/36049038", "doi": "", "pmid": "36049038", "publication_date": "2022-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1521, "title": "To treat or not to treat? High-potency benzodiazepine use in a case of comorbid hallucinogen persisting perception disorder and alcohol use disorder.", "authors": "Christensen JA, Fipps DC, Bostwick JM.", "journal": "Experimental and Clinical Psychopharmacology", "publication_date": "2022-08-31", "publication_year": 2022, "doi": "10.1037/pha0000597", "pubmed_id": "36048112", "openalex_id": "https://openalex.org/W4294127245", "source_url": "https://doi.org/10.1037/pha0000597", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36048112", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1037/pha0000597", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36048112", "source_url": "https://doi.org/10.1037/pha0000597", "doi": "10.1037/pha0000597", "pmid": "36048112", "publication_date": "2022-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1679, "title": "Macrodosing to microdosing with psychedelics: Clinical, social, and cultural perspectives.", "authors": "Kaypak AC, Raz A.", "journal": null, "publication_date": "2022-08-28", "publication_year": 2022, "doi": "10.1177/13634615221119386", "pubmed_id": "36031848", "openalex_id": null, "source_url": "https://doi.org/10.1177/13634615221119386", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Creativity,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:36031848", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/13634615221119386", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36031848", "source_url": "https://doi.org/10.1177/13634615221119386", "doi": "10.1177/13634615221119386", "pmid": "36031848", "publication_date": "2022-08-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4941, "title": "A-118 Psychedelic Interventions for Neuropsychological Conditions", "authors": "Brian Peacock", "journal": "Archives of Clinical Neuropsychology", "publication_date": "2022-08-16", "publication_year": 2022, "doi": "10.1093/arclin/acac060.118", "pubmed_id": null, "openalex_id": "https://openalex.org/W4292089187", "source_url": "https://doi.org/10.1093/arclin/acac060.118", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Receptor Pharmacology,Clinical Trial,Safety,Contraindications", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1093/arclin/acac060.118", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1093/arclin/acac060.118", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1093/arclin/acac060.118", "source_url": "https://doi.org/10.1093/arclin/acac060.118", "doi": "10.1093/arclin/acac060.118", "pmid": "", "publication_date": "2022-08-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1650, "title": "Psychedelic drug abuse potential assessment research for new drug applications and Controlled Substances Act scheduling.", "authors": "Henningfield JE, Coe MA, Griffiths RR, Belouin SJ, Berger A, Coker AR, Comer SD, Heal DJ, Hendricks PS, Nichols CD, Sapienza F, Vocci FJ, Zia FZ.", "journal": null, "publication_date": "2022-08-16", "publication_year": 2022, "doi": "10.1016/j.neuropharm.2022.109220", "pubmed_id": "35987353", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neuropharm.2022.109220", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Consciousness,Spirituality,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35987353", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2022.109220", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35987353", "source_url": "https://doi.org/10.1016/j.neuropharm.2022.109220", "doi": "10.1016/j.neuropharm.2022.109220", "pmid": "35987353", "publication_date": "2022-08-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1608, "title": "The Canadian Network for Mood and Anxiety Treatments (CANMAT) Task Force Report: Serotonergic Psychedelic Treatments for Major Depressive Disorder.", "authors": "Rosenblat JD, Husain MI, Lee Y, McIntyre RS, Mansur RB, Castle D, Offman H, Parikh SV, Frey BN, Schaffer A, Greenway KT, Garel N, Beaulieu S, Kennedy SH, Lam RW, Milev R, Ravindran AV, Tourjman V, Ameringen MV, Yatham LN, Taylor V.", "journal": null, "publication_date": "2022-08-16", "publication_year": 2022, "doi": "10.1177/07067437221111371", "pubmed_id": "35975555", "openalex_id": null, "source_url": "https://doi.org/10.1177/07067437221111371", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:35975555", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/07067437221111371", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35975555", "source_url": "https://doi.org/10.1177/07067437221111371", "doi": "10.1177/07067437221111371", "pmid": "35975555", "publication_date": "2022-08-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1685, "title": "Inconsistencies between national drug policy and professional beliefs about psychoactive drugs among psychiatrists in the United States.", "authors": "Levin A, Nagib PB, Deiparine S, Gao T, Mitchell J, Davis AK.", "journal": null, "publication_date": "2022-08-10", "publication_year": 2022, "doi": "10.1016/j.drugpo.2022.103816", "pubmed_id": "35964449", "openalex_id": "https://openalex.org/W4290990311", "source_url": "https://doi.org/10.1016/j.drugpo.2022.103816", "substance_tags": "psilocybin", "topic_tags": "Aging,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:35964449", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.drugpo.2022.103816", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35964449", "source_url": "https://doi.org/10.1016/j.drugpo.2022.103816", "doi": "10.1016/j.drugpo.2022.103816", "pmid": "35964449", "publication_date": "2022-08-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1700, "title": "Psilocybin use patterns and perception of risk among a cohort of Black individuals with Opioid Use Disorder.", "authors": "Clifton JM, Belcher AM, Greenblatt AD, Welsh CM, Cole TO, Davis AK.", "journal": "Journal of Psychedelic Studies", "publication_date": "2022-08-04", "publication_year": 2022, "doi": "10.1556/2054.2022.00214", "pubmed_id": "36686617", "openalex_id": "https://openalex.org/W4291721232", "source_url": "https://doi.org/10.1556/2054.2022.00214", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:36686617", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1556/2054.2022.00214", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36686617", "source_url": "https://doi.org/10.1556/2054.2022.00214", "doi": "10.1556/2054.2022.00214", "pmid": "36686617", "publication_date": "2022-08-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4946, "title": "Med Check: Psilocybin for OCD, Nuplazid Vote, and More", "authors": "Terri D’Arrigo", "journal": "Psychiatric News", "publication_date": "2022-07-31", "publication_year": 2022, "doi": "10.1176/appi.pn.2022.08.8.2", "pubmed_id": null, "openalex_id": "https://openalex.org/W4289781881", "source_url": "https://doi.org/10.1176/appi.pn.2022.08.8.2", "substance_tags": "psilocybin", "topic_tags": "Depression,OCD,Headache / Migraine,Pharmacology,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2022.08.8.2", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2022.08.8.2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2022.08.8.2", "source_url": "https://doi.org/10.1176/appi.pn.2022.08.8.2", "doi": "10.1176/appi.pn.2022.08.8.2", "pmid": "", "publication_date": "2022-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1729, "title": "Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness.", "authors": "Rosa WE, Sager Z, Miller M, Bernstein I, Doerner Rinaldi A, Addicott K, Ljuslin M, Adrian C, Back AL, Beachy J, Bossis AP, Breitbart WS, Cosimano MP, Fischer SM, Guss J, Knighton E, Phelps J, Richards BD, Richards WA, Tulsky JA, Williams MT, Beaussant Y", "journal": "Journal of palliative medicine", "publication_date": "2022-07-31", "publication_year": 2022, "doi": "10.1089/jpm.2022.0036", "pubmed_id": "35285721", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35285721/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:35285721", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35285721/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35285721", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35285721/", "doi": "10.1089/jpm.2022.0036", "pmid": "35285721", "publication_date": "2022-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1725, "title": "The emerging science of microdosing: A systematic review of research on low dose psychedelics (1955-2021) and recommendations for the field.", "authors": "Polito V, Liknaitzky P", "journal": "Neuroscience and biobehavioral reviews", "publication_date": "2022-07-31", "publication_year": 2022, "doi": "10.1016/j.neubiorev.2022.104706", "pubmed_id": "35609684", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35609684/", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Consciousness,Microdosing,Wellbeing,Personality Change,Creativity,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:35609684", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35609684/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35609684", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35609684/", "doi": "10.1016/j.neubiorev.2022.104706", "pmid": "35609684", "publication_date": "2022-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3594, "title": "Evaluation of Psilocybin in Anorexia Nervosa: Safety and Efficacy", "authors": "University of California, San Diego", "journal": "ClinicalTrials.gov", "publication_date": "2022-07-24", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04661514", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04661514", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04661514", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04661514", "source_url": "https://clinicaltrials.gov/study/NCT04661514", "doi": "", "pmid": "", "publication_date": "2022-07-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1426, "title": "Psilocybin in neuropsychiatry: a review of its pharmacology, safety, and efficacy.", "authors": "Dodd S, Norman TR, Eyre HA, Stahl SM, Phillips A, Carvalho AF, Berk M.", "journal": null, "publication_date": "2022-07-10", "publication_year": 2022, "doi": "10.1017/s1092852922000888", "pubmed_id": "35811423", "openalex_id": null, "source_url": "https://doi.org/10.1017/s1092852922000888", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:00", "bibtex": null, "source_record_id": "PMID:35811423", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/s1092852922000888", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35811423", "source_url": "https://doi.org/10.1017/s1092852922000888", "doi": "10.1017/s1092852922000888", "pmid": "35811423", "publication_date": "2022-07-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3220, "title": "Psilocybin-induced reduction in chronic cluster headache attack frequency correlates with changes in hypothalamic functional connectivity", "authors": "Madsen MK, Petersen AS, Stenbæk DS, Sørensen IM, Schiønning H, Fjeld T, Nykjær CH, Ulv Larsen SM, Grzywacz M, Mathiesen T, Klausen IL, Overgaard-Hansen O, Brendstrup-Brix K, Linnet K, Johansen SS, Fisher PM, Jensen RH, Knudsen GM.", "journal": "medRxiv", "publication_date": "2022-07-09", "publication_year": 2022, "doi": "10.1101/2022.07.10.22277414", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2022.07.10.22277414", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "DOI:10.1101/2022.07.10.22277414", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2022.07.10.22277414", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2022.07.10.22277414", "source_url": "https://doi.org/10.1101/2022.07.10.22277414", "doi": "10.1101/2022.07.10.22277414", "pmid": "", "publication_date": "2022-07-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3379, "title": "Pharmacotherapy for the Secondary Prevention of Suicide: Leads from the Social Pain Hypothesis", "authors": "Rajkumar RP.", "journal": "Preprints.org", "publication_date": "2022-07-04", "publication_year": 2022, "doi": "10.20944/preprints202207.0064.v1", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.20944/preprints202207.0064.v1", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.20944/preprints202207.0064.v1", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.20944/preprints202207.0064.v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "DOI:10.20944/preprints202207.0064.v1", "source_url": "https://doi.org/10.20944/preprints202207.0064.v1", "doi": "10.20944/preprints202207.0064.v1", "pmid": "", "publication_date": "2022-07-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1738, "title": "Psychedelics in the treatment of unipolar and bipolar depression.", "authors": "Bosch OG, Halm S, Seifritz E.", "journal": null, "publication_date": "2022-07-04", "publication_year": 2022, "doi": "10.1186/s40345-022-00265-5", "pubmed_id": "35788817", "openalex_id": null, "source_url": "https://doi.org/10.1186/s40345-022-00265-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35788817", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1186/s40345-022-00265-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35788817", "source_url": "https://doi.org/10.1186/s40345-022-00265-5", "doi": "10.1186/s40345-022-00265-5", "pmid": "35788817", "publication_date": "2022-07-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1693, "title": "Psychedelic drugs for psychiatric disorders.", "authors": "da Costa SC, Oesterle T, Rummans TA, Richelson E, Gold M.", "journal": null, "publication_date": "2022-07-04", "publication_year": 2022, "doi": "10.1016/j.jns.2022.120332", "pubmed_id": "35841696", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jns.2022.120332", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Consciousness,Aging,Spirituality,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35841696", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jns.2022.120332", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35841696", "source_url": "https://doi.org/10.1016/j.jns.2022.120332", "doi": "10.1016/j.jns.2022.120332", "pmid": "35841696", "publication_date": "2022-07-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1735, "title": "A Single Method for 127 Recommended and Additional DUID Drugs in Blood and Urine by LC-MS-MS.", "authors": "Farley M, Tran H, Towler S, Gevorkyan J, Pearring S, Rodda LN.", "journal": null, "publication_date": "2022-06-30", "publication_year": 2022, "doi": "10.1093/jat/bkab075", "pubmed_id": "34159389", "openalex_id": "https://openalex.org/W3177184994", "source_url": "https://doi.org/10.1093/jat/bkab075", "substance_tags": "psilocin", "topic_tags": "Addiction,Safety,Toxicity", "study_type": "Qualitative Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:34159389", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1093/jat/bkab075", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34159389", "source_url": "https://doi.org/10.1093/jat/bkab075", "doi": "10.1093/jat/bkab075", "pmid": "34159389", "publication_date": "2022-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3653, "title": "Randomized Double Blind Placebo Controlled Assessing the Efficacy of Micro-dosed Psilocybin in Reducing Anxiety and or Depression Levels in Adults", "authors": "Wake Network, Inc.", "journal": "ClinicalTrials.gov", "publication_date": "2022-06-29", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04989972", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04989972", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04989972", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04989972", "source_url": "https://clinicaltrials.gov/study/NCT04989972", "doi": "", "pmid": "", "publication_date": "2022-06-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1753, "title": "3,4-Methylenedioxymethamphetamine (MDMA)-Assisted Therapy in Hawaii: A Brief Review.", "authors": "Inouye A, Wolfgang A.", "journal": null, "publication_date": "2022-06-27", "publication_year": 2022, "doi": "10.7759/cureus.26402", "pubmed_id": "35915689", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.26402", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35915689", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.26402", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35915689", "source_url": "https://doi.org/10.7759/cureus.26402", "doi": "10.7759/cureus.26402", "pmid": "35915689", "publication_date": "2022-06-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1703, "title": "Psychedelics as preventive treatment in headache and chronic pain disorders.", "authors": "Schindler EAD.", "journal": null, "publication_date": "2022-06-15", "publication_year": 2022, "doi": "10.1016/j.neuropharm.2022.109166", "pubmed_id": "35718005", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neuropharm.2022.109166", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Mechanism of Action,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35718005", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2022.109166", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35718005", "source_url": "https://doi.org/10.1016/j.neuropharm.2022.109166", "doi": "10.1016/j.neuropharm.2022.109166", "pmid": "35718005", "publication_date": "2022-06-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4956, "title": "Psychedelic assisted therapy for major depressive disorder: Recent work and clinical directions", "authors": "Annie M. McCartney, H. T. McGovern, Alexander De Foe", "journal": "Journal of Psychedelic Studies", "publication_date": "2022-06-08", "publication_year": 2022, "doi": "10.1556/2054.2022.00211", "pubmed_id": null, "openalex_id": "https://openalex.org/W4282040347", "source_url": "https://doi.org/10.1556/2054.2022.00211", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2022.00211", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2022.00211", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2022.00211", "source_url": "https://doi.org/10.1556/2054.2022.00211", "doi": "10.1556/2054.2022.00211", "pmid": "", "publication_date": "2022-06-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4962, "title": "SP56 Psychedelic drugs and pain", "authors": "M Rekatsina, E Moka, A Vadalouca, G Varrassi", "journal": null, "publication_date": "2022-05-31", "publication_year": 2022, "doi": "10.1136/rapm-2022-esra.62", "pubmed_id": null, "openalex_id": "https://openalex.org/W4291018630", "source_url": "https://doi.org/10.1136/rapm-2022-esra.62", "substance_tags": "psilocybin", "topic_tags": "Addiction,Chronic Pain,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1136/rapm-2022-esra.62", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/rapm-2022-esra.62", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1136/rapm-2022-esra.62", "source_url": "https://doi.org/10.1136/rapm-2022-esra.62", "doi": "10.1136/rapm-2022-esra.62", "pmid": "", "publication_date": "2022-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4959, "title": "The safety and efficacy of psilocybin therapy in patients with cancer and major depressive disorder.", "authors": "Manish Agrawal, Paul Thambi, Sarah Shnayder", "journal": "Journal of Clinical Oncology", "publication_date": "2022-05-31", "publication_year": 2022, "doi": "10.1200/jco.2022.40.16_suppl.12097", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281784879", "source_url": "https://doi.org/10.1200/jco.2022.40.16_suppl.12097", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Observational Study,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1200/jco.2022.40.16_suppl.12097", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1200/jco.2022.40.16_suppl.12097", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1200/jco.2022.40.16_suppl.12097", "source_url": "https://doi.org/10.1200/jco.2022.40.16_suppl.12097", "doi": "10.1200/jco.2022.40.16_suppl.12097", "pmid": "", "publication_date": "2022-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1776, "title": "Serotonin toxicity of serotonergic psychedelics.", "authors": "Malcolm B, Thomas K", "journal": "Psychopharmacology", "publication_date": "2022-05-31", "publication_year": 2022, "doi": "10.1007/s00213-021-05876-x", "pubmed_id": "34251464", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34251464/", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Safety,Toxicity,Drug Interactions", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:34251464", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34251464/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34251464", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34251464/", "doi": "10.1007/s00213-021-05876-x", "pmid": "34251464", "publication_date": "2022-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1762, "title": "Can the revival of serotonergic psychedelic drugs as treatments for mental disorders help to characterize their risks and benefits?", "authors": "Husain MI, Umer M, Mulsant BH", "journal": "Expert opinion on drug safety", "publication_date": "2022-05-31", "publication_year": 2022, "doi": "10.1080/14740338.2022.2063274", "pubmed_id": "35387542", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35387542/", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:35387542", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35387542", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35387542/", "doi": "10.1080/14740338.2022.2063274", "pmid": "35387542", "publication_date": "2022-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1724, "title": "Postpartum depression: A role for psychedelics?", "authors": "Jairaj C, Rucker JJ.", "journal": null, "publication_date": "2022-05-29", "publication_year": 2022, "doi": "10.1177/02698811221093793", "pubmed_id": "35638179", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811221093793", "substance_tags": "psilocybin", "topic_tags": "Depression,Aging,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35638179", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811221093793", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35638179", "source_url": "https://doi.org/10.1177/02698811221093793", "doi": "10.1177/02698811221093793", "pmid": "35638179", "publication_date": "2022-05-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1713, "title": "Review of potential psychedelic treatments for PTSD.", "authors": "Henner RL, Keshavan MS, Hill KP.", "journal": null, "publication_date": "2022-05-29", "publication_year": 2022, "doi": "10.1016/j.jns.2022.120302", "pubmed_id": "35700643", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jns.2022.120302", "substance_tags": "psilocybin", "topic_tags": "PTSD,Mechanism of Action,Clinical Trial,Review Article,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35700643", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jns.2022.120302", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35700643", "source_url": "https://doi.org/10.1016/j.jns.2022.120302", "doi": "10.1016/j.jns.2022.120302", "pmid": "35700643", "publication_date": "2022-05-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4967, "title": "Psilocybin-Assisted Therapy Found to Improve Depression, Offer Other Benefits", "authors": "Richard Karel", "journal": "Psychiatric News", "publication_date": "2022-05-22", "publication_year": 2022, "doi": "10.1176/appi.pn.2022.06.6.30", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281400661", "source_url": "https://doi.org/10.1176/appi.pn.2022.06.6.30", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Pharmacology,Consciousness,Wellbeing,Spirituality,Mystical Experience,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2022.06.6.30", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2022.06.6.30", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2022.06.6.30", "source_url": "https://doi.org/10.1176/appi.pn.2022.06.6.30", "doi": "10.1176/appi.pn.2022.06.6.30", "pmid": "", "publication_date": "2022-05-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4966, "title": "An Overview on the Taxonomy, Phylogenetics and Ecology of the Psychedelic Genera Psilocybe, Panaeolus, Pluteus and Gymnopilus", "authors": "Dominique Strauss, Soumya Ghosh, Zurika Murray, Marieka Gryzenhout", "journal": "Frontiers in Forests and Global Change", "publication_date": "2022-05-22", "publication_year": 2022, "doi": "10.3389/ffgc.2022.813998", "pubmed_id": null, "openalex_id": "https://openalex.org/W4281296724", "source_url": "https://doi.org/10.3389/ffgc.2022.813998", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.3389/ffgc.2022.813998", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/ffgc.2022.813998", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.3389/ffgc.2022.813998", "source_url": "https://doi.org/10.3389/ffgc.2022.813998", "doi": "10.3389/ffgc.2022.813998", "pmid": "", "publication_date": "2022-05-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3676, "title": "Psilocybin Versus Ketamine - Fast Acting Antidepressant Strategies in Treatment-resistant Depression", "authors": "National Institute of Mental Health, Czech Republic", "journal": "ClinicalTrials.gov", "publication_date": "2022-05-19", "publication_year": 2022, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT05383313", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Neuroplasticity,Brain Imaging,Biomarkers,Aging,Emotional Processing,Clinical Trial,Healthy Volunteers,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:28", "last_checked": "2026-07-01 11:22:34", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT05383313", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT05383313", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT05383313", "source_url": "https://clinicaltrials.gov/study/NCT05383313", "doi": "", "pmid": "", "publication_date": "2022-05-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1788, "title": "Safety considerations in the evolving legal landscape of psychedelic-assisted psychotherapy.", "authors": "Mocanu V, Mackay L, Christie D, Argento E.", "journal": "Substance Abuse Treatment Prevention and Policy", "publication_date": "2022-05-13", "publication_year": 2022, "doi": "10.1186/s13011-022-00468-0", "pubmed_id": "35568884", "openalex_id": "https://openalex.org/W4280525486", "source_url": "https://doi.org/10.1186/s13011-022-00468-0", "substance_tags": "psilocybin", "topic_tags": "Aging,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35568884", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1186/s13011-022-00468-0", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35568884", "source_url": "https://doi.org/10.1186/s13011-022-00468-0", "doi": "10.1186/s13011-022-00468-0", "pmid": "35568884", "publication_date": "2022-05-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4973, "title": "P450. Pilot Study Evaluation of Psilocybin Therapy for Anorexia Nervosa: Safety, Acceptability, and Preliminary Efficacy", "authors": "Stéphanie Knatz Peck, Samatha Shao, Susan Murray, Walter H. Kaye", "journal": "Biological Psychiatry", "publication_date": "2022-04-27", "publication_year": 2022, "doi": "10.1016/j.biopsych.2022.02.686", "pubmed_id": null, "openalex_id": "https://openalex.org/W4293242421", "source_url": "https://doi.org/10.1016/j.biopsych.2022.02.686", "substance_tags": "psilocybin", "topic_tags": "Eating Disorders,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1016/j.biopsych.2022.02.686", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.biopsych.2022.02.686", "source_url": "https://doi.org/10.1016/j.biopsych.2022.02.686", "doi": "10.1016/j.biopsych.2022.02.686", "pmid": "", "publication_date": "2022-04-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1761, "title": "Safety issues of psilocybin and LSD as potential rapid acting antidepressants and potential challenges.", "authors": "Rossi GN, Hallak JEC, Bouso Saiz JC, Dos Santos RG.", "journal": "Expert Opinion on Drug Safety", "publication_date": "2022-04-26", "publication_year": 2022, "doi": "10.1080/14740338.2022.2066650", "pubmed_id": "35426754", "openalex_id": "https://openalex.org/W4223893856", "source_url": "https://doi.org/10.1080/14740338.2022.2066650", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35426754", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/14740338.2022.2066650", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35426754", "source_url": "https://doi.org/10.1080/14740338.2022.2066650", "doi": "10.1080/14740338.2022.2066650", "pmid": "35426754", "publication_date": "2022-04-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1744, "title": "The Effects of Psilocybin in Adults with Major Depressive Disorder and the General Population: Findings from Neuroimaging Studies.", "authors": "Gill H, Puramat P, Patel P, Gill B, Marks CA, Rodrigues NB, Castle D, Cha DS, Mansur RB, Rosenblat JD, McIntyre RS.", "journal": null, "publication_date": "2022-04-25", "publication_year": 2022, "doi": "10.1016/j.psychres.2022.114577", "pubmed_id": "35580433", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2022.114577", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Aging,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35580433", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2022.114577", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35580433", "source_url": "https://doi.org/10.1016/j.psychres.2022.114577", "doi": "10.1016/j.psychres.2022.114577", "pmid": "35580433", "publication_date": "2022-04-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1428, "title": "Is PTSD an Evolutionary Survival Adaptation Initiated by Unrestrained Cytokine Signaling and Maintained by Epigenetic Change?", "authors": "Rudzki S.", "journal": "Military Medicine", "publication_date": "2022-04-20", "publication_year": 2022, "doi": "10.1093/milmed/usac095", "pubmed_id": "35446412", "openalex_id": "https://openalex.org/W4224232624", "source_url": "https://doi.org/10.1093/milmed/usac095", "substance_tags": "psilocybin", "topic_tags": "PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Epigenetics,Review Article,Safety,Genomics,Inflammation,Immune Function", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35446412", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1093/milmed/usac095", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35446412", "source_url": "https://doi.org/10.1093/milmed/usac095", "doi": "10.1093/milmed/usac095", "pmid": "35446412", "publication_date": "2022-04-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4976, "title": "Combining FTIR-ATR and OPLS-DA methods for magic mushrooms discrimination", "authors": "Cátia Esteves, Elena M. M. de Redrojo, José Luis Manjón, Gabriel Moreno, Filipe E. Antunes, Gemma Montalvo, Fernando E. Ortega-Ojeda", "journal": "Forensic Chemistry", "publication_date": "2022-04-07", "publication_year": 2022, "doi": "10.1016/j.forc.2022.100421", "pubmed_id": null, "openalex_id": "https://openalex.org/W4224903330", "source_url": "https://doi.org/10.1016/j.forc.2022.100421", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1016/j.forc.2022.100421", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.forc.2022.100421", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.forc.2022.100421", "source_url": "https://doi.org/10.1016/j.forc.2022.100421", "doi": "10.1016/j.forc.2022.100421", "pmid": "", "publication_date": "2022-04-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1728, "title": "Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms.", "authors": "Kopra EI, Ferris JA, Winstock AR, Young AH, Rucker JJ.", "journal": "Journal of Psychopharmacology", "publication_date": "2022-04-06", "publication_year": 2022, "doi": "10.1177/02698811221084063", "pubmed_id": "35388724", "openalex_id": "https://openalex.org/W4226060882", "source_url": "https://doi.org/10.1177/02698811221084063", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Spirituality,Observational Study,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35388724", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811221084063", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35388724", "source_url": "https://doi.org/10.1177/02698811221084063", "doi": "10.1177/02698811221084063", "pmid": "35388724", "publication_date": "2022-04-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1793, "title": "Psilocybin Therapy of Psychiatric Disorders Is Not Hampered by hERG Potassium Channel-Mediated Cardiotoxicity.", "authors": "Hackl B, Todt H, Kubista H, Kubista H, Hilber K, Koenig X.", "journal": "The International Journal of Neuropsychopharmacology", "publication_date": "2022-03-31", "publication_year": 2022, "doi": "10.1093/ijnp/pyab085", "pubmed_id": "34871422", "openalex_id": "https://openalex.org/W4200455094", "source_url": "https://doi.org/10.1093/ijnp/pyab085", "substance_tags": "psilocybin,psilocin", "topic_tags": "Aging,Clinical Trial,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34871422", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1093/ijnp/pyab085", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34871422", "source_url": "https://doi.org/10.1093/ijnp/pyab085", "doi": "10.1093/ijnp/pyab085", "pmid": "34871422", "publication_date": "2022-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4980, "title": "Demystifying Psychedelic Treatments in Psychiatry: Is Ego Dissolution the Solution?", "authors": "Michael Avissar, Adrian Jacques H. Ambrose", "journal": "Psychiatric News", "publication_date": "2022-03-23", "publication_year": 2022, "doi": "10.1176/appi.pn.2022.04.4.35", "pubmed_id": null, "openalex_id": "https://openalex.org/W4220982704", "source_url": "https://doi.org/10.1176/appi.pn.2022.04.4.35", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,Eating Disorders,End-of-Life Distress,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Biomarkers,Personality Change,Emotional Processing,Mystical Experience,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:57", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2022.04.4.35", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2022.04.4.35", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2022.04.4.35", "source_url": "https://doi.org/10.1176/appi.pn.2022.04.4.35", "doi": "10.1176/appi.pn.2022.04.4.35", "pmid": "", "publication_date": "2022-03-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1804, "title": "Race, Ethnic, and Sex Differences in Prevalence of and Trends in Hallucinogen Consumption Among Lifetime Users in the United States Between 2015 and 2019.", "authors": "Davis AK, Arterberry BJ, Xin Y, Agin-Liebes G, Schwarting C, Williams MT.", "journal": "Frontiers in Epidemiology", "publication_date": "2022-03-22", "publication_year": 2022, "doi": "10.3389/fepid.2022.876706", "pubmed_id": "38455323", "openalex_id": "https://openalex.org/W4220885585", "source_url": "https://doi.org/10.3389/fepid.2022.876706", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:38455323", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fepid.2022.876706", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:38455323", "source_url": "https://doi.org/10.3389/fepid.2022.876706", "doi": "10.3389/fepid.2022.876706", "pmid": "38455323", "publication_date": "2022-03-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1764, "title": "Development of an E. coli-based norbaeocystin production platform and evaluation of behavioral effects in rats.", "authors": "Adams AM, Anas NA, Sen AK, Hinegardner-Hendricks JD, O'Dell PJ, Gibbons WJ, Flower JE, McMurray MS, Jones JA.", "journal": "Metabolic Engineering Communications", "publication_date": "2022-03-11", "publication_year": 2022, "doi": "10.1016/j.mec.2022.e00196", "pubmed_id": "35310468", "openalex_id": "https://openalex.org/W4220669239", "source_url": "https://doi.org/10.1016/j.mec.2022.e00196", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Animal Study,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:37", "bibtex": null, "source_record_id": "PMID:35310468", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.mec.2022.e00196", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35310468", "source_url": "https://doi.org/10.1016/j.mec.2022.e00196", "doi": "10.1016/j.mec.2022.e00196", "pmid": "35310468", "publication_date": "2022-03-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1552, "title": "A systematic literature review and meta-analysis of the effect of psilocybin and methylenedioxymethamphetamine on mental, behavioural or developmental disorders.", "authors": "Kisely S, Connor M, Somogyi AA, Siskind D.", "journal": null, "publication_date": "2022-03-11", "publication_year": 2022, "doi": "10.1177/00048674221083868", "pubmed_id": "35285280", "openalex_id": null, "source_url": "https://doi.org/10.1177/00048674221083868", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,OCD,End-of-Life Distress,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35285280", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/00048674221083868", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35285280", "source_url": "https://doi.org/10.1177/00048674221083868", "doi": "10.1177/00048674221083868", "pmid": "35285280", "publication_date": "2022-03-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1809, "title": "Mycotherapy: Potential of Fungal Bioactives for the Treatment of Mental Health Disorders and Morbidities of Chronic Pain.", "authors": "Meade E, Hehir S, Rowan N, Garvey M.", "journal": null, "publication_date": "2022-03-10", "publication_year": 2022, "doi": "10.3390/jof8030290", "pubmed_id": "35330292", "openalex_id": null, "source_url": "https://doi.org/10.3390/jof8030290", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Review Article,Safety,Inflammation,Immune Function", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35330292", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/jof8030290", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35330292", "source_url": "https://doi.org/10.3390/jof8030290", "doi": "10.3390/jof8030290", "pmid": "35330292", "publication_date": "2022-03-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1813, "title": "Depression and Long-Term Prescription Opioid Use and Opioid Use Disorder: Implications for Pain Management in Cancer.", "authors": "Bates N, Bello JK, Osazuwa-Peters N, Sullivan MD, Scherrer JF.", "journal": null, "publication_date": "2022-03-06", "publication_year": 2022, "doi": "10.1007/s11864-022-00954-4", "pubmed_id": "35254595", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11864-022-00954-4", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,End-of-Life Distress,Chronic Pain,Receptor Pharmacology,Aging,Cancer Patients,Healthcare Workers,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35254595", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11864-022-00954-4", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35254595", "source_url": "https://doi.org/10.1007/s11864-022-00954-4", "doi": "10.1007/s11864-022-00954-4", "pmid": "35254595", "publication_date": "2022-03-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1811, "title": "Methodological challenges in psychedelic drug trials: Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - Rationale and study design.", "authors": "Mertens LJ, Koslowski M, Betzler F, Evens R, Gilles M, Jungaberle A, Jungaberle H, Majić T, Ströhle A, Wolff M, Wellek S, Gründer G.", "journal": "Neuroscience Applied", "publication_date": "2022-03-06", "publication_year": 2022, "doi": "10.1016/j.nsa.2022.100104", "pubmed_id": "40656230", "openalex_id": "https://openalex.org/W4220708535", "source_url": "https://doi.org/10.1016/j.nsa.2022.100104", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:40656230", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.nsa.2022.100104", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:40656230", "source_url": "https://doi.org/10.1016/j.nsa.2022.100104", "doi": "10.1016/j.nsa.2022.100104", "pmid": "40656230", "publication_date": "2022-03-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1769, "title": "The therapeutic potential of psilocybin: a systematic review.", "authors": "van Amsterdam J, van den Brink W.", "journal": null, "publication_date": "2022-03-01", "publication_year": 2022, "doi": "10.1080/14740338.2022.2047929", "pubmed_id": "35225143", "openalex_id": null, "source_url": "https://doi.org/10.1080/14740338.2022.2047929", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35225143", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/14740338.2022.2047929", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35225143", "source_url": "https://doi.org/10.1080/14740338.2022.2047929", "doi": "10.1080/14740338.2022.2047929", "pmid": "35225143", "publication_date": "2022-03-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1768, "title": "Effects of the 5-HT2A receptor antagonist volinanserin on head-twitch response and intracranial self-stimulation depression induced by different structural classes of psychedelics in rodents.", "authors": "Jaster AM, Elder H, Marsh SA, de la Fuente Revenga M, Negus SS, González-Maeso J.", "journal": null, "publication_date": "2022-03-01", "publication_year": 2022, "doi": "10.1007/s00213-022-06092-x", "pubmed_id": "35233648", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00213-022-06092-x", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35233648", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-022-06092-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35233648", "source_url": "https://doi.org/10.1007/s00213-022-06092-x", "doi": "10.1007/s00213-022-06092-x", "pmid": "35233648", "publication_date": "2022-03-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1815, "title": "Adverse effects of psychedelics: From anecdotes and misinformation to systematic science.", "authors": "Schlag AK, Aday J, Salam I, Neill JC, Nutt DJ", "journal": "Journal of psychopharmacology (Oxford, England)", "publication_date": "2022-02-28", "publication_year": 2022, "doi": "10.1177/02698811211069100", "pubmed_id": "35107059", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35107059/", "substance_tags": "psilocybin", "topic_tags": "Review Article,Healthcare Workers,Safety,Toxicity,Abuse Liability", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:35107059", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35107059/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35107059", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35107059/", "doi": "10.1177/02698811211069100", "pmid": "35107059", "publication_date": "2022-02-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1611, "title": "The Use of Psilocybin in the Treatment of Psychiatric Disorders with Attention to Relative Safety Profile: A Systematic Review.", "authors": "Hodge AT, Sukpraprut-Braaten S, Narlesky M, Strayhan RC.", "journal": null, "publication_date": "2022-02-27", "publication_year": 2022, "doi": "10.1080/02791072.2022.2044096", "pubmed_id": "35225726", "openalex_id": null, "source_url": "https://doi.org/10.1080/02791072.2022.2044096", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35225726", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2022.2044096", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35225726", "source_url": "https://doi.org/10.1080/02791072.2022.2044096", "doi": "10.1080/02791072.2022.2044096", "pmid": "35225726", "publication_date": "2022-02-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1822, "title": "Trajectory of Antidepressant Effects after Single- or Two-Dose Administration of Psilocybin: A Systematic Review and Multivariate Meta-Analysis.", "authors": "Yu CL, Liang CS, Yang FC, Tu YK, Hsu CW, Carvalho AF, Stubbs B, Thompson T, Tsai CK, Yeh TC, Yang SN, Shin JI, Chu CS, Tseng PT, Su KP.", "journal": null, "publication_date": "2022-02-10", "publication_year": 2022, "doi": "10.3390/jcm11040938", "pubmed_id": "35207210", "openalex_id": null, "source_url": "https://doi.org/10.3390/jcm11040938", "substance_tags": "psilocybin", "topic_tags": "Depression,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35207210", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/jcm11040938", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35207210", "source_url": "https://doi.org/10.3390/jcm11040938", "doi": "10.3390/jcm11040938", "pmid": "35207210", "publication_date": "2022-02-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1799, "title": "Diversity, biology, and history of psilocybin-containing fungi: Suggestions for research and technological development.", "authors": "Van Court RC, Wiseman MS, Meyer KW, Ballhorn DJ, Amses KR, Slot JC, Dentinger BTM, Garibay-Orijel R, Uehling JK.", "journal": null, "publication_date": "2022-02-10", "publication_year": 2022, "doi": "10.1016/j.funbio.2022.01.003", "pubmed_id": "35314062", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.funbio.2022.01.003", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35314062", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.funbio.2022.01.003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35314062", "source_url": "https://doi.org/10.1016/j.funbio.2022.01.003", "doi": "10.1016/j.funbio.2022.01.003", "pmid": "35314062", "publication_date": "2022-02-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1770, "title": "The Therapeutic Potential of Psychedelic-assisted Therapies for Symptom Control in Patients Diagnosed With Serious Illness: A Systematic Review.", "authors": "Maia LO, Beaussant Y, Garcia ACM.", "journal": null, "publication_date": "2022-02-10", "publication_year": 2022, "doi": "10.1016/j.jpainsymman.2022.01.024", "pubmed_id": "35157985", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jpainsymman.2022.01.024", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Spirituality,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35157985", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jpainsymman.2022.01.024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35157985", "source_url": "https://doi.org/10.1016/j.jpainsymman.2022.01.024", "doi": "10.1016/j.jpainsymman.2022.01.024", "pmid": "35157985", "publication_date": "2022-02-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1825, "title": "Analysis of Psilocybin-Assisted Therapy in Medicine: A Narrative Review.", "authors": "Ziff S, Stern B, Lewis G, Majeed M, Gorantla VR.", "journal": null, "publication_date": "2022-02-04", "publication_year": 2022, "doi": "10.7759/cureus.21944", "pubmed_id": "35273885", "openalex_id": null, "source_url": "https://doi.org/10.7759/cureus.21944", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35273885", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.7759/cureus.21944", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35273885", "source_url": "https://doi.org/10.7759/cureus.21944", "doi": "10.7759/cureus.21944", "pmid": "35273885", "publication_date": "2022-02-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1827, "title": "Efficacy and safety of psilocybin-assisted treatment for major depressive disorder: Prospective 12-month follow-up.", "authors": "Gukasyan N, Davis AK, Barrett FS, Cosimano MP, Sepeda ND, Johnson MW, Griffiths RR.", "journal": "Journal of Psychopharmacology", "publication_date": "2022-01-31", "publication_year": 2022, "doi": "10.1177/02698811211073759", "pubmed_id": "35166158", "openalex_id": "https://openalex.org/W4212903385", "source_url": "https://doi.org/10.1177/02698811211073759", "substance_tags": "psilocybin", "topic_tags": "Depression,Wellbeing,Spirituality,Mystical Experience,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:35166158", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811211073759", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35166158", "source_url": "https://doi.org/10.1177/02698811211073759", "doi": "10.1177/02698811211073759", "pmid": "35166158", "publication_date": "2022-01-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1832, "title": "Evaluating the Potential Use of Serotonergic Psychedelics in Autism Spectrum Disorder.", "authors": "Markopoulos A, Inserra A, De Gregorio D, Gobbi G.", "journal": null, "publication_date": "2022-01-26", "publication_year": 2022, "doi": "10.3389/fphar.2021.749068", "pubmed_id": "35177979", "openalex_id": null, "source_url": "https://doi.org/10.3389/fphar.2021.749068", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Review Article,Animal Study,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35177979", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fphar.2021.749068", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35177979", "source_url": "https://doi.org/10.3389/fphar.2021.749068", "doi": "10.3389/fphar.2021.749068", "pmid": "35177979", "publication_date": "2022-01-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1773, "title": "Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.", "authors": "Bender D, Hellerstein DJ.", "journal": null, "publication_date": "2022-01-12", "publication_year": 2022, "doi": "10.1007/s00213-021-06049-6", "pubmed_id": "35022823", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00213-021-06049-6", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Aging,Clinical Trial,Review Article,Case Report,Observational Study,Healthy Volunteers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:35022823", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-021-06049-6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35022823", "source_url": "https://doi.org/10.1007/s00213-021-06049-6", "doi": "10.1007/s00213-021-06049-6", "pmid": "35022823", "publication_date": "2022-01-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1849, "title": "MDMA/ecstasy use and psilocybin use are associated with lowered odds of psychological distress and suicidal thoughts in a sample of US adults.", "authors": "Jones GM, Nock MK.", "journal": "Journal of Psychopharmacology", "publication_date": "2022-01-04", "publication_year": 2022, "doi": "10.1177/02698811211058923", "pubmed_id": "34983249", "openalex_id": "https://openalex.org/W4206486089", "source_url": "https://doi.org/10.1177/02698811211058923", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Adolescents,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34983249", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811211058923", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34983249", "source_url": "https://doi.org/10.1177/02698811211058923", "doi": "10.1177/02698811211058923", "pmid": "34983249", "publication_date": "2022-01-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1847, "title": "The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.", "authors": "Rucker JJ, Marwood L, Ajantaival RJ, Bird C, Eriksson H, Harrison J, Lennard-Jones M, Mistry S, Saldarini F, Stansfield S, Tai SJ, Williams S, Weston N, Malievskaia E, Young AH.", "journal": "Journal of Psychopharmacology", "publication_date": "2022-01-03", "publication_year": 2022, "doi": "10.1177/02698811211064720", "pubmed_id": "35090363", "openalex_id": "https://openalex.org/W4205906672", "source_url": "https://doi.org/10.1177/02698811211064720", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Emotional Processing,Clinical Trial,Randomized Controlled Trial,Healthy Volunteers,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:35090363", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811211064720", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35090363", "source_url": "https://doi.org/10.1177/02698811211064720", "doi": "10.1177/02698811211064720", "pmid": "35090363", "publication_date": "2022-01-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5004, "title": "Psychedelic Agents as Potential Therapeutics for Obsessive Compulsive Disorder", "authors": "Josh Nagra", "journal": "DOAJ (DOAJ: Directory of Open Access Journals)", "publication_date": "2021-12-31", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W4390649922", "source_url": "https://doaj.org/article/7ce75968f7bc41c58d82163435d80b03", "substance_tags": "psilocybin", "topic_tags": "Anxiety,OCD,Receptor Pharmacology,Safety,Inflammation", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "https://doaj.org/article/7ce75968f7bc41c58d82163435d80b03", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doaj.org/article/7ce75968f7bc41c58d82163435d80b03", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://doaj.org/article/7ce75968f7bc41c58d82163435d80b03", "source_url": "https://doaj.org/article/7ce75968f7bc41c58d82163435d80b03", "doi": "", "pmid": "", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5002, "title": "The safety and efficacy of COMP360 psilocybin therapy in treatment-resistant depression: results from a phase IIb randomised controlled trial", "authors": "G.M. Goodwin, Scott T. Aaronson, Boadie W. Dunlop, David Feifel, David J. Hellerstein, N. Hewitt, L. Marwood, S. Mistry, Metten Somers, S.C. Stansfield, J. Tsai, S. Williams, Antony Young, Sidney Zisook, E. Malievskaia", "journal": "Neuroscience Applied", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1016/j.nsa.2022.100511", "pubmed_id": null, "openalex_id": "https://openalex.org/W4313199626", "source_url": "https://doi.org/10.1016/j.nsa.2022.100511", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.nsa.2022.100511", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.nsa.2022.100511", "source_url": "https://doi.org/10.1016/j.nsa.2022.100511", "doi": "10.1016/j.nsa.2022.100511", "pmid": "", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4998, "title": "An Interpretative Phenomenological Analysis of the use of psilocybin by veterans with symptoms of trauma", "authors": "F. N. Smith, Joanna C. Neill, Verity Wainwright", "journal": "Drug Science Policy and Law", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1177/20503245221124117", "pubmed_id": null, "openalex_id": "https://openalex.org/W4295169116", "source_url": "https://doi.org/10.1177/20503245221124117", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Veterans,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1177/20503245221124117", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/20503245221124117", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/20503245221124117", "source_url": "https://doi.org/10.1177/20503245221124117", "doi": "10.1177/20503245221124117", "pmid": "", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 4996, "title": "Should Adolescents be Included in Emerging Psychedelic Research?", "authors": "Khaleel Rajwani", "journal": "Canadian Journal of Bioethics", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.7202/1089784ar", "pubmed_id": null, "openalex_id": "https://openalex.org/W4285297088", "source_url": "https://doi.org/10.7202/1089784ar", "substance_tags": "psilocybin", "topic_tags": "Adolescents,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.7202/1089784ar", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.7202/1089784ar", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.7202/1089784ar", "source_url": "https://doi.org/10.7202/1089784ar", "doi": "10.7202/1089784ar", "pmid": "", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1843, "title": "Psychedelics in the Treatment of Headache and Chronic Pain Disorders.", "authors": "Schindler EAD.", "journal": null, "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1007/7854_2022_365", "pubmed_id": "35546382", "openalex_id": null, "source_url": "https://doi.org/10.1007/7854_2022_365", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:35546382", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/7854_2022_365", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35546382", "source_url": "https://doi.org/10.1007/7854_2022_365", "doi": "10.1007/7854_2022_365", "pmid": "35546382", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1841, "title": "Classic Psychedelics in Addiction Treatment: The Case for Psilocybin in Tobacco Smoking Cessation.", "authors": "Johnson MW.", "journal": null, "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1007/7854_2022_327", "pubmed_id": "35704271", "openalex_id": null, "source_url": "https://doi.org/10.1007/7854_2022_327", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:35704271", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/7854_2022_327", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35704271", "source_url": "https://doi.org/10.1007/7854_2022_327", "doi": "10.1007/7854_2022_327", "pmid": "35704271", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1840, "title": "Psilocybin for Trauma-Related Disorders.", "authors": "Khan AJ, Bradley E, O'Donovan A, Woolley J.", "journal": null, "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1007/7854_2022_366", "pubmed_id": "35711024", "openalex_id": null, "source_url": "https://doi.org/10.1007/7854_2022_366", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Emotional Processing,Veterans,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:35711024", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/7854_2022_366", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:35711024", "source_url": "https://doi.org/10.1007/7854_2022_366", "doi": "10.1007/7854_2022_366", "pmid": "35711024", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1807, "title": "Effects of Naturalistic Psychedelic Use on Depression, Anxiety, and Well-Being: Associations With Patterns of Use, Reported Harms, and Transformative Mental States.", "authors": "Raison CL, Jain R, Penn AD, Cole SP, Jain S", "journal": "Frontiers in psychiatry", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.3389/fpsyt.2022.831092", "pubmed_id": "35370864", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35370864/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Wellbeing,Emotional Processing,Mystical Experience,Clinical Trial,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:35370864", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35370864/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35370864", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35370864/", "doi": "10.3389/fpsyt.2022.831092", "pmid": "35370864", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1783, "title": "Psychedelics and Psychotherapy: Cognitive-Behavioral Approaches as Default.", "authors": "Yaden DB, Earp D, Graziosi M, Friedman-Wheeler D, Luoma JB, Johnson MW", "journal": "Frontiers in psychology", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.3389/fpsyg.2022.873279", "pubmed_id": "35677124", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/35677124/", "substance_tags": "psilocybin", "topic_tags": "Spirituality,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:35677124", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/35677124/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:35677124", "source_url": "https://pubmed.ncbi.nlm.nih.gov/35677124/", "doi": "10.3389/fpsyg.2022.873279", "pmid": "35677124", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1708, "title": "Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States.", "authors": "Davis AK, Agin-Liebes G, España M, Pilecki B, Luoma J", "journal": "Journal of psychoactive drugs", "publication_date": "2021-12-31", "publication_year": 2021, "doi": "10.1080/02791072.2021.1971343", "pubmed_id": "34468293", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34468293/", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:38", "bibtex": null, "source_record_id": "PMID:34468293", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34468293/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34468293", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34468293/", "doi": "10.1080/02791072.2021.1971343", "pmid": "34468293", "publication_date": "2021-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5025, "title": "Critique of the Royal Australian and New Zealand College of Psychiatrists Psychedelic Therapy Clinical Memorandum, Dated May 2020", "authors": "Victor Chiruta, Paulina K Zemla, Pixie Miller, Nicola Santarossa, John A Hannan", "journal": "Journal of Medical and Health Studies", "publication_date": "2021-12-30", "publication_year": 2021, "doi": "10.32996/jmhs.2021.2.2.18", "pubmed_id": null, "openalex_id": "https://openalex.org/W3129289556", "source_url": "https://doi.org/10.32996/jmhs.2021.2.2.18", "substance_tags": "psilocybin", "topic_tags": "Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.32996/jmhs.2021.2.2.18", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.32996/jmhs.2021.2.2.18", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.32996/jmhs.2021.2.2.18", "source_url": "https://doi.org/10.32996/jmhs.2021.2.2.18", "doi": "10.32996/jmhs.2021.2.2.18", "pmid": "", "publication_date": "2021-12-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1871, "title": "Palliative care provider attitudes toward existential distress and treatment with psychedelic-assisted therapies.", "authors": "Niles H, Fogg C, Kelmendi B, Lazenby M", "journal": "BMC palliative care", "publication_date": "2021-12-19", "publication_year": 2021, "doi": "10.1186/s12904-021-00889-x", "pubmed_id": "34930220", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34930220/", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Spirituality,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:34930220", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34930220/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34930220", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34930220/", "doi": "10.1186/s12904-021-00889-x", "pmid": "34930220", "publication_date": "2021-12-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1817, "title": "Beating pain with psychedelics: Matter over mind?", "authors": "Elman I, Pustilnik A, Borsook D.", "journal": null, "publication_date": "2021-12-15", "publication_year": 2021, "doi": "10.1016/j.neubiorev.2021.12.005", "pubmed_id": "34922987", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neubiorev.2021.12.005", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Chronic Pain,Neuroplasticity,Brain Imaging,Mechanism of Action,Consciousness,Aging,Emotional Processing,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:34922987", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neubiorev.2021.12.005", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34922987", "source_url": "https://doi.org/10.1016/j.neubiorev.2021.12.005", "doi": "10.1016/j.neubiorev.2021.12.005", "pmid": "34922987", "publication_date": "2021-12-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1808, "title": "Psilocybin-assisted psychotherapy for depression: Emerging research on a psychedelic compound with a rich history.", "authors": "Pearson C, Siegel J, Gold JA.", "journal": null, "publication_date": "2021-12-15", "publication_year": 2021, "doi": "10.1016/j.jns.2021.120096", "pubmed_id": "34942586", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jns.2021.120096", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:34942586", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jns.2021.120096", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34942586", "source_url": "https://doi.org/10.1016/j.jns.2021.120096", "doi": "10.1016/j.jns.2021.120096", "pmid": "34942586", "publication_date": "2021-12-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5037, "title": "P.0421 Efficacy and safety of psilocybin in treatment-resistant major depression (EPIsoDE) - study design, rationale and current status", "authors": "Lea J. Mertens, Michael Koslowski, Felix Betzler, Ricarda Evens, Maria Gilles, Andrea Jungaberle, Henrik Jungaberle, Tomislav Majić, Max Wolff, Andreas Ströhle, Stefan Wellek, Gerhard Gründer", "journal": "European Neuropsychopharmacology", "publication_date": "2021-11-30", "publication_year": 2021, "doi": "10.1016/j.euroneuro.2021.10.394", "pubmed_id": null, "openalex_id": "https://openalex.org/W4200326768", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.394", "substance_tags": "psilocybin", "topic_tags": "Depression,Consciousness,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.394", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.394", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.394", "doi": "10.1016/j.euroneuro.2021.10.394", "pmid": "", "publication_date": "2021-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5034, "title": "P.0623 The clinical relevance of the pharmacokinetics of psilocybin", "authors": "A. Andreiev, E. Bucuci, James Chue, Charl Els, Pierre Chue", "journal": "European Neuropsychopharmacology", "publication_date": "2021-11-30", "publication_year": 2021, "doi": "10.1016/j.euroneuro.2021.10.588", "pubmed_id": null, "openalex_id": "https://openalex.org/W4200545220", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.588", "substance_tags": "psilocybin", "topic_tags": "Addiction,Pharmacology,Receptor Pharmacology,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.588", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.588", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.euroneuro.2021.10.588", "source_url": "https://doi.org/10.1016/j.euroneuro.2021.10.588", "doi": "10.1016/j.euroneuro.2021.10.588", "pmid": "", "publication_date": "2021-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5041, "title": "Marijuana, Hallucinogen Use Reach Historic Levels Among Young Adults", "authors": "Linda M. Richmond", "journal": "Psychiatric News", "publication_date": "2021-11-29", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.11.29", "pubmed_id": null, "openalex_id": "https://openalex.org/W3216860842", "source_url": "https://doi.org/10.1176/appi.pn.2021.11.29", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Spirituality,Mystical Experience,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.11.29", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.11.29", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.11.29", "source_url": "https://doi.org/10.1176/appi.pn.2021.11.29", "doi": "10.1176/appi.pn.2021.11.29", "pmid": "", "publication_date": "2021-11-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5045, "title": "Psychedelic Drugs for Mental Disorders and Human Potential: Placebo or Panacea", "authors": "David J. Hellerstein, Kevin A. Sabet, Jeffrey A. Lieberman", "journal": "Psychiatric News", "publication_date": "2021-11-28", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.12.14", "pubmed_id": null, "openalex_id": "https://openalex.org/W3216344082", "source_url": "https://doi.org/10.1176/appi.pn.2021.12.14", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Mystical Experience,Review Article,Adolescents,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:58", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.12.14", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.12.14", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.12.14", "source_url": "https://doi.org/10.1176/appi.pn.2021.12.14", "doi": "10.1176/appi.pn.2021.12.14", "pmid": "", "publication_date": "2021-11-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3335, "title": "Bibliometric Analysis of Academic Journal Articles Reporting Results of Psychedelic Clinical Studies", "authors": "Weleff J, Akiki TJ, Barnett BS.", "journal": "medRxiv", "publication_date": "2021-11-23", "publication_year": 2021, "doi": "10.1101/2021.11.22.21266718", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2021.11.22.21266718", "substance_tags": "psilocybin", "topic_tags": "Addiction,Safety", "study_type": "Other", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.1101/2021.11.22.21266718", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2021.11.22.21266718", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2021.11.22.21266718", "source_url": "https://doi.org/10.1101/2021.11.22.21266718", "doi": "10.1101/2021.11.22.21266718", "pmid": "", "publication_date": "2021-11-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1882, "title": "Psilocybin, a Naturally Occurring Indoleamine Compound, Could Be Useful to Prevent Suicidal Behaviors.", "authors": "Strumila R, Nobile B, Korsakova L, Lengvenyte A, Olie E, Lopez-Castroman J, Guillaume S, Courtet P.", "journal": null, "publication_date": "2021-11-23", "publication_year": 2021, "doi": "10.3390/ph14121213", "pubmed_id": "34959614", "openalex_id": null, "source_url": "https://doi.org/10.3390/ph14121213", "substance_tags": "psilocybin", "topic_tags": "Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Oxidative Stress,Spirituality,Review Article,Safety,Inflammation", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:34959614", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ph14121213", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34959614", "source_url": "https://doi.org/10.3390/ph14121213", "doi": "10.3390/ph14121213", "pmid": "34959614", "publication_date": "2021-11-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1856, "title": "Psychedelics for the treatment of depression, anxiety, and existential distress in patients with a terminal illness: a systematic review.", "authors": "Schimmers N, Breeksema JJ, Smith-Apeldoorn SY, Veraart J, van den Brink W, Schoevers RA.", "journal": null, "publication_date": "2021-11-22", "publication_year": 2021, "doi": "10.1007/s00213-021-06027-y", "pubmed_id": "34812901", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00213-021-06027-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Wellbeing,Spirituality,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:34812901", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-021-06027-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34812901", "source_url": "https://doi.org/10.1007/s00213-021-06027-y", "doi": "10.1007/s00213-021-06027-y", "pmid": "34812901", "publication_date": "2021-11-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3459, "title": "The Safety and Efficacy of Psilocybin in Cancer Patients With Major Depressive Disorder", "authors": "Maryland Oncology Hematology, PA", "journal": "ClinicalTrials.gov", "publication_date": "2021-10-14", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04593563", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Clinical Trial,Cancer Patients,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04593563", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04593563", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04593563", "source_url": "https://clinicaltrials.gov/study/NCT04593563", "doi": "", "pmid": "", "publication_date": "2021-10-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1899, "title": "Psilocybin for End-of-Life Anxiety Symptoms: A Systematic Review and Meta-Analysis.", "authors": "Yu CL, Yang FC, Yang SN, Tseng PT, Stubbs B, Yeh TC, Hsu CW, Li DJ, Liang CS.", "journal": null, "publication_date": "2021-10-07", "publication_year": 2021, "doi": "10.30773/pi.2021.0209", "pubmed_id": "34619818", "openalex_id": null, "source_url": "https://doi.org/10.30773/pi.2021.0209", "substance_tags": "psilocybin", "topic_tags": "Anxiety,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:34619818", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.30773/pi.2021.0209", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34619818", "source_url": "https://doi.org/10.30773/pi.2021.0209", "doi": "10.30773/pi.2021.0209", "pmid": "34619818", "publication_date": "2021-10-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1862, "title": "United States National Institutes of Health grant funding for psychedelic-assisted therapy clinical trials from 2006-2020.", "authors": "Barnett BS, Parker SE, Weleff J.", "journal": null, "publication_date": "2021-10-05", "publication_year": 2021, "doi": "10.1016/j.drugpo.2021.103473", "pubmed_id": "34624734", "openalex_id": "https://openalex.org/W3203419443", "source_url": "https://doi.org/10.1016/j.drugpo.2021.103473", "substance_tags": "psilocybin", "topic_tags": "Addiction,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:34624734", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.drugpo.2021.103473", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34624734", "source_url": "https://doi.org/10.1016/j.drugpo.2021.103473", "doi": "10.1016/j.drugpo.2021.103473", "pmid": "34624734", "publication_date": "2021-10-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1573, "title": "Novel antidepressant drugs: Beyond monoamine targets.", "authors": "Gonda X, Dome P, Neill JC, Tarazi FI.", "journal": null, "publication_date": "2021-09-29", "publication_year": 2021, "doi": "10.1017/s1092852921000791", "pubmed_id": "34588093", "openalex_id": null, "source_url": "https://doi.org/10.1017/s1092852921000791", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:34588093", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/s1092852921000791", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34588093", "source_url": "https://doi.org/10.1017/s1092852921000791", "doi": "10.1017/s1092852921000791", "pmid": "34588093", "publication_date": "2021-09-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1904, "title": "Rediscovering Psilocybin as an Antidepressive Treatment Strategy.", "authors": "Zeiss R, Gahr M, Graf H.", "journal": null, "publication_date": "2021-09-27", "publication_year": 2021, "doi": "10.3390/ph14100985", "pubmed_id": "34681209", "openalex_id": null, "source_url": "https://doi.org/10.3390/ph14100985", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Mechanism of Action,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "PMID:34681209", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/ph14100985", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34681209", "source_url": "https://doi.org/10.3390/ph14100985", "doi": "10.3390/ph14100985", "pmid": "34681209", "publication_date": "2021-09-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1910, "title": "Treatment-Resistant Depression: Approaches to Treatment.", "authors": "Kverno KS, Mangano E.", "journal": null, "publication_date": "2021-08-31", "publication_year": 2021, "doi": "10.3928/02793695-20210816-01", "pubmed_id": "34459676", "openalex_id": null, "source_url": "https://doi.org/10.3928/02793695-20210816-01", "substance_tags": "psilocybin", "topic_tags": "Depression,Review Article,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:34459676", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3928/02793695-20210816-01", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34459676", "source_url": "https://doi.org/10.3928/02793695-20210816-01", "doi": "10.3928/02793695-20210816-01", "pmid": "34459676", "publication_date": "2021-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3395, "title": "Therapeutic interventions for PTSD - current evidence on the the role of psychedelics", "authors": "Figueiredo I, Viegas F, Ferreira F, Santos A, Ramos J, Miranda J.", "journal": null, "publication_date": "2021-08-12", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9475922", "substance_tags": "psilocybin", "topic_tags": "PTSD,Mechanism of Action,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9475922", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9475922", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9475922", "source_url": "https://europepmc.org/article/PMC/PMC9475922", "doi": "", "pmid": "", "publication_date": "2021-08-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3346, "title": "Treating addiction with psychedelics - are we waking up?", "authors": "Miranda J, Barbosa M, Figueiredo I, Mota P, Tarelho A.", "journal": null, "publication_date": "2021-08-12", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC9480123", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Mystical Experience,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC9480123", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC9480123", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC9480123", "source_url": "https://europepmc.org/article/PMC/PMC9480123", "doi": "", "pmid": "", "publication_date": "2021-08-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5071, "title": "What can we learn from the history of research on psychedelic drugs in the addictions?", "authors": "Wayne Hall, Michael Farrell", "journal": "Addiction", "publication_date": "2021-08-11", "publication_year": 2021, "doi": "10.1111/add.15560", "pubmed_id": "34382252", "openalex_id": "https://openalex.org/W3187445852", "source_url": "https://doi.org/10.1111/add.15560", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Mechanism of Action,Receptor Pharmacology,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Healthcare Workers,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34382252", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/add.15560", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:34382252", "source_url": "https://doi.org/10.1111/add.15560", "doi": "10.1111/add.15560", "pmid": "34382252", "publication_date": "2021-08-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1877, "title": "Use of hallucinogens in Slovakia: Does it differ from global trends?", "authors": "Lukačovič M, Masaryk R.", "journal": null, "publication_date": "2021-08-04", "publication_year": 2021, "doi": "10.1016/j.drugpo.2021.103385", "pubmed_id": "34364200", "openalex_id": "https://openalex.org/W3193012633", "source_url": "https://doi.org/10.1016/j.drugpo.2021.103385", "substance_tags": "psilocybin", "topic_tags": "Observational Study,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:34364200", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.drugpo.2021.103385", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34364200", "source_url": "https://doi.org/10.1016/j.drugpo.2021.103385", "doi": "10.1016/j.drugpo.2021.103385", "pmid": "34364200", "publication_date": "2021-08-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1911, "title": "Classic Psychedelic Coadministration with Lithium, but Not Lamotrigine, is Associated with Seizures: An Analysis of Online Psychedelic Experience Reports.", "authors": "Nayak SM, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR.", "journal": "Pharmacopsychiatry", "publication_date": "2021-08-03", "publication_year": 2021, "doi": "10.1055/a-1524-2794", "pubmed_id": "34348413", "openalex_id": "https://openalex.org/W3160183306", "source_url": "https://doi.org/10.1055/a-1524-2794", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34348413", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1055/a-1524-2794", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34348413", "source_url": "https://doi.org/10.1055/a-1524-2794", "doi": "10.1055/a-1524-2794", "pmid": "34348413", "publication_date": "2021-08-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2137, "title": "Migraine prevalence in visual snow with prior illicit drug use (hallucinogen persisting perception disorder) versus without.", "authors": "van Dongen RM, Alderliefste GJ, Onderwater GLJ, Ferrari MD, Terwindt GM", "journal": "European journal of neurology", "publication_date": "2021-07-31", "publication_year": 2021, "doi": "10.1111/ene.14914", "pubmed_id": "33979006", "openalex_id": "https://openalex.org/W3160485194", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33979006/", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33979006", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33979006/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33979006", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33979006/", "doi": "10.1111/ene.14914", "pmid": "33979006", "publication_date": "2021-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2139, "title": "The Potential Role of Serotonergic Hallucinogens in Depression Treatment.", "authors": "Psiuk D, Nowak E, Cholewa K, Łopuszańska U, Samardakiewicz M.", "journal": null, "publication_date": "2021-07-28", "publication_year": 2021, "doi": "10.3390/life11080765", "pubmed_id": "34440508", "openalex_id": null, "source_url": "https://doi.org/10.3390/life11080765", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:34440508", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/life11080765", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34440508", "source_url": "https://doi.org/10.3390/life11080765", "doi": "10.3390/life11080765", "pmid": "34440508", "publication_date": "2021-07-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5074, "title": "Safer Tripping: Serotonergic Psychedelics and Drug Checking. Submission and Detection Rates, Potential Harms, and Challenges for Drug Analysis", "authors": "Tim Hirschfeld, Laura Smit-Rigter, Daan van der Gouwe, Simon Reiche, Heino Stöver, Tomislav Majić", "journal": "Current Addiction Reports", "publication_date": "2021-07-25", "publication_year": 2021, "doi": "10.1007/s40429-021-00385-5", "pubmed_id": null, "openalex_id": "https://openalex.org/W3186726344", "source_url": "https://doi.org/10.1007/s40429-021-00385-5", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Receptor Pharmacology,Review Article,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1007/s40429-021-00385-5", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1007/s40429-021-00385-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1007/s40429-021-00385-5", "source_url": "https://doi.org/10.1007/s40429-021-00385-5", "doi": "10.1007/s40429-021-00385-5", "pmid": "", "publication_date": "2021-07-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5075, "title": "Psychedelic Therapy Hits Another Milestone, But Caution Urged", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2021-07-21", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.7.14", "pubmed_id": null, "openalex_id": "https://openalex.org/W3193219878", "source_url": "https://doi.org/10.1176/appi.pn.2021.7.14", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Review Article,Cancer Patients,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.7.14", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.7.14", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.7.14", "source_url": "https://doi.org/10.1176/appi.pn.2021.7.14", "doi": "10.1176/appi.pn.2021.7.14", "pmid": "", "publication_date": "2021-07-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3481, "title": "A Randomised, Placebo Controlled Trial of Psilocybin in Treatment Resistant Depression: A Feasibility Study", "authors": "King's College London", "journal": "ClinicalTrials.gov", "publication_date": "2021-07-21", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT04959253", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT04959253", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT04959253", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT04959253", "source_url": "https://clinicaltrials.gov/study/NCT04959253", "doi": "", "pmid": "", "publication_date": "2021-07-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1865, "title": "Exploring the Use of Psilocybin Therapy for Existential Distress: A Qualitative Study of Palliative Care Provider Perceptions.", "authors": "Mayer CE, LeBaron VT, Acquaviva KD.", "journal": "Journal of Psychoactive Drugs", "publication_date": "2021-07-15", "publication_year": 2021, "doi": "10.1080/02791072.2021.1916659", "pubmed_id": "34266372", "openalex_id": "https://openalex.org/W3178288974", "source_url": "https://doi.org/10.1080/02791072.2021.1916659", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Safety", "study_type": "Qualitative Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34266372", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2021.1916659", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34266372", "source_url": "https://doi.org/10.1080/02791072.2021.1916659", "doi": "10.1080/02791072.2021.1916659", "pmid": "34266372", "publication_date": "2021-07-15", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3786, "title": "Psychedelic Assisted Therapy for Major Depressive Disorder: A Review", "authors": "McCartney A, McGovern H, De Foe A.", "journal": "PsyArXiv", "publication_date": "2021-06-26", "publication_year": 2021, "doi": "10.31234/osf.io/9kuhs", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/9kuhs", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:22", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/9kuhs", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/9kuhs", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/9kuhs", "source_url": "https://doi.org/10.31234/osf.io/9kuhs", "doi": "10.31234/osf.io/9kuhs", "pmid": "", "publication_date": "2021-06-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3336, "title": "Psychedelic Assisted Therapy for Major Depressive Disorder: A Review", "authors": "", "journal": "PsyArXiv", "publication_date": "2021-06-26", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "source_url": "https://osf.io/preprints/psyarxiv/9kuhs_v1", "doi": "", "pmid": "", "publication_date": "2021-06-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5080, "title": "Psilocybin as a Novel Pharmacotherapy for Treatment-Refractory Anorexia Nervosa", "authors": "Sarah-Catherine Rodan, Phillip Aouad, Iain S. McGregor, Sarah Maguire", "journal": "OBM Neurobiology", "publication_date": "2021-06-23", "publication_year": 2021, "doi": "10.21926/obm.neurobiol.2102102", "pubmed_id": null, "openalex_id": "https://openalex.org/W3174884462", "source_url": "https://doi.org/10.21926/obm.neurobiol.2102102", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Eating Disorders,Receptor Pharmacology,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.21926/obm.neurobiol.2102102", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.21926/obm.neurobiol.2102102", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.21926/obm.neurobiol.2102102", "source_url": "https://doi.org/10.21926/obm.neurobiol.2102102", "doi": "10.21926/obm.neurobiol.2102102", "pmid": "", "publication_date": "2021-06-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3208, "title": "Psilocybin: the magic medicine for depression?", "authors": "Corrigan A, Burchill E, Pelton L, Marrocu A, Mazzoleni A, Shackshaft L.", "journal": null, "publication_date": "2021-06-17", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://europepmc.org/article/PMC/PMC8770735", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Default Mode Network,Aging,Personality Change,Emotional Processing,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:48", "last_checked": "2026-07-01 11:22:02", "bibtex": null, "source_record_id": "https://europepmc.org/article/PMC/PMC8770735", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/PMC/PMC8770735", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "https://europepmc.org/article/PMC/PMC8770735", "source_url": "https://europepmc.org/article/PMC/PMC8770735", "doi": "", "pmid": "", "publication_date": "2021-06-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5085, "title": "Participant Reports of Mindfulness, Posttraumatic Growth, and Social Connectedness in Psilocybin-Assisted Group Therapy: An Interpretive Phenomenological Analysis", "authors": "Gabrielle Agin-Liebes, Eve Ekman, B. Anderson, Maxx Malloy, Alexandra Haas, Josh Woolley", "journal": "Journal of Humanistic Psychology", "publication_date": "2021-06-11", "publication_year": 2021, "doi": "10.1177/00221678211022949", "pubmed_id": null, "openalex_id": "https://openalex.org/W3166459008", "source_url": "https://doi.org/10.1177/00221678211022949", "substance_tags": "psilocybin", "topic_tags": "Emotional Processing,Spirituality,Safety", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1177/00221678211022949", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/00221678211022949", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1177/00221678211022949", "source_url": "https://doi.org/10.1177/00221678211022949", "doi": "10.1177/00221678211022949", "pmid": "", "publication_date": "2021-06-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1751, "title": "Psilocybin: A brief overview for psychiatric mental health nurse practitioners.", "authors": "Fradkin D.", "journal": "Perspectives In Psychiatric Care", "publication_date": "2021-06-07", "publication_year": 2021, "doi": "10.1111/ppc.12888", "pubmed_id": "34101846", "openalex_id": "https://openalex.org/W3169192423", "source_url": "https://doi.org/10.1111/ppc.12888", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34101846", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/ppc.12888", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34101846", "source_url": "https://doi.org/10.1111/ppc.12888", "doi": "10.1111/ppc.12888", "pmid": "34101846", "publication_date": "2021-06-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1901, "title": "Ethnoracial health disparities and the ethnopsychopharmacology of psychedelic-assisted psychotherapies.", "authors": "Fogg C, Michaels TI, de la Salle S, Jahn ZW, Williams MT.", "journal": "Experimental and Clinical Psychopharmacology", "publication_date": "2021-06-06", "publication_year": 2021, "doi": "10.1037/pha0000490", "pubmed_id": "34096755", "openalex_id": "https://openalex.org/W3171546624", "source_url": "https://doi.org/10.1037/pha0000490", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Pharmacology,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34096755", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1037/pha0000490", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34096755", "source_url": "https://doi.org/10.1037/pha0000490", "doi": "10.1037/pha0000490", "pmid": "34096755", "publication_date": "2021-06-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5087, "title": "Psilocybin: the magic medicine for depression?", "authors": "Amber Elyse Corrigan, Ella Burchill, Lucy Pelton, Alessia Marrocu, Adele Mazzoleni, Lydia Shackshaft", "journal": "BJPsych Open", "publication_date": "2021-05-31", "publication_year": 2021, "doi": "10.1192/bjo.2021.456", "pubmed_id": null, "openalex_id": "https://openalex.org/W3173209673", "source_url": "https://doi.org/10.1192/bjo.2021.456", "substance_tags": "psilocybin", "topic_tags": "Depression,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Default Mode Network,Aging,Personality Change,Emotional Processing,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1192/bjo.2021.456", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1192/bjo.2021.456", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1192/bjo.2021.456", "source_url": "https://doi.org/10.1192/bjo.2021.456", "doi": "10.1192/bjo.2021.456", "pmid": "", "publication_date": "2021-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3385, "title": "Psychedelic-Assisted Psychotherapy for Post-Traumatic Stress Disorder, Anxiety Disorders, Mood Disorders, or Substance Use Disorders", "authors": "Chao YS, Horton J.", "journal": "Canadian Agency for Drugs and Technologies in Health, Ottawa (ON)", "publication_date": "2021-05-31", "publication_year": 2021, "doi": null, "pubmed_id": "36170470", "openalex_id": null, "source_url": "https://europepmc.org/article/MED/36170470", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Consciousness,Emotional Processing,Clinical Trial,Review Article,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:36170470", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/36170470", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:36170470", "source_url": "https://europepmc.org/article/MED/36170470", "doi": "", "pmid": "36170470", "publication_date": "2021-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1867, "title": "Psychedelics and health behaviour change.", "authors": "Teixeira PJ, Johnson MW, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris RL.", "journal": null, "publication_date": "2021-05-28", "publication_year": 2021, "doi": "10.1177/02698811211008554", "pubmed_id": "34053342", "openalex_id": null, "source_url": "https://doi.org/10.1177/02698811211008554", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Mechanism of Action,Wellbeing,Safety,Toxicity", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:05", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:34053342", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/02698811211008554", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34053342", "source_url": "https://doi.org/10.1177/02698811211008554", "doi": "10.1177/02698811211008554", "pmid": "34053342", "publication_date": "2021-05-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5091, "title": "The need for publicly funded research on therapeutic use of psychedelic drugs", "authors": "Wayne Hall", "journal": "World Psychiatry", "publication_date": "2021-05-17", "publication_year": 2021, "doi": "10.1002/wps.20847", "pubmed_id": "34002493", "openalex_id": "https://openalex.org/W3162774823", "source_url": "https://doi.org/10.1002/wps.20847", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Headache / Migraine,Pharmacology,Mechanism of Action,Receptor Pharmacology,Wellbeing,Emotional Processing,Spirituality,Clinical Trial,Randomized Controlled Trial,Observational Study,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:34002493", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/wps.20847", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:34002493", "source_url": "https://doi.org/10.1002/wps.20847", "doi": "10.1002/wps.20847", "pmid": "34002493", "publication_date": "2021-05-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2146, "title": "The Potential Role of Psychedelic Drugs in Mental Health Care of the Future.", "authors": "Gründer G, Jungaberle H.", "journal": "Pharmacopsychiatry", "publication_date": "2021-05-11", "publication_year": 2021, "doi": "10.1055/a-1486-7386", "pubmed_id": "33979868", "openalex_id": "https://openalex.org/W3162909048", "source_url": "https://doi.org/10.1055/a-1486-7386", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33979868", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1055/a-1486-7386", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33979868", "source_url": "https://doi.org/10.1055/a-1486-7386", "doi": "10.1055/a-1486-7386", "pmid": "33979868", "publication_date": "2021-05-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5094, "title": "Addressing the Implicit Impacts of Sexual Trauma: An Exploration of Somatic Experiencing as an Adjunct to Psilocybin-Assisted Therapy", "authors": "Despina Stratidakis", "journal": "National University System Repository (National University System)", "publication_date": "2021-04-30", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3168063229", "source_url": "http://hdl.handle.net/20.500.11803/1295", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "http://hdl.handle.net/20.500.11803/1295", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://hdl.handle.net/20.500.11803/1295", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://hdl.handle.net/20.500.11803/1295", "source_url": "http://hdl.handle.net/20.500.11803/1295", "doi": "", "pmid": "", "publication_date": "2021-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2156, "title": "Effects of Ayahuasca on the Recognition of Facial Expressions of Emotions in Naive Healthy Volunteers: A Pilot, Proof-of-Concept, Randomized Controlled Trial.", "authors": "Rocha JM, Rossi GN, de Lima Osório F, Bouso JC, de Oliveira Silveira G, Yonamine M, Campos AC, Bertozi G, Cecílio Hallak JE, Dos Santos RG.", "journal": "Journal of Clinical Psychopharmacology", "publication_date": "2021-04-30", "publication_year": 2021, "doi": "10.1097/jcp.0000000000001396", "pubmed_id": "33843820", "openalex_id": "https://openalex.org/W3154361912", "source_url": "https://doi.org/10.1097/jcp.0000000000001396", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Wellbeing,Emotional Processing,Randomized Controlled Trial,Healthy Volunteers,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33843820", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/jcp.0000000000001396", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33843820", "source_url": "https://doi.org/10.1097/jcp.0000000000001396", "doi": "10.1097/jcp.0000000000001396", "pmid": "33843820", "publication_date": "2021-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2164, "title": "Psilocybin: From Serendipity to Credibility?", "authors": "Rucker JJ, Young AH.", "journal": "Frontiers in Psychiatry", "publication_date": "2021-04-20", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.659044", "pubmed_id": "33967860", "openalex_id": "https://openalex.org/W3154999065", "source_url": "https://doi.org/10.3389/fpsyt.2021.659044", "substance_tags": "psilocybin", "topic_tags": "Aging,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33967860", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2021.659044", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33967860", "source_url": "https://doi.org/10.3389/fpsyt.2021.659044", "doi": "10.3389/fpsyt.2021.659044", "pmid": "33967860", "publication_date": "2021-04-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3255, "title": "Evaluating the Risk of Psilocybin for the Treatment of Bipolar Depression: A Review of the Research Literature and Published Case Studies", "authors": "Gard DE, Pleet MM, Bradley ER, Penn A, Gallenstein ML, Riley LS, DellaCrosse M, Garfinkle E, Michalak EE, Woolley JD.", "journal": "medRxiv", "publication_date": "2021-04-06", "publication_year": 2021, "doi": "10.1101/2021.04.02.21254838", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2021.04.02.21254838", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.1101/2021.04.02.21254838", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2021.04.02.21254838", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2021.04.02.21254838", "source_url": "https://doi.org/10.1101/2021.04.02.21254838", "doi": "10.1101/2021.04.02.21254838", "pmid": "", "publication_date": "2021-04-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5115, "title": "The Return of Psychedelics: Still Time to Prevent Tragedy", "authors": "Stanley N. Caroff", "journal": "Psychiatric News", "publication_date": "2021-03-30", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.4.8", "pubmed_id": null, "openalex_id": "https://openalex.org/W3147930394", "source_url": "https://doi.org/10.1176/appi.pn.2021.4.8", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,End-of-Life Distress,Chronic Pain,Headache / Migraine,Pharmacology,Consciousness,Emotional Processing,Clinical Trial,Review Article,Case Report,Observational Study,Adolescents,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:51:59", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.4.8", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.4.8", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.4.8", "source_url": "https://doi.org/10.1176/appi.pn.2021.4.8", "doi": "10.1176/appi.pn.2021.4.8", "pmid": "", "publication_date": "2021-03-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3799, "title": "Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)", "authors": "Teixeira PJ, Johnson M, Timmermann C, Watts R, Erritzoe D, Douglass H, Kettner H, Carhart-Harris R.", "journal": "PsyArXiv", "publication_date": "2021-03-23", "publication_year": 2021, "doi": "10.31234/osf.io/8vks6", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/8vks6", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Pharmacology,Mechanism of Action,Wellbeing,Safety,Toxicity", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:10:23", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/8vks6", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/8vks6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/8vks6", "source_url": "https://doi.org/10.31234/osf.io/8vks6", "doi": "10.31234/osf.io/8vks6", "pmid": "", "publication_date": "2021-03-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3374, "title": "Psychedelics and Health Behavior Change - Journal of Psychopharmacology (in press)", "authors": "", "journal": "PsyArXiv", "publication_date": "2021-03-23", "publication_year": 2021, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/8vks6_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Pharmacology,Mechanism of Action,Wellbeing,Safety,Toxicity", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/8vks6_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/8vks6_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/8vks6_v1", "source_url": "https://osf.io/preprints/psyarxiv/8vks6_v1", "doi": "", "pmid": "", "publication_date": "2021-03-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1880, "title": "Medicinal psychedelics for mental health and addiction: Advancing research of an emerging paradigm.", "authors": "Perkins D, Sarris J, Rossell S, Bonomo Y, Forbes D, Davey C, Hoyer D, Loo C, Murray G, Hood S, Schubert V, Galvão-Coelho NL, O'Donnell M, Carter O, Liknaitzky P, Williams M, Siskind D, Penington D, Berk M, Castle D.", "journal": "Australian & New Zealand Journal of Psychiatry", "publication_date": "2021-03-20", "publication_year": 2021, "doi": "10.1177/0004867421998785", "pubmed_id": "33745287", "openalex_id": "https://openalex.org/W3134642859", "source_url": "https://doi.org/10.1177/0004867421998785", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33745287", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0004867421998785", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33745287", "source_url": "https://doi.org/10.1177/0004867421998785", "doi": "10.1177/0004867421998785", "pmid": "33745287", "publication_date": "2021-03-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2175, "title": "Hallucinogenic/psychedelic 5HT2A receptor agonists as rapid antidepressant therapeutics: Evidence and mechanisms of action.", "authors": "Dos Santos RG, Hallak JE, Baker G, Dursun S.", "journal": "Journal of Psychopharmacology", "publication_date": "2021-03-18", "publication_year": 2021, "doi": "10.1177/0269881120986422", "pubmed_id": "33740877", "openalex_id": "https://openalex.org/W3137933781", "source_url": "https://doi.org/10.1177/0269881120986422", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Animal Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33740877", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881120986422", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33740877", "source_url": "https://doi.org/10.1177/0269881120986422", "doi": "10.1177/0269881120986422", "pmid": "33740877", "publication_date": "2021-03-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2168, "title": "Acute and Sustained Reductions in Loss of Meaning and Suicidal Ideation Following Psilocybin-Assisted Psychotherapy for Psychiatric and Existential Distress in Life-Threatening Cancer.", "authors": "Ross S, Agin-Liebes G, Lo S, Zeifman RJ, Ghazal L, Benville J, Franco Corso S, Bjerre Real C, Guss J, Bossis A, Mennenga SE.", "journal": "ACS Pharmacology & Translational Science", "publication_date": "2021-03-17", "publication_year": 2021, "doi": "10.1021/acsptsci.1c00020", "pubmed_id": "33860185", "openalex_id": "https://openalex.org/W3138429576", "source_url": "https://doi.org/10.1021/acsptsci.1c00020", "substance_tags": "psilocybin", "topic_tags": "Depression,End-of-Life Distress,Clinical Trial,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33860185", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsptsci.1c00020", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33860185", "source_url": "https://doi.org/10.1021/acsptsci.1c00020", "doi": "10.1021/acsptsci.1c00020", "pmid": "33860185", "publication_date": "2021-03-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2173, "title": "On the Relationship between Classic Psychedelics and Suicidality: A Systematic Review.", "authors": "Zeifman RJ, Singhal N, Breslow L, Weissman CR.", "journal": null, "publication_date": "2021-03-10", "publication_year": 2021, "doi": "10.1021/acsptsci.1c00024", "pubmed_id": "33860173", "openalex_id": null, "source_url": "https://doi.org/10.1021/acsptsci.1c00024", "substance_tags": "psilocybin", "topic_tags": "Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:33860173", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acsptsci.1c00024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33860173", "source_url": "https://doi.org/10.1021/acsptsci.1c00024", "doi": "10.1021/acsptsci.1c00024", "pmid": "33860173", "publication_date": "2021-03-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5119, "title": "Session on Psychedelics Sure to Be Enlightening", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2021-02-28", "publication_year": 2021, "doi": "10.1176/appi.pn.2021.3.14", "pubmed_id": null, "openalex_id": "https://openalex.org/W3133604748", "source_url": "https://doi.org/10.1176/appi.pn.2021.3.14", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Consciousness,Wellbeing,Emotional Processing,Review Article,Cancer Patients,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2021.3.14", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2021.3.14", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2021.3.14", "source_url": "https://doi.org/10.1176/appi.pn.2021.3.14", "doi": "10.1176/appi.pn.2021.3.14", "pmid": "", "publication_date": "2021-02-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3370, "title": "Classic psychedelic coadministration with lithium, but not lamotrigine, is associated with seizures: an analysis of online psychedelic experience reports", "authors": "Nayak S, Gukasyan N, Barrett FS, Erowid E, Erowid F, Griffiths RR.", "journal": "PsyArXiv", "publication_date": "2021-02-23", "publication_year": 2021, "doi": "10.31234/osf.io/r726d", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/r726d", "substance_tags": "psilocybin", "topic_tags": "Depression,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:51", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/r726d", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/r726d", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/r726d", "source_url": "https://doi.org/10.31234/osf.io/r726d", "doi": "10.31234/osf.io/r726d", "pmid": "", "publication_date": "2021-02-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2198, "title": "Development and Evaluation of a Therapist Training Program for Psilocybin Therapy for Treatment-Resistant Depression in Clinical Research.", "authors": "Tai SJ, Nielson EM, Lennard-Jones M, Johanna Ajantaival RL, Winzer R, Richards WA, Reinholdt F, Richards BD, Gasser P, Malievskaia E.", "journal": "Frontiers in Psychiatry", "publication_date": "2021-02-02", "publication_year": 2021, "doi": "10.3389/fpsyt.2021.586682", "pubmed_id": "33643087", "openalex_id": "https://openalex.org/W3127909847", "source_url": "https://doi.org/10.3389/fpsyt.2021.586682", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33643087", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2021.586682", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33643087", "source_url": "https://doi.org/10.3389/fpsyt.2021.586682", "doi": "10.3389/fpsyt.2021.586682", "pmid": "33643087", "publication_date": "2021-02-02", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2180, "title": "Use and abuse of dissociative and psychedelic drugs in adolescence.", "authors": "Bates MLS, Trujillo KA.", "journal": null, "publication_date": "2021-01-27", "publication_year": 2021, "doi": "10.1016/j.pbb.2021.173129", "pubmed_id": "33515586", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pbb.2021.173129", "substance_tags": "psilocybin", "topic_tags": "Addiction,Review Article,Animal Study,Adolescents,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:33515586", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pbb.2021.173129", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33515586", "source_url": "https://doi.org/10.1016/j.pbb.2021.173129", "doi": "10.1016/j.pbb.2021.173129", "pmid": "33515586", "publication_date": "2021-01-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2144, "title": "Psychedelic Psychiatry and the Consult-Liaison Psychiatrist: A Primer.", "authors": "Barnett BS, Greer GR.", "journal": null, "publication_date": "2021-01-20", "publication_year": 2021, "doi": "10.1016/j.jaclp.2020.12.011", "pubmed_id": "34210406", "openalex_id": "https://openalex.org/W3123670341", "source_url": "https://doi.org/10.1016/j.jaclp.2020.12.011", "substance_tags": "psilocybin", "topic_tags": "Depression,PTSD,Addiction,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:34210406", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jaclp.2020.12.011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:34210406", "source_url": "https://doi.org/10.1016/j.jaclp.2020.12.011", "doi": "10.1016/j.jaclp.2020.12.011", "pmid": "34210406", "publication_date": "2021-01-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2148, "title": "Classical Psychedelics as Therapeutics in Psychiatry - Current Clinical Evidence and Potential Therapeutic Mechanisms in Substance Use and Mood Disorders.", "authors": "Mertens LJ, Preller KH.", "journal": null, "publication_date": "2021-01-19", "publication_year": 2021, "doi": "10.1055/a-1341-1907", "pubmed_id": "33472250", "openalex_id": null, "source_url": "https://doi.org/10.1055/a-1341-1907", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Clinical Trial,Randomized Controlled Trial,Review Article,Animal Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:33472250", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1055/a-1341-1907", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33472250", "source_url": "https://doi.org/10.1055/a-1341-1907", "doi": "10.1055/a-1341-1907", "pmid": "33472250", "publication_date": "2021-01-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5143, "title": "The Effect of Psilocybin on Personality", "authors": "Ravital LaBua", "journal": "CUNY Academic Works (City University of New York)", "publication_date": "2020-12-31", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3194396335", "source_url": "https://academicworks.cuny.edu/gc_etds/4460", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Personality Change,Mystical Experience,Safety,Drug Interactions,Contraindications", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "https://academicworks.cuny.edu/gc_etds/4460", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://academicworks.cuny.edu/gc_etds/4460", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://academicworks.cuny.edu/gc_etds/4460", "source_url": "https://academicworks.cuny.edu/gc_etds/4460", "doi": "", "pmid": "", "publication_date": "2020-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5141, "title": "Unmet need in depression: Psilocybin, a breakthrough treatment option", "authors": "Yogesh Kumar Chahar", "journal": "International Journal of Advanced Research in Medicine", "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.22271/27069567.2021.v3.i1f.159", "pubmed_id": null, "openalex_id": "https://openalex.org/W3164081616", "source_url": "https://doi.org/10.22271/27069567.2021.v3.i1f.159", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:00", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "DOI:10.22271/27069567.2021.v3.i1f.159", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.22271/27069567.2021.v3.i1f.159", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.22271/27069567.2021.v3.i1f.159", "source_url": "https://doi.org/10.22271/27069567.2021.v3.i1f.159", "doi": "10.22271/27069567.2021.v3.i1f.159", "pmid": "", "publication_date": "2020-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2214, "title": "Psychedelics in Psychiatry: Neuroplastic, Immunomodulatory, and Neurotransmitter Mechanisms.", "authors": "Inserra A, De Gregorio D, Gobbi G.", "journal": null, "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.1124/pharmrev.120.000056", "pubmed_id": "33328244", "openalex_id": null, "source_url": "https://doi.org/10.1124/pharmrev.120.000056", "substance_tags": "psilocybin", "topic_tags": "PTSD,Neuroplasticity,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Review Article,Observational Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:33328244", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1124/pharmrev.120.000056", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33328244", "source_url": "https://doi.org/10.1124/pharmrev.120.000056", "doi": "10.1124/pharmrev.120.000056", "pmid": "33328244", "publication_date": "2020-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2211, "title": "Psychedelic Medicines in Major Depression: Progress and Future Challenges.", "authors": "Bouso JC, Ona G, Dos Santos RG, Hallak JEC.", "journal": null, "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.1007/978-981-33-6044-0_26", "pubmed_id": "33834416", "openalex_id": null, "source_url": "https://doi.org/10.1007/978-981-33-6044-0_26", "substance_tags": "psilocybin", "topic_tags": "Depression,Mechanism of Action,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:33834416", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/978-981-33-6044-0_26", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33834416", "source_url": "https://doi.org/10.1007/978-981-33-6044-0_26", "doi": "10.1007/978-981-33-6044-0_26", "pmid": "33834416", "publication_date": "2020-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 1889, "title": "Translating Psychedelic Therapies From Clinical Trials to Community Clinics: Building Bridges and Addressing Potential Challenges Ahead.", "authors": "Williams ML, Korevaar D, Harvey R, Fitzgerald PB, Liknaitzky P, O'Carroll S, Puspanathan P, Ross M, Strauss N, Bennett-Levy J", "journal": "Frontiers in psychiatry", "publication_date": "2020-12-31", "publication_year": 2020, "doi": "10.3389/fpsyt.2021.737738", "pubmed_id": "34803761", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/34803761/", "substance_tags": "psilocybin", "topic_tags": "Depression,Creativity,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:48:06", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:34803761", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/34803761/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:34803761", "source_url": "https://pubmed.ncbi.nlm.nih.gov/34803761/", "doi": "10.3389/fpsyt.2021.737738", "pmid": "34803761", "publication_date": "2020-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2221, "title": "Effects and safety of Psilocybe cubensis and Panaeolus cyanescens magic mushroom extracts on endothelin-1-induced hypertrophy and cell injury in cardiomyocytes", "authors": "Sanah Malomile Nkadimeng, Christiaan M.L. Steinmann, J.N. Eloff", "journal": "Scientific Reports", "publication_date": "2020-12-17", "publication_year": 2020, "doi": "10.1038/s41598-020-79328-5", "pubmed_id": "33339902", "openalex_id": "https://openalex.org/W3115524456", "source_url": "https://doi.org/10.1038/s41598-020-79328-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33339902", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1038/s41598-020-79328-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:33339902", "source_url": "https://doi.org/10.1038/s41598-020-79328-5", "doi": "10.1038/s41598-020-79328-5", "pmid": "33339902", "publication_date": "2020-12-17", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2170, "title": "Psilocybin-Assisted Group Therapy and Attachment: Observed Reduction in Attachment Anxiety and Influences of Attachment Insecurity on the Psilocybin Experience", "authors": "Christopher S. Stauffer, B. Anderson, Kile Ortigo, Joshua Woolley", "journal": "ACS Pharmacology & Translational Science", "publication_date": "2020-12-08", "publication_year": 2020, "doi": "10.1021/acsptsci.0c00169", "pubmed_id": "33860182", "openalex_id": "https://openalex.org/W3112557491", "source_url": "https://doi.org/10.1021/acsptsci.0c00169", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mystical Experience,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:38", "bibtex": null, "source_record_id": "PMID:33860182", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acsptsci.0c00169", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:33860182", "source_url": "https://doi.org/10.1021/acsptsci.0c00169", "doi": "10.1021/acsptsci.0c00169", "pmid": "33860182", "publication_date": "2020-12-08", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3491, "title": "Effects of Serotonin Transporter Inhibition on the Subjective Response to Psilocybin in Healthy Subjects", "authors": "University Hospital, Basel, Switzerland", "journal": "ClinicalTrials.gov", "publication_date": "2020-11-30", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT03912974", "substance_tags": "psilocybin", "topic_tags": "Depression,Neuroplasticity,Receptor Pharmacology,Consciousness,Safety", "study_type": "Other", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT03912974", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT03912974", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT03912974", "source_url": "https://clinicaltrials.gov/study/NCT03912974", "doi": "", "pmid": "", "publication_date": "2020-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2226, "title": "Psychedelic Psychiatry: Preparing for Novel Treatments Involving Altered States of Consciousness.", "authors": "Holoyda B", "journal": "Psychiatric services (Washington, D.C.)", "publication_date": "2020-11-30", "publication_year": 2020, "doi": "10.1176/appi.ps.202000213", "pubmed_id": "33050796", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/33050796/", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Aging,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:33050796", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/33050796/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:33050796", "source_url": "https://pubmed.ncbi.nlm.nih.gov/33050796/", "doi": "10.1176/appi.ps.202000213", "pmid": "33050796", "publication_date": "2020-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2201, "title": "Therapeutic effects of classic serotonergic psychedelics: A systematic review of modern-era clinical studies.", "authors": "Andersen KAA, Carhart-Harris R, Nutt DJ, Erritzoe D.", "journal": null, "publication_date": "2020-11-30", "publication_year": 2020, "doi": "10.1111/acps.13249", "pubmed_id": "33125716", "openalex_id": null, "source_url": "https://doi.org/10.1111/acps.13249", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:33125716", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/acps.13249", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33125716", "source_url": "https://doi.org/10.1111/acps.13249", "doi": "10.1111/acps.13249", "pmid": "33125716", "publication_date": "2020-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3822, "title": "Advancing elite athlete mental health treatment with psychedelic-assisted psychotherapy", "authors": "Courtney C. Walton, Paul Liknaitzky", "journal": "Journal of Applied Sport Psychology", "publication_date": "2020-11-09", "publication_year": 2020, "doi": "10.1080/10413200.2020.1848941", "pubmed_id": null, "openalex_id": "https://openalex.org/W3100320203", "source_url": "https://doi.org/10.1080/10413200.2020.1848941", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Aging,Wellbeing,Healthcare Workers,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1080/10413200.2020.1848941", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/10413200.2020.1848941", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1080/10413200.2020.1848941", "source_url": "https://doi.org/10.1080/10413200.2020.1848941", "doi": "10.1080/10413200.2020.1848941", "pmid": "", "publication_date": "2020-11-09", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2225, "title": "Post-acute psychological effects of classical serotonergic psychedelics: a systematic review and meta-analysis.", "authors": "Goldberg SB, Shechet B, Nicholas CR, Ng CW, Deole G, Chen Z, Raison CL.", "journal": null, "publication_date": "2020-11-03", "publication_year": 2020, "doi": "10.1017/s003329172000389x", "pubmed_id": "33143790", "openalex_id": null, "source_url": "https://doi.org/10.1017/s003329172000389x", "substance_tags": "psilocybin", "topic_tags": "Personality Change,Spirituality,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:33143790", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1017/s003329172000389x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33143790", "source_url": "https://doi.org/10.1017/s003329172000389x", "doi": "10.1017/s003329172000389x", "pmid": "33143790", "publication_date": "2020-11-03", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3429, "title": "Effects of Psilocybin on Anxiety and Psychosocial Distress in Cancer Patients", "authors": "NYU Langone Health", "journal": "ClinicalTrials.gov", "publication_date": "2020-10-19", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://clinicaltrials.gov/study/NCT00957359", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Mechanism of Action,Consciousness,Emotional Processing,Spirituality,Mystical Experience,Review Article,Cancer Patients,Safety", "study_type": "Review Article", "source_name": "ClinicalTrials.gov", "publication_status": "clinical trial", "date_added": "2026-07-01 11:04:27", "last_checked": "2026-07-01 11:22:33", "bibtex": null, "source_record_id": "https://clinicaltrials.gov/study/NCT00957359", "abstract_available": true, "abstract_source": "ClinicalTrials.gov", "abstract_source_url": "https://clinicaltrials.gov/study/NCT00957359", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "ClinicalTrials.gov", "source_record_id": "https://clinicaltrials.gov/study/NCT00957359", "source_url": "https://clinicaltrials.gov/study/NCT00957359", "doi": "", "pmid": "", "publication_date": "2020-10-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2227, "title": "Potential safety, benefits, and influence of the placebo effect in microdosing psychedelic drugs: A systematic review.", "authors": "Ona G, Bouso JC.", "journal": null, "publication_date": "2020-10-04", "publication_year": 2020, "doi": "10.1016/j.neubiorev.2020.09.035", "pubmed_id": "33031815", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neubiorev.2020.09.035", "substance_tags": "psilocybin", "topic_tags": "Microdosing,Creativity,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:33031815", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neubiorev.2020.09.035", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:33031815", "source_url": "https://doi.org/10.1016/j.neubiorev.2020.09.035", "doi": "10.1016/j.neubiorev.2020.09.035", "pmid": "33031815", "publication_date": "2020-10-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2237, "title": "Psilocybin-assisted group therapy: A new hope for demoralization", "authors": "Peter S. Hendricks", "journal": "EClinicalMedicine", "publication_date": "2020-09-30", "publication_year": 2020, "doi": "10.1016/j.eclinm.2020.100557", "pubmed_id": "33073220", "openalex_id": "https://openalex.org/W3089864945", "source_url": "https://doi.org/10.1016/j.eclinm.2020.100557", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Pharmacology,Personality Change,Mystical Experience,Systematic Review,Review Article,Older Adults,Safety", "study_type": "Systematic Review", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:33073220", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.eclinm.2020.100557", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:33073220", "source_url": "https://doi.org/10.1016/j.eclinm.2020.100557", "doi": "10.1016/j.eclinm.2020.100557", "pmid": "33073220", "publication_date": "2020-09-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2228, "title": "The emerging role of psilocybin and MDMA in the treatment of mental illness.", "authors": "Gill H, Gill B, Chen-Li D, El-Halabi S, Rodrigues NB, Cha DS, Lipsitz O, Lee Y, Rosenblat JD, Majeed A, Mansur RB, Nasri F, Ho R, McIntyre RS.", "journal": null, "publication_date": "2020-09-29", "publication_year": 2020, "doi": "10.1080/14737175.2020.1826931", "pubmed_id": "32954860", "openalex_id": null, "source_url": "https://doi.org/10.1080/14737175.2020.1826931", "substance_tags": "psilocybin", "topic_tags": "Emotional Processing,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:32954860", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/14737175.2020.1826931", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32954860", "source_url": "https://doi.org/10.1080/14737175.2020.1826931", "doi": "10.1080/14737175.2020.1826931", "pmid": "32954860", "publication_date": "2020-09-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3834, "title": "Wait for the Science Before Widespread Use of Psilocybin", "authors": "Nicole Harrington Cirino", "journal": "Psychiatric News", "publication_date": "2020-09-28", "publication_year": 2020, "doi": "10.1176/appi.pn.2020.10a32", "pubmed_id": null, "openalex_id": "https://openalex.org/W3091539953", "source_url": "https://doi.org/10.1176/appi.pn.2020.10a32", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2020.10a32", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2020.10a32", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2020.10a32", "source_url": "https://doi.org/10.1176/appi.pn.2020.10a32", "doi": "10.1176/appi.pn.2020.10a32", "pmid": "", "publication_date": "2020-09-28", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2238, "title": "Psilocybin-assisted group therapy for demoralized older long-term AIDS survivor men: An open-label safety and feasibility pilot study", "authors": "B. Anderson, Alicia Danforth, Prof Robert Daroff, Christopher S. Stauffer, Eve Ekman, Gabrielle Agin-Liebes, Alexander Trope, Matthew Tyler Boden, James Dilley, Jennifer Mitchell, Joshua Woolley", "journal": "EClinicalMedicine", "publication_date": "2020-09-23", "publication_year": 2020, "doi": "10.1016/j.eclinm.2020.100538", "pubmed_id": "33150319", "openalex_id": "https://openalex.org/W3087859780", "source_url": "https://doi.org/10.1016/j.eclinm.2020.100538", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Chronic Pain,Veterans,Safety,Adverse Events,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:33150319", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.eclinm.2020.100538", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:33150319", "source_url": "https://doi.org/10.1016/j.eclinm.2020.100538", "doi": "10.1016/j.eclinm.2020.100538", "pmid": "33150319", "publication_date": "2020-09-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2247, "title": "Psilocybin as a New Approach to Treat Depression and Anxiety in the Context of Life-Threatening Diseases-A Systematic Review and Meta-Analysis of Clinical Trials.", "authors": "Vargas AS, Luís Â, Barroso M, Gallardo E, Pereira L.", "journal": null, "publication_date": "2020-09-04", "publication_year": 2020, "doi": "10.3390/biomedicines8090331", "pubmed_id": "32899469", "openalex_id": null, "source_url": "https://doi.org/10.3390/biomedicines8090331", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Clinical Trial,Meta-Analysis,Systematic Review,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:32899469", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3390/biomedicines8090331", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32899469", "source_url": "https://doi.org/10.3390/biomedicines8090331", "doi": "10.3390/biomedicines8090331", "pmid": "32899469", "publication_date": "2020-09-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2254, "title": "Compassionate use of psychedelics.", "authors": "Greif A, Šurkala M.", "journal": null, "publication_date": "2020-08-31", "publication_year": 2020, "doi": "10.1007/s11019-020-09958-z", "pubmed_id": "32468195", "openalex_id": null, "source_url": "https://doi.org/10.1007/s11019-020-09958-z", "substance_tags": "psilocybin", "topic_tags": "End-of-Life Distress,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:05", "bibtex": null, "source_record_id": "PMID:32468195", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s11019-020-09958-z", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32468195", "source_url": "https://doi.org/10.1007/s11019-020-09958-z", "doi": "10.1007/s11019-020-09958-z", "pmid": "32468195", "publication_date": "2020-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2151, "title": "Psychedelic science in post-COVID-19 psychiatry", "authors": "John R. Kelly, Matthew Crockett, Laith Alexander, Martin Haran, Amanda Baker, Lisa M. Burke, Christine Brennan, Veronica O’Keane", "journal": "Irish Journal of Psychological Medicine", "publication_date": "2020-08-18", "publication_year": 2020, "doi": "10.1017/ipm.2020.94", "pubmed_id": "32811575", "openalex_id": "https://openalex.org/W3054886531", "source_url": "https://doi.org/10.1017/ipm.2020.94", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32811575", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1017/ipm.2020.94", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32811575", "source_url": "https://doi.org/10.1017/ipm.2020.94", "doi": "10.1017/ipm.2020.94", "pmid": "32811575", "publication_date": "2020-08-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3846, "title": "A potential role for psilocybin in the treatment of obsessive-compulsive disorder", "authors": "Edward Jacobs", "journal": "Journal of Psychedelic Studies", "publication_date": "2020-05-31", "publication_year": 2020, "doi": "10.1556/2054.2020.00128", "pubmed_id": null, "openalex_id": "https://openalex.org/W3048223422", "source_url": "https://doi.org/10.1556/2054.2020.00128", "substance_tags": "psilocybin", "topic_tags": "Addiction,OCD,Mechanism of Action,Receptor Pharmacology,Randomized Controlled Trial,Review Article,Animal Study,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2020.00128", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2020.00128", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2020.00128", "source_url": "https://doi.org/10.1556/2054.2020.00128", "doi": "10.1556/2054.2020.00128", "pmid": "", "publication_date": "2020-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3848, "title": "Journal Digest: Home Environment; Postpartum Mental Illness; Placebo in Psychedelic Study; Single Gene Mutation; Topiramate", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2020-05-27", "publication_year": 2020, "doi": "10.1176/appi.pn.2020.6a34", "pubmed_id": null, "openalex_id": "https://openalex.org/W3033314635", "source_url": "https://doi.org/10.1176/appi.pn.2020.6a34", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Eating Disorders,Brain Imaging,Pharmacology,Consciousness,Aging,Creativity,Case Report,Observational Study,Healthcare Workers,Safety,Adverse Events", "study_type": "Case Report", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2020.6a34", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2020.6a34", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2020.6a34", "source_url": "https://doi.org/10.1176/appi.pn.2020.6a34", "doi": "10.1176/appi.pn.2020.6a34", "pmid": "", "publication_date": "2020-05-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2274, "title": "Ethics and ego dissolution: the case of psilocybin", "authors": "William Smith, Dominic Sisti", "journal": "Journal of Medical Ethics", "publication_date": "2020-05-26", "publication_year": 2020, "doi": "10.1136/medethics-2020-106070", "pubmed_id": "32461241", "openalex_id": "https://openalex.org/W3029961383", "source_url": "https://doi.org/10.1136/medethics-2020-106070", "substance_tags": "psilocybin", "topic_tags": "Addiction,Personality Change,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32461241", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/medethics-2020-106070", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32461241", "source_url": "https://doi.org/10.1136/medethics-2020-106070", "doi": "10.1136/medethics-2020-106070", "pmid": "32461241", "publication_date": "2020-05-26", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3850, "title": "Psychedelics, Safety and Clinical Trial Design", "authors": "Ron Shore", "journal": "QSpace (Queen's University Library)", "publication_date": "2020-05-19", "publication_year": 2020, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3043468905", "source_url": "http://hdl.handle.net/1974/27835", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://hdl.handle.net/1974/27835", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://hdl.handle.net/1974/27835", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://hdl.handle.net/1974/27835", "source_url": "http://hdl.handle.net/1974/27835", "doi": "", "pmid": "", "publication_date": "2020-05-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3863, "title": "Can Psychedelics Radically Change SUD Treatment?", "authors": "Katie O’Connor", "journal": "Psychiatric News", "publication_date": "2020-03-19", "publication_year": 2020, "doi": "10.1176/appi.pn.2020.2a12", "pubmed_id": null, "openalex_id": "https://openalex.org/W3012401750", "source_url": "https://doi.org/10.1176/appi.pn.2020.2a12", "substance_tags": "psilocybin", "topic_tags": "Anxiety,PTSD,Addiction,Chronic Pain,Pharmacology,Consciousness,Clinical Trial,Observational Study,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2020.2a12", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2020.2a12", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2020.2a12", "source_url": "https://doi.org/10.1176/appi.pn.2020.2a12", "doi": "10.1176/appi.pn.2020.2a12", "pmid": "", "publication_date": "2020-03-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2283, "title": "Psilocybin Therapeutic Research: The Present and Future Paradigm", "authors": "Robert B. Kargbo", "journal": "ACS Medicinal Chemistry Letters", "publication_date": "2020-03-01", "publication_year": 2020, "doi": "10.1021/acsmedchemlett.0c00048", "pubmed_id": "32292538", "openalex_id": "https://openalex.org/W3009264042", "source_url": "https://doi.org/10.1021/acsmedchemlett.0c00048", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32292538", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1021/acsmedchemlett.0c00048", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32292538", "source_url": "https://doi.org/10.1021/acsmedchemlett.0c00048", "doi": "10.1021/acsmedchemlett.0c00048", "pmid": "32292538", "publication_date": "2020-03-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3866, "title": "Psychedelic Birth: Bodies, Boundaries and the Perception of Pain in the 1970s", "authors": "Wendy Kline", "journal": "Gender & History", "publication_date": "2020-02-29", "publication_year": 2020, "doi": "10.1111/1468-0424.12471", "pubmed_id": null, "openalex_id": "https://openalex.org/W3016699155", "source_url": "https://doi.org/10.1111/1468-0424.12471", "substance_tags": "psilocybin", "topic_tags": "PTSD,Chronic Pain,Mechanism of Action,Consciousness,Personality Change,Emotional Processing,Creativity,Spirituality,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1111/1468-0424.12471", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1111/1468-0424.12471", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1111/1468-0424.12471", "source_url": "https://doi.org/10.1111/1468-0424.12471", "doi": "10.1111/1468-0424.12471", "pmid": "", "publication_date": "2020-02-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2272, "title": "Microdosing psychedelics: Demographics, practices, and psychiatric comorbidities", "authors": "Daniel Rosenbaum, Cory R. Weissman, Thomas Anderson, Rotem Petranker, Lê-Anh Dinh-Williams, Katrina Hui, Emma Hapke", "journal": "Journal of Psychopharmacology", "publication_date": "2020-02-27", "publication_year": 2020, "doi": "10.1177/0269881120908004", "pubmed_id": "32108529", "openalex_id": "https://openalex.org/W3007315114", "source_url": "https://doi.org/10.1177/0269881120908004", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Microdosing,Randomized Controlled Trial,Observational Study,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32108529", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/0269881120908004", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32108529", "source_url": "https://doi.org/10.1177/0269881120908004", "doi": "10.1177/0269881120908004", "pmid": "32108529", "publication_date": "2020-02-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2295, "title": "Self-reported negative outcomes of psilocybin users: A quantitative textual analysis", "authors": "Bheatrix Bienemann, Nina Stamato Ruschel, Maria Luiza Pesse Campos, Marco Aurélio Negreiros, Daniel C. Mograbi", "journal": "PLoS ONE", "publication_date": "2020-02-20", "publication_year": 2020, "doi": "10.1371/journal.pone.0229067", "pubmed_id": "32084160", "openalex_id": "https://openalex.org/W3007379062", "source_url": "https://doi.org/10.1371/journal.pone.0229067", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Treatment-Resistant Depression,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32084160", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0229067", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32084160", "source_url": "https://doi.org/10.1371/journal.pone.0229067", "doi": "10.1371/journal.pone.0229067", "pmid": "32084160", "publication_date": "2020-02-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2297, "title": "Population Survey Data Informing the Therapeutic Potential of Classic and Novel Phenethylamine, Tryptamine, and Lysergamide Psychedelics", "authors": "James Sexton, Charles D. Nichols, Peter S. Hendricks", "journal": "Frontiers in Psychiatry", "publication_date": "2020-02-10", "publication_year": 2020, "doi": "10.3389/fpsyt.2019.00896", "pubmed_id": "32116806", "openalex_id": "https://openalex.org/W3006069447", "source_url": "https://doi.org/10.3389/fpsyt.2019.00896", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:32116806", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2019.00896", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:32116806", "source_url": "https://doi.org/10.3389/fpsyt.2019.00896", "doi": "10.3389/fpsyt.2019.00896", "pmid": "32116806", "publication_date": "2020-02-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2282, "title": "A review of emerging therapeutic potential of psychedelic drugs in the treatment of psychiatric illnesses.", "authors": "Chi T, Gold JA.", "journal": null, "publication_date": "2020-01-30", "publication_year": 2020, "doi": "10.1016/j.jns.2020.116715", "pubmed_id": "32044687", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jns.2020.116715", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Review Article,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:32044687", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jns.2020.116715", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:32044687", "source_url": "https://doi.org/10.1016/j.jns.2020.116715", "doi": "10.1016/j.jns.2020.116715", "pmid": "32044687", "publication_date": "2020-01-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2301, "title": "The experimental effects of psilocybin on symptoms of anxiety and depression: A meta-analysis.", "authors": "Goldberg SB, Pace BT, Nicholas CR, Raison CL, Hutson PR.", "journal": null, "publication_date": "2020-01-01", "publication_year": 2020, "doi": "10.1016/j.psychres.2020.112749", "pubmed_id": "31931272", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.psychres.2020.112749", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Randomized Controlled Trial,Meta-Analysis,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "PMID:31931272", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.psychres.2020.112749", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31931272", "source_url": "https://doi.org/10.1016/j.psychres.2020.112749", "doi": "10.1016/j.psychres.2020.112749", "pmid": "31931272", "publication_date": "2020-01-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3895, "title": "Analysis of Newspaper Coverage of Psilocybin from January 1, 1989 to December 31, 2019", "authors": "Dax Oliver", "journal": "CUNY Academic Works (City University of New York)", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3121348693", "source_url": "https://academicworks.cuny.edu/gc_etds/4074", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "https://academicworks.cuny.edu/gc_etds/4074", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://academicworks.cuny.edu/gc_etds/4074", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://academicworks.cuny.edu/gc_etds/4074", "source_url": "https://academicworks.cuny.edu/gc_etds/4074", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3891, "title": "The Therapeutic Potential of Psilocybin and 3,4-Methylenedioxymethamphetamine in the Treatment of Depression and Post-Traumatic Stress Disorder", "authors": "Sofia Gyllvik", "journal": "Diva portal (Dalarna University Library)", "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3083741926", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Mechanism of Action,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "source_url": "http://urn.kb.se/resolve?urn=urn:nbn:se:his:diva-18729", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3882, "title": "Medicinal use of psilocybin: Reducing restrictions on research and treatment.", "authors": "James Rucker, Jessie Schnall, Daniel D’Hotman, David King, Timmy Davis, Joanna C. Neill", "journal": null, "publication_date": "2019-12-31", "publication_year": 2019, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W3047998072", "source_url": "https://www.drugsandalcohol.ie/32599/", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "https://www.drugsandalcohol.ie/32599/", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://www.drugsandalcohol.ie/32599/", "source_url": "https://www.drugsandalcohol.ie/32599/", "doi": "", "pmid": "", "publication_date": "2019-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2287, "title": "Psychedelic Microdosing: A Subreddit Analysis.", "authors": "Lea T, Amada N, Jungaberle H", "journal": "Journal of psychoactive drugs", "publication_date": "2019-12-31", "publication_year": 2019, "doi": "10.1080/02791072.2019.1683260", "pubmed_id": "31648596", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/31648596/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Microdosing,Wellbeing,Creativity,Safety,Drug Interactions", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:20:39", "bibtex": null, "source_record_id": "PMID:31648596", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/31648596/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:31648596", "source_url": "https://pubmed.ncbi.nlm.nih.gov/31648596/", "doi": "10.1080/02791072.2019.1683260", "pmid": "31648596", "publication_date": "2019-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3285, "title": "Mapping Psilocybin-Assisted Therapies: A Scoping Review", "authors": "Shore R, Ioudovski P, Goldie C, McKeown S, Dumont E, Queen’s University, Kingston On.", "journal": "medRxiv", "publication_date": "2019-12-11", "publication_year": 2019, "doi": "10.1101/2019.12.04.19013896", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.1101/2019.12.04.19013896", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Clinical Trial,Randomized Controlled Trial,Review Article,Safety", "study_type": "Randomized Controlled Trial", "source_name": "medRxiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:49", "last_checked": "2026-07-01 11:22:03", "bibtex": null, "source_record_id": "DOI:10.1101/2019.12.04.19013896", "abstract_available": true, "abstract_source": "medRxiv", "abstract_source_url": "https://doi.org/10.1101/2019.12.04.19013896", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "medRxiv", "source_record_id": "DOI:10.1101/2019.12.04.19013896", "source_url": "https://doi.org/10.1101/2019.12.04.19013896", "doi": "10.1101/2019.12.04.19013896", "pmid": "", "publication_date": "2019-12-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2318, "title": "Twenty percent better with 20 micrograms? A qualitative study of psychedelic microdosing self-rapports and discussions on YouTube", "authors": "Martin Andersson, Anette Kjellgren", "journal": "Harm Reduction Journal", "publication_date": "2019-11-27", "publication_year": 2019, "doi": "10.1186/s12954-019-0333-3", "pubmed_id": "31779667", "openalex_id": "https://openalex.org/W2991503240", "source_url": "https://doi.org/10.1186/s12954-019-0333-3", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Microdosing,Emotional Processing,Safety,Toxicity,Drug Interactions", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:31779667", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1186/s12954-019-0333-3", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:31779667", "source_url": "https://doi.org/10.1186/s12954-019-0333-3", "doi": "10.1186/s12954-019-0333-3", "pmid": "31779667", "publication_date": "2019-11-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2224, "title": "DARK Classics in Chemical Neuroscience: NBOMes.", "authors": "Poulie CBM, Jensen AA, Halberstadt AL, Kristensen JL.", "journal": null, "publication_date": "2019-11-11", "publication_year": 2019, "doi": "10.1021/acschemneuro.9b00528", "pubmed_id": "31657895", "openalex_id": null, "source_url": "https://doi.org/10.1021/acschemneuro.9b00528", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Receptor Pharmacology,Review Article,Safety,Toxicity", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:31657895", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1021/acschemneuro.9b00528", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31657895", "source_url": "https://doi.org/10.1021/acschemneuro.9b00528", "doi": "10.1021/acschemneuro.9b00528", "pmid": "31657895", "publication_date": "2019-11-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3915, "title": "Johns Hopkins Opens Research Center on Psychedelics", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2019-10-27", "publication_year": 2019, "doi": "10.1176/appi.pn.2019.10a16", "pubmed_id": null, "openalex_id": "https://openalex.org/W2982427347", "source_url": "https://doi.org/10.1176/appi.pn.2019.10a16", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Eating Disorders,Consciousness,Biomarkers,Clinical Trial,Healthcare Workers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2019.10a16", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2019.10a16", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2019.10a16", "source_url": "https://doi.org/10.1176/appi.pn.2019.10a16", "doi": "10.1176/appi.pn.2019.10a16", "pmid": "", "publication_date": "2019-10-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3920, "title": "Psilocybin for depression: Considerations for clinical trial design", "authors": "Kelley C. O’Donnell, Sarah E. Mennenga, Michael P. Bogenschutz", "journal": "Journal of Psychedelic Studies", "publication_date": "2019-08-31", "publication_year": 2019, "doi": "10.1556/2054.2019.026", "pubmed_id": null, "openalex_id": "https://openalex.org/W2974814938", "source_url": "https://doi.org/10.1556/2054.2019.026", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Receptor Pharmacology,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1556/2054.2019.026", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1556/2054.2019.026", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1556/2054.2019.026", "source_url": "https://doi.org/10.1556/2054.2019.026", "doi": "10.1556/2054.2019.026", "pmid": "", "publication_date": "2019-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2330, "title": "Hallucinogens and Their Therapeutic Use: A Literature Review.", "authors": "Begola MJ, Schillerstrom JE.", "journal": null, "publication_date": "2019-08-31", "publication_year": 2019, "doi": "10.1097/pra.0000000000000409", "pubmed_id": "31505518", "openalex_id": null, "source_url": "https://doi.org/10.1097/pra.0000000000000409", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:31505518", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/pra.0000000000000409", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31505518", "source_url": "https://doi.org/10.1097/pra.0000000000000409", "doi": "10.1097/pra.0000000000000409", "pmid": "31505518", "publication_date": "2019-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2320, "title": "Classical psychedelics for the treatment of depression and anxiety: A systematic review.", "authors": "Muttoni S, Ardissino M, John C.", "journal": null, "publication_date": "2019-07-29", "publication_year": 2019, "doi": "10.1016/j.jad.2019.07.076", "pubmed_id": "31382100", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.jad.2019.07.076", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Headache / Migraine,Clinical Trial,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:31382100", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.jad.2019.07.076", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31382100", "source_url": "https://doi.org/10.1016/j.jad.2019.07.076", "doi": "10.1016/j.jad.2019.07.076", "pmid": "31382100", "publication_date": "2019-07-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2331, "title": "Microdosing psychedelics: More questions than answers? An overview and suggestions for future research.", "authors": "Kuypers KP, Ng L, Erritzoe D, Knudsen GM, Nichols CD, Nichols DE, Pani L, Soula A, Nutt D.", "journal": null, "publication_date": "2019-07-13", "publication_year": 2019, "doi": "10.1177/0269881119857204", "pubmed_id": "31303095", "openalex_id": null, "source_url": "https://doi.org/10.1177/0269881119857204", "substance_tags": "psilocybin", "topic_tags": "Pharmacology,Receptor Pharmacology,Microdosing,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:31303095", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881119857204", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31303095", "source_url": "https://doi.org/10.1177/0269881119857204", "doi": "10.1177/0269881119857204", "pmid": "31303095", "publication_date": "2019-07-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3926, "title": "The Potential of Psilocybin Administration in Terminal Cancer Patients", "authors": "Richard Simoneaux", "journal": "Oncology Times", "publication_date": "2019-06-27", "publication_year": 2019, "doi": "10.1097/01.cot.0000574916.46844.cf", "pubmed_id": null, "openalex_id": "https://openalex.org/W2956046898", "source_url": "https://doi.org/10.1097/01.cot.0000574916.46844.cf", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Chronic Pain,Pharmacology,Receptor Pharmacology,Consciousness,Clinical Trial,Cancer Patients,Treatment-Resistant Depression,Healthcare Workers,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1097/01.cot.0000574916.46844.cf", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1097/01.cot.0000574916.46844.cf", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1097/01.cot.0000574916.46844.cf", "source_url": "https://doi.org/10.1097/01.cot.0000574916.46844.cf", "doi": "10.1097/01.cot.0000574916.46844.cf", "pmid": "", "publication_date": "2019-06-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3936, "title": "Psychedelic Medicine: Careful Studies, Regulations Are the Answer", "authors": "Paul Summergrad", "journal": "Psychiatric News", "publication_date": "2019-04-29", "publication_year": 2019, "doi": "10.1176/appi.pn.2019.5a25", "pubmed_id": null, "openalex_id": "https://openalex.org/W2943550935", "source_url": "https://doi.org/10.1176/appi.pn.2019.5a25", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Pharmacology,Mechanism of Action,Aging,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2019.5a25", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2019.5a25", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2019.5a25", "source_url": "https://doi.org/10.1176/appi.pn.2019.5a25", "doi": "10.1176/appi.pn.2019.5a25", "pmid": "", "publication_date": "2019-04-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2351, "title": "The Past and Future of Psychedelic Science: An Introduction to This Issue", "authors": "Richard Doblin, Merete Bruun Christiansen, Lisa Jerome, Brad Burge", "journal": "Journal of Psychoactive Drugs", "publication_date": "2019-03-14", "publication_year": 2019, "doi": "10.1080/02791072.2019.1606472", "pubmed_id": "31132970", "openalex_id": "https://openalex.org/W2947995541", "source_url": "https://doi.org/10.1080/02791072.2019.1606472", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,Receptor Pharmacology,Creativity,Spirituality,Mystical Experience,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:31132970", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1080/02791072.2019.1606472", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:31132970", "source_url": "https://doi.org/10.1080/02791072.2019.1606472", "doi": "10.1080/02791072.2019.1606472", "pmid": "31132970", "publication_date": "2019-03-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3943, "title": "Is Psychedelic Medicine on the Horizon?", "authors": "Nick Zagorski", "journal": "Psychiatric News", "publication_date": "2019-02-27", "publication_year": 2019, "doi": "10.1176/appi.pn.2019.1b1", "pubmed_id": null, "openalex_id": "https://openalex.org/W2918650357", "source_url": "https://doi.org/10.1176/appi.pn.2019.1b1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,End-of-Life Distress,Consciousness,Review Article,Case Report,Observational Study,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-02 20:42:13", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "DOI:10.1176/appi.pn.2019.1b1", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1176/appi.pn.2019.1b1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1176/appi.pn.2019.1b1", "source_url": "https://doi.org/10.1176/appi.pn.2019.1b1", "doi": "10.1176/appi.pn.2019.1b1", "pmid": "", "publication_date": "2019-02-27", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3732, "title": "Microdosing psychedelics: personality, mental health, and creativity differences in microdosers.", "authors": "Anderson T, Petranker R, Rosenbaum D, Weissman CR, Dinh-Williams LA, Hui K, Hapke E, Farb NAS.", "journal": null, "publication_date": "2019-01-01", "publication_year": 2019, "doi": "10.1007/s00213-018-5106-2", "pubmed_id": "30604183", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00213-018-5106-2", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Wellbeing,Personality Change,Emotional Processing,Creativity,Observational Study,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 11:08:44", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:30604183", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-018-5106-2", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30604183", "source_url": "https://doi.org/10.1007/s00213-018-5106-2", "doi": "10.1007/s00213-018-5106-2", "pmid": "30604183", "publication_date": "2019-01-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 3405, "title": "Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers", "authors": "Anderson T, Petranker R, Rosenbaum D, Weissman C, Dinh-Williams L, Hui K, Hapke E, Farb NAS.", "journal": "PsyArXiv", "publication_date": "2018-11-01", "publication_year": 2018, "doi": "10.31234/osf.io/gk4jd", "pubmed_id": null, "openalex_id": null, "source_url": "https://doi.org/10.31234/osf.io/gk4jd", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Wellbeing,Personality Change,Emotional Processing,Creativity,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 11:03:52", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "DOI:10.31234/osf.io/gk4jd", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://doi.org/10.31234/osf.io/gk4jd", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "DOI:10.31234/osf.io/gk4jd", "source_url": "https://doi.org/10.31234/osf.io/gk4jd", "doi": "10.31234/osf.io/gk4jd", "pmid": "", "publication_date": "2018-11-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2360, "title": "Microdosing Psychedelics: Personality, mental health, and creativity differences in microdosers", "authors": "", "journal": "PsyArXiv", "publication_date": "2018-11-01", "publication_year": 2018, "doi": null, "pubmed_id": null, "openalex_id": null, "source_url": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Microdosing,Wellbeing,Personality Change,Emotional Processing,Creativity,Safety", "study_type": "Other", "source_name": "PsyArXiv", "publication_status": "preprint", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:30", "bibtex": null, "source_record_id": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "abstract_available": true, "abstract_source": "PsyArXiv", "abstract_source_url": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PsyArXiv", "source_record_id": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "source_url": "https://osf.io/preprints/psyarxiv/gk4jd_v1", "doi": "", "pmid": "", "publication_date": "2018-11-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5157, "title": "Serotonin, psychedelics and psychiatry", "authors": "Robin Carhart-Harris", "journal": "World Psychiatry", "publication_date": "2018-09-06", "publication_year": 2018, "doi": "10.1002/wps.20555", "pubmed_id": "30192100", "openalex_id": "https://openalex.org/W2891343109", "source_url": "https://doi.org/10.1002/wps.20555", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Neuroplasticity,Neurogenesis,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Randomized Controlled Trial,Safety", "study_type": "Randomized Controlled Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:01", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:30192100", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1002/wps.20555", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:30192100", "source_url": "https://doi.org/10.1002/wps.20555", "doi": "10.1002/wps.20555", "pmid": "30192100", "publication_date": "2018-09-06", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2370, "title": "Does getting high hurt? Characterization of cases of LSD and psilocybin-containing mushroom exposures to national poison centers between 2000 and 2016.", "authors": "Leonard JB, Anderson B, Klein-Schwartz W.", "journal": "Journal of Psychopharmacology", "publication_date": "2018-09-04", "publication_year": 2018, "doi": "10.1177/0269881118793086", "pubmed_id": "30182795", "openalex_id": "https://openalex.org/W2889566085", "source_url": "https://doi.org/10.1177/0269881118793086", "substance_tags": "psilocybin", "topic_tags": "Adolescents,Safety,Toxicity", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:39", "bibtex": null, "source_record_id": "PMID:30182795", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881118793086", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30182795", "source_url": "https://doi.org/10.1177/0269881118793086", "doi": "10.1177/0269881118793086", "pmid": "30182795", "publication_date": "2018-09-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2389, "title": "Efficacy, tolerability, and safety of serotonergic psychedelics for the management of mood, anxiety, and substance-use disorders: a systematic review of systematic reviews.", "authors": "Dos Santos RG, Bouso JC, Alcázar-Córcoles MÁ, Hallak JEC.", "journal": null, "publication_date": "2018-08-22", "publication_year": 2018, "doi": "10.1080/17512433.2018.1511424", "pubmed_id": "30102078", "openalex_id": null, "source_url": "https://doi.org/10.1080/17512433.2018.1511424", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:30102078", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/17512433.2018.1511424", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30102078", "source_url": "https://doi.org/10.1080/17512433.2018.1511424", "doi": "10.1080/17512433.2018.1511424", "pmid": "30102078", "publication_date": "2018-08-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2391, "title": "Current perspectives on psychedelic therapy: use of serotonergic hallucinogens in clinical interventions.", "authors": "Garcia-Romeu A, Richards WA", "journal": "International review of psychiatry (Abingdon, England)", "publication_date": "2018-07-31", "publication_year": 2018, "doi": "10.1080/09540261.2018.1486289", "pubmed_id": "30422079", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/30422079/", "substance_tags": "psilocybin", "topic_tags": "Spirituality,Safety", "study_type": "Other", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:20:40", "bibtex": null, "source_record_id": "PMID:30422079", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/30422079/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:30422079", "source_url": "https://pubmed.ncbi.nlm.nih.gov/30422079/", "doi": "10.1080/09540261.2018.1486289", "pmid": "30422079", "publication_date": "2018-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2397, "title": "Psychedelic-Assisted Psychotherapy: A Paradigm Shift in Psychiatric Research and Development.", "authors": "Schenberg EE.", "journal": "Frontiers in Pharmacology", "publication_date": "2018-07-04", "publication_year": 2018, "doi": "10.3389/fphar.2018.00733", "pubmed_id": "30026698", "openalex_id": "https://openalex.org/W2831064708", "source_url": "https://doi.org/10.3389/fphar.2018.00733", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:30026698", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fphar.2018.00733", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:30026698", "source_url": "https://doi.org/10.3389/fphar.2018.00733", "doi": "10.3389/fphar.2018.00733", "pmid": "30026698", "publication_date": "2018-07-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2375, "title": "The abuse potential of medical psilocybin according to the 8 factors of the Controlled Substances Act.", "authors": "Johnson MW, Griffiths RR, Hendricks PS, Henningfield JE.", "journal": null, "publication_date": "2018-06-04", "publication_year": 2018, "doi": "10.1016/j.neuropharm.2018.05.012", "pubmed_id": "29753748", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neuropharm.2018.05.012", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Review Article,Cancer Patients,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:29753748", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2018.05.012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29753748", "source_url": "https://doi.org/10.1016/j.neuropharm.2018.05.012", "doi": "10.1016/j.neuropharm.2018.05.012", "pmid": "29753748", "publication_date": "2018-06-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2364, "title": "Ceremonial \"plant medicine\" use and its relationship to recreational drug use: an exploratory study.", "authors": "Dorsen C, Palamar J, Shedlin MG.", "journal": "Addiction Research & Theory", "publication_date": "2018-03-29", "publication_year": 2018, "doi": "10.1080/16066359.2018.1455187", "pubmed_id": "31534445", "openalex_id": "https://openalex.org/W2794634193", "source_url": "https://doi.org/10.1080/16066359.2018.1455187", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:31534445", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/16066359.2018.1455187", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:31534445", "source_url": "https://doi.org/10.1080/16066359.2018.1455187", "doi": "10.1080/16066359.2018.1455187", "pmid": "31534445", "publication_date": "2018-03-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2425, "title": "The hidden therapist: evidence for a central role of music in psychedelic therapy.", "authors": "Kaelen M, Giribaldi B, Raine J, Evans L, Timmerman C, Rodriguez N, Roseman L, Feilding A, Nutt D, Carhart-Harris R.", "journal": "Psychopharmacology", "publication_date": "2018-02-01", "publication_year": 2018, "doi": "10.1007/s00213-017-4820-5", "pubmed_id": "29396616", "openalex_id": "https://openalex.org/W2784069100", "source_url": "https://doi.org/10.1007/s00213-017-4820-5", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Emotional Processing,Mystical Experience,Treatment-Resistant Depression,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29396616", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-017-4820-5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29396616", "source_url": "https://doi.org/10.1007/s00213-017-4820-5", "doi": "10.1007/s00213-017-4820-5", "pmid": "29396616", "publication_date": "2018-02-01", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2417, "title": "Taking Psychedelics Seriously.", "authors": "Byock I.", "journal": null, "publication_date": "2018-01-21", "publication_year": 2018, "doi": "10.1089/jpm.2017.0684", "pubmed_id": "29356590", "openalex_id": null, "source_url": "https://doi.org/10.1089/jpm.2017.0684", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Emotional Processing,Spirituality,Treatment-Resistant Depression,Healthcare Workers,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:29356590", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1089/jpm.2017.0684", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29356590", "source_url": "https://doi.org/10.1089/jpm.2017.0684", "doi": "10.1089/jpm.2017.0684", "pmid": "29356590", "publication_date": "2018-01-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5173, "title": "Psychedelics, the Spiritual and Consciousness-an Evolving Confluence in the Cultural Stream", "authors": "Phil Wolfson", "journal": "Tikkun", "publication_date": "2017-12-31", "publication_year": 2017, "doi": "10.1215/08879982-4354390", "pubmed_id": null, "openalex_id": "https://openalex.org/W2800678235", "source_url": "https://doi.org/10.1215/08879982-4354390", "substance_tags": "psilocybin", "topic_tags": "PTSD,Addiction,Consciousness,Aging,Emotional Processing,Creativity,Spirituality,Mystical Experience,Observational Study,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1215/08879982-4354390", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1215/08879982-4354390", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1215/08879982-4354390", "source_url": "https://doi.org/10.1215/08879982-4354390", "doi": "10.1215/08879982-4354390", "pmid": "", "publication_date": "2017-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2441, "title": "Therapeutic Applications of Classic Hallucinogens.", "authors": "Bogenschutz MP, Ross S.", "journal": null, "publication_date": "2017-12-31", "publication_year": 2017, "doi": "10.1007/7854_2016_464", "pubmed_id": "28512684", "openalex_id": null, "source_url": "https://doi.org/10.1007/7854_2016_464", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,End-of-Life Distress,Mechanism of Action,Receptor Pharmacology,Aging,Clinical Trial,Review Article,Observational Study,In Vitro Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28512684", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/7854_2016_464", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28512684", "source_url": "https://doi.org/10.1007/7854_2016_464", "doi": "10.1007/7854_2016_464", "pmid": "28512684", "publication_date": "2017-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2377, "title": "Psychiatry & the psychedelic drugs. Past, present & future.", "authors": "Rucker JJH, Iliff J, Nutt DJ.", "journal": null, "publication_date": "2017-12-24", "publication_year": 2017, "doi": "10.1016/j.neuropharm.2017.12.040", "pubmed_id": "29284138", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.neuropharm.2017.12.040", "substance_tags": "psilocybin", "topic_tags": "Aging,Clinical Trial,Randomized Controlled Trial,Meta-Analysis,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:29284138", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.neuropharm.2017.12.040", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29284138", "source_url": "https://doi.org/10.1016/j.neuropharm.2017.12.040", "doi": "10.1016/j.neuropharm.2017.12.040", "pmid": "29284138", "publication_date": "2017-12-24", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5181, "title": "„Terapia szokowa”, czyli agoniści receptor 5-HT2A w leczeniu depresji i lęku", "authors": "Joanna Stefaniuk", "journal": "CeON Repository (Centre for Evaluation in Education and Science)", "publication_date": "2017-11-30", "publication_year": 2017, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2771603125", "source_url": "https://depot.ceon.pl/handle/123456789/13483", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:02", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "https://depot.ceon.pl/handle/123456789/13483", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://depot.ceon.pl/handle/123456789/13483", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://depot.ceon.pl/handle/123456789/13483", "source_url": "https://depot.ceon.pl/handle/123456789/13483", "doi": "", "pmid": "", "publication_date": "2017-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2446, "title": "Pharmacokinetics of Escalating Doses of Oral Psilocybin in Healthy Adults.", "authors": "Brown RT, Nicholas CR, Cozzi NV, Gassman MC, Cooper KM, Muller D, Thomas CD, Hetzel SJ, Henriquez KM, Ribaudo AS, Hutson PR.", "journal": "Clinical Pharmacokinetics", "publication_date": "2017-11-30", "publication_year": 2017, "doi": "10.1007/s40262-017-0540-6", "pubmed_id": "28353056", "openalex_id": "https://openalex.org/W2600624779", "source_url": "https://doi.org/10.1007/s40262-017-0540-6", "substance_tags": "psilocybin,psilocin", "topic_tags": "Depression,Addiction,Pharmacology,Clinical Trial,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:28353056", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s40262-017-0540-6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28353056", "source_url": "https://doi.org/10.1007/s40262-017-0540-6", "doi": "10.1007/s40262-017-0540-6", "pmid": "28353056", "publication_date": "2017-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2447, "title": "The \"Endless Trip\" among the NPS Users: Psychopathology and Psychopharmacology in the Hallucinogen-Persisting Perception Disorder. A Systematic Review.", "authors": "Orsolini L, Papanti GD, De Berardis D, Guirguis A, Corkery JM, Schifano F.", "journal": null, "publication_date": "2017-11-19", "publication_year": 2017, "doi": "10.3389/fpsyt.2017.00240", "pubmed_id": "29209235", "openalex_id": null, "source_url": "https://doi.org/10.3389/fpsyt.2017.00240", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Systematic Review,Review Article,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:29209235", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3389/fpsyt.2017.00240", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29209235", "source_url": "https://doi.org/10.3389/fpsyt.2017.00240", "doi": "10.3389/fpsyt.2017.00240", "pmid": "29209235", "publication_date": "2017-11-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2427, "title": "Psilocybin with psychological support for treatment-resistant depression: six-month follow-up.", "authors": "Carhart-Harris RL, Bolstridge M, Day CMJ, Rucker J, Watts R, Erritzoe DE, Kaelen M, Giribaldi B, Bloomfield M, Pilling S, Rickard JA, Forbes B, Feilding A, Taylor D, Curran HV, Nutt DJ.", "journal": "Psychopharmacology", "publication_date": "2017-11-07", "publication_year": 2017, "doi": "10.1007/s00213-017-4771-x", "pubmed_id": "29119217", "openalex_id": "https://openalex.org/W2767530231", "source_url": "https://doi.org/10.1007/s00213-017-4771-x", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Treatment-Resistant Depression,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:29119217", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-017-4771-x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:29119217", "source_url": "https://doi.org/10.1007/s00213-017-4771-x", "doi": "10.1007/s00213-017-4771-x", "pmid": "29119217", "publication_date": "2017-11-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2449, "title": "Psychedelic Drugs in Biomedicine.", "authors": "Kyzar EJ, Nichols CD, Gainetdinov RR, Nichols DE, Kalueff AV.", "journal": null, "publication_date": "2017-09-21", "publication_year": 2017, "doi": "10.1016/j.tips.2017.08.003", "pubmed_id": "28947075", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.tips.2017.08.003", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Animal Study,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28947075", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.tips.2017.08.003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28947075", "source_url": "https://doi.org/10.1016/j.tips.2017.08.003", "doi": "10.1016/j.tips.2017.08.003", "pmid": "28947075", "publication_date": "2017-09-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2424, "title": "Serotonergic hallucinogens in the treatment of anxiety and depression in patients suffering from a life-threatening disease: A systematic review.", "authors": "Reiche S, Hermle L, Gutwinski S, Jungaberle H, Gasser P, Majić T.", "journal": null, "publication_date": "2017-09-21", "publication_year": 2017, "doi": "10.1016/j.pnpbp.2017.09.012", "pubmed_id": "28947181", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2017.09.012", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,End-of-Life Distress,Receptor Pharmacology,Clinical Trial,Randomized Controlled Trial,Systematic Review,Review Article,Safety,Adverse Events", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28947181", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2017.09.012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28947181", "source_url": "https://doi.org/10.1016/j.pnpbp.2017.09.012", "doi": "10.1016/j.pnpbp.2017.09.012", "pmid": "28947181", "publication_date": "2017-09-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2459, "title": "Psychoactive substances as a last resort-a qualitative study of self-treatment of migraine and cluster headaches.", "authors": "Andersson M, Persson M, Kjellgren A.", "journal": "Harm Reduction Journal", "publication_date": "2017-09-04", "publication_year": 2017, "doi": "10.1186/s12954-017-0186-6", "pubmed_id": "28870224", "openalex_id": "https://openalex.org/W2751240458", "source_url": "https://doi.org/10.1186/s12954-017-0186-6", "substance_tags": "psilocybin", "topic_tags": "Headache / Migraine,Safety,Adverse Events", "study_type": "Qualitative Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:28870224", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1186/s12954-017-0186-6", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28870224", "source_url": "https://doi.org/10.1186/s12954-017-0186-6", "doi": "10.1186/s12954-017-0186-6", "pmid": "28870224", "publication_date": "2017-09-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2418, "title": "Psychedelic Drugs as Therapeutics: No Illusions About the Challenges.", "authors": "Sellers EM, Leiderman DB.", "journal": "Clinical Pharmacology & Therapeutics", "publication_date": "2017-08-23", "publication_year": 2017, "doi": "10.1002/cpt.776", "pubmed_id": "28836272", "openalex_id": "https://openalex.org/W2745723818", "source_url": "https://doi.org/10.1002/cpt.776", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:28836272", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1002/cpt.776", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28836272", "source_url": "https://doi.org/10.1002/cpt.776", "doi": "10.1002/cpt.776", "pmid": "28836272", "publication_date": "2017-08-23", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2430, "title": "The 21st century psychedelic renaissance: heroic steps forward on the back of an elephant.", "authors": "Sessa B.", "journal": null, "publication_date": "2017-08-22", "publication_year": 2017, "doi": "10.1007/s00213-017-4713-7", "pubmed_id": "28831571", "openalex_id": null, "source_url": "https://doi.org/10.1007/s00213-017-4713-7", "substance_tags": "psilocybin", "topic_tags": "Emotional Processing,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28831571", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s00213-017-4713-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28831571", "source_url": "https://doi.org/10.1007/s00213-017-4713-7", "doi": "10.1007/s00213-017-4713-7", "pmid": "28831571", "publication_date": "2017-08-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2454, "title": "LSD treatment in Scandinavia: emphasizing indications and short-term treatment outcomes of 151 patients in Denmark.", "authors": "Larsen JK.", "journal": "Nordic Journal of Psychiatry", "publication_date": "2017-07-04", "publication_year": 2017, "doi": "10.1080/08039488.2017.1336251", "pubmed_id": "28678583", "openalex_id": "https://openalex.org/W2727276162", "source_url": "https://doi.org/10.1080/08039488.2017.1336251", "substance_tags": "psilocybin", "topic_tags": "OCD,Review Article,Safety,Adverse Events", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:28678583", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/08039488.2017.1336251", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28678583", "source_url": "https://doi.org/10.1080/08039488.2017.1336251", "doi": "10.1080/08039488.2017.1336251", "pmid": "28678583", "publication_date": "2017-07-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2467, "title": "Potential Therapeutic Effects of Psilocybin.", "authors": "Johnson MW, Griffiths RR.", "journal": null, "publication_date": "2017-06-30", "publication_year": 2017, "doi": "10.1007/s13311-017-0542-y", "pubmed_id": "28585222", "openalex_id": null, "source_url": "https://doi.org/10.1007/s13311-017-0542-y", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Mechanism of Action,Review Article,Cancer Patients,Treatment-Resistant Depression,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:28585222", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1007/s13311-017-0542-y", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28585222", "source_url": "https://doi.org/10.1007/s13311-017-0542-y", "doi": "10.1007/s13311-017-0542-y", "pmid": "28585222", "publication_date": "2017-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2466, "title": "[Psychotherapy with Adjuvant use of Serotonergic Psychoactive Substances: Possibilities and Challenges].", "authors": "Majić T, Jungaberle H, Jungaberle H, Schmidt TT, Zeuch A, Hermle L, Gallinat J.", "journal": null, "publication_date": "2017-06-30", "publication_year": 2017, "doi": "10.1055/s-0043-103085", "pubmed_id": "28768346", "openalex_id": null, "source_url": "https://doi.org/10.1055/s-0043-103085", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Addiction,OCD,End-of-Life Distress,Receptor Pharmacology,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:28768346", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1055/s-0043-103085", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28768346", "source_url": "https://doi.org/10.1055/s-0043-103085", "doi": "10.1055/s-0043-103085", "pmid": "28768346", "publication_date": "2017-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2450, "title": "Psilocybin-Assisted Therapy: A Review of a Novel Treatment for Psychiatric Disorders.", "authors": "Thomas K, Malcolm B, Lastra D.", "journal": null, "publication_date": "2017-05-07", "publication_year": 2017, "doi": "10.1080/02791072.2017.1320734", "pubmed_id": "28481178", "openalex_id": null, "source_url": "https://doi.org/10.1080/02791072.2017.1320734", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Receptor Pharmacology,Default Mode Network,Clinical Trial,Review Article,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:28481178", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2017.1320734", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:28481178", "source_url": "https://doi.org/10.1080/02791072.2017.1320734", "doi": "10.1080/02791072.2017.1320734", "pmid": "28481178", "publication_date": "2017-05-07", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5216, "title": "Psychedelics as change agents in addiction and mood disorders.", "authors": "Albert Garcia-Romeu", "journal": null, "publication_date": "2016-12-31", "publication_year": 2016, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2805577811", "source_url": "https://www.drugsandalcohol.ie/29118/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Brain Imaging,Mechanism of Action,Receptor Pharmacology,Aging,Wellbeing,Personality Change,Mystical Experience,Safety", "study_type": "Qualitative Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "https://www.drugsandalcohol.ie/29118/", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://www.drugsandalcohol.ie/29118/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "https://www.drugsandalcohol.ie/29118/", "source_url": "https://www.drugsandalcohol.ie/29118/", "doi": "", "pmid": "", "publication_date": "2016-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2498, "title": "The Challenging Experience Questionnaire: Characterization of challenging experiences with psilocybin mushrooms.", "authors": "Barrett FS, Bradstreet MP, Leoutsakos JS, Johnson MW, Griffiths RR.", "journal": "Journal of Psychopharmacology", "publication_date": "2016-11-16", "publication_year": 2016, "doi": "10.1177/0269881116678781", "pubmed_id": "27856683", "openalex_id": "https://openalex.org/W2549202270", "source_url": "https://doi.org/10.1177/0269881116678781", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Consciousness,Wellbeing,Emotional Processing,Spirituality,Case Report,Observational Study,Safety", "study_type": "Case Report", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:27856683", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881116678781", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27856683", "source_url": "https://doi.org/10.1177/0269881116678781", "doi": "10.1177/0269881116678781", "pmid": "27856683", "publication_date": "2016-11-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2497, "title": "Psychedelics in the treatment of unipolar mood disorders: a systematic review.", "authors": "Rucker JJ, Jelen LA, Flynn S, Frowde KD, Young AH.", "journal": null, "publication_date": "2016-11-16", "publication_year": 2016, "doi": "10.1177/0269881116679368", "pubmed_id": "27856684", "openalex_id": null, "source_url": "https://doi.org/10.1177/0269881116679368", "substance_tags": "psilocybin", "topic_tags": "Depression,Clinical Trial,Systematic Review,Review Article,Healthcare Workers,Safety", "study_type": "Systematic Review", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:27856684", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881116679368", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27856684", "source_url": "https://doi.org/10.1177/0269881116679368", "doi": "10.1177/0269881116679368", "pmid": "27856684", "publication_date": "2016-11-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2462, "title": "[New patterns of substance use and abuse among French adolescents, a knowledge synthesis].", "authors": "Jeanne G, Purper-Ouakil D, Rigole H, Franc N.", "journal": null, "publication_date": "2016-10-05", "publication_year": 2016, "doi": "10.1016/j.encep.2016.05.012", "pubmed_id": "27720453", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.encep.2016.05.012", "substance_tags": "psilocybin", "topic_tags": "Addiction,Pharmacology,Review Article,Adolescents,Healthcare Workers,Safety,Toxicity", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:27720453", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.encep.2016.05.012", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27720453", "source_url": "https://doi.org/10.1016/j.encep.2016.05.012", "doi": "10.1016/j.encep.2016.05.012", "pmid": "27720453", "publication_date": "2016-10-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2500, "title": "Survey study of challenging experiences after ingesting psilocybin mushrooms: Acute and enduring positive and negative consequences.", "authors": "Carbonaro TM, Bradstreet MP, Barrett FS, MacLean KA, Jesse R, Johnson MW, Griffiths RR.", "journal": "Journal of Psychopharmacology", "publication_date": "2016-08-29", "publication_year": 2016, "doi": "10.1177/0269881116662634", "pubmed_id": "27578767", "openalex_id": "https://openalex.org/W2513336695", "source_url": "https://doi.org/10.1177/0269881116662634", "substance_tags": "psilocybin", "topic_tags": "Wellbeing,Emotional Processing,Observational Study,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:27578767", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881116662634", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27578767", "source_url": "https://doi.org/10.1177/0269881116662634", "doi": "10.1177/0269881116662634", "pmid": "27578767", "publication_date": "2016-08-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2486, "title": "Return of the psychedelics: Psilocybin for treatment resistant depression.", "authors": "Patra S.", "journal": null, "publication_date": "2016-08-22", "publication_year": 2016, "doi": "10.1016/j.ajp.2016.08.010", "pubmed_id": "27931907", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.ajp.2016.08.010", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Brain Imaging,Mechanism of Action,Aging,Clinical Trial,Safety", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:27931907", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.ajp.2016.08.010", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27931907", "source_url": "https://doi.org/10.1016/j.ajp.2016.08.010", "doi": "10.1016/j.ajp.2016.08.010", "pmid": "27931907", "publication_date": "2016-08-22", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2478, "title": "Psilocybin for treating substance use disorders?", "authors": "de Veen BT, Schellekens AF, Verheij MM, Homberg JR.", "journal": null, "publication_date": "2016-08-11", "publication_year": 2016, "doi": "10.1080/14737175.2016.1220834", "pubmed_id": "27684102", "openalex_id": null, "source_url": "https://doi.org/10.1080/14737175.2016.1220834", "substance_tags": "psilocybin", "topic_tags": "Depression,Addiction,Mechanism of Action,Receptor Pharmacology,Emotional Processing,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:27684102", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/14737175.2016.1220834", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27684102", "source_url": "https://doi.org/10.1080/14737175.2016.1220834", "doi": "10.1080/14737175.2016.1220834", "pmid": "27684102", "publication_date": "2016-08-11", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2511, "title": "Psilocybin with psychological support for treatment-resistant depression: an open-label feasibility study.", "authors": "Carhart-Harris RL, Bolstridge M, Rucker J, Day CM, Erritzoe D, Kaelen M, Bloomfield M, Rickard JA, Forbes B, Feilding A, Taylor D, Pilling S, Curran VH, Nutt DJ.", "journal": "The Lancet Psychiatry", "publication_date": "2016-05-16", "publication_year": 2016, "doi": "10.1016/s2215-0366(16)30065-7", "pubmed_id": "27210031", "openalex_id": "https://openalex.org/W2396675581", "source_url": "https://doi.org/10.1016/s2215-0366(16)30065-7", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,OCD,End-of-Life Distress,Headache / Migraine,Receptor Pharmacology,Randomized Controlled Trial,Treatment-Resistant Depression,Safety,Adverse Events", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:27210031", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/s2215-0366(16)30065-7", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:27210031", "source_url": "https://doi.org/10.1016/s2215-0366(16)30065-7", "doi": "10.1016/s2215-0366(16)30065-7", "pmid": "27210031", "publication_date": "2016-05-16", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5248, "title": "The “Endless Trip”: Psychopathology and psychopharmacology in the Hallucinogen Persisting Perception Disorder (HPPD)", "authors": "Laura Orsolini, Alessandro Valchera, Duccio Papanti, R. Vecchiotti, Domenico De Berardis", "journal": "European Psychiatry", "publication_date": "2016-02-29", "publication_year": 2016, "doi": "10.1016/j.eurpsy.2016.01.1060", "pubmed_id": null, "openalex_id": "https://openalex.org/W2376514477", "source_url": "https://doi.org/10.1016/j.eurpsy.2016.01.1060", "substance_tags": "psilocybin", "topic_tags": "Depression,Pharmacology,Receptor Pharmacology,Review Article,Case Report,Safety,Toxicity", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:03", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "DOI:10.1016/j.eurpsy.2016.01.1060", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1016/j.eurpsy.2016.01.1060", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/j.eurpsy.2016.01.1060", "source_url": "https://doi.org/10.1016/j.eurpsy.2016.01.1060", "doi": "10.1016/j.eurpsy.2016.01.1060", "pmid": "", "publication_date": "2016-02-29", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2522, "title": "The use of illicit drugs as self-medication in the treatment of cluster headache: Results from an Italian online survey.", "authors": "Di Lorenzo C, Coppola G, Di Lorenzo G, Bracaglia M, Rossi P, Pierelli F.", "journal": "Cephalalgia", "publication_date": "2015-04-21", "publication_year": 2015, "doi": "10.1177/0333102415583145", "pubmed_id": "25903763", "openalex_id": "https://openalex.org/W1999427970", "source_url": "https://doi.org/10.1177/0333102415583145", "substance_tags": "psilocybin", "topic_tags": "Addiction,Headache / Migraine,Observational Study,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:25903763", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0333102415583145", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:25903763", "source_url": "https://doi.org/10.1177/0333102415583145", "doi": "10.1177/0333102415583145", "pmid": "25903763", "publication_date": "2015-04-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2540, "title": "Legal highs: staying on top of the flood of novel psychoactive substances.", "authors": "Baumeister D, Tojo LM, Tracy DK.", "journal": null, "publication_date": "2015-03-31", "publication_year": 2015, "doi": "10.1177/2045125314559539", "pubmed_id": "26240749", "openalex_id": null, "source_url": "https://doi.org/10.1177/2045125314559539", "substance_tags": "psilocybin", "topic_tags": "Addiction,Pharmacology,Review Article,Animal Study,Healthcare Workers,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:26240749", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/2045125314559539", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:26240749", "source_url": "https://doi.org/10.1177/2045125314559539", "doi": "10.1177/2045125314559539", "pmid": "26240749", "publication_date": "2015-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2523, "title": "Classic hallucinogens in the treatment of addictions.", "authors": "Bogenschutz MP, Johnson MW.", "journal": null, "publication_date": "2015-03-13", "publication_year": 2015, "doi": "10.1016/j.pnpbp.2015.03.002", "pubmed_id": "25784600", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pnpbp.2015.03.002", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Mystical Experience,Clinical Trial,Meta-Analysis,Review Article,Safety", "study_type": "Meta-Analysis", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:25784600", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pnpbp.2015.03.002", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:25784600", "source_url": "https://doi.org/10.1016/j.pnpbp.2015.03.002", "doi": "10.1016/j.pnpbp.2015.03.002", "pmid": "25784600", "publication_date": "2015-03-13", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2542, "title": "Psychedelics not linked to mental health problems or suicidal behavior: a population study.", "authors": "Johansen PØ, Krebs TS.", "journal": "Journal of Psychopharmacology", "publication_date": "2015-03-04", "publication_year": 2015, "doi": "10.1177/0269881114568039", "pubmed_id": "25744618", "openalex_id": "https://openalex.org/W2097999899", "source_url": "https://doi.org/10.1177/0269881114568039", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Addiction,Adolescents,Safety,Adverse Events", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:25744618", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881114568039", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:25744618", "source_url": "https://doi.org/10.1177/0269881114568039", "doi": "10.1177/0269881114568039", "pmid": "25744618", "publication_date": "2015-03-04", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2545, "title": "Psilocybin-assisted treatment for alcohol dependence: a proof-of-concept study.", "authors": "Bogenschutz MP, Forcehimes AA, Pommy JA, Wilcox CE, Barbosa PC, Strassman RJ.", "journal": "Journal of Psychopharmacology", "publication_date": "2015-01-12", "publication_year": 2015, "doi": "10.1177/0269881114565144", "pubmed_id": "25586396", "openalex_id": "https://openalex.org/W2075238613", "source_url": "https://doi.org/10.1177/0269881114565144", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mechanism of Action,Receptor Pharmacology,Safety,Adverse Events", "study_type": "Qualitative Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:40", "bibtex": null, "source_record_id": "PMID:25586396", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881114565144", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:25586396", "source_url": "https://doi.org/10.1177/0269881114565144", "doi": "10.1177/0269881114565144", "pmid": "25586396", "publication_date": "2015-01-12", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2555, "title": "Pilot study of the 5-HT2AR agonist psilocybin in the treatment of tobacco addiction.", "authors": "Johnson MW, Garcia-Romeu A, Cosimano MP, Griffiths RR.", "journal": "Journal of Psychopharmacology", "publication_date": "2014-09-10", "publication_year": 2014, "doi": "10.1177/0269881114548296", "pubmed_id": "25213996", "openalex_id": "https://openalex.org/W2122459973", "source_url": "https://doi.org/10.1177/0269881114548296", "substance_tags": "psilocybin", "topic_tags": "Addiction,Receptor Pharmacology,Biomarkers,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:25213996", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881114548296", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:25213996", "source_url": "https://doi.org/10.1177/0269881114548296", "doi": "10.1177/0269881114548296", "pmid": "25213996", "publication_date": "2014-09-10", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2558, "title": "Classical hallucinogens as antidepressants? A review of pharmacodynamics and putative clinical roles.", "authors": "Baumeister D, Barnes G, Giaroli G, Tracy D", "journal": "Therapeutic advances in psychopharmacology", "publication_date": "2014-07-31", "publication_year": 2014, "doi": "10.1177/2045125314527985", "pubmed_id": "25083275", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/25083275/", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Spirituality,Clinical Trial,Review Article,Safety,Toxicity", "study_type": "Clinical Trial", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:20:40", "bibtex": null, "source_record_id": "PMID:25083275", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/25083275/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:25083275", "source_url": "https://pubmed.ncbi.nlm.nih.gov/25083275/", "doi": "10.1177/2045125314527985", "pmid": "25083275", "publication_date": "2014-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5300, "title": "PSILOCYBIN RESEARCH AT JOHNS HOPKINS: A2014 REPORT", "authors": "Robert L. Jesse, Roland R. Griffi", "journal": null, "publication_date": "2013-12-31", "publication_year": 2013, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W2551216332", "source_url": "http://csp.org/HopkinsPsilocybin2014.pdf", "substance_tags": "psilocybin", "topic_tags": "Addiction,Wellbeing,Spirituality,Mystical Experience,Observational Study,Cancer Patients,Safety", "study_type": "Observational Study", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "http://csp.org/HopkinsPsilocybin2014.pdf", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://csp.org/HopkinsPsilocybin2014.pdf", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://csp.org/HopkinsPsilocybin2014.pdf", "source_url": "http://csp.org/HopkinsPsilocybin2014.pdf", "doi": "", "pmid": "", "publication_date": "2013-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5306, "title": "Literature review: Considerations for Psychedelic Research", "authors": "Charlesice Hawkins", "journal": "UC Merced Undergraduate Research Journal", "publication_date": "2013-12-19", "publication_year": 2013, "doi": "10.5070/m451020759", "pubmed_id": null, "openalex_id": "https://openalex.org/W2767418535", "source_url": "https://doi.org/10.5070/m451020759", "substance_tags": "psilocybin", "topic_tags": "Receptor Pharmacology,Review Article,Safety", "study_type": "Review Article", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "DOI:10.5070/m451020759", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.5070/m451020759", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.5070/m451020759", "source_url": "https://doi.org/10.5070/m451020759", "doi": "10.5070/m451020759", "pmid": "", "publication_date": "2013-12-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2577, "title": "A proposal to evaluate mechanistic efficacy of hallucinogens in addiction treatment.", "authors": "Burdick BV, Adinoff B.", "journal": "The American Journal of Drug and Alcohol Abuse", "publication_date": "2013-08-31", "publication_year": 2013, "doi": "10.3109/00952990.2013.811513", "pubmed_id": "23968172", "openalex_id": "https://openalex.org/W2043530175", "source_url": "https://doi.org/10.3109/00952990.2013.811513", "substance_tags": "psilocybin", "topic_tags": "Addiction,Mystical Experience,Clinical Trial,Randomized Controlled Trial,Safety,Toxicity", "study_type": "Randomized Controlled Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:23968172", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3109/00952990.2013.811513", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:23968172", "source_url": "https://doi.org/10.3109/00952990.2013.811513", "doi": "10.3109/00952990.2013.811513", "pmid": "23968172", "publication_date": "2013-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2579, "title": "Psychedelics and mental health: a population study.", "authors": "Krebs TS, Johansen PØ.", "journal": "PLoS ONE", "publication_date": "2013-08-18", "publication_year": 2013, "doi": "10.1371/journal.pone.0063972", "pubmed_id": "23976938", "openalex_id": "https://openalex.org/W2014761647", "source_url": "https://doi.org/10.1371/journal.pone.0063972", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,PTSD,Observational Study,Adolescents,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:23976938", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1371/journal.pone.0063972", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:23976938", "source_url": "https://doi.org/10.1371/journal.pone.0063972", "doi": "10.1371/journal.pone.0063972", "pmid": "23976938", "publication_date": "2013-08-18", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5309, "title": "PSYCHEDELIC DRUGS, MAGICAL THINKING AND PSYCHOSIS", "authors": "Robin Carhart-Harris", "journal": "Journal of Neurology Neurosurgery & Psychiatry", "publication_date": "2013-08-05", "publication_year": 2013, "doi": "10.1136/jnnp-2013-306103.17", "pubmed_id": null, "openalex_id": "https://openalex.org/W2003006205", "source_url": "https://doi.org/10.1136/jnnp-2013-306103.17", "substance_tags": "psilocybin", "topic_tags": "Anxiety,End-of-Life Distress,Brain Imaging,Pharmacology,Mechanism of Action,Receptor Pharmacology,Consciousness,Aging,Personality Change,Spirituality,Mystical Experience,Review Article,Healthy Volunteers,Safety", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:04", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "DOI:10.1136/jnnp-2013-306103.17", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1136/jnnp-2013-306103.17", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1136/jnnp-2013-306103.17", "source_url": "https://doi.org/10.1136/jnnp-2013-306103.17", "doi": "10.1136/jnnp-2013-306103.17", "pmid": "", "publication_date": "2013-08-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2060, "title": "Fungal hallucinogens psilocin, ibotenic acid, and muscimol: analytical methods and biologic activities.", "authors": "Stebelska K.", "journal": null, "publication_date": "2013-07-31", "publication_year": 2013, "doi": "10.1097/ftd.0b013e31828741a5", "pubmed_id": "23851905", "openalex_id": null, "source_url": "https://doi.org/10.1097/ftd.0b013e31828741a5", "substance_tags": "psilocybin,psilocin", "topic_tags": "Mechanism of Action,Review Article,Safety,Toxicity", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:52:05", "last_checked": "2026-07-01 11:22:04", "bibtex": null, "source_record_id": "PMID:23851905", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/ftd.0b013e31828741a5", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:23851905", "source_url": "https://doi.org/10.1097/ftd.0b013e31828741a5", "doi": "10.1097/ftd.0b013e31828741a5", "pmid": "23851905", "publication_date": "2013-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2582, "title": "Methoxetamine (MXE)--a phenomenological study of experiences induced by a \"legal high\" from the internet.", "authors": "Kjellgren A, Jonsson K.", "journal": "Journal of Psychoactive Drugs", "publication_date": "2013-06-30", "publication_year": 2013, "doi": "10.1080/02791072.2013.803647", "pubmed_id": "24175493", "openalex_id": "https://openalex.org/W2060192760", "source_url": "https://doi.org/10.1080/02791072.2013.803647", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Addiction,Consciousness,Emotional Processing,Spirituality,Safety", "study_type": "Qualitative Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:24175493", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1080/02791072.2013.803647", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:24175493", "source_url": "https://doi.org/10.1080/02791072.2013.803647", "doi": "10.1080/02791072.2013.803647", "pmid": "24175493", "publication_date": "2013-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2581, "title": "Identification of novel psychoactive drug use in Sweden based on laboratory analysis--initial experiences from the STRIDA project.", "authors": "Helander A, Beck O, Hägerkvist R, Hultén P.", "journal": null, "publication_date": "2013-05-21", "publication_year": 2013, "doi": "10.3109/00365513.2013.793817", "pubmed_id": "23692208", "openalex_id": "https://openalex.org/W2028152704", "source_url": "https://doi.org/10.3109/00365513.2013.793817", "substance_tags": "psilocybin,psilocin", "topic_tags": "Receptor Pharmacology,Adolescents,Safety,Toxicity", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:23692208", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3109/00365513.2013.793817", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:23692208", "source_url": "https://doi.org/10.3109/00365513.2013.793817", "doi": "10.3109/00365513.2013.793817", "pmid": "23692208", "publication_date": "2013-05-21", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2602, "title": "Moral transhumanism: the next step.", "authors": "Tennison MN.", "journal": "The Journal of Medicine and Philosophy A Forum for Bioethics and Philosophy of Medicine", "publication_date": "2012-07-31", "publication_year": 2012, "doi": "10.1093/jmp/jhs024", "pubmed_id": "22855738", "openalex_id": "https://openalex.org/W2123238370", "source_url": "https://doi.org/10.1093/jmp/jhs024", "substance_tags": "psilocybin", "topic_tags": "Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:22855738", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1093/jmp/jhs024", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:22855738", "source_url": "https://doi.org/10.1093/jmp/jhs024", "doi": "10.1093/jmp/jhs024", "pmid": "22855738", "publication_date": "2012-07-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2595, "title": "Substance use initiation: the role of simultaneous polysubstance use.", "authors": "Olthuis JV, Darredeau C, Barrett SP.", "journal": "Drug and Alcohol Review", "publication_date": "2012-05-20", "publication_year": 2012, "doi": "10.1111/j.1465-3362.2012.00470.x", "pubmed_id": "22612987", "openalex_id": "https://openalex.org/W1892791858", "source_url": "https://doi.org/10.1111/j.1465-3362.2012.00470.x", "substance_tags": "psilocybin", "topic_tags": "Addiction,Adolescents,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:22612987", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1111/j.1465-3362.2012.00470.x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:22612987", "source_url": "https://doi.org/10.1111/j.1465-3362.2012.00470.x", "doi": "10.1111/j.1465-3362.2012.00470.x", "pmid": "22612987", "publication_date": "2012-05-20", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2622, "title": "Harm potential of magic mushroom use: a review.", "authors": "van Amsterdam J, Opperhuizen A, van den Brink W", "journal": "Regulatory toxicology and pharmacology: RTP", "publication_date": "2011-03-31", "publication_year": 2011, "doi": "10.1016/j.yrtph.2011.01.006", "pubmed_id": "21256914", "openalex_id": null, "source_url": "https://pubmed.ncbi.nlm.nih.gov/21256914/", "substance_tags": "psilocybin", "topic_tags": "Review Article,Safety,Toxicity,Abuse Liability", "study_type": "Review Article", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 06:54:14", "bibtex": null, "source_record_id": "PMID:21256914", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/21256914/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:21256914", "source_url": "https://pubmed.ncbi.nlm.nih.gov/21256914/", "doi": "10.1016/j.yrtph.2011.01.006", "pmid": "21256914", "publication_date": "2011-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2626, "title": "Absorption, distribution, metabolism and excretion pharmacogenomics of drugs of abuse.", "authors": "Meyer MR, Maurer HH.", "journal": null, "publication_date": "2011-01-31", "publication_year": 2011, "doi": "10.2217/pgs.10.171", "pubmed_id": "21332315", "openalex_id": null, "source_url": "https://doi.org/10.2217/pgs.10.171", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Pharmacology,Safety,Drug Interactions,Genomics", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:21332315", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.2217/pgs.10.171", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:21332315", "source_url": "https://doi.org/10.2217/pgs.10.171", "doi": "10.2217/pgs.10.171", "pmid": "21332315", "publication_date": "2011-01-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2625, "title": "Maternal influenza viral infection causes schizophrenia-like alterations of 5-HT₂A and mGlu₂ receptors in the adult offspring.", "authors": "Moreno JL, Kurita M, Holloway T, López J, Cadagan R, Martínez-Sobrido L, García-Sastre A, González-Maeso J.", "journal": "Journal of Neuroscience", "publication_date": "2011-01-31", "publication_year": 2011, "doi": "10.1523/jneurosci.4230-10.2011", "pubmed_id": "21289196", "openalex_id": "https://openalex.org/W2072898255", "source_url": "https://doi.org/10.1523/jneurosci.4230-10.2011", "substance_tags": "psilocybin", "topic_tags": "Mechanism of Action,Receptor Pharmacology,Animal Study,Safety", "study_type": "Animal Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:21289196", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1523/jneurosci.4230-10.2011", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:21289196", "source_url": "https://doi.org/10.1523/jneurosci.4230-10.2011", "doi": "10.1523/jneurosci.4230-10.2011", "pmid": "21289196", "publication_date": "2011-01-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2628, "title": "Turn on, tune in, but don't drop out: The impact of neo-liberalism on magic mushroom users' (in)ability to imagine collectivist social worlds.", "authors": "Riley S, Thompson J, Griffin C.", "journal": null, "publication_date": "2010-10-31", "publication_year": 2010, "doi": "10.1016/j.drugpo.2010.07.001", "pubmed_id": "20810266", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.drugpo.2010.07.001", "substance_tags": "psilocybin,psilocin", "topic_tags": "Aging,Spirituality,Adolescents,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:20810266", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.drugpo.2010.07.001", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:20810266", "source_url": "https://doi.org/10.1016/j.drugpo.2010.07.001", "doi": "10.1016/j.drugpo.2010.07.001", "pmid": "20810266", "publication_date": "2010-10-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2615, "title": "Acute, subacute and long-term subjective effects of psilocybin in healthy humans: a pooled analysis of experimental studies.", "authors": "Studerus E, Kometer M, Hasler F, Vollenweider FX.", "journal": "Journal of Psychopharmacology", "publication_date": "2010-09-19", "publication_year": 2010, "doi": "10.1177/0269881110382466", "pubmed_id": "20855349", "openalex_id": "https://openalex.org/W1981740630", "source_url": "https://doi.org/10.1177/0269881110382466", "substance_tags": "psilocybin", "topic_tags": "Anxiety,Observational Study,Safety,Adverse Events", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:20855349", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881110382466", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:20855349", "source_url": "https://doi.org/10.1177/0269881110382466", "doi": "10.1177/0269881110382466", "pmid": "20855349", "publication_date": "2010-09-19", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2627, "title": "Pilot study of psilocybin treatment for anxiety in patients with advanced-stage cancer.", "authors": "Grob CS, Danforth AL, Chopra GS, Hagerty M, McKay CR, Halberstadt AL, Greer GR.", "journal": "Archives of General Psychiatry", "publication_date": "2010-09-05", "publication_year": 2010, "doi": "10.1001/archgenpsychiatry.2010.116", "pubmed_id": "20819978", "openalex_id": "https://openalex.org/W2161555895", "source_url": "https://doi.org/10.1001/archgenpsychiatry.2010.116", "substance_tags": "psilocybin", "topic_tags": "Depression,Anxiety,Aging,Personality Change,Safety,Adverse Events", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:20819978", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1001/archgenpsychiatry.2010.116", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:20819978", "source_url": "https://doi.org/10.1001/archgenpsychiatry.2010.116", "doi": "10.1001/archgenpsychiatry.2010.116", "pmid": "20819978", "publication_date": "2010-09-05", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2616, "title": "The administration of psilocybin to healthy, hallucinogen-experienced volunteers in a mock-functional magnetic resonance imaging environment: a preliminary investigation of tolerability.", "authors": "Carhart-Harris RL, Williams TM, Sessa B, Tyacke RJ, Rich AS, Feilding A, Nutt DJ.", "journal": "Journal of Psychopharmacology", "publication_date": "2010-04-14", "publication_year": 2010, "doi": "10.1177/0269881110367445", "pubmed_id": "20395317", "openalex_id": "https://openalex.org/W2051426845", "source_url": "https://doi.org/10.1177/0269881110367445", "substance_tags": "psilocybin", "topic_tags": "Brain Imaging,Aging,Safety", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:20395317", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1177/0269881110367445", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:20395317", "source_url": "https://doi.org/10.1177/0269881110367445", "doi": "10.1177/0269881110367445", "pmid": "20395317", "publication_date": "2010-04-14", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5343, "title": "The non-hallucinogen 2-bromo-lysergic acid diethylamide as preventative treatment for cluster headache: An open, non-randomized case series", "authors": "Matthias Karst, John H. Halpern, Michael Bernateck, Torsten Passie", "journal": "Cephalalgia", "publication_date": "2010-03-25", "publication_year": 2010, "doi": "10.1177/0333102410363490", "pubmed_id": "20713566", "openalex_id": "https://openalex.org/W2151828427", "source_url": "https://doi.org/10.1177/0333102410363490", "substance_tags": "psilocybin", "topic_tags": "Chronic Pain,Headache / Migraine,Mechanism of Action,Receptor Pharmacology,Case Report,Observational Study,Safety,Adverse Events", "study_type": "Clinical Trial", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:05", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:20713566", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1177/0333102410363490", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "PMID:20713566", "source_url": "https://doi.org/10.1177/0333102410363490", "doi": "10.1177/0333102410363490", "pmid": "20713566", "publication_date": "2010-03-25", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5380, "title": "Safety, Tolerability, and Efficacy of Psilocybin in 9 Patients With Obsessive-Compulsive Disorder", "authors": "J.C. Ballenger", "journal": "Yearbook of Psychiatry and Applied Mental Health", "publication_date": "2007-12-31", "publication_year": 2007, "doi": "10.1016/s0084-3970(08)70820-x", "pubmed_id": null, "openalex_id": "https://openalex.org/W2323886621", "source_url": "https://doi.org/10.1016/s0084-3970(08)70820-x", "substance_tags": "psilocybin", "topic_tags": "OCD,Pharmacology,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:06", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "DOI:10.1016/s0084-3970(08)70820-x", "abstract_available": false, "abstract_source": null, "abstract_source_url": null, "abstract_redistributed": false, "text_rights_status": "not_applicable_no_text", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1016/s0084-3970(08)70820-x", "source_url": "https://doi.org/10.1016/s0084-3970(08)70820-x", "doi": "10.1016/s0084-3970(08)70820-x", "pmid": "", "publication_date": "2007-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5387, "title": "Mad Thoughts on Mushrooms: Discourse and Power in the Study of Psychedelic Consciousness", "authors": "Andy Letcher", "journal": "Anthropology of Consciousness", "publication_date": "2007-08-31", "publication_year": 2007, "doi": "10.1525/ac.2007.18.2.74", "pubmed_id": null, "openalex_id": "https://openalex.org/W2131711520", "source_url": "https://doi.org/10.1525/ac.2007.18.2.74", "substance_tags": "psilocybin", "topic_tags": "Consciousness,Spirituality,Safety", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:06", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "DOI:10.1525/ac.2007.18.2.74", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "https://doi.org/10.1525/ac.2007.18.2.74", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "DOI:10.1525/ac.2007.18.2.74", "source_url": "https://doi.org/10.1525/ac.2007.18.2.74", "doi": "10.1525/ac.2007.18.2.74", "pmid": "", "publication_date": "2007-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2675, "title": "The adverse effects of hallucinogens from intramural perspective.", "authors": "Frecska E, Luna LE.", "journal": "PubMed", "publication_date": "2006-11-30", "publication_year": 2006, "doi": null, "pubmed_id": "17211054", "openalex_id": "https://openalex.org/W110752286", "source_url": "https://europepmc.org/article/MED/17211054", "substance_tags": "psilocybin", "topic_tags": "Personality Change,Clinical Trial,Review Article,Safety,Drug Interactions", "study_type": "Clinical Trial", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:17211054", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/17211054", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:17211054", "source_url": "https://europepmc.org/article/MED/17211054", "doi": "", "pmid": "17211054", "publication_date": "2006-11-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2678, "title": "Safety, tolerability, and efficacy of psilocybin in 9 patients with obsessive-compulsive disorder.", "authors": "Moreno FA, Wiegand CB, Taitano EK, Delgado PL.", "journal": "The Journal of Clinical Psychiatry", "publication_date": "2006-10-31", "publication_year": 2006, "doi": "10.4088/jcp.v67n1110", "pubmed_id": "17196053", "openalex_id": "https://openalex.org/W2043197532", "source_url": "https://doi.org/10.4088/jcp.v67n1110", "substance_tags": "psilocybin", "topic_tags": "Anxiety,OCD,Chronic Pain,Receptor Pharmacology,Safety,Drug Interactions", "study_type": "Other", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-04 07:00:41", "bibtex": null, "source_record_id": "PMID:17196053", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.4088/jcp.v67n1110", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:17196053", "source_url": "https://doi.org/10.4088/jcp.v67n1110", "doi": "10.4088/jcp.v67n1110", "pmid": "17196053", "publication_date": "2006-10-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2700, "title": "Hallucinogens and dissociative agents naturally growing in the United States.", "authors": "Halpern JH.", "journal": null, "publication_date": "2004-04-30", "publication_year": 2004, "doi": "10.1016/j.pharmthera.2004.03.003", "pubmed_id": "15163594", "openalex_id": null, "source_url": "https://doi.org/10.1016/j.pharmthera.2004.03.003", "substance_tags": "psilocybin,psilocin", "topic_tags": "Review Article,Safety", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:06", "bibtex": null, "source_record_id": "PMID:15163594", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1016/j.pharmthera.2004.03.003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:15163594", "source_url": "https://doi.org/10.1016/j.pharmthera.2004.03.003", "doi": "10.1016/j.pharmthera.2004.03.003", "pmid": "15163594", "publication_date": "2004-04-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2709, "title": "[Hallucinogens, amphetamines and entactogens].", "authors": "Vollenweider FX, Vollenweider-Scherpenhuyzen MF.", "journal": null, "publication_date": "2003-05-31", "publication_year": 2003, "doi": "10.1024/0040-5930.60.6.323", "pubmed_id": "12848067", "openalex_id": "https://openalex.org/W2145879190", "source_url": "https://doi.org/10.1024/0040-5930.60.6.323", "substance_tags": "psilocybin", "topic_tags": "Emotional Processing,Observational Study,Safety,Toxicity", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:12848067", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1024/0040-5930.60.6.323", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:12848067", "source_url": "https://doi.org/10.1024/0040-5930.60.6.323", "doi": "10.1024/0040-5930.60.6.323", "pmid": "12848067", "publication_date": "2003-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 5645, "title": "Electrocardiographic examination of heart function in rats exposed to hallucinogens from Psilocybe mushrooms", "authors": "Krzysztof Borowiak, Anna Machoy-Mokrzyńska, Leszek Domański, Sławomir Majdanik, Edward Dutkiewicz, K Safranow, Tomasz Janus, V Mikolajek", "journal": "Acta Toxicologica", "publication_date": "2002-12-31", "publication_year": 2002, "doi": null, "pubmed_id": null, "openalex_id": "https://openalex.org/W1435711203", "source_url": "http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-d607ea49-70b5-4739-b280-7088af5d6e30", "substance_tags": "psilocybin,psilocin", "topic_tags": "Pharmacology,Receptor Pharmacology,Safety,Toxicity", "study_type": "Other", "source_name": "OpenAlex", "publication_status": "published", "date_added": "2026-07-04 06:52:11", "last_checked": "2026-07-04 06:52:11", "bibtex": null, "source_record_id": "http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-d607ea49-70b5-4739-b280-7088af5d6e30", "abstract_available": true, "abstract_source": "OpenAlex", "abstract_source_url": "http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-d607ea49-70b5-4739-b280-7088af5d6e30", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "OpenAlex", "source_record_id": "http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-d607ea49-70b5-4739-b280-7088af5d6e30", "source_url": "http://yadda.icm.edu.pl/yadda/element/bwmeta1.element.agro-article-d607ea49-70b5-4739-b280-7088af5d6e30", "doi": "", "pmid": "", "publication_date": "2002-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2721, "title": "Drugs of abuse monitoring in blood for control of driving under the influence of drugs.", "authors": "Moeller MR, Kraemer T.", "journal": null, "publication_date": "2002-03-31", "publication_year": 2002, "doi": "10.1097/00007691-200204000-00003", "pubmed_id": "11897967", "openalex_id": null, "source_url": "https://doi.org/10.1097/00007691-200204000-00003", "substance_tags": "psilocybin,psilocin", "topic_tags": "Addiction,Review Article,Safety,Toxicity", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:11897967", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1097/00007691-200204000-00003", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:11897967", "source_url": "https://doi.org/10.1097/00007691-200204000-00003", "doi": "10.1097/00007691-200204000-00003", "pmid": "11897967", "publication_date": "2002-03-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2729, "title": "Patterns of recreational drug use at dance events in Edinburgh, Scotland.", "authors": "Riley SC, James C, Gregory D, Dingle H, Cadger M.", "journal": null, "publication_date": "2001-06-30", "publication_year": 2001, "doi": "10.1046/j.1360-0443.2001.967103513.x", "pubmed_id": "11440614", "openalex_id": "https://openalex.org/W2151598790", "source_url": "https://doi.org/10.1046/j.1360-0443.2001.967103513.x", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Adolescents,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:11440614", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.1046/j.1360-0443.2001.967103513.x", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:11440614", "source_url": "https://doi.org/10.1046/j.1360-0443.2001.967103513.x", "doi": "10.1046/j.1360-0443.2001.967103513.x", "pmid": "11440614", "publication_date": "2001-06-30", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2728, "title": "Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine).", "authors": "Ho E, Karimi-Tabesh L, Koren G", "journal": "Neurotoxicology and teratology", "publication_date": "2000-12-31", "publication_year": 2000, "doi": "10.1016/s0892-0362(01)00178-7", "pubmed_id": "11792525", "openalex_id": "https://openalex.org/W2092775753", "source_url": "https://pubmed.ncbi.nlm.nih.gov/11792525/", "substance_tags": "psilocybin", "topic_tags": "Addiction,Emotional Processing,Observational Study,Safety", "study_type": "Observational Study", "source_name": "PubMed", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 06:54:14", "bibtex": null, "source_record_id": "PMID:11792525", "abstract_available": true, "abstract_source": "PubMed", "abstract_source_url": "https://pubmed.ncbi.nlm.nih.gov/11792525/", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "PubMed", "source_record_id": "PMID:11792525", "source_url": "https://pubmed.ncbi.nlm.nih.gov/11792525/", "doi": "10.1016/s0892-0362(01)00178-7", "pmid": "11792525", "publication_date": "2000-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2739, "title": "Nonmedical drug use among adolescent students: highlights from the 1999 Ontario Student Drug Use Survey.", "authors": "Adlaf EM, Paglia A, Ivis FJ, Ialomiteanu A.", "journal": null, "publication_date": "2000-05-31", "publication_year": 2000, "doi": null, "pubmed_id": "10870495", "openalex_id": "https://openalex.org/W1871973545", "source_url": "https://europepmc.org/article/MED/10870495", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Adolescents,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:10870495", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/10870495", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:10870495", "source_url": "https://europepmc.org/article/MED/10870495", "doi": "", "pmid": "10870495", "publication_date": "2000-05-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2757, "title": "Recent findings from the Ontario Student Drug Use Survey.", "authors": "Adlaf EM, Ivis FJ.", "journal": null, "publication_date": "1998-08-31", "publication_year": 1998, "doi": null, "pubmed_id": "9757168", "openalex_id": "https://openalex.org/W2098941694", "source_url": "https://europepmc.org/article/MED/9757168", "substance_tags": "psilocybin", "topic_tags": "Addiction,Observational Study,Adolescents,Safety", "study_type": "Observational Study", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:9757168", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://europepmc.org/article/MED/9757168", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:9757168", "source_url": "https://europepmc.org/article/MED/9757168", "doi": "", "pmid": "9757168", "publication_date": "1998-08-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2760, "title": "Psilocybin mushroom (Psilocybe semilanceata) intoxication with myocardial infarction.", "authors": "Borowiak KS, Ciechanowski K, Waloszczyk P.", "journal": null, "publication_date": "1997-12-31", "publication_year": 1997, "doi": "10.3109/15563659809162584", "pubmed_id": "9541042", "openalex_id": "https://openalex.org/W2139748231", "source_url": "https://doi.org/10.3109/15563659809162584", "substance_tags": "psilocybin", "topic_tags": "Randomized Controlled Trial,Case Report,Adolescents,Safety,Toxicity", "study_type": "Case Report", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:9541042", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3109/15563659809162584", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:9541042", "source_url": "https://doi.org/10.3109/15563659809162584", "doi": "10.3109/15563659809162584", "pmid": "9541042", "publication_date": "1997-12-31", "importer_version": "2.1.2", "text_redistributed": false } }, { "id": 2778, "title": "Toward a comparative overview of dependence potential and acute toxicity of psychoactive substances used nonmedically.", "authors": "Gable RS.", "journal": null, "publication_date": "1992-12-31", "publication_year": 1992, "doi": "10.3109/00952999309001618", "pubmed_id": "8213692", "openalex_id": null, "source_url": "https://doi.org/10.3109/00952999309001618", "substance_tags": "psilocybin", "topic_tags": "Review Article,Safety,Toxicity,Abuse Liability", "study_type": "Review Article", "source_name": "Europe PMC", "publication_status": "published", "date_added": "2026-07-01 06:54:14", "last_checked": "2026-07-01 11:22:07", "bibtex": null, "source_record_id": "PMID:8213692", "abstract_available": true, "abstract_source": "Europe PMC", "abstract_source_url": "https://doi.org/10.3109/00952999309001618", "abstract_redistributed": false, "text_rights_status": "unverified_not_redistributed", "text_license_uri": null, "source_provenance": { "source_name": "Europe PMC", "source_record_id": "PMID:8213692", "source_url": "https://doi.org/10.3109/00952999309001618", "doi": "10.3109/00952999309001618", "pmid": "8213692", "publication_date": "1992-12-31", "importer_version": "2.1.2", "text_redistributed": false } } ] }